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Supervisor:  Stephen F. Martin 
 
In the context of ongoing efforts toward C-aryl glycoside synthesis, a recently 
developed approach to form C-aryl glycals from 2-deoxysugar lactones was expanded to 
form novel substrates.  This approach has been applied to the synthesis of various furyl 
glycals, allowing access to C-aryl glycals via a benzyne furan [4+2] cycloaddition 
methodology. The hydroboration-oxidation of said C-aryl glycals has allowed access to 
C(2)-oxygenated C-aryl glycosides via the benzyne cycloaddition approach.  
An approach to the total synthesis of 5-hydoxyaloin A is detailed, in which 
regioselective benzyne furan [4+2] cycloadditions were achieved via the use of a silicon 
tether. Two approaches to the anthrone core have been applied; one in which an 
unsymmetrically-substituted aryl ring is first constructed by means of a silicon tether, and 
one in which the unsymmetrically-substituted ring is formed last, also utilizing a silicon 
tether.  The latter approach has allowed access to the anthrone core of 5-hydroxyaloin A, 
and only a final desulfurization remains in order to access the natural product.  
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CHAPTER 1: C-Aryl glycoside synthesis 
 
1.1. C-GLYCOSIDE NATURAL PRODUCTS 
The synthetic community has seen has seen marked development in methods to 
synthesize C-aryl glycosides over the past three decades.  The increased interest is owed 
to their range of biological activity, in particular, the anti-cancer properties of many of 
these compounds.  Carbohydrates in general are significant biologically; the glycoside 
moiety of cell surface glycoproteins plays a role in inflammation, metastasis, and immune 
response.1 In biological systems, the O-glycosidic linkage is subject to hydrolysis by 
glycosidases (Figure 1.1). Replacement of the O-glycosidic 1.1 bond with a C-glycosidic 
linkage 1.2 results in analogs that retain the biological activity of the natural O-glycoside, 
but are more resistant to both enzymatic- and acid-hydrolysis.2  
 













C-Aryl glycosides have been classified by Parker using a system that relates the 
substitution pattern of sugar and hydroxyl groups about the aromatic ring (Figure 1.2).3 
Group I examples of C-aryl glycosides 1.3 possess a sugar moiety para to a hydroxyl 
group, while in Group II members 1.4 the phenol and sugar moieties are ortho. Members 
of the Group III family 1.5 contain two sugar moieties, which are arranged ortho and para 
 2 
to a phenolic hydroxyl group.  Finally, Group IV examples of C-aryl glycosides 1.6 
contain a single glycoside on a hydroquinone ring. 
 
Figure 1.2: Major classes of C-aryl glycosides 
 













1.3 1.4 1.5 1.6
 
 
There are members of each class that exhibit biological activity, so the 
development of approaches to all four groups is a worthwhile synthetic task.  Gilvocarcin 
M (1.7a), V (1.7b), and E (1.7c) are examples of C-aryl glycosides belonging to the 
Group I family (Figure 1.3). Isolated from a streptomyces culture broth, these compounds 
exhibit antimicrobial activity.4 A representative example of a Group II C-aryl glycoside is 
vineomycinone B2 methyl ester (1.8), which was also isolated from a streptomyces 
culture broth.  There has been much interest in the synthesis of this natural product, 
owing to its activity against gram-positive bacteria and sarcoma-180 tumors in mice.5 
Five syntheses of this molecule have been reported,6-9 with the most recent approach 
coming from the Martin research group.10, 11 Kidamycin (1.9), which belongs to the Group 
III family of C-aryl glycosides, is also a member of the pluramycin family, all members 
of which exhibit potent antitumor activity.12 Although a number of groups have reported 
efforts toward the total synthesis of this molecule,13-15 to date a successful total synthesis 
has not been described. Mederrhodin A (1.10) belongs to the Group IV subclass of C-aryl 
glycosides.5 This family of antimicrobial compounds comes from a genetically 
 3 
engineered strain of streptomyces.  The strain is recombinant and the natural products 
that are produced by this organism are referred to as “hybrid antibiotics.” 
 





































1.7a: R = Me
1.7b: R = vinyl














1.2. MAJOR APPROACHES TO C-ARYL GLYCOSIDES 
There are several reviews on the varied approaches to C-aryl glycosides.16-21 Key 
approaches will be discussed here with emphasis placed on those methods that have been 
utilized in natural product synthesis.  In the majority of these processes, the inherent 
electrophilicity of the sugar moiety has been used to create the C-glycosidic bond; 
however, carbohydrate glycals have allowed for the development of methods in which 
the sugar is the nucleophile.  Cross coupling of substituted arenes and sugars has allowed 
 4 
direct access to C-aryl glycosides and there are now several examples of these types of 
reactions in the total syntheses of C-aryl glycoside natural products.  Other approaches 
involve the de novo synthesis of a sugar moiety onto a preformed aromatic core, although 
this method has yet to find utility in total synthesis. Finally, methods exist in which an 
appropriately substituted C-glycoside is elaborated to form a C-aryl glycoside.    
 
1.2.1. Electrophilic sugars 
Sugars are naturally pro-electrophiles, thus many methods to form C-aryl 
glycosides have relied on the formation of an oxonium ion by displacement of a leaving 
group at the anomeric position of the sugar moiety (Scheme 1.1); the earliest examples of 
this type of transformation date back to the 1950s.22-24 In these types of C-glycoside 
forming reactions, a glycoside bearing an anomeric leaving group 1.11 forms an oxonium 
ion 1.12 when treated with Lewis acid.  Friedel–Crafts reaction of an aryl group onto the 
anomeric carbon would furnish C-aryl glycosides 1.13.  There have been reports of 
lactols, thioglycosides, anomeric acetates, and glycosyl halides being utilized in the 
transformation shown in Scheme 1.   
 











An intramolecular variant of this transformation allowed for the synthesis of an 
ortho acid 1.17 (Scheme 1.2).25 Veyrieres and coworkers reported that the treatment of 
 5 
glycosyl chloride 1.14 with silver tetrafluoroborate (AgBF4) resulted in the formation of 
an intermediate oxonium ion, which underwent intramolecular Friedel–Crafts reaction 
with the benzyl protecting group at the C(2) position of the sugar.  The resultant tricycle 
1.15 was oxidized to lactone 1.16, which resulted in oxidation of the benzylic carbon 
atom of the protecting groups as well. Methanolysis of 1.16 resulted in the global 
deprotection and lactone cleavage, providing C-aryl glycoside 1.17.  This intramolecular 
approach allowed for the facile introduction of a sugar ortho to an electron-withdrawing 
group, the formation of which would not have been trivial via an intermolecular Friedel–
Crafts reaction.   
 



































The O→C glycoside rearrangement has been a widely employed method in C-
glycoside synthesis and has allowed access to various C-aryl glycoside natural products 
(Scheme 1.3).  In general, this rearrangement involves the nucleophilic addition of a 
phenol 1.18 to an oxonium ion 1.12 to give adduct 1.19.  Direct evidence for the initial 
 6 
formation of O-glycosylated products such as 1.19 was first shown by Ramesh and 
Balasubramanian.26 Dissociation of 1.19 to form the tight ion pair 1.20 often results in 
preferential, if not exclusive, formation of the ortho C-aryl glycoside 1.21, which is a 
member of the Group II subclass.  This reaction has been thoroughly investigated by 
Suzuki, who has demonstrated that the choice of Lewis acid is critical to the 
stereochemical outcome of the resultant glycoside in both furanose27 and pyranose27-38 
sugar systems.   
 





















1.19 1.20 1.21  
 
The reaction conditions can dictate the stereochemical outcome of the Friedel–
Crafts reaction, and reaction temperature can also play a role. The formation of the 
kinetic product should be favored with the correct choice of Lewis acid at low 
temperature.  In many pyranose systems this is the α-anomer, due to axial attack of the 
nucleophilic arene. It is proposed that the α- and β-anomer 1.22 and 1.24, respectively, 
can equilibrate by interconversion via the intermediate quinone methide 1.23, thus 
equilibrating conditions will favor the thermodynamic product (Scheme 1.4).39  
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1.22 1.23 1.24  
 
In Suzuki’s total synthesis of galtamycinone,40, 41 the O→C rearrangement allowed 
for the regioselective coupling of glycoside 1.25 with phenol 1.26 (Scheme 1.5). 
Treatment of 1.25 and 1.26 with Cp2HfCl2-AgCl2 as the Lewis acid, which had been 
shown to give excellent β selectivity, provided C-aryl glycoside 1.27 in 95% yield.  O-
Methylation of 1.27, followed by cleavage of the silyl ether provided an intermediate 
phenol, which was converted to triflate 1.28 by treatment with diisopropylethylamine 
(DIPEA) and triflic anhydride (Tf2O). Triflate 1.28 underwent a regioselective benzyne 
cycloaddition with furan 1.29. Acidification of the intermediate provided chlorojuglone 
1.30 following oxidation.  A dipolar cycloaddition of 1.30 with the anion generated from 
1.31 followed by decarboxylation furnished angucycline 1.32, which was deprotected by 
treatment with boron tribromide (BBr3) to provide galtamycinone (1.33).   
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1. NaH, (MeO)2SO2, 96%
2. TBAF, THF, 100%






















































The regioselective cycloaddition of the benzyne generated from 1.28 and furan 
1.29 is another key feature of Suzuki’s galtamycinone synthesis.  Suzuki has shown 
remarkable selectivity in benzyne cycloaddition reactions that involve substrates 
containing electron-donating groups. Suzuki demonstrated that the [4+2] cycloaddition of 
the benzyne generated from triflate 1.34 with 2-methoxyfuran (1.35) proceeded with 
complete regioselectivity to give cycloadduct 1.37,42 which spontaneously underwent ring 
opening to provide phenol 1.38 (Scheme 1.6). The methoxy groups are aligned on the 
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same side of the molecule, thus this has been termed a “head-to-head” cycloaddition.41 
The formation of the single regioisomer can be rationalized by depicting a stepwise 
mechanism for the cycloaddition involving the formation of a zwitterionic intermediate, 
as shown by 1.36.  If indeed the bonds form at different rates, the formation of 1.36 
would produce an anion that is inductively stabilized by the electron withdrawing 
methoxy group, while the positive charge developing in the furan moiety could be 
resonance stabilized as shown.   
 

















1.34 1.381.371.361.35  
 
Sargent and coworkers have demonstrated “head-to-tail” regioselectivity in the 
cycloaddition of the benzyne generated from 1.34 with 3-methoxyfuran (1.39) (Scheme 
1.7).43, 44 Invoking the stepwise mechanism for the cycloaddition would result in the 
formation of adduct 1.40.  The methoxy group could participate in resonance stabilization 
of the positive charge developing in the furan.  Indeed, 1.41 was the major product, 
although this reaction did not proceed with complete regioselectivity, as the head-to-head 
product 1.42 was also formed in 14% yield.   
 
 10 



























Suzuki has had much success in natural product synthesis by employing both the 
O→C rearrangement and regioselective benzyne cycloadditions.  However, at first glance 
it seems that the O→C is not amenable to the synthesis of Group I examples of C-aryl 
glycosides, as the sugar moiety is almost always introduced ortho to the phenol.  Suzuki 
has developed a method to work around this limitation, which he applied to the total 
synthesis of ravidomycin,45, 46 a member of the Group I class of C-aryl glycosides 
(Scheme 1.8). Treatment of a mixture of fluoride 1.43 and phenol 1.44 with Lewis acid 
resulted in the formation of ortho phenol 1.45 in 83% yield with exclusive β-selectivity.  
The phenol 1.45 was converted to triflate 1.46.  Upon treatment of 1.46 with n-BuLi, a 
benzyne was generated that underwent a head-to-head cycloaddition with 2-
methoxyfuran (1.35) to provide an intermediate cycloadduct and effectively eliminate the 
ortho hydroxyl group.  Ring opening and protection of the resultant phenol as its MOM 
ether gave 1.47.  The C(3)-amino group was introduced in a four step process to provide 
1.48. Cleavage of the MOM ether of 1.48 by treatment with HCl followed by coupling 
with acid 1.49 provided ester 1.50.  The next step of the synthesis required oxidative 
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insertion of palladium into the triflate–arene bond, followed by cyclization via C–H 
insertion.  The insertion reaction was complicated by deactivation of various palladium 
catalysts, which the author attributed to the poisoning of the catalyst by the amine. 
Although an obvious disadvantage to this synthesis, treatment of 1.50 with stoichiometric 
palladium acetate in the presence of silver carbonate furnished tetracycle 1.51, which was 
converted to ravidomycin (1.52) in three steps.   
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Another method to form C-aryl glycosides that has been widely utilized in C-aryl 
glycoside synthesis involves the addition of aryl nucleophiles to sugar lactones.47, 48 The 
process group at Bristol-Meyers Squibb wanted to prepare the C-aryl glycosides 1.56 on 
a multikilogram scale (Scheme 1.9).49 Protecting groups that had to be removed by 
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hydrogenolysis were avoided because of the size of the reaction. Thus, silyl ether 
protecting groups were introduced onto the sugar, and then various aryllithium reagents 
were added to lactone 1.53.  The resultant lactols were converted to methyl acetals 1.54. 
A protecting group swap furnished peracylated sugars 1.55, which were reduced by 
treatment with boron trifluoride diethyl etherate (BF3•OEt2) and triethylsilane (Et3SiH) to 
provide C-aryl glycosides 1.56 with high β-selectivity. The authors state that C-aryl 
glycosides 1.56 were formed in “good yield,” although they do not specify yields in the 
article or supporting information. Hydride delivery occurred from the bottom face, as 
shown by 1.57.  It is well precedented that acetate protecting groups can engage in 
neighboring group participation,50, 51 as shown by intermediate 1.58, which would result 
in the formation of the α-anomer; however, in this study this was not the case. Another 
interesting finding of this investigation was that water was necessary for the reduction of 
1.55 to occur.  On large scale, the reduction did not reach completion without the addition 
of water, a result believed to be due to the formation of the Brønsted acid, BF3•OH2+.  
The authors hypothesized that this acid was required to facilitate formation of the 
required oxonium ion in the presence of the electron withdrawing protecting groups.   
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Boyd and Sulikowski utilized a similar approach for the synthesis of 
urdamycinone B (1.65) and antibiotic 104-2 (1.66), angucycline antibiotics isolated from 
Streptomyces fradiae (Scheme 1.10).52 Lithiation of phenol 1.59, followed by addition of 
the lactone 1.60 provided an intermediate lactol that was reduced using NaCNBH4 to give 
the C-aryl glycoside 1.61.  Bromojuglone 1.62, which was accessed in several steps from 
1.61, underwent a regioselective Diels-Alder cycloaddition with diene 1.63 to give the 
tetracycle 1.64.  This approach allowed for the synthesis of urdamycinone (1.65) and 
antibiotic 104-2 (1.66).  
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1.65: X = H
1.66: X = OH






























The electrophilicity of glycal enol ethers allows for aromatic substitution in the 
Ferrier rearrangement.  In an example reported by DuBois, SN2′ addition of the zincates 
of various arenes to glycal 1.67 provided 1.68 (Scheme 1.11).53 This method resulted in 
the loss of a stereocenter at C(3), which may be disadvantageous in some cases.  Notably, 
no β-hydride elimination was observed in this case, which is surprising, as Daves and 


















1.67 1.68  
 
1.2.2. The nucleophilic sugar approach 
Parker has developed a method in which nucleophilic sugar derivatives are used 
to form C-aryl glycosides (Schemes 1.12–1.14). In this “reverse polarity” approach, 
lithiated glycals were added to quinones,3, 13, 56-62 which allowed access to C-aryl 
glycosides that are models for members of Groups I, III, and IV.   
The divergent approach to Groups I and IV involved the addition of lithiated 
rhamnal 1.70 to quinone ketal 1.69 to provide alcohol 1.71 (Scheme 1.12). When treated 
with ZnCl2, 1.71 underwent rearrangement, furnishing C-aryl glycal 1.72, which has the 
Group IV substitution pattern.  Alternatively, 1.71 could be reduced by treatment with 
DIBAL-H to form a mixture (2:1) of 1.73 and C-aryl glycal 1.74; quinol 1.73 could be 
converted to 1.74 in 95% overall yield.  Hydroboration-oxidation of 1.74 furnished the 
C(2)-oxygenated C-aryl glycoside 1.75.  It should be noted that hydroboration occurred 
selectively from the face opposite the C(3) substituent, as is well precedented for this 
reaction.63-65   
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Parker applied this strategy to the synthesis of a Group III C-aryl glycoside model 
compound for the pluramycin family (Scheme 1.13).13 Quinol 1.76 was treated with 
lithiated glycal 1.70, furnishing alcohol 1.77 in 85% yield.  The alcohol 1.77 was 
converted to bis C-aryl glycal 1.78 by treatment with ZnCl2.  
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Scheme 1.13: The reverse polarity approach in the synthesis of a model of a Group 





































Parker has attempted to apply the reverse polarity approach to the synthesis of the 
griseusin family of natural products (Scheme 1.14).62 In this approach, glycal 1.79 was 
lithiated and added to the quinone 1.80 to give quinol 1.81 and the conjugate addition 
product 1.82.  Unfortunately, all attempts to convert quinol 1.81 to quinone 1.82 failed. 
Reduction of 1.82 provided 1.83, which was protected as its bis TES ether to provide 
1.84. Because direct cross coupling reaction of 1.82 with stannane 1.85 was unsuccessful, 
1.84 was used in the coupling reaction.  Palladium-catalyzed cross coupling of 1.84 and 
1.85 provided 1.86, which was not elaborated to griseusin A (1.87), but served as a model 
system for this family of natural products.   
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 Although not C-aryl-glycosides, anthrone C-glycosides are of interest to the 
Martin group as well. The only anthrone C-glycoside to be successfully synthesized and 
reported in the literature is cassialoin (1.95) (Scheme 1.15).66 Recently, Suzuki reported 
the total synthesis of this molecule, involving the regioselective addition of lithiated 
glycal 1.88 to nitrile oxide 1.89, which served as a masked anthrone.  Methyleneation of 
the resultant adduct 1.90 gave bis ether 1.91, which underwent aromatization when 
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treated with strong base furnishing phenol 1.92.  Protection of 1.92 and hydrolysis of the 
imine unmasked the anthrone to give 1.93. 
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 The stage was now set for a C(2)-functionalization of the glycal, which would 
provide all of the necessary oxygen atoms of the sugar moiety (Scheme 1.16). Direct 
hydroboration of 1.93 failed; product mixtures contained cleaved sugar and aglycone, 
which Suzuki hypothesized was the result of the decomposition pathway depicted by 
1.96.  This problem was remedied by epoxidizing the glycal 1.93 followed by reductive 
opening to provide the C(2)-oxygenated glycoside 1.94.  Global deprotection then 
furnished the natural product 1.95.   
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Scheme 1.16: Cassialoin endgame via epoxide opening 
 
1, PPTS, t-BuOH
    reflux, 1 h, 81%




































    CH2Cl2 (1:2), 0 ºC
2. BH3•THF, THF, 0 ºC




1.2.3: Metal-Mediated approaches to C-aryl glycosides 
Metal-mediated approaches, such as cross couplings, have proved valuable 
synthetic tools to access C-aryl glycosides. Dubois and Beau reported an early approach 
to both the chaetiacandin 1.102 and papulacandin skeletons 1.105 (Scheme 1.17).53, 67 The 
natural product chaetiacandin (1.97) is a simple C-aryl glycoside, while papulacandins 
are spirocyclic C-aryl glycosides (Figure 1.4).  Papulacandin A (1.98) is an illustrative 
example of this class of natural products. 
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A common approach to these classes of natural products was applied, as they are 
structurally similar (Scheme 1.17).  To accomplish this, glycal stannane 1.99 was coupled 
with bromide 1.100 in the presence of palladium tetrakis (Pd(PPh3)4) and base to provide 
glycal 1.101.  It is noteworthy that in the absence of sodium bicarbonate (NaHCO3) a 
spirocycle was obtained.  Because these natural products contain a C(2)-substituent, the 
concomitant spirocyclization was a disadvantage. Hydroboration-oxidation provided 
1.102, which is a model for the chaeticandins. A model for the papulacandin skeleton was 
obtained via epoxidation of glycal 1.101 by treatment with meta chloroperbenzoic acid 
(mCPBA) in the presence of base. Epoxidation occurred from the face opposite the C(3) 
substituent.  Subsequent cyclization of the benzyl alcohol provided a mixture of 
spirocycles 1.103 and 1.104.  This mixture could be converted to a single isomer 
following deprotection.  O-Acetylation of 1.103 and 1.104 provided heptaacetate 1.105, 
which is identical to a heptaacetate isolated from degradation of the natural product 1.97.   
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Recently, Denmark and coworkers reported the successful synthesis of 
papulacandin D (1.97) using a similar cross coupling approach (Scheme 1.18).68 
Treatment of a mixture of silanol 1.106 and iodide 1.107 with Pd2(dba)3•CHCl3 in the 
presence of sodium t-butoxide furnished C-aryl glycal 1.108a in 82% yield.  The addition 
of DIBAL-H to 1.108a effected the removal of the Piv group and furnished benzyl 
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alcohol 1.108b, which underwent epoxidation and cyclization to provide 1.109. 
Spirocycle 1.109 was converted to the natural product 1.97 in six steps.     
 








































1.108a: R = Piv






















Tius reported the total synthesis of vineomycinone B2 methyl ester using a 
palladium-catalyzed cross coupling approach (Scheme 1.19).7, 69 The coupling was 
achieved by treating ZnCl2 1.110 and aryl iodide 1.111 with Pd(PPh3)2Cl2 in the presence 
of (diisobutylaluminum hydride) DIBAL-H. Reduction of the resultant C-aryl glycal 
1.112 by treatment with NaCNBH4 furnished the desired β-C-aryl glycoside 1.113, which 
was elaborated to vineomycinone B2 methyl ester (1.114) in six steps.  
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Scheme 1.19: The total synthesis of vineomycinone B2 methyl ester via palladium 








































Cross coupling approaches have historically been limited to sp2 hybridized 
anomeric centers.  When sp3 substrates are employed in these reactions, β-hydride 
elimination of 1.115 to produce glycal 1.116 or elimination of the C(2)-substituent to 
form glycal 1.117 is a competing reaction (Scheme 1.20).54 
 

























Fu and others have demonstrated that β-elimination can be suppressed when 
“pincer” ligands, tridentate ligands that bind a metal in a coplanar arrangement, are 
employed in cross coupling reactions.70 Mechanistically, it is believed that the ligand 
blocks the coordination site on the metal that is aligned with the C-H bond in the 
transition state, preventing β-hydride elimination from occurring. Gagné and coworkers 
utilized a modification of Fu’s conditions to access C-alky and C-aryl glycosides; 
examples of the latter are shown (Table 1.1).71   
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Table 1.1: Negishi approach with sp3 hybridized sugars 
O
X



















































Reaction conditions: glycosyl bromide (0.24 mmol, 0.19 M in DMF), Ni(COD)2 
(0.024 mmol), t-Bu-Terpy (0.036 mmol), and ArZnI•LiCl (~0.5 M in DMF at
















Peracylated C-aryl glycosides 1.120 and 1.121 were obtained in over 70% yield 
(entries 1 and 2).  The method was extended to the formation of furanosyl C-aryl 
glycoside 1.122 with less efficiency.  In cases in which the reaction was slow, hydrolysis 
of the sugar halide to a lactol was observed (entry 4), which accounted for lower yields of 
perbenzylated 1.123.   
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Daves was among the first to apply a Heck-type coupling to the synthesis of C-
aryl glycosides.54, 72 Early work with mercuric arenes required the use of stoichiometric 
palladium,72 however by employing aryl iodides the reaction could be rendered catalytic 
(Scheme 1.21).54 Coupling of glycal 1.125 with aryl iodide 1.126 in the presence of 
catalytic palladium acetate provided silyl enol ether 1.127.  Treatment of 1.127 with 
TBAF furnished a ketone, and acylation of the primary alcohol by treatment with Ac2O in 
pyridine furnished 1.128.  This model for the gilvocarcins lacks the C(2)-substituent of 
the sugar, and some functionality on the aromatic ring. 
 






























Maddaford utilized a palladium catalyzed Ferrier rearrangement to access C-aryl 
glycosides (Scheme 1.22).73 A mixture of glycal 1.129 and phenylboronic acid was 
treated with palladium acetate.  The intermediate π-allyl underwent addition of the 
boronic acid to give 1.130. Notably, none of the β-hydride elimination product was 
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formed under these reaction conditions, which had been reported in palladium catalyzed 
reactions by Daves with similar glycals.54 
 












1.129 1.130  
 
1.2.4: Approaches involving sugar cyclization  
Some methods to form C-aryl glycosides rely on the de novo formation of the 
sugar onto a preformed aromatic ring.  A major drawback to many of these approaches is 
the fact that all of the stereocenters of the sugar must be introduced at a later time. 
Approaches that involve cleavage and subsequent reformation of the sugar moiety are 
included in this section as well.    
In an approach to the papulacandin skeleton, Danishefsky employed his namesake 
diene 1.131 in a ytterbium-mediated hetero Diels–Alder reaction with aldehyde 1.132 to 
form the vinylogous lactone 1.133 (Scheme 1.23).74 Upon treatment of 1.133 with 
vinylmagnesium bromide in the presence of CuI and DMS, 1.133 underwent conjugate 
addition to provide the tetrahydropyrone 1.134.  The alkene moiety was converted to 
benzoyl ester 1.135 using a multistep sequence that was not well outlined in the 
publication.  Treatment of 1.135 with HMDS and TMSI formed an intermediate silyl enol 
ether, which underwent stereoselective epoxidation, followed by desilylation and 
concomitant epoxide opening.  Protection of the intermediate alcohol as its benzoyl ester 
provided 1.136.  Treatment of ketone 1.136 with LiHMDS and TMSCl, followed by 
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stirring with Pd(OAc)2 gave enone 1.137. Treatment of 1.137 with DIBAL-H effected the 
stereoselective reduction of the ketone to give an alcohol that was subsequently protected 
as the acetate to give 1.138.  Epoxidation of 1.138 by treatment with m-CPBA in 
methanol resulted in the formation of 1.139. Methyl acetal 1.139 could be converted to 
1.105, a compound obtained from degradation studies of papulacandin A, in three steps.  
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Danishefsky’s approach was quite lengthy, highlighting the difficulty of installing 
many stereocenters onto an unsubstituted pyran ring.  In another de novo sugar approach, 
Schmidt used inverse electron demand hetero-Diels–Alder reaction to furnish C-aryl 
glycosides (Scheme 1.24).75 The elegant feature of this synthesis was the early 
establishment of the stereocenters on the dihydropyran ring, which set the stage for 
elaboration of the glycoside to a glucose moiety.  Also, the olefin would allow for 
introduction of the C(4)-substituent.  Toward this end, substituted vinyl sulfide 1.140 
underwent cycloaddition with styrene 1.141 to provide 1.142.  This reaction set the 
stereocenters at the anomeric carbon, C(2), and C(3). Desulfurization of 1.142 by 
treatment with Raney-Ni allowed for regio- and stereoselective hydroboration/oxidation 
to install the C(4)-hydroxyl group. Debenzylation of the intermediate benzyl ether using 
palladium on activated carbon, followed by treatment with acetic anhydride in pyridine 
furnished the C-aryl glycoside 1.143.   
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In a ring-closing metathesis approach to C-aryl glycosides, Postema utilized 
glycal 1.144 as a starting material, to benefit from the existing stereochemistry on the 
sugar moiety (Scheme 1.25).76 In this approach, the perbenzylated glycal 1.144 was 
subjected to ozonolysis, and deprotection of the formyl group followed by cyclization 
provided lactol 1.146.  Wittig reaction on the open form of hemiacetal 1.146 provided 
alcohol 1.147.  Subsequent oxidation of 1.147, followed by a modified Takeda 
olefination gave 1.148, which underwent ring-closing metathesis when treated with 
Schrock’s catalyst (1.150) to provide C-aryl glycal 1.149.  Although this approach was 
much shorter than Danishefsky’s, this route suffered from its own setbacks as well.  
Disadvantages of this sequence were high catalyst loading, which was up to 23%, and the 
fact that in order to achieve high yields the reaction had to be performed in the glove box. 
Another major drawback is the length of the synthesis; it takes six steps to introduce a 
phenyl ring onto 1.144. From this example, it is clear that efficient methods to form C-
aryl glycals were lacking at this point in time.   
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An approach by Sharma and coworkers involved nucleophilic additions to lactols 
1.151, which provided diols 1.152 (Scheme 1.26).77-79 Nucleophiles utilized in the 
transformation shown in Scheme 26 ranged from thiophene78 to substituted phenyl 
rings.79 Treatment of diols such as 1.153 with lanthanide Lewis acids, such as ytterbium 
triflate (Yb(OTf)3), or iron trichloride (FeCl3) effected cyclization providing 
tetrahydrofuran 1.154 (Scheme 1.27).  
 










1.151 1.152  














1.153 1.154  
 
1.2.5. C-aryl glycosides via C-glycosides 
There have been approaches to C-aryl glycosides that involve the use of an 
appropriately substituted C-glycoside to construct the aryl moiety. A popular application 
of this approach involves the use of alkynyl-substituted C-glycosides. For example, 
Kaliappan used alkynyl substituted pyranose 1.155 in a metathesis approach to C-aryl 
glycosides (Scheme 1.28).80 Enyne metathesis of 1.155 under an ethylene atmosphere 
yielded diene 1.156.  When diene 1.156 was heated with juglone, the Diels–Alder 
reaction was followed by elimination to provide a mixture of C-aryl glycoside 1.157a and 
1.157b.   
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1.157a: R = H, R' = OH





McDonald was able to utilize an alkyne to directly access a C-aryl glycoside in a 
cyclotrimerization reaction (Scheme 1.29).81 Alkynyl glycal 1.160 was formed by 
treatment of lactone 1.158 with alkynyl Grignard reagent 1.159. Alkynyl glycal 1.161 and 
diyne 1.162 were then treated with ClRh(PPh3)3 to afford the C-aryl glycal 1.163.   
 







































The cyclotrimerization approach was also used by McDonald to form a 
spirocyclic C-aryl glycoside (Scheme 1.30).81 Addition of the lithiated alkyne 1.165 to 
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lactone 1.164 gave a lactol 1.166a, which was acylated to provide the anomeric acetates 
1.166b.  Lewis acid catalyzed C-glycosylation of 1.166b with silated propargyl alcohol 
provided 167a, which was deprotected to furnish the bis terminal alkyne 1.167b.  
Cyclotrimerization provided a mixture of C-aryl glycosides 1.168.   
 














1.166a: R = H









SnCl4 (10 mol %)

















1.167a: R = TMS













An elegant example of C-aryl glycoside formation from a C-glycoside was 
reported by Yamaguchi and coworkers in the total synthesis of urdamycinone (1.65) 
(Scheme 1.31).82 To set the stage for a polyketide cyclization, the enolate of 1.170 was 
added into lactone 1.169, and reduction provided diester 1.171.  Double Claisen 
condensation of dianion 1.172 with 1.173 provided 1.174, which underwent 
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cycloaddition when treated with Ca(OAc)2 in refluxing MeOH.   Intermediate 1.174 was 
converted to urdamycinone (1.65).   
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1.65   
 
The Dötz reaction has been utilized to access C-aryl glycosides as well.83 
Although this is a metal-mediated approach, it also involves the elaboration of a C-
glycoside to a C-aryl glycoside via two complementary approaches (Scheme 1.32).  In 
the first, the anion of the chromium carbene complex 1.176 was added to lactone 1.175, 
forming an alcohol, which underwent elimination to provide 1.177.  Treatment of the 
glycosidic carbene with TMS-acetylene under a carbon monoxide atmosphere formed a 
phenol, which was acylated to provide C-aryl glycoside 1.178.   
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The complementary approach involved the addition of the Grignard reagent 1.180 
to lactone 1.179, followed by reduction to furnish the glycoside 1.181 or dehydration to 
provide glycal 1.184 (Scheme 1.33).  When 1.181 or 1.184 was treated with carbene 
1.182, both sugars underwent Dötz reaction to provide C-aryl glycoside 1.183 or C-aryl 
glycal 1.185, respectively.  
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1.3. THE MARTIN GROUP APPROACH TO C-ARYL GLYCOSIDES 
1.3.1. The unified approach 
The design and development of a unified approach to all four Groups of C-aryl 
glycosides has been pursued over the past decade in the Martin research group (Scheme 
1.34).84, 85 Two paths were utilized in this method.  In the first, acid catalyzed ring 
opening of 1.186 was used to access the four Groups of C-aryl glycosides 1.187a–d.  The 
second approach involved the SN2′ opening of oxabicycle 1.186, and provided access to 
Group II 1.187b and Group III 1.187c.   
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a: Group I: R1 = Sugar; R2 = H
b: Group II: R1 = H; R2 = Sugar
c: Group III: R1 = R2 = Sugar




The synthesis of a model for Group I C-aryl glycosides was achieved via the 
cycloaddition of the benzyne generated from 2-chloro-1,4-dimethoxybenzene (1.188) 
with furan 1.189 (Scheme 1.35).  Acid-catalyzed ring opening of the resultant 
cycloadduct 1.190 using TFA provided C-aryl glycoside 1.191 in excellent yield.   
 
































Compounds representing Group II and IV C-aryl glycosides were accessed in a 
similar fashion (Scheme 1.36).  Cycloaddition of the benzyne generated from 2-chloro-
1,4-dimethoxybenzene with the C(3)-substituted furan 1.192 provided oxabicycle 1.193, 
which underwent ring opening when treated with acid to give 1.194, which is a Group II 
 40 
C-aryl glycoside.  Oxidation of 1.194 to the quinone using iodosobenzene diacetate, 
followed by reduction to the hydroquinone furnished 1.195, a Group IV C-aryl glycoside.   
 












































Glycosides that serve as models for Group III C-aryl glycosides were then 
accessed via the acid-catalyzed ring-opening of oxabicycles (Scheme 1.37).  Successive 
additions of furyl anions to sugar lactones 1.197 and 1.199 gave disubstituted furan 
1.200. The furan 1.200 underwent cycloaddition with benzyne 1.201, which was 
generated from 2-chloro-1,4-dimethoxybenzene.  The resultant bis-glycoside 1.202 was 
subjected to acid-catalyzed ring opening to give C-aryl glycoside 1.203.   
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An alternative approach to access Group II and III was developed as well.  In this 
method, the SN2′ ring opening of oxabicycle 1.205 via a sugar nucleophile was employed 
(Schemes 1.38 and 1.39). Palladium-catalyzed coupling of iodide 1.204 and oxabicycle 
1.205 to give a mixture (4:1) of alcohols 1.206 and 1.207, oxidation of which provided C-
aryl glycal 1.208.86 
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Zn0 (10 eq), DMF
Pd(OAc)2 (14 mol %)



































An efficient synthesis of Group III C-aryl glycosides was developed via a similar 
approach.84 In this process, sugar nucleophile 1.204 was used to open oxabicycle 1.190 in 
an SN2′ fashion (Scheme 1.39).  Simple reduction of glycal 1.209 allowed access to 
glycoside 1.210.   
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1.3.2. Regioselective benzyne cycloadditions using a silicon tether 
In order to synthesize simple C-aryl glycosides, 2-choro-1,4-dimethoxybenzene 
(3) was invariably used as the benzyne precursor.  Because a symmetrical benzyne was 
generated, the regiochemistry of the [4+2] cycloaddition was therefore not an issue with 
these systems.  However, in the context of natural product synthesis, C-aryl glycosides 
often contain unsymmetrically-substituted ring systems.  Suzuki has addressed the 
regioselectivity problem by using systems that are electronically tuned to undergo 
regioselective cycloadditions based on substrate control alone (Section 1.2.1).  How is 
regioselectivity to be invoked in a system that is not electronically modified to undergo a 
regioselective cycloaddition?  The Martin group elegantly addressed this question by 
developing a method that utilizes silicon tethers87 to control the regioselectivity of the 
cycloaddition, but then can be readily cleaved.   
Two approaches were established,88, 89 which utilized tethers of varying length.   
To create the system with a silicon linker that contained one carbon atom, which will be 
referred to as the “one-carbon tether,” furan 1.189 was treated with LDA, and the 
resultant anion was trapped with bromomethyl chlorodimethylsilane to provide silane 
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1.211 (Scheme 1.40).  Williamson etherification90 of 1.211 with phenol 1.212 provided 
ether 1.213 in 83% yield.  When performing the Williamson etherification with the one-
carbon tether, attack at the silicon atom can be problematic vide infra.91, 92  
When ether 1.213 was treated with s-BuLi, adduct 1.214 was formed in 68% 
yield.  The tether could now be cleaved to provide one of two products.  If TBAF in DMF 
was used, both carbon–silicon bonds were cleaved to provide methyl ether 1.215.  If a 
free phenol was the target, a two-step sequence was employed where adduct 1.214 was 
treated with TBAF in THF to give a silanol that was subsequently oxidized to provide 
phenol 1.216.   
 

















































































The major side reaction that occurred during the etherification reaction of 1.217 
was attack at the silicon atom (Scheme 1.41). 91, 92 When silane 1.217 was treated with 
sodium methoxide (1.218), 1.219 was obtained, along with a small amount 1.220, which 
arose from the attack at the silicon atom.  In dioxane, attack at the silicon atom increased, 
and the rearranged product 1.221 was the major product. Formation of 1.221 involved 
initial attack at the silicon atom followed by migration of a methyl group.  The authors 
hypothesized this was a solvation effect; the more “naked” nucleophile attacked at the 
silicon atom more readily.  In a separate study, they discovered that using KOMe or 
CsOMe as nucleophiles also resulted in increased attack at the silicon atom, supporting 
their “naked” anion hypothesis.  In some cases with the one-carbon tether, attack at the 
silicon atom was problematic, and careful selection of bases and solvent was required for 
optimization.  With this initial one-carbon tether model system (Scheme 1.40), it was 
found that K2CO3 in acetone was sufficient for minimal attack at silicon.88   
 




































In addition to the one-carbon tether, a two-carbon silicon linker was also 
developed, which will be referred to as the “two-carbon tether.”  Treatment of the anion 
generated by the lithiation of furan 1.189 with chlorodimethylvinlysilane gave 1.222, 
which was converted into alcohol 1.223 by hydroboration-oxidation (Scheme 1.42).  The 
issues associated with the Williamson etherification could be avoided with the two-
carbon tether.  Because an alcohol was formed, a Mitsunobu etherification93 could be 
used to link 1.223 with phenol 1.212, affording 1.224 in 75% yield.  Using these “more 
neutral” conditions there was no attack at the silicon atom observed. When ether 1.224 
was treated with t-BuLi, adduct 1.225 was obtained in 81% yield.  Cleavage of the tether 
using TBAF in DMF afforded oxabicycle 1.226. Perhaps noteworthy is that this 
cycloaddition was slightly more efficient than that leading to 1.214.   
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1.3.3. The unified approach in synthesis 
In order to demonstrate the utility of the methodology, a formal synthesis of 
galtamycinone, which belongs to the Group II family of C-aryl glycosides, was achieved 
(Scheme 1.43).94 Thus, 3-bromofuran (1.227) was lithiated, and the resultant anion was 
added to lactone 1.228 to provide glycosyl furan 1.229.  Cycloaddition of 1.229 with 
benzyne 1.201, which was generated by lithiation of 2-chloro-1,4-dimethoxybenzene, 
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provided oxabicycle 1.230.  Adduct 1.230 was not purified, but rather the crude mixture 
was subjected to ring opening to give phenol 1.231 in 74% yield over two steps.  
Protection of phenol 1.231 and oxidation of the aromatic ring to the quinone furnished 
1.232, which was converted to chlorojuglone 1.233 by sequential chlorination and 
elimination.  This constituted a formal synthesis of galtamycinone, as Suzuki had 
formerly converted chloride 1.30 into galtamycinone (1.33) as previously discussed 
(Section 1.2.1, Scheme 1.5).40, 41 
 













































































The total synthesis of vineomycinone B2 methyl ester (1.8) was achieved using a 
two-carbon tether,10, 11 representing the first total syntheses of a C-aryl glycoside natural 
product using the Martin group’s tether approach (Scheme 1.44).  The first furan unit 
1.234 was installed onto 1.233 via Mitsunobu etherification, and then selective removal 
of the TBS group of ether 1.235 provided phenol 1.236.  A second Mitsunobu 
etherification was used to install the glycosyl furan moiety 1.237 to provide the bis ether 
1.238.  A double benzyne-furan cycloaddition of 1.238 provided adduct 1.239.  In this 
synthesis, the tether was not cleaved with a fluoride source, but rather treatment with base 
to afford an intermediate silanol, which was treated with acid to provide the quinone 
1.240.  Removal of the PMP group, followed by oxidation of the resultant alcohol to the 
acid provided 1.241.  Global debenzylation was effected by treatment with BBr3, and 
subsequent methanolysis provided vineomycinone B2 methyl ester (1.8).    
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1.235: R = TBS































































BBr3, CH2Cl2, –78 ºC













1.4. C(2)-OXYGENATED C-ARYL GLYCOSIDES 
1.4.1. Biologically important 2-oxygenated C-aryl glycosides 
Although less abundant, C-aryl glycosides containing (C)2-oxygenated sugar 
moieties are also important. (C)2-Oxygenated C-aryl glycosides exhibit antiproliferic 
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activity against human promyelocytic leukemia cell line (HL60).1 The previously 
discussed examples of C(2)-oxygenated C-aryl glycosides also exhibit biological activity.  
Recall that the gilvocarcins 1.7a–c, which contain 2-oxygenated fucose sugar moieties, 
exhibit antimicrobial and antitumor activity (Figure 1.5). A C-aryl glycoside related to 
the gilvocarcins, ravidomycin (1.52) also exhibits biological activity (Figure).  Isolated 
from Streptomyces ravidus culture broth, ravidomycin exhibits antibacterial activity 
against gram-positive organisms in addition to potent antitumor activity. The 
ravidomycin aglycone is identical to that of the gilvocarcin V, and the synthesis of 
ravidomycin was also achieved by Suzuki, via another application of his regioselective 
benzyne cycloaddition methodology (Section 1.2.1, Scheme 1.8).45, 46  
 











1.7a: R = Me
1.7b: R = vinyl













5-Hydroxyaloin A (1.243) is a C(2)-oxygenated anthrone C-glycoside that can be 
envisioned as synthetically coming from a group I C-aryl glycoside (Scheme 1.45).  The 
biological activity of aloins will be discussed in Section 3.1. 
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1.4.2. Previous studies toward the total synthesis of 5-hydroxyaloin A 
5-Hydroxyaloin A was selected as a synthetic target for several reasons.  Until 
this point, all target molecules pursued in the Martin group had been C(2)-deoxygenated 
sugars, and we wished to explore the application of our method to C(2)-oxygenated 
sugars, and 5-hydroxyaloin A was a suitable target.  In addition, the unsymmetrically 
substituted C ring of 5-hydroxyaloin A would allow us to again apply our silicon tether 
methodology.   
When Dr. Li began his analysis of 5-hydroxyaloin A (1.242), he envisioned two 
approaches to the molecule (Scheme 1.45).95 The first of these is via route a, in which the 
hydroquinone, ring A, is formed last.  This approach would involve a benzyne–furan 
cycloaddition of the naphthyne generated from either glycoside 1.243 or 1.244 and a 
substituted furan.  The C ring in this route would be constructed by an intramolecular 
cycloaddition of silane 1.245 or 1.246 using a one- or two-carbon tether.  The alternative 
route b would involve formation of the C ring last, where a substrate-controlled head-to-
head naphthyne cycloaddition would be implemented in the endgame (Section 1.2.1, 
Scheme 1.6), between naphthyne 1.247 and furan 1.248.  The resultant cycloadduct 
would contain an additional oxygen atom relative to the natural product, thus this 
approach would involve a late stage deoxygenation.   
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1.245: X = H
1.246: X = Cl
1.243: X = H
1.244: X = Cl
 
 
1.4.2.1. Tether to control regioselectivity 
Li first attempted to use a one carbon tether as a means to control the 
regiochemistry of the first cycloaddition, according to route a (Scheme 1.46).  Li had 
considerable difficulty implementing the Williamson etherification.  An assortment of 
bases and solvents were explored for the etherification reaction of iodide 1.250.  
However, ethers 1.253 or 1.254 were never isolated from the reaction mixture, and only 
the rearrangement product 1.256, which resulted from attack at the silicon atom, was 
observed.  
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1.253:  R = TBS
1.254:  R = TIPS
1. NaI, NaOAc, 
    DMF, 70 ºC 
    78%
1.256
2. LAH, Et2O 




1.251:  R = TBS
1.252:  R = TIPS
1.249: X = Br




Because of these difficulties, Li investigated the Mitsunobu etherification as well. 
To explore this route, bromide 1.249 was converted to alcohol 1.255.  Alcohol 1.255 did 
allowed access to ethers 1.253 and 1.254. However, when these ethers were treated with 
s-BuLi, cycloadducts 1.260 and 1.261 were not obtained (Scheme 1.47).  Instead, 
significant cleavage of the tether was observed, presumably from direct attack of s-
butyllithium at the silicon atom.  Also complicating this reaction was the loss of chloride 
from the furan, presumably due to metal-halogen exchange and protonation upon 
workup.  Although metal-halogen exchange with chlorine is usually a slow process, it 
was clearly competing with deprotonation under these reaction conditions.   
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Scheme 1.47: Unsuccessful benzyne cycloadditions 
1.253: X = H, Y = Cl, R = CH2OTBS
1.254:  X = H, Y = Cl, R = CO2Me
1.257; X = Cl, Y = Br, Z = H, R = CO2Me
1.258: X = Cl, Y = Br, Z = H, R = OTBS
























1.260: R = CH2OTBS, Z = Cl
1.261: R = CO2Me, Z = Cl
1.262: R = CO2Me, Z = H
1.263: R = OTBS, Z = H







Dr. Li thus switched to a substrate lacking a chlorine substituent on the furan.  
Although he was able to form 1.257–1.259 via Mitsunobu etherifications, he was unable 
to effect the cycloadditions to access cycloadducts 1.262–1.263 upon treatment of 1.257–
1.259 with n-BuLi. Again, products resulting from alkyllithium attack at the silicon atom 
were observed. 
Dr. Li also investigated the use of a two-carbon tether. Namely, the 
intramolecular cycloaddition of the benzyne generated from 1.265 was attempted, but 
cycloadduct 1.267 was not obtained (Scheme 1.48).  Cleavage of the silicon tether was 
again observed based upon the 1H NMR spectrum of the crude mixture, and the reaction 
was further complicated by loss of the chlorine atom from the furan ring. A dihaloarene 
benzyne precursor 1.266 was also synthesized using the two-carbon tether.  
Unfortunately, treating ether 1.266 with n-BuLi only resulted in an intractable mixture, 
and cycloadduct 1.268 was not isolated.  Problematic side reactions, including tether 
cleavage, caused Li to reexamine the route, and he chose to investigate systems that could 































1.265: R = TBS, X = H, Y = Cl, Z = Cl
1.266: R = MOM, X = Cl, Y = Br, Z = H
1.267: R = TBS, Z = Cl





1.4.2.2. Bimolecular cycloadditions 
Li began to investigate bimolecular cycloadditions as a method to form the C ring 
of 5-hydroxyaloin A.  Given the precedent for electronically-driven, regioselective 
benzyne cycloadditions of Suzuki, Li attempted the cycloaddition of chlorofuran 1.269 
with benzynes generated from 1.270 and 1.271 (Scheme 1.49).  From these reactions, Li 
reported the isolation of only one regioisomeric cycloadduct, although due to the low 
yield it is not certain that this was the only regioisomer formed.  Regardless, attempts to 
achieve the ring opening of 1.272 and 1.273 with various Lewis and Brønsted acids 
failed; the cycloadducts were extremely resistant to ring opening.  When stronger Lewis 
acids such as TMSOTf were employed, cleavage of the sugar from the aglycone was 
observed, and phenols 1.274 and 1.275 were not formed.   
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1.270: R = TBS
1.271: R = TIPS
1.269 1.272:  R = TBS










1.274: R = TBS





As 2-chloro-1,4-dimethoxybenzene (1.188) readily underwent benzyne generation 
when deprotonated, Dr. Li sought to develop a route to the tricyclic core of hydroxyaloin 
A building the hydroquinone ring first (Cf. Scheme 1.44, route b).  Li was able to 
synthesize chloronaphthalene 1.276. Generation of a naphthyne from chloride 1.276 with 
s-BuLi was successful, and Dr. Li was able to obtain a 55% yield of diasteriomeric 
cycloadducts 1.277 (Scheme 1.50).  When cycloadducts 1.277 were treated with TFA, a 
mixture of anthrones 1.278 and 1.279 was obtained.  This experiment provided critical 
precedent that these chloronaphthalenes could be directly deprotonated to generate 
naphthynes.   
 

















































Having successfully formed the anthrone core, Dr. Li performed some model 
studies to see if a late stage dehydration or deoxygenation would be possible, since 
construction of the unsymmetrical ring via a cycloaddition of 1.280 with a substituted 
furan 1.281 would yield a product with an additional oxygen atom (Scheme 1.51).  He 
tried to effect such transformations with a variety of model substrates, however all 
attempts to deoxygenate were ultimately unsuccessful.   
 































1.4.3. 2-Oxygenated glycosides vs. 2-deoxygenated glycosides 
The acid-catalyzed ring opening of oxabicycles to provide C-aryl glycosides had 
proceeded smoothly in prior work in the group (Section 1.3.1).  The C(2)-deoxygenated 
cycloadduct 1.190 underwent ring-opening upon treatment with TFA at room 
temperature for several days (Scheme 1.34).84 Li’s 2-oxygenated cycloadducts such as 
1.284 rearranged under these conditions to form naphthol 1.286 in only moderate yield 
(Scheme 1.52).95 Dr. Li hypothesized that a glycal might allow for a smoother entry into 
naphthols, reasoning that it may be the electron-withdrawing C(2)-substituent of 
cycloadducts 1.284 that was destabilizing the formation of the requisite carbocation in 
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intermediate 1.285 when these adducts were treated with acid, which in turn resulted in 
low yields of 1.286.    
 















































Such a destabilizing effect might have contributed not only to lower yields of 
naphthol 1.286 relative to those for forming naphthol 1.191, but also the more forcing 
conditions required for the opening of C(2)-oxygenated substrates.  An additional pitfall 
was that the cycloadditions that formed oxabicycles such as 1.284 proceeded in slightly 
lower yield in substrates with a C(2)-substituent.  Li’s hypothesis prompted him to 
consider an approach that utilized glycals. Glycals lack an electron withdrawing C(2)-
substituent but the double bond could provide a functional handle for introducing various 
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functionality at C(2).  For example, a C(2)-oxygenated glycoside could potentially be 
accessed from a glycal via hydroboration-oxidation.   
 
1.4.4. Attempted hydroboration of TIPS-protected glycals  
Preliminary investigations into the hydroboration and oxidation of C-aryl glycals 
were initiated by J. Gabrielle Kolakowski.96 TIPS-protected glucal 1.287 was lithiated 
and transmetallated to its zincate, which was treated with I2 to give unstable iodoglycal 
1.288 (Scheme 1.53).  Compound 1.288 underwent Negishi coupling with 2-furylzinc 
chloride (1.289), to provide furyl glycal 1.290 in 91% yield.  A major complication to 
this approach is the instability of iodoglycal 1.288, which was extremely difficult to work 
with as this glycal had to be stored under vacuum and used immediately in the coupling 
reaction.    
 







I1. t-BuLi, then ZnCl2















The [4+2] cycloaddition reaction of furan 1.290 with the benzyne generated from 
1.188 gave cycloadduct 1.291 in good yield (Scheme 1.54).  As Dr. Li had expected, the 
ring opening did proceed more efficiently with this substrate. While many of the 
glycosides previously investigated opened with protic acid at room temperature over the 
course of days, these glycals opened readily at low temperature with Lewis acid.  The 
intermediate naphthol was isolated and protected to provide naphthalene 1.292 in 67% 
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yield over two steps, thereby setting the stage for the investigation of the hydroboration 
step. 
 

























   CH2Cl2, 





    NaH, THF
 67% (2 steps)
 
 
Kolakowski attempted to hydroborate both the free phenol 1.293 and naphthalene 
1.292 (Scheme 1.55).  Unfortunately, these rhamnals did not undergo hydroboration-
oxidation, and prolonged reaction times only resulted in substrate decomposition.   
Because she hypothesized that the bulky TIPS group was hindering the hydroboration 
step, she decided to introduce a smaller protecting group onto the sugar.   
 

























Toward this end, the TIPS protecting group was removed and benzyl groups were 
introduced onto rhamnal 1.292, providing glycal 1.296 (Scheme 1.56). Hydroboration-
oxidation of 1.296 was successful, and alcohol 1.297 was formed in 33% unoptimized 
yield.  Hydroboration occurred from the face opposite the C(3) substituent, as evidenced 
by the two large coupling constants for the proton at C(2) (dd, J = 9.2, 8.6 Hz). As 
mentioned previously, hydroboration from this face is well precedented in the literature.57, 
64, 65, 97 
 










2. NaH, BnBr, DMF
           85%
1. BH3•THF













In order to streamline the synthesis of 1.297, a route was required that did not 
involve this late stage protecting group swap.  This necessitated the development of an 
improved method to synthesize benzyl-protected furyl glycals.   
 
1.4.5. Furyl Glycals via Sugar-Derived Lactones 
There was a need to develop a versatile, expedient synthesis of C-aryl glycals. 
Use of the Negishi coupling illustrated by the conversion of 1.287 to 1.289 would not be 
feasible with benzylated glycals (Scheme 1.56) because Friesen had previously reported 
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that t-BuLi is necessary to lithiate glycals 1.298 at the C(1) position.98 Although TIPS-
protected glycals were compatible with this process, benzylated glycals suffered from 
lithiation of the benzylic methylene group when treated with t-BuLi (Scheme 1.57). We 
required a method to form glycals 1.300 containing benzyl protecting groups, thus this 
method would not be compatible.  
 































The method described by Postema using a ring closing metathesis approach 
would also not be viable (Scheme 1.58).  Although they were able to employ a 
perbenzylated glycal 1.301 as a starting material, this approach required the use of 25–50 
mol% of Grubbs catalyst, making this approach not amenable to scale up.  In addition, 
the sequence was lengthy, requiring eight steps to glycals 1.302 from commercially 
available tri-O-acetyl-D-glucal.   
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Sulikowski had also described an approach to C-aryl glycals, which utilized 
readily available 2-deoxy glycosyl lactones as the starting material (Scheme 1.59).  
Unfortunately, this two step approach involved the use of excess Martin sulfurane (1.304) 
in order to achieve good yields of glycal 1.303.99 
 













    sulfurane (5 eq.)










The procedure of Sulikowski served as the starting point for Dr. Li’s 
investigations.  For example, the addition of 2-furyllithium to sugar lactone 1.199 
proceeded smoothly, but Dr. Li found that the hemiacetal addition product 1.307 existed 
primarily in the open form 1.305 at room temperature in CDCl3 (Scheme 1.60).  Although 
this equilibrium is well known, it did not appear to interfere with previously reported 
reductive processes to form C-aryl glycosides. However, when this mixture of hemiacetal 
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1.307 and hydroxy ketone 1.305 was treated with Martin’s sulfurane according to the 
two-pot procedure of Sulikowski, the desired glycal 1.306 was obtained in only 32% 
yield; Li was unable to optimize the procedure. 
 























































Li reasoned that the difficulties with the ring-chain tautomerism might be avoided 
if the intermediate lithium alkoxide of the hemiketal 1.307 could be trapped in situ to 
give a derivative that would undergo elimination to provide the desired glycal 1.306.  
Thus, following addition of 2-furyllithium to lactone 1.199, the resultant alkoxide 1.307 
was treated at –78 °C with a mixture of pyridine, 4-N,N-dimethylaminopyridine 
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(DMAP), and trifluoroacetic anhydride (TFAA) to furnish furylglucal 1.306 in very good 
yield  (Scheme 1.59).  If an excess of TFAA was present, acylation of the glycal enol 
ether ensued, affording the α-furyl-β-trifluroacetoxyglucal 1.308 as a significant by-
product (22% yield).  Indeed, when 1.307 was treated with a large excess of TFAA in the 
presence of pyridine and DMAP, trifluoroacetate 1.308 was isolated in 63% yield. 
Dr. Li extended this method to the formation of various aryl glycals, examples of 
which are shown (Table 1.2).100 Aryl glucals 1.303 and 1.310 were typically formed in 
about 75% yield (entries 1 and 2), whereas C-aryl rhamnals 1.312–1.314 were invariably 
formed in high yield, regardless of the aryl substituent (entries 3–5).  
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Table 1.2: Formation of aryl glycals dervived from glucal and rhamnal 
O Ar








































a Products obtained were >95% pure by 1H NMR. 
b Reported yield for 0.2 mmol scale reaction. 





















1.5. SUMMARY AND CONCLUSION 
The methods to synthesize C-aryl glycosides were summarized, with emphasis 
placed on those that have found utility in natural product synthesis.  Of the many methods 
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to synthesize this class of antibiotics, only two allow access to all four groups of C-aryl 
glycosides: the umpolong method of Parker, and the acid-catalyzed opening of 
oxabicycles developed in the Martin group.   
The Martin group method had yet to be applied to an efficient synthesis of C(2)-
oxygenated C-aryl glycosides via glycals, due to limited protecting group choices for the 
existing methods to make glycals.  Thus, a novel approach to benzylated aryl glycals was 
developed within the group.  This method allowed for the formation of 1-aryl glycals in a 
one pot process from 2-deoxysugar lactones. However, there remained a need explore the 
substrate scope of this reaction and to extend the method to sugars with varying 
substitution on the sugar moiety. In addition, the streamlined route to the C(2)-
oxygenated sugars by employing perbenzylated glycals required investigation.   
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Chapter 2: The synthesis and functionalization of C-aryl glycals 
A novel, one pot method to form aryl glycals, including furyl glycals 2.2, from 
sugar lactones 1.1 had been developed to circumvent difficulties with the hydroboration-
oxidation of TIPS-protected C-aryl glycals (Scheme 2.1).  Because Li had established the 
generality of the method, my first task was to synthesize furyl glycals 2.2 and convert 
them to C-aryl glycals 2.5. Cycloadducts 2.4 would come from the cycloaddition of furyl 
glycals 2.2 with benzyne 2.3, which would be generated in situ from 2-chloro-1,4-
dimethoxybenzene. Ring opening of oxabicycle 2.4 would provide naphthols, which 
could be protected as ethers if necessary. The resultant glycals 2.5 could be 
functionalized stereoselectively to provide C(2)-oxygenated C-aryl glycosides 2.6a, R′ = 
OH via hydroboration-oxidation.  
In addition to forming the aforementioned C(2)-oxygenated substrates, we 
foresaw an opportunity to introduce other R′ groups via the functionalization of 2.5. The 
antibiotic properties of aminoglycosides inspired us to also target C(2)-aminated C-aryl 
glycosides via the hydroboration-amination of glycals 2.5, allowing access to 2.6b. 
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2.6a: R' = OH
2.6b: R' = NH2  
 
We anticipated that this approach may also help to circumvent difficulties that had 
been observed when C(2)-oxygenated examples were engaged in the Martin group 
methodology. Namely, glucose-derived glycosides synthesized by Li underwent 
cycloaddition and ring opening with less efficiency as compared to the C(2)-
deoxygenated substrates typically employed by Kaelin and others (Schemes 2.2 and 2.3).  
Li could obtain phenol 1.286 in only 61% yield over two steps from furan 1.283 (Scheme 
2.2).  He reported the formation of many “phenolic” products when other acids were 
used.  By contrast, the C(2)-deoxygenated phenol 1.191 was obtained in 83% yield over 
two steps (Scheme 2.3). 
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Li hypothesized that the electron withdrawing C(2) substituent was destabilizing 
the cationic intermediate formed in the ring opening step as illustrated by 1.285. If it was 
indeed this substituent that was the cause of the inefficiency in these reactions, the 
approach detailed in this chapter could potentially be employed to improve the route to 5-
hydroxyaloin A.  
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2.1 GLUCAL  
Tri-O-acetyl-D-glucal (2.7) was chosen as the starting point for the investigation 
shown in Scheme 2.1, as this sugar is relatively inexpensive and readily available.  
Multigram quantities of lactone 2.10 were prepared using a previously developed 
sequence (Scheme 2.4).88 The acetoxy groups of peracylated glucal 2.7 were first 
removed by saponification, and the hydroxyl groups were then globally protected as 
benzyl ethers, providing glycal 2.8 in high yield.  Although pyridinium chlorochromate 
(PCC) has been used to oxidize glycals to lactones,101 this process had been shown to be 
somewhat unpredictable in prior work in the group,88 and we had found a two-step 
procedure that was more efficient.  Thus, hydration of glucal 2.8 in the presence of 
PPh3·HBr102 gave lactol 2.9 that was subsequently oxidized with TPAP,103 providing sugar 
lactone 2.10 in 87% yield over two steps.  Conversion of lactone 2.10 to the furyl glycal 
2.12 proceeded smoothly on a mmol scale when lactone 2.10 was treated with 2-
furyllithium (2.11) at low temperature, followed by the addition of DMAP, pyridine, and 
TFAA and warming to room temperature.   
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75% up to 23%  
 
Although the formation of 2.12 was efficient on mmol scale, the yields were 
generally about 10% lower when the reaction was performed on a smaller scale.  This is 
perhaps due to adventitious water, which could quench the anion resulting from the 
addition of 2.11 to lactone 2.10.  The hydroxy ketone side product 2.13 was consistently 
isolated from these small-scale reactions in yields up to 23%.  
In order to improve this reaction to give 2.12, a number of variables were 
screened (Table 2.1).  In this study, the molar equivalents of 2-furyllithium, DMAP and 
Et3N remained a constant at 1.2, 1.2, and 3.0 equivalents, respectively.  The amount of 
TFAA was varied, with an upper limit set at 3.0 equivalents because the trifluoride 2.14 
was formed in the presence of a large excess of TFAA.  It was determined that a 
minimum of 2.0 equivalents of TFAA was required in order to obtain the glycal 2.12 as 
the major product, rather than hydroxy ketone 2.13 (entry 1).  There was, however, no 
significant difference in yield when 2.0 or 3.0 equivalents of TFAA were used (entries 2 
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and 3).  Of the solvents investigated, THF was the optimal choice, as the reaction was 
less efficient when other solvents were used (entries 4 and 5).  
When the two stages of the reaction were performed at –78 ºC, only hydroxy 
ketone 2.13 was isolated, indicating that the dehydration step occurred at warmer 
temperature (entry 8).  Accordingly, the reaction was warmed to –20 ºC after the addition 
of 2-furyllithium, and then Et3N, DMAP, and TFAA were added at this temperature 
(entry 9); however, no improvement was observed.  
The use of HMPA as an additive was also explored, with the intention of making 
the tertiary alkoxide ion more nucleophilic, thereby facilitating acylation (entries 10 and 
11), but hydroxy ketone 2.13 was again the major product.  One possible explanation of 
these results is that HMPA destabilized the addition adduct by sequestering the lithium 
counterion, thus making the undesired ring opening more favorable.  If the amine bases 
could sequester the lithium counterion similarly, this could be the reason for the 
formation of hydroxy ketone 2.13.  This hypothesis prompted an experiment in which the 
TFAA was added to the reaction mixture first at –78 ºC to trap the alkoxide.  The amine 
bases were then added to the reaction.  This change in the order of addition furnished 
furan 2.12 in only 56% yield.   
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a Following the addition of 2-furyllithium, the reaction was stirred at the initial 
   temperature for 2 h.  Following the addition of the other reagents, the mixture was allowed 
   to warm to the second temperature.
b reaction analyzed by TLC. c isolated yield of product after chromatography.
d HMPA added prior to the addition of Et3N, DMAP, and TFAA.  
d HMPA added 










   
We explored other reagents to acylate the alkoxide. Namely methanesulfonyl 
chloride (MsCl), acetyl chloride (AcCl), and methyl chloroformate were used in lieu of 
TFAA.  MsCl was the best of these three reagents, but comparing the ratios of the desired 
glycal 2.12 and hydroxy ketone 2.13 in the 1H NMR spectrum of the crude material 
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revealed a mixture (~1:1) of products, and a more thorough investigation of alternative 
acylating reagents was not undertaken.   
All attempts to improve Li’s results for the formation of furyl glycal 2.12 did not 
meet with success; however, these investigations were needed to determine if it was a 
matter of reaction conditions or substrate specificity that was determining the yield of 
furyl glycal in this reaction (see Section 2.3.2).  Although the original conditions 
employed by Li proved to be the best, we had gained valuable information regarding 
substrate specificity that will be discussed further (Section 2.3.2).   
With furyl glycal 2.12 in hand, its reaction with the benzyne generated from 2-
chloro-1,4-dimethoxybenzene was examined.  In the event, 2.15 was lithiated with s-
BuLi at –95 ºC, and furyl glycal 2.12 was added after 10 min to the mixture at –95 ºC 
(Scheme 2.5). The mixture was warmed quickly to –10 ºC to effect benzyne generation 
and subsequent [4+2] cycloaddition, and the cycloadduct 2.16 was isolated in 99% yield.  
This was a clear benefit to using glycals in this reaction, as yields in the range of 50–75% 
are observed when C(2)-substituted glycosides are employed in the benzyne 
cycloaddition with the benzyne generated from 2-chloro-1,4-dimethoxybenzene (Sections 
1.4.3 and 3.6). 
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We then attempted to apply the conditions developed by Kolakowski and Li for 
the ring opening of TIPS-protected rhamnal 1.291 to the benzyl protected glucal 2.16.  
However, treatment of 2.16 with BF3•OEt2 and 2,6-lutidine gave a complex mixture of 
phenols as evidenced by the appearance of many singlets between 9.8 and 10.0 ppm in 
the 1H NMR spectrum of the crude material (Scheme 2.5). 
Various oxaphilic Lewis acids were employed in an effort to improve this reaction 
(Table 2.2, entries 1-7),104 but these reactions also failed to provide 2.17. The first 
promising result was achieved when cycloadduct 2.16 was treated with scandium triflate 
(Sc(OTf)3) at room temperature for 1 h (entry 8). Although a significant amount of 
starting material remained, one singlet was observed in the 1H NMR spectrum of the 
crude material at 9.86 ppm.  When this reaction was allowed to run for extended periods 
of time, many phenolic products were formed (entries 6 and 7). When trimethylsilyl 
trifluoromethanesulfonate (TMSOTf) was employed as the Lewis acid, the desired 
phenol 2.17 was formed, albeit in low isolated yield (entry 9).   
The Lewis acid of choice for this reaction was ZnCl2 (entries 10 and 11).  
Complex mixtures of phenolic products were observed when the reaction was run at 0 ºC, 
and the reaction did not proceed at –78 °C. However, when ZnCl2 was added to 2.16 at –
78 ºC and the reaction mixture was warmed to 0 °C, the reaction went to completion 
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within minutes.  Only one singlet at 9.86 ppm was observed in the 1H NMR spectrum of 
the crude material.  It was critical to the success of this reaction to add ZnCl2 at low 
temperature, or more complex product mixtures were obtained.   
 
Table 2.2: Optimization of the ring-opening of glucal 































































many phenolic products a
53–85% c
a Analysis of the 1H NMR spectrum of the crude material; many singlets between 9.8–10.0 ppm.
b Both CH2Cl2 and THF/H2O used as solvent.  





Although the 1H NMR spectra of the crude reaction mixtures from reactions using 
the conditions described in entry 11 appeared to be nearly identical, the yields of 2.17 
following flash chromatography on silica gel ranged from 53–85%.  When a sample of 
naphthol 2.17 containing a minor impurity was resubjected to flash chromatography, the 
“purified” material contained more side products than the original sample.  In addition, 
when a sample of 2.17 was stored in the freezer, the formation of side products was 
apparent after as little as 12 h.   
Because naphthol 2.17 could not be stored without significant decomposition, 
immediate protection of 2.17 was necessary.  Accordingly, naphthol 2.17 was converted 
to its benzyl ether 2.18 (Scheme 2.6).  This tandem procedure provided naphthalene 2.18 
in very good yield.   
 














    CH2Cl2
2. NaH, BnBr
    DMF
    85% (2 steps)
2.182.16  
 
Although a hydroboration/oxidation of a substrate similar to 2.18 had already 
been successfully performed, the reaction had proceeded in only 33% yield (Section 
1.4.4, Scheme 1.56).  It was necessary to optimize this step (Table 2.3).   
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Table 2.3: Representative hydroboration conditions for glucal 

























a Hydroboration temp/oxidation temp b Isolated yield after flash chromatography. 
c Sodium perborate was used as the oxidant, instead of H2O2. 
d Complex mixture 





































Hydroboration of 2.18 using borane-methylsulfide (BH3•DMS) complex was 
sluggish at room temperature (entry 1), and even reaction times of several days resulted 
in low conversion.  Raising the temperature increased the yield, and the optimal 
conditions involved heating glycal 2.18 with BH3•DMS at 50 ºC for 1.5 h, which 
provided alcohol 2.19 in 44% yield (entry 2).  Longer reaction times resulted in decreased 
yields of alcohol 2.19.  Hydroboration of glycal 2.18 using BH3•THF was also slow at 
room temperature, although conversion in the hydroboration stage appeared superior to 
the BH3•DMS reaction by TLC.  When this reaction was conducted at 50 ºC, the yields 
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were better, though still moderate (entry 3).  Concerned that the oxidation step might be 
problematic, sodium perborate was used in lieu of peroxide (entry 4).105 However, there 
was no dramatic improvement in yield, and the reaction mixture has to be heated to 50 ºC 
to effect oxidation.   
With extended hydroboration times, many new spots were observed by TLC 
during the first stage of the reaction, which led us to think that the intermediate borane 
may not be stable under the reaction conditions.  Indeed, longer reaction times resulted in 
the formation of complex mixtures following oxidation (entry 5).  Optimized conditions 
for this reaction required the use of a large excess of borane, and the oxidation was 
performed after 2 h (entry 6) to give 2.19 in 64% yield.  As expected, hydroboration 
occurred from the face opposite the C(3)-substituent, as evidenced by the two large 
coupling constants for the proton at C(2) (app td, J = 9.0, 5.2 Hz), which is indicative of 
the axial orientation of the proton at C(2) that is coupled to axial protons of C(1) and 
C(3).  The coupling constant of 5.2 Hz derives from coupling of the C(2)-H with the –OH 
proton of alcohol 2.19.   
Having optimized conditions for the ring opening transformation of 2.16 to 2.17 
and the hydroboration of glycal 2.18 to form 2.19, efforts were made to apply these 
conditions to other substrates in order to evaluate the scope of our method.  Our initial 
targets were 2-oxygenated C-aryl glycosides derived from commercially available 




2.2.1. Hydroboration studies 
The optimized conditions for the glucal were readily applied to form a C(2)-
oxygenated C-aryl rhamnose.  Hydration of enol ether 2.20 and subsequent oxidation of 
the intermediate hemiacetal furnished lactone 2.21 in 96% overall yield (Scheme 2.7).  
Treating lactone 2.21 with 2-furyllithium (2.11), followed by acylation and elimination 
furnished furyl rhamnal 2.22 in 92% yield.  This result was consistent with Dr. Li’s 
results, in which C-aryl rhamnals were invariably formed in high yield, regardless of the 
aryl substituent (Section 1.4.5).   
 














THF, –78 ºC ! rt
92%
1. PPh3•HBr
    THF, 81%
2. NMO, TPAP
    4Å MS, CH2Cl2





Furyl rhamnal 2.22 then underwent cycloaddition with the benzyne generated 
from 2-chloro-1,4-dimethoxybenzene to give cycloadduct 2.23, and sequential ring 
opening of 2.23, followed by protection of the intermediate naphthol gave 2.24 in 60% 
yield over three steps (Scheme 2.8).  Subsequent hydroboration of the enol ether 2.24 
occurred from the face opposite the C(3)-substituent to give 2.25.  The stereochemical 
assignment was based upon the appearance of the proton at C(2) in the 1H NMR spectrum 
(app td, J = 9.0, 5.6 Hz) of alcohol 2.25.   
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2.24 2.25  
 
2.2.2. Hydroboration-amination studies and attempted aziridination 
We became interested in the hydroboration-amination of glycals due to the 
diverse array of biological activities exhibited by aminoglycoside antibiotics, examples of 
which include kanamycin (2.26) and neamine (2.27) (Figure 2.1).  These 
aminoglycosides are active against both gram positive and gram negative bacteria.106 The 
mode of antibiotic activity involves binding the bacterial ribosome and preventing protein 
biosynthesis, thus resulting in cell death.  Aminoglycoside antibiotics are also active 
against some viral strains, including herpes simplex 1 and influenza virus.107  
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2.26 2.27  
 
As with all microbes, the development of antibiotic resistant genes has rendered 
some aminoglycoside antibiotics useless in the treatment of certain diseases.  For 
example, various aminoglycosides have become ineffective against methicillin-resistant 
streptococcus aureus (MRSA).106 This resistance occurs due to the production of 
aminoglycoside modifying enzymes (AMEs) that alter the structure of the antibiotics.108 
The development of antibiotic resistance has necessitated the production of novel 
aminoglycoside antibiotics.  By targeting C-aryl aminoglycosides, we aimed to 
synthesize new antibiotics that might be engendered with interesting biological 
properties. 
Of the commercially available substrates investigated (Sections 2.1–2.3) tri-O-
acetyl-L-rhamnal 2.24 underwent hydroboration-oxidation in the best yield. Hence 
attempts were been made to effect the hydroboration-amination of this glycal.  
Hydroxylamine-O-sulfonic acid is often the reagent of choice for hydroboration-
amination of simple substrates, but it is often ineffective with monoalkylboranes.109 As 
rhamnal 2.24 is large, it is likely that under these hydroboration conditions there is only 
one sugar moiety associated with the boron atom as shown by 2.28 (Figure 2.2).   
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Even though the formation of a monoalkylborane such as 2.28 might make the 
amination difficult, we attempted the hydroboration/amination of 2.24 (Scheme 2.9). 
When the alkyl borane generated by hydroboration of 2.24 was treated with 
hydroxylamine-O-sulfonic acid, a complex mixture was obtained. The presence of an 
anomeric proton at the typical shift of 6.0 ppm in the 1H NMR spectrum of the crude 
material was not observed.  In another attempt, hydrazoic acid was generated in situ from 
hydroxylamine and sulfuric acid.110 This reaction resulted in the formation of a complex 
mixture.   
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We had already optimized the hydroboration of glycals, so hydroboration-
amination would be a convenient one-pot extension of the method we were developing. 
However, this is not the only way to form C(2)-aminated C-aryl glycosides. Namely, the 
aziridination of glycals has been previously reported to give 2-amino lactols (Schemes 
2.11 and 2.13),111, 112 and it was thought that aziridination of 2.24, followed by opening of 
the aziridine with diisobutylaluminum hydride (DIBAL-H) might provide the desired 2-
amino glycoside 2.31 (Scheme 2.10).   
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Generally, the aziridination of glycals is a multistep procedure. In the two step 
protocol described by Griffith and Danishefsky, glycal 2.32 was converted into 
iodosulfamide 2.33 (Scheme 2.11).111 Upon treatment of 2.33 with Et3N in THF/H2O, the 
amino alcohol 2.35 was formed in good yield; however, the yields were low to moderate 
when other nucleophiles were employed.   
 
































An efficient dipolar cycloaddition approach to 2-aminosugars has been reported 
(Scheme 2.12).113 Treatment of tri-O-acetyl-D-glucal (2.7) with benzyl azide and 
triethylorthoformate provided the triazine 2.36 in excellent yield, and irradiation of 2.36 
in acetone yielded the aziridine 2.37.  The intermediate aziridine could be treated with 
various nucleophiles, affording 2-aminosugars 2.38 in 88–98% yield. Unfortunately this 
method only works well with strongly electron-withdrawing substituents on the sugar 
moiety.  Acetate O-protecting groups worked best for the example shown in Scheme 
2.10. Few readily removable electron withdrawing groups would be compatible with the 
strong base chemistry required to form glycals such as 2.24, thus excluding this method 
for aziridination.   
 




































A method developed by Du Bois and Carriera,112, 114, 115 which utilizes the 
manganese nitrido complex (saltmen)Mn(N) (2.40) as the nitrogen transfer agent, seemed 
most appealing as they have demonstrated the compatibility of this one-pot method with 
a variety of sugar protecting groups (Scheme 2.13).  A range of furanose and pyranose 
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glycals 2.39 were aziridinated using (saltmen)Mn(N) activated with trifluoroacetic 
anhydride (TFAA); these aziridines were then hydrated to form amino alcohols 2.41.  
This method was shown to be compatible with various O-protecting groups on the sugar, 
including PMB, benzyl, acetal, and silyl groups. 
 
Scheme 2.13: Literature precedent for the aziridination of glycals 
O
1. 














Based upon the work of Du Bois and Carreira, we intended to open the aziridine 
in a tandem process using DIBAL-H.  The (saltmen)Mn(N) nitrido complex (2.40) was 
prepared, and we attempted the aziridination of rhamnal-derived glycal 2.24 using the 
procedure reported for the aziridation of 6-membered glycals (Scheme 2.14).  In this 
protocol, TFAA was added to the glycal first, and then (saltmen)Mn(N) (2.40) was added 
as a solution in CH2Cl2. DIBAL-H was then added to the mixture at –78 ºC.  
Unfortunately, a complex mixture of intractable products resulted, and the doublet typical 
of the anomeric C-H (J ~ 6.0 ppm) of glycosides such as 2.25 was not observed in the 1H 
NMR spectrum of the crude material. We also tried to apply Carreira’s exact conditions 
for the formation of five-membered glycals in which 2,6-di-tert-butylpyridine and 
(saltmen)Mn(N) (2.40) were added prior to TFAA. Unfortunately, a complex mixture 
resulted from this reaction as well.  
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   (saltmen)Mn(N) (2.40), rt
   or –78 ºC to rt





Attempts were then made to repeat Du Bois and Carreira’s aziridination/hydration 
procedure on glycal 2.24 to determine if we could access rhamnose-derived amino lactol 
2.43 (Scheme 2.15).   The absence of the –OH stretch in the infrared spectrum (IR) of the 
crude material and the formation of many products by analysis of the crude 1H NMR 
spectrum finally caused us to abandon this method.   
 



















   TFAA, 2,6-di-tert-butyl-
   4-methylpyridine -78 oC
ii. silica gel, celite, pentane





2.3.1. The hydroboration-oxidation of galactal 
There have been no reported hydroboration-oxidation reactions using galactals to 
give 2-oxygenated C-aryl galactoses.  Introducing this sugar moiety onto aromatic rings 
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might also produce C-aryl glycosides with interesting biological properties, as galactose 
motifs are present in various naturally occurring sugars. The role of galactose moieties on 
cell surface sugars in processes such as inflammation and infection makes aryl galactals 
interesting targets for the study of biological properties.1 Furthermore, C-glycoside 
analogs of O-glycosides that contain galactose moieties have been found to retain the 
biological activity of the corresponding O-linked analog, while being less susceptible to 
hydrolysis.116  
Hydration and oxidation of perbenzylated galactal 2.44 furnished lactone 2.45 in 
96% overall yield (Scheme 2.16).  Formation of the furyl galactal 2.46 was highly 
problematic, however.  When optimized conditions for forming glucal 2.12 were 
employed, only low yields of 2.46 were obtained.  Even on a 5.0 mmol scale, the best 




























    THF, 86%
2. NMO, TPAP
    4Å MS, CH2Cl2










Although further optimization of the transformation from 2.45 to 2.46 was not 
achieved, we were able to access the 2-oxygenated C-aryl glycoside 2.50 (Scheme 2.17).  
The cycloaddition of 2.46 with the benzyne generated from 2-chloro-1,4-
dimethoxybenzene provided cycloadduct 2.48 in 75% yield.  Ring opening and protection 
of 2.48 gave naphthalene 2.49 in moderate yield over two steps.  Hydroboration-
oxidation of 2.49 gave a single alcohol 2.50. The stereochemistry of 2.50 was assigned 
based on prior precedent because the C(2)-proton was obscured in the 1H NMR spectrum 
in various solvents and the coupling constants could not be measured. Due to the oily 
nature of this alcohol, a crystal structure could not be obtained.  Although this route did 
not provide 2-oxygenated C-aryl galactal 2.50 with high efficiency, this example was 
significant, as it represented the first reported hydroboration-oxidation of a galactal.   
 
 93 


























    CH2Cl2
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2.49 2.50  
 
2.3.2. Rationale for the difficulty with furyl glycal formation 
Attempts to optimize the addition/elimination reaction to form galactal, illustrated 
by the transformation of 2.45 to 2.46, led us to conclude that it is the nature of the sugar 
substituents that dictates the efficiency of this reaction.  In addition, the glucal-derived 
lactone 2.10 underwent the addition/elimination sequence less efficiently than rhamnal-
derived lactone 2.21. Aside from relative stereochemistry, the C(6)-benzyloxy substituent 
is the only difference between glucal and rhamnal, therefore this group must be 
contributing in some way to the formation of hydroxy ketone 2.10.   
The first step of the sequence is addition to the lactone by 2-furyllithium, which 
can occur in an axial or equatorial fashion.  Because 2-furyllithium is a large nucleophile, 
equatorial attack is expected to predominate.  This prediction is based on precedent 
involving a substituted cyclohexanone, which allows for accurate analysis of the attack 
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(Scheme 2.14).117 Cyclohexanone 2.51 should sit in the chair-like conformation, with the 
methyl and isopropyl groups equatorial as drawn.  In this example, furan addition occurs 
selectively, providing axial alcohol 2.52 as a single regioisomer due to favorable 
equatorial attack. 
 













Thus, we can expect equatorial attack to predominate in the addition to our sugars 
and, although we cannot rule out that some axial attack will also occur with this pyranose 
system, the products resulting from equatorial attack are shown (Schemes 2.19 and 2.21). 
Treatment of 2.10 with 2-furyllithium (2.11) would yield intermediate alkoxide 2.53, 
which can be acylated and undergo elimination leading to the formation of 2.12. There is 
an equilibrium favoring the open-chain form 2.13 of hemiacetal 2.55 in CDCl3 (Scheme 
2.20).  It is possible that there is a similar equilibration with this system as well.  If ring-
opened, glucal 2.53 could produce a favorable 5-membered chelate 2.54.  Ring closure to 
reform 2.53 would be less favorable, and hydroxy ketone 2.13 would be formed.  The 
rhamnal-derived lactone 2.20 lacks a C(6)-substituent to participate in chelation, which 
may allow the equilibrium to favor the closed chain form. 
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The differences in glucal and galactal must also be addressed, due to the marked 
difference in efficiency between these substrates.  The lower yields in forming furyl 
galactal 2.46 may be due to equilibration to the ring opened form being more favorable 
(Scheme 2.21). Indeed, galactose is present in open chain form to a greater extent as 
compared to glucose in aqueous solution, 0.002 and 0.02 percent acyclic form, 
respectively.118 If alkoxide 2.56 equilibrates with the open chain form, there are two 



















































With the hydroboration sequence successfully applied to commercially available 
substrates (Scheme 2.1), the next goal became targeting other structures that could serve 
as models for naturally occurring C-aryl glycosides. Model systems for ravidomycin and 
the gilvocarcins were chosen (Figure 2.3).  The ravidomycin analog 2.59, a C(3)-
aminoglycoside, was targeted first. Ravidomycin contains a C(6)-deoxysugar, and these 
are most compatible with our method to produce furyl glycals, as exemplified by the 
excellent yield obtained in the transformation of 2.21 to furyl rhamnal 2.22 (Scheme 2.7).   
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To access an aminosugar, di-O-acetyl-L-rhamnal (2.61) was converted to azide 
2.62 in two steps (Scheme 2.22).119 Lewis acid-catalyzed methanolysis of 2.62 gave a 
mixture of acetals, which could be separated by chromatography, to provide the α-methyl 
acetal 2.63 as the major diastereomer.  The stereochemistry at C(1) was assigned to be α 
based on the small coupling constant for this proton in the 1H NMR spectrum (d, J = 3.4 
Hz). The C(3) proton was determined to be equatorial (ddd, J = 12.3, 9.6, 4.8 Hz) based 
on the two large coupling constants.  Removal of the acetyl group from 2.63 using K2CO3 
in MeOH, followed by O-methylation provided dimethoxy azide 2.64 in 99% yield over 
two steps.  Hydrolysis of the acetal moiety of 2.64, followed by oxidation of the resultant 
lactol 2.65 using NMO/TPAP furnished lactone 2.66.  Reduction of the azide group of 
2.66 and protection of the amino group gave carbamate 2.67 in 87% yield.  
Unfortunately, all attempts to N-methylate the amine of 2.67 were unsuccessful.  No 
reaction was observed upon treatment of 2.67 with NaH and MeI, and stronger bases 
caused the formation of many products, possibly due to competitive enolization of the 
lactone.   
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1. H2O,  80 ˚C
    then AcOH, NaN3
2. Ac2O, Py, CH2Cl2
    96% over 2 steps
1. K2CO3, MeOH
2. NaH, MeI












The aminolactone synthesis was modified such that a selective deprotonation was 
not required.  The acetate 2.62 was treated with K-10 Montmorillonite and benzyl alcohol 
to provide benzyl acetal 2.69 in 50% yield (Scheme 2.23).  The α-anomer was separated 
by chromatography, and the stereochemistry at the anomeric carbon of 2.69 was assigned 
based on the small coupling constant for the proton at C(1) (d, J = 3.5 Hz), which 
suggests the C(1) hydrogen is equatorial.  The stereochemistry of the C(3) azide was 
assigned based on the two large coupling constants for the hydrogen atom at C(3) (ddd, J 
= 12.3, 9.8, 4.9 Hz), which is expected for an axial hydrogen.  Removal of the acetate at 
C(4) of 2.69 followed by O-methylation gave 2.70.  Reduction of the azide and protection 
of the resultant amine as a Boc carbamate gave 2.71.  The amino group of carbamate 2.71 
was then N-methylated to give 2.72, and hydrogenolysis of the anomeric benzyl group 
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followed by NMO/TPAP oxidation of the intermediate lactol furnished the desired 
lactone 2.69 in 93% yield over two steps. 
 



























1. H2, Pd/C, EtOAc
BnOH, K-10 








2. MeI, NaH, DMF
2.  Boc2O, CH2Cl2




2.72 2.68  
 
Conversion of lactone 2.68 to furyl glycal 2.73 was accomplished by treating 2.68 
with 2-furyllithium followed by dehydration (Scheme 2.24).100 Cycloaddition of 2.73 
with the benzyne generated from 2-chloro-1,4-dimethoxybenzene proceeded smoothly to 
give 2.74, which underwent ring opening when treated with ZnCl2. However, the mixture 
had to be warmed from –78 °C to room temperature in order for the reaction to go to 
completion.  The resultant phenol was protected as its benzyl ether to give naphthalene 
2.75 in 57% yield over two steps.  Unfortunately, glycal 2.75 did not undergo 
hydroboration using the previously developed conditions, and only starting material was 
recovered from the reaction, in nearly quantitative yield.   
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THF, -95 oC  -> -5 oC
quantitative
1. ZnCl2, CH2Cl2
    -78 oC to rt
2. BnBr, NaH, DMF
57%






In prior studies in the group, it had been observed that TIPS-protected glycals 
such as 1.292 did not undergo hydroboration, and this failure was attributed to a steric 
interaction between the bulky protecting groups and the approaching borane (Section 
1.4.4).  Hypothesizing that a similar steric interaction between the N-Boc group of 2.75 
and BH3•THF prevented hydroboration from occurring, attempts were made to convert 
the Boc group of carbamate 2.75 to a methyl group using LAH (Scheme 2.25).  This 
reaction was slow at room temperature, and when the mixture was stirred for extended 
periods of time, starting material and free phenol 2.78 were observed in the 1H NMR 
spectrum.120, 121 None of the desired tertiary amine 2.77 was obtained.   
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Because the benzyl protecting group of naphthalene 2.75 was labile under these 
reductive conditions, the phenol was protected as its methyl ether (Scheme 2.26).  In the 
event, ring-opening of 2.74 gave naphthalene 2.79 in 76% yield.  Reduction of the Boc 
group with LAH proceeded smoothly when the reaction mixture was heated to 70 °C, 
providing tertiary amine 2.80 in 78% yield.   
 
















2. MeI, NaH, DMF













With 2.80 in hand, efforts were turned to its hydroboration-oxidation (Scheme 
2.27).  Treatment of 2.80 with a large excess of BH3•THF did not result in the formation 
alcohol 2.82, but rather amine borate salt 2.81. 
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At this point, Vedejs’ method for the intramolecular hydroboration of homoallylic 
amines seemed a viable approach, as the amine borate salt is utilized to direct 
hydroboration to the same face as the amine.122 If this procedure were successful, we 
would extend this method to allylic examples, and we would obtain a regiochemistry 
opposite that observed in the direct hydroboration-oxidation of glycals.  Toward that end, 
we found that simple concentration of the reaction mixture from the hydroboration 
reaction provided salt 2.81 in quantitative yield (Scheme 2.28).   
 
































Unfortunately, when 2.81 was treated sequentially with iodine and then basic 
H2O2, a complex mixture was obtained (Scheme 2.28).  The presence of a doublet (J = 
9.0 Hz) in the crude 1H NMR spectrum at 5.7 ppm may indicate the presence of the 
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desired alcohol 2.83, as this signal is near the typical shift for anomeric protons in CDCl3 
for similar molecules.  However, the desired product could not be isolated cleanly from 
the complex mixture.  Attempts to optimize the sequence by varying the temperature of 
the iodination reaction failed, and a complex mixture of many products was again 
obtained.   
Parker has reported the hydroboration-oxidation of a similar amine (Scheme 
2.29).61 Specifically, the phenol 2.85 was subjected to hydroboration-oxidation, and the 
intermediate was acylated to give the diacetate 2.86 in good overall yield from quinol 
2.84.  When 2.80 was subjected to the Parker conditions, salt 2.81 was again obtained.  
The reason for this difference in reactivity of the substrates could be due to a steric 
interaction between the OTBDPS and NMe2 groups. This interaction could cause the 
methyl groups of the amine could orient themselves away from the large silyl group, 
rendering the lone pair of amine 2.85 less available for attack at the boron atom. We 
chose not to further explore this system, because the protecting group changes would 
necessitate a reworking of the entire synthesis.   
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2. Ac2O, DMAP






THF/H2O 46% over 
3 steps
2.84 2.85 2.86  
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2.5. RIBOSE-DERIVED GLYCAL 
To investigate gilvocarcin-like substrates, a five-membered sugar lactone 2.91 
was synthesized (Scheme 2.30).  2-Deoxy-D-ribose (2.87) was converted to its methyl 
acetal by treatment with HCl in MeOH.123 The resultant acetal 2.88 was protected to give 
benzyl ether 2.89 in 83% yield.124 Hydrolysis of the acetal in aqueous acetic acid afforded 
lactol 2.90, which was oxidized using TPAP to give benzylated lactone 2.91.   
 

































2.89 2.90 2.91  
 
Lactone 2.91 was then treated with 2-furyllithium, followed by the addition of 
Et3N, DMAP, and TFAA (Scheme 2.31).  However, this reaction yielded a complex 
mixture of multiple products.  When DMPU was added to the reaction, a compound 
tentatively assigned as the desired product 2.92 was obtained, albeit in low yield.  The 
instability of the isolated compound precluded full characterization.   
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THF, –78 to 0 ºC
2.91 2.92  
 
We attempted to optimize the first step, addition of 2-furyllithium into the lactone, 
however starting material was consistently observed in the 1H NMR spectrum of the 
crude material.  This gave important information regarding the scope of this reaction; the 
application to five-membered sugars was not straightforward.  We chose not to further 
explore this model system.   
 
2.6. EXPLORING NAPHTHYNE CYCLOADDITIONS WITH GLYCALS 
The naphthyne cycloaddition is an area central to the total syntheses in our group.  
Several of our projects, including the total synthesis of 5-hydroxyaloin A, involve a 
naphthyne cycloaddition, so we took advantage of this opportunity to explore naphthyne 
reactivity. Li’s example of naphthyne generation via direct deprotonation of a 
chloronaphthalene is not well precedented in the literature, thus we wanted to explore this 
approach further (Section 1.4.2.2).  
To this end, 2-chloro-1,4-dimethoxynaphthalene (2.95) was synthesized as a 
potential precursor of a naphthyne.  Utilizing a procedure developed in the group,125 
sodium hydrosulfite (Na2S2O4) reduction of 1,4-naphthoquinone (2.93), followed by 
methylation delivered 1,4-dimethoxynaphthalene (2.94) in 80% yield over two steps 
(Scheme 2.30).  Reacting 2.94 with a mixture of iodosobenzene diacetate and 
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chlorotrimethylsilane (TMS-Cl) according to a procedure described by Evans gave 2-
chloro-1,4-dimethoxynaphthalene (2.95) in 78% yield.126  
 




    CH2Cl2, H2O












2.93 2.94 2.95  
 
Treatment of naphthalene 2.95 with s-BuLi or t-BuLi did not provide oxabicyle 
2.96, but rather resulted in recovered starting material exclusively (Scheme 2.33).  This 
result was unexpected, as Dr. Li had been able to a deprotonate chloronaphthalene with s-
BuLi (Section 1.4.2.2).  Deuterium-labeling studies were performed in order to assess if 
the problem was with the deprotonation or elimination step. There was no detectible 
deuterium incorporation with this substrate.   
 


















2.95 2.96  
 
Investigation of the deprotonation of an aryl bromide was also undertaken. 2-
Bromo-1,4-dimethoxynaphthalene (2.97) was synthesized according to Evans’ 
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procedure.126 Deprotonation of 2.97 was attempted using lithium diisopropylamide 
(LDA) (Scheme 2.34).  Because cycloadduct 2.96 was not isolated when the reaction was 
performed at –78 °C, the reagents were combined at –78 °C, and then the reaction was 
allowed to warm to –10 ºC. This procedure gave the desired oxabicycle 2.96 in 48% 
yield, along with 20% yield of 2.98, which arose from the competitive deprotonation of 
furan 2.22.  
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THF

























As direct deprotonation of 2.97 to effect naphthyne formation met with limited 
success, naphthyne generation from a dihalonaphthalene was explored. Metal-halogen 
exchange, followed by elimination is an alternate method to generate naphthyne. To 
explore this, 2-chloro-3-bromo-1,4-dimethoxynaphthalene (2.99) was prepared according 
to Evans’ procedure.126 When 2.99 was allowed to react with n-BuLi and furan 2.22, 2.96 
was obtained in 89% yield (Scheme 2.35).  
Previously, oxabicyclic glycals were shown to undergo ring opening smoothly 
when treated with ZnCl2 at –78 °C, followed by warming to 0 °C (Sections 2.1–2.3).  
However, when ZnCl2 was added to oxabicycle 2.96 at –78 °C, starting material was not 
consumed, even when the reaction was warmed to room temperature.  When 2.96 was 
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treated with ZnCl2 at –25 °C and the reaction mixture was warmed to room temperature, 
starting material was consumed; however, 2.100 was obtained in only 33% yield (Scheme 
2.35).  The hydroboration-oxidation of 2.100 was performed to provide the 2-hydroxy C-
aryl glycoside 2.101 in an unoptimized 33% yield.   
 
Scheme 2.35: Efficient benzyne generation from a dihalonaphthalenes and the 
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2.7. SUMMARY AND CONCLUSION 
In the context of expanding methods to form C-aryl glycals, a one-pot two-stage 
synthesis of glycals from sugar lactones was applied to novel substrates. Namely, a furyl 
galactal and 3-aminoglycal were synthesized using this procedure. The difficulty in 
applying the dehydration method to the formation of a furanosyl glycal represents an 
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ongoing challenge for the synthetic community.  Although furanosyl glycals are 
known,112, 127, 128 methods to synthesize C(1)-substituted furanoid glycals remain rare.129 
A two-stage benzyne furan cycloaddition methodology was successfully applied 
to form 2-oxygenated C-aryl glycosides. Cycloadditions using glycals proceed more 
efficiently as compared with 2-oxygenated substrates, demonstrating an important 
advantage to the use of 1,2-anhydrosugars. The hydroboration-oxidation of these 
substrates provided target C(2)-oxygenated substrates derived from glucose, rhamnose, 
and galactose. Careful considerations must be made when performing hydroboration-
oxidation on aminoglycosides, as amine borate salt formation can interfere with 
hydroboration.   
Benzyne generation via the direct deprotonation of arenes is not always general.  
Dihalonaphthalenes can serve as a reliable alternative, and can undergo metal-halogen 
exchange followed by elimination to form naphthyne.  We have demonstrated the 
effectiveness of dihalonaphthalenes for benzyne generation in a situation in which 
deprotonation of a monohalonaphthalene was unsuccessful.  
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CHAPTER 3: 5-Hydroxyaloin A 
3.1. THE BIOLOGY AND CHEMISTRY OF ALOE 
Since Roman times, and perhaps even earlier, aloe has been recognized as an 
important therapeutic agent.130 The aloe plant has persevered as a remedy throughout 
history and remains a constituent of burn creams and cosmetics today.131, 132 The prevalent 
interest in the aloe plant is evidenced by its widespread cultivation.  Although naturally 
found in eastern and southern Africa predominantly, large farms in the United States, 
Mexico, Columbia, Venezuela, China, and Thailand exist for the farming of the plant for 
commercial aloe products.133  
 
Figure 3.1: Aloe vera (photograph is copyright by the author) 
 
 
 The medicinal extracts are derived from two sections of the aloe plant, and 
different therapeutic properties have been attributed to the mucilage from each segment.  
The thick substance from the inside of the leaves is referred to as gel and is the 
component found in cosmetics and skin care creams.  Some of the drug-like effects of the 
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gel include enhanced immunity, improved liver function, prevention of asthma, and anti-
inflammatory, anti-ulcer, anti-diabetes and anti-hypertension properties.133 The liquid 
derived from the cells adjacent to the vascular bundle is referred to as the exudate,131 
which is known to exhibit purgative properties, owing to its use in laxatives.133 The 
exudate is sometimes used as a bittering agent in beverages as well.133  
The longstanding interest in aloe and its diverse applications have prompted the 
study of its constituents in order to gain a better understanding of the therapeutic 
properties associated with the plant extracts.  In a 2000 review, Dagne and coworkers 
compiled a list of all compounds known to exist in the gel and exudate.133 The gel, or leaf 
pulp, is more than 98% water, and its alcohol-insoluble portion comprises 
polysaccharides, monosaccharides, uronic acid, and several enzymes.  The exudate 
contains a diverse array of compounds; the major groups include alkaloids, 
anthraquinones, anthrones, chromones, coumarins, pyrans, pyrones, flavanoids, steroid-
derived compounds, phenols, and other small aromatic compounds. Although many 
compounds have been isolated from aloe, a systematic study of each individual 
component has not been reported, and it is still believed the synergistic action of many of 
these compounds produces the ultimate therapeutic effect.131 In some cases, the 
processing of aloe may destroy many of the believed active components, and in these 
instances, it may simply be the moisturizing effect of the gel that lends to its curative 
properties in the context of dry skin and burn relief.132  
Of the classes of natural products produced by aloe plants, the anthrones are of 
greatest interest to the Martin group (Figure 3.2). Many of the anthrones contain a sugar 
moiety at C(10). Although not technically C-aryl glycosides, the fact that the sugar 
moiety is connected directly to the anthrone could lend to an application of our unified 
approach to form C-aryl glycosides.84, 85 Some representative members of this group are 
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shown; the most abundant and well-studied are aloins A (3.1a) and B (3.1b) (Figure 3.2).  
The numbering for the anthrone aglycone is shown on structure 3.1.   
 















3.1a: R1 = H, R2 = !-D-glucose




















3.4: R = !-D-glucose
10-hydroxyaloin
aloins A and B (barbaloin)
 
 
 Aloins A (3.1a) and B (3.1b) are collectively known as barbaloin, as they were 
first isolated from aloe vera, which was formerly called barbados aloe.  Barbaloin is 
present in about 85% of the aloe species and comprises between 10–30% of the exudate.  
Structurally, the aloins differ in configuration only at C(10) of the anthrone.  Aloin B 
(3.1a) (10R, 1′S) is the natural product synthesized by the plant, which epimerizes to the 
more stable aloin A (3.1b) (10S, 1′S) upon standing.133  
The aloe-emodin anthrone (3.7) has been detected thus far in the flowers of the 
aloe plant, but not in the leaves.133 It is believed that the aloe-emodin anthrone and 
glucose moiety are attached as a final step in the biosynthesis of aloin B.  In a study by 
Grün and Franz, a crude enzyme extract from the leaves of A. arborescens was prepared 
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in order to investigate the attachment of the sugar to aloe-emodin anthrone in a cell-free 
environment.134 They studied various labeled glucose-containing moieties, including free 
glucose, glucose-1-phosphate, ADP-glucose, GDP-glucose, and UDP-glucose (3.6), and 
they discovered that the species that transfers the glucose molecule to the aloin-emodin 
anthrone (3.7) is UDP-glucose (Scheme 3.1).  The mechanism of the transfer has not 
been elucidated to this date, and the authors do not comment on the stereochemistry at 
C(10) in the aloin product 3.1. 
 




































5-Hydroxyaloin A (3.5) is a scarcer anthrone, isolated from only a few aloe 
species, including Aloe marlothii135 and Aloe broomi.136 Its name derives from the fact 
that it differs from aloins A and B by an additional hydroxyl group at C(5) of the 
anthrone.  The absolute configuration is the more stable A-configuration (10R, 1′S), and 
it is the only anthrone C-glycoside that has not been found to exist as a diastereomeric 
pair in plants. The biological activity of this specific anthrone has not been studied; 
however it may have biological effects similar to other aloe-derived anthrones.  The fact 
that 5-hydroxyaloin A is less abundant also makes it an apt synthetic target, and efforts 
toward its total synthesis have been undertaken by our research group.   
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3.2. THE INTRAMOLECULAR CYCLOADDITION APPROACH TO 5-HYDROXYALOIN A 
Li’s investigations provided valuable insight into the synthetic approach to 5-
hydroxyaloin A (Section 1.4.2).  Li had generated a naphthyne via chloronaphthalene 
1.276, and was able to access 1.277, demonstrating that the tricyclic aryl moiety of 5-
hydroxyaloin A could be formed by benzyne generation via the direct deprotonation of a 
chloronaphthalene (Figure 3.3). The ring system Li had generated could not be elaborated 
to the natural product, however. 
 























Given this precedent, we expected to be able to generate naphthyne 3.9 from a 
chloronaphthalene, providing access to 5-hydroxyaloin A (3.7) (Scheme 3.2). Our 
retrosynthetic analysis involves the use of path a to access the natural product (Section 
1.4.2, Scheme 1.45). Thus, 5-hydroxyaloin A (3.5) would come from cycloadduct 3.8, 
which would be synthesized via the cycloaddition of naphthyne 3.9 with a substituted 
furan (Scheme 3.2).  Naphthyne 3.9 would derive from silane 3.10, which is formed via 
an intramolecular benzyne cycloaddition of ether 3.11.  The ether would come from the 
linkage of furan 3.12 with triflate 3.13, via a one-carbon or two-carbon tether.  Triflate 
3.13 would be accessed from the commercially available α-resorcyclic acid (3.14).   
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3.2.1. The one-carbon tether approach 
Recall that Li had often experienced difficulties generating benzyne via the direct 
deprotonation of benzenes (Section 1.4.2, Schemes 1.47 and 1.48). This issue, coupled 
with the fact that his benzyne precursors such as 1.251 and 1.252 required many steps to 
synthesize, made the first task the development of an expedient synthesis of a suitable 
aryne.  We sought an aromatic substrate that would undergo metal-halogen exchange 
followed by elimination to produce the reactive species, as prior experiments had 
revealed that this to be an efficient method to form benzyne without problematic side 
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reactions (Section 2.6).  A resorcinol derivative seemed suitable, as it could be converted 
to an iodo-triflate species readily, which Suzuki had shown to undergo benzyne 
generation successfully in various publications. 37, 137 
To form the triflate, alcohol 3.15 was prepared from acid 3.14 according to a 
known literature procedure.138 Alcohol 3.15 was protected to give an intermediate that 
underwent regioselective iodination as is well precedented for resorcinol systems,139 and 
the desired iodide 3.16 was isolated in 59% yield after recrystallization.  The introduction 
of a single triflate group onto bis-phenol 3.16 was unsuccessful.  In fact, starting phenol 
3.16 and a bis triflate were the only products isolated from such reactions.   Suzuki has 
addressed this unselective process by developing a procedure for removal of one triflate 
group from a bis triflate using Cs2CO3 in glyme,139 and we adapted this procedure to 
arrive at the desired target, iodotriflate 3.13.  Unfortunately, this two-step process was not 
as efficient as when performed on 2-iodoresorcinol; we were only able to obtain a 28% 
yield of the phenol 3.13 from bis phenol 3.16. 
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With the synthesis of the requisite phenol 3.13 in place, we then formed a sugar 
containing the one-carbon tether (Scheme 3.4). Lactol 3.17, which was available in two 
steps from commercially available methyl α -D-glucopyranoside, was converted to the 
corresponding acetate, which underwent Friedel-Crafts alkylation to afford furan 3.18.  
The furan that is initially formed is the α-anomer, so the mixture must be equilibrated 
overnight to yield exclusively the β-furyl glycoside 3.18 in 80% yield.48 Lithiation of 
3.18 α to the furan oxygen atom, followed by treatment with bromomethyl 
chlorodimethylsilane provided silane 3.19. The Williamson etherification of bromide 
3.19 and phenol 3.13 proceeded in 62% yield,89 furnishing ether 3.20 and setting the stage 
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–78 ºC to rt
 
 
Although Dr. Li had experienced difficulty with tether cleavage when using the 
one-carbon tether, we thought that our new aryl piece might render our system a superior 
benzyne precursor.  Instead of direct deprotonation of the aromatic ring to form benzyne 
as is required by many of Li’s precursors, iodide 3.20 could undergo metal-halogen 
exchange followed by elimination to generate a benzyne.  Hopefully, metal-halogen 
exchange would occur faster than attack at the silicon atom, and tether cleavage would be 
minimized with our system.   
Treatment of iodo-triflate 3.20 with n-BuLi did indeed furnish cycloadduct 3.21, 
in better yield than most of Dr. Li’s precursors, but furan 3.18 was also formed in 13% 
isolated yield (Scheme 3.5).  The remaining material was an intractable mixture of 
products that was not identified.  Cleavage of the tether with TBAF in DMF furnished 
silanol 3.22 in an unoptimized 20% yield.   
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4.1.2. The two-carbon tether approach 
Because of the problems associated with attack at the silicon atom during 
Williamson etherifications when using the one-carbon tether, intermediates containing 
the two-carbon tether was being formed concurrently.89 Installation of the vinylsilane 
proceeded smoothly when furan 3.18 was lithiated and treated with 
chlorodimethylvinylsilane, which provided 3.23 in 77% yield.  Hydroboration/oxidation 
of 3.23 furnished alcohol 3.24, a suitable partner for a Mitsunobu etherification.  With the 
requisite alcohol in hand, efforts were turned to the coupling of sugar 3.24 with phenol 
3.13.  The etherification of 3.13 proceeded in an average 50% yield, and although various 
parameters were changed, including solvent, coupling reagent, and order of addition, the 
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yield could not be improved.  We began preliminary investigations into the 
intramolecular cycloaddition of 3.25 (Table 3.1). 
 



























































Although we were able to begin investigating the intramolecular cycloaddition of 
3.25, low yields in the synthesis of triflate 3.13 left little material to work with, thus an 
alternative approach to benzyne precursor 3.25 was developed.  The Mitsunobu 
etherification was attempted with phenol 3.15, a precursor in the synthesis of 3.13 
(Scheme 3.7).  The optimized conditions for the etherification of alcohol 3.24 with bis-
phenol 3.15 provided ether 3.26 in 62% yield.  Phenol 3.26 was converted to triflate 3.25 
in 86% yield.  In addition to circumventing the inefficient two-step procedure to form 























































With an improved synthesis of the triflate in place, efforts were focused on the 
intramolecular cycloaddition (Table 3.1). In order to assess if tether cleavage could be 
minimized using 3.25, we attempted metal-halogen exchange with various alkyllithiums 
at a range of temperatures.  When n-BuLi was added at –78 °C and this temperature was 
maintained for 3 h, cycloadduct 3.27 was not formed (entry 1).  At –45 °C (entry 2), 
traces of both the desired product 3.27 and furan 3.18 were present; however, the reaction 
was still very slow.  Adding n-BuLi at –20 °C resulted in the formation of both 
cycloadduct 3.27 and furan 3.18 (entry 3).  When 3.25 was treated with s-BuLi at –20 °C, 
we observed the desired cycloadduct 3.27 in the 1H NMR spectrum of the crude material 
































































both 3.27and 3.18 formed
both 3.27and 3.18 formed
3.27 observed, many TBS signals








a The reactions were analyzed by the 1H NMR spectrum of the crude reaction mixture.  
 
We thought that use of a bulkier base might minimize tether cleavage, thus t-BuLi 
was tried (entries 5 and 6).  Cycloadduct 3.27 was observed by 1H NMR spectroscopy; 
however, the appearance of many peaks in the crude 1H NMR from 0.00–0.10 ppm 
caused us to abandon this method.  This result was not observed in any of the other trials 
and those peaks were known to not correspond with the diastereomeric cycloadducts 
3.27.   
The best conditions for generating a benzyne from triflate 3.25 involved the slow 
addition, via syringe pump, of a dilute solution of n-BuLi (Scheme 3.8).  Following 
workup, the crude mixture of cycloadduct 3.27, which contained furan 3.18, was treated 
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with TBAF in DMF.  Using this procedure we could access alcohol 3.28 in 36% yield 
over two steps.  
 












































The unavoidable attack at the silicon atom of the tether prompted us to investigate 
other reagents to form benzyne.  Knochel used Grignard reagents to induce benzyne 
formation from iodosulfonates, so this seemed an appealing method to try.140 Knochel 
found that benzynes could be generated from aryl sulfonates using i-PrMgCl; however, 
the reactions were leaving group dependant.  To investigate the effect of the departing 
group, he reacted sulfonates 3.29a–d with i-PrMgCl at –78 ºC, and the mixture was 
stirred at –78 ºC for 15 min (Scheme 3.9).  At this point, furan was cannulated into the 
flask, and the mixture was allowed to warm from –78 ºC to –10 ºC. The reaction mixture 
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was then stirred for the amount of time indicated to allow for the generation of benzyne 
3.31, and subsequent [4+2] cycloaddition to form the desired cycloadduct 3.32.   
 













a: R = CF3SO2                                      0 % yield of oxabicycle
b: R = CH3SO2                                     72 % (30 h)
c: R = 2,5-Cl2C6H3SO2                        87% (1 h)





Knochel was unable to isolate 3.32 when triflate 3.29a was used; a result he 
hypothesized had to do with the “rapid decomposition” of aryl triflates to form benzyne.  
If benzyne was generated quickly, by the time furan was added, there would be no 
benzyne left to trap, and benzyne dimerization products would predominate.  However, 
Knochel did not report the isolation of dimers.  The optimal leaving group was the p-
chlorophenylsulfonate group, which allowed for the formation of cycloadduct 3.32 in 
93% yield after 4 h. 
We were eager to try these conditions using triflate 3.25, as our cycloaddition 
partner was tethered to the molecule.  We felt that this “rapid decomposition” of aryl 
triflates proposed by Knochel would engender our molecule with the reactivity we 
needed to form cycloadduct 3.27 efficiently.  We also hoped that the i-PrMgCl would not 
attack the silicon tether as readily as alkyllithium reagents.   
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When we treated 3.25 with i-PrMgCl, we did not observe attack on the silicon 
tether, however reduced triflate 3.33 was the only product from the reaction (Scheme 
3.10).  We hypothesized that the triflate group did not eliminate at cold temperature and 
that the arylmagnesium species was quenched with water upon workup to give 3.33, 
hence the reaction was warmed from –78 °C to room temperature, but reduced material 
was again obtained.  
Glycosides like 3.25 often exist as viscous oils, which can trap solvents and water, 
Consequently, the starting material was rigorously dried by azeotroping it with benzene 
and heating the oils at 90 ºC under vacuum in an oil bath.  Regardless of all efforts to dry 
the material, 3.33 was the only product isolated from the reaction of triflate 3.25 with i-
PrMgCl.  It seems likely that the reducing agent in this case was the Grignard reagent 
itself, perhaps resulting from a single electron transfer mechanism being operative.141, 142  
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Difficulties using triflate as a leaving group for this reaction prompted us to look 
at other sulfonate leaving groups that Knochel had used, although we expected these to 
be less reactive.  Toward this goal, the tosyl analog 3.34 and p-chlorophenylsulfonyl 3.35 
analogs were both synthesized (Scheme 3.11 and 3.12).  Benzyne generation from 
tosylate 3.34 was inefficient (Scheme 3.11), and even with extended reaction times as 













































3.34 3.28  
 
Use of the p-chlorobenzene sulfonyl group as the leaving group was also explored 
(Scheme 3.12). When phenol 3.26 was treated with the p-chlorosulfonyl chloride and 
Et3N, sulfonate 3.35 was obtained in excellent yield.  Treatment of 3.35 with i-PrMgCl, 
according to Knochel’s protocol, followed by cleavage of the tether and concomitant 
TBS removal, gave alcohol 3.28 in 60% yield over two steps. This procedure provided 
the most efficient synthesis of the C ring of 5-hydroxyaloin A.   
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The ability to generate benzyne from 3.35 and not 3.25 raised questions about the 
effectiveness of the triflate leaving group. In theory, triflate should be a superior leaving 
group to the p-chlorobenzene sulfonate group that finally provided us with acceptable 
yield of 3.28.  Knochel had assumed that the failure of triflate with his method was due to 
the high reactivity of the group; however it is not certain that this was the case.  When 
they treated triflate 3.29a with i-PrMgCl then added furan, they did not isolate any of 
cycloadduct 3.32 from the mixture. However, they do not specify what the products of 
the reaction were, i. e. dimers or reduced material.  It is possible that benzyne was not at 
all formed in this case.  Perhaps the triflate group is so inductively electron withdrawing 
that it promotes reduction by the Grignard reagent via nucleophilic aromatic substitution, 
as shown by 3.25a and 3.25b, rather than functioning as a leaving group.    
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In order to determine if it was simply the change in leaving group to the p-
chlorophenyl sulfonate leaving group that caused this newfound efficiency with benzyne 
generation, we tried reacting sulfonate 3.35 with alkyllithium reagents.  When 3.35 was 
treated with n-BuLi, the desired cycloadduct was formed; however, furan 3.18 was also 
produced, and the use of alkyllithiums in this reaction was discontinued.   
With the unsymmetrically-substituted C ring of 5-hydroxyaloin A in place, we 
needed to set the stage for a selective halogenation.  Toward this end, phenol 3.28 was 
protected as its dibenzyl ether 3.36 (Scheme 3.13).  Treatment of oxabicycle 3.36 with 
TFA furnished the desired phenol 3.37 in excellent yield.   
 


































3.28 3.36 3.37  
 
 
3.3. BIMOLECULAR BENZYNE CYCLOADDITIONS 
3.3.1. Bimolecular cycloaddition without attempts to control regiochemistry 
Although the synthesis of phenol 3.37 had been achieved, the low yields in a few 
of the steps left little material to work with by the time the synthesis of phenol 3.37 was 
accomplished.  A more efficient route to 3.36 was needed, simply to bring forward 
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enough material to investigate the halogenation of phenol 3.37.  Thus, a bimolecular 
approach to 3.36 was also explored.   
The aim of the bimolecular cycloaddition was to form a benzyne precursor that 
could undergo a non-regioselective cycloaddition.  A mixture of four cycloadducts, 3.36 
and 3.39, would be formed (Scheme 3.14).  We could then separate the desired 
regioisomers 3.36 at this stage.  Thus, half of the material would be discarded, but if this 
route proceeded more efficiently than the intramolecular cycloaddition, we could still 
perhaps achieve a more efficient, though less elegant, synthesis of phenol 3.37.   
 



























3.18 3.38 3.36 3.39  
 
With the synthesis of furan 3.18 already in place, all that was required was a route 
to a suitable precursor of benzyne 3.38.  Sulfonate 3.45 was chosen to generate 3.38 
(Scheme 3.15).  Toward this end, acid 3.16 was converted into benzyl ether 3.40 using a 
known procedure.143 Iodination of 3.40 proceeded regioselectively, but slowly to give 
3.41a.  When 1.2 equivalents of iodine were used, the reaction did not reach completion; 
however, starting material could be recovered. If a large excess of iodine was used, the 
bis-iodinated compound 3.41b would form before the first iodination went to completion.  
Although 3.41a could not be monobenylated selectively, 3.42 could be separated from 
the mixture of starting material and a bisbenzyloxy compound and was obtained in 27% 
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yield. Phenol 3.42 was converted to sulfonate 3.43 in excellent yield.  Reduction of the 
ester efficiently provided alcohol 3.44, but reaction of 3.44 with NaH and BnBr did not 
afford 3.45; rather phenol 3.46 was obtained.    
 









































































3.41a X = H









Benzylation of alcohol 3.44 was then attempted using K2CO3 and BnBr, but even 
with overnight heating, only starting material was recovered (Scheme 3.16).  Treatment 
of alcohol 3.44 with benzyl-2,2,2-trichloroacetimidate144 in the presence of a catalytic 
amount of TfOH afforded a complex mixture of products, from which the desired benzyl 
ether 3.45 was not isolated.  
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Dudley has reported the benzylation of acid- and base-sensitive substrates under 
mild, neutral conditions using 2-benzyloxy-1-methylpyridinium triflate (Scheme 3.17).145, 
146 These conditions proved ideal for protecting alcohol 3.44 as its benzyl ether.  Heating 
alcohol 3.44 with the pyridinium salt and MgO in α,α,α-trifluorotoluene provided 3.45 in 
80% yield.   
 
























80% 3.453.44  
 
When a mixture of 3.18 and 3.45 was treated with i-PrMgCl, the desired 
cycloadduct was formed in low yield, as evidenced by the 1H NMR spectrum of the crude 
reaction mixture (Scheme 3.18).  Because we did not need to worry about attack at the Si 
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atom with this system, n-BuLi was also tried; however, only a trace of the cycloadducts 
was again observed.     
 






































In this situation the silicon tether is not an issue; therefore, we decided to again try 
a triflate leaving group and use n-BuLi for the metal-halogen exchange. Phenol 3.42 was 
converted to triflate 3.47 (Scheme 3.19).  Reduction of the benzyl ester provided 3.48.  
O-Benzylation of the alcohol using Dudley’s reagent gave triflate 3.49.   
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The cycloaddition using triflate 3.49 was much more successful, but in order to 
achieve moderate yields, 3.5 equivalents of 3.18 had to be used (Scheme 3.20).  Although 
unreacted furan could be recovered, its isolation required a difficult separation. Despite 
challenging chromatographic separations, we were able to obtain phenol 3.37 in 






























































3.3.2. Attempted bimolecular, regioselective benzyne cycloaddition 
While exploring the bimolecular reaction with sulfonate 3.46, it occurred to us 
that perhaps we could design a substrate that would undergo a regioselective 
cycloaddition based on electronics.  Because the α-position of furan 3.18 is readily 
deprotonated, we sought to introduce an electron donating group that would direct the 
cycloaddition in a head-to-head fashion, providing the correct regiochemistry of the 
unsymmetrical ring of 5-hydroxyaloin A (Scheme 3.21).  We required a group that could 
be readily removed, so we thought a sulfide might prove effective for our purposes.   
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Introduction of the sulfide moiety proceeded smoothly when furan 3.18 was 
lithiated and treated with dimethyl disulfide (3.53) (Scheme 3.22).  Again, 3.5 
equivalents of triflate 3.49 were used in the cycloaddition, and an inseparable mixture of 
products was obtained from the reaction.  In order to determine if the desired regioisomer 
predominated, or was present at all, cleavage of the carbon-sulfur bond was attempted.  
Cleavage would provide 3.36, a compound that had been fully characterized previously. 
Because of the extremely reactive double bond in the molecule, we attempted to use 
deactivated Raney-Ni for this process; however, we were unable to cleave the C-S bond.   
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3.4. THE ORTHO HALOGENATION OF NAPHTHOLS 
At this stage, it was necessary to introduce a halogen ortho to the phenol of 3.37 
(Scheme 3.24). Because of our past success generating naphthyne from 
monobromonaphthalene 2.97 using LDA (Figure 3.4 and Section 2.9), we first targeted 
bromonaphthalene 3.57 (Scheme 3.23).  Ortho brominations of phenols have been 
reported using molecular bromine as the halogenating reagent;147 however, good results 
for ortho brominations have also been reported using pyridium bromide perbromide 
(PyHBr•Br2).148 Treatment of phenol 3.37 with PyHBr•Br2 furnished the ortho-
bromophenol 3.56 in quantitative yield, and protection of 3.56 as its benzyl ether gave 
bromonaphthalene 3.57, from which we aimed to form a naphthyne.   
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At this point, a model reaction was performed to assess whether a naphthyne 
could be formed from bromide 3.57 (Scheme 3.24). Treatment of bromide 3.57 with 
LDA and furan unfortunately did not provide cycloadduct 3.58, and starting bromide 3.57 
was recovered in 90% yield.   
 



























The reaction shown in Scheme 3.24 could be complicated by side reactions, as 
LDA can also deprotonate furan α to the oxygen atom at –45 °C (Section 2.6).  Given 
this possibility, and the fact that 3.58 was not formed, we targeted the chloro and fluoro 
analogs of 3.58.   
The chlorination of phenol 3.37 with sulfuryl chloride in the presence of 
benzylmethylamine provided 3.59 in acceptable yield (Scheme 3.25).149, 150 Chlorinations 
using NCS were much less efficient.  The phenol was then protected as its benzyl ether to 
give naphthalene 3.60.   
 



































3.37 3.59 3.60  
 
Furans 3.61a and 3.61b were first explored as cycloaddition partners for the 
naphthyne generated from 3.60.  These furans should react to provide cycloadducts 3.62a 
or 3.62b that could be desilylated (Scheme 3.26).   s-BuLi was added at –78 °C to a 
solution of 3.60, furan 3.61b was added, and the solution was warmed to room 
temperature.  Unfortunately, only chloride 3.60 was observed in the 1H NMR spectrum.  
We attempted to use 2-(trimethylsiloxy)furan (3.61a) in the reaction, and then the more 
robust 2-methoxyfuran (3.61c) in the event that the furan was labile under the reaction 
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conditions.  None of these reagents resulted in the formation of cycloadduct 3.62, 
however.   
 



















3.62a: R = TMS
3.62b: R = TIPS








3.61a: R = TMS
3.61b: R = TIPS
3.61c: R = Me
 
 
In view of these failures, investigations were undertaken in order to determine 
whether or not deprotonation of 3.60 was occurring (Scheme 3.27).  Toward this end, 
chloride 3.60 was treated with t-BuLi or s-BuLi at –45, –78, and –100 ºC in THF or Et2O, 
and then the reaction mixture was treated with CH3OD.  These results were inconclusive, 
unfortunately, as the singlet corresponding to proton “a” is obscured in the 1H NMR 
spectrum by the numerous signals from the phenyl rings of the benzyl protecting groups.  
HRMS was also inconclusive for determining if deuterium incorporation had indeed 
occurred.   
 
 141 


























We thought that we might have better results if we could render the proton α to 
the halogen more acidic by introducing a more electronegative halogen.  Because very 
good results have been reported for the generation of benzyne via deprotonation α to a 
fluorine atom,151-155 routes to the fluoro analog of 3.60 were investigated.  We searched 
the literature for procedures for the ortho fluorination of phenols using electrophilic 
fluorinating reagents, which led us to examine the DABCO-derived Selectfluor (3.65).156-
161 This reagent is a commercially available electrophilic source of fluorine and is soluble 
in a limited number of polar solvents, including water, CH3CN, MeOH, and DMF. An 
advantage to this reagent is that the consumption of Selectfluor can be monitored via 
starch-iodide paper; a positive test indicates that the reagent has not been fully consumed.  
The fluorination of phenols using Selectfluor is most often carried out at elevated 
temperature in CH3CN,162 although in one case, the selectivity of ortho fluorination was 
improved using MeOH as solvent (Scheme 3.28).157 The ipso substitution product 3.67 
was observed in the fluorinations of phenol 3.64 in CH3CN; however, in MeOH, 
improved yields of the desired ortho-fluorinated phenol 3.66 were reported.  In this study, 
the alkyl group was varied, with smaller alkyl groups showing greater amounts of the 
ipso-substitution product being formed in CH3CN.  
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CH3CN (84%)      60                         40




Despite the fact that ipso substitution could be problematic, we attempted to form 
ortho-fluorophenol 3.68.  We initially tried the reaction in DMF because we found that 
phenol 3.37 was insoluble in both MeOH and CH3CN (Table 3.2, entry 1).  After 10 min 
the reaction was worked up, based on a negative starch-iodide paper test.  On this 20 mg 
scale however, the test was deceptive and the reaction was not complete.  Stopping the 
reaction early was fortunate, as multiple products had formed, and we were able to 
recover some of our starting phenol from this trial.  Two singlets, interpreted as phenolic 
signals were observed downfield from 10 ppm in the 1H NMR spectrum of the crude 
material, which were presumably phenolic products from unselective fluorination.    
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2 singlets > 10 ppm, 71% RSM
6 singlets > 10 ppm
2 singlets > 10 ppm, 63% RSM
Many singlets >10 ppm










a The reactions were analyzed by the 1 H NMR spectrum of the crude reaction mixture.  b 1 eq. DABCO 



























We found 3.37 was soluble in hot CH3CN, although fluorination of phenol 3.37 
under reflux in CH3CN proved too harsh (entry 2), and many singlets were observed in 
the 1H NMR spectrum around 10 ppm.  When 3.37 in CH3CN was cooled from 70 ºC to 
room temperature, phenol 3.37 remained in solution, and we were thus able to attempt 
this reaction at room temperature.  Unfortunately, many phenolic products were again 
observed.  Running the reaction in MeOH (entry 5), warming first to solubilize the 
phenol, gave similar results.  Finally, one equivalent of DABCO was added to the 
reaction, as we hypothesized that the presence of a phenoxide ion might help direct the 
ortho fluorination; unfortunately, no reaction occurred (entry 6).   
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Other commercially available fluorinating reagents that have been utilized for the 
ortho-fluorination of phenols are N-fluoropyridinium triflate (NFPT) (3.69)163 and N-
fluorosulfonimide (NFS) (3.70) (Table 3.3),158 so phenol 3.37 was treated with these 
fluorinating reagents under a variety of conditions.  The reactions were sluggish as 
compared to those using Selectfluor.  Over long periods of time, phenolic peaks were 
observed in the 1H NMR spectrum of the crude reaction mixture when phenol 3.37 was 
treated with NFS.  NFPT in CH2Cl2 provided none of the desired product at room 
temperature (entry 2), and when this reagent was heated with 3.37, many phenolic signals 
were again observed (entries 3 and 4), perhaps resulting from non-selective fluorination 
on various positions of the aromatic ring.   
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Table 3.3: Other attempted fluorinations of phenol 3.37 
entry temp time result asolvent
a The reactions were analyzed by the 1 H NMR spectrum of the crude reaction mixture.  b 




























rt to 70 ºC c
rt to 70 ºC c








mainly 3.37, 3 new phenolic signals
no reaction
mainly 3.37, 3 new phenolic signals

































In an attempt to improve the reaction, 2,6-lutidine was added to the reaction. We 
hoped that this non-nucleophilic base would furnish the phenoxide ion of 3.37 and 
potentially improve the reaction by directing the ortho fluorination.  Unfortunately, the 
addition of base completely shut down the reactions (entries 5–7), and even with 
prolonged heating, only starting material was recovered.   
As the direct ortho fluorination of phenol 3.37 was not providing the desired 
fluoride 3.68 cleanly, a new approach to 3.68 was needed.  Based on literature example, 
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bromides can be converted into fluorides via metal-halogen exchange followed by 
treatment of the intermediate anion with NFS (3.70) (Scheme 3.29).158 Accordingly, 
bromide 3.57 was lithiated, and NFS (3.70) was then added to provide fluoride 3.71 in 
moderate yield.  
 
































We attempted to lithiate 3.71, and to introduce a deuterium atom ortho to fluorine 
by adding deuterated methanol to the mixture.  Although these reactions were 
inconclusive, we attempted the cycloaddition reaction nevertheless. Fluoride 3.71 was 
treated with t-BuLi at –78 ˚C for 3 h (Table 3.4), siloxyfuran 3.61a was added, and the 
reaction was warmed to rt.  Unfortunately, only starting material was observed.  We were 
concerned that adventitious water might be quenching the alkyllithium reagent, so 
another reaction was attempted, in which NaH was added to the reaction in order to dry 
fluoride 3.71 (entry 2).  Lithiation and cycloaddition were attempted as described in the 
previous reaction; however, starting fluoride 3.71 was again recovered, along with 2-
furanone. 
2-Methoxyfuran 3.61c was also examined as a reaction partner (Table 3.4).  
Lithiation of 3.71 was attempted at various temperatures using various alkyllithiums, 
furan 3.61c was added, and the reaction was warmed to room temperature and stirred 
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overnight.  Unfortunately, we did not isolate 3.62a or 3.62c from the reaction, and only 
starting fluoride 3.71 and butenolide were observed in the 1H NMR spectrum of the crude 
material.   
 
Table 3.4: Attempted benzyne generation with the fluoride 
entry temp time b result d
a 1.5–2 eq. of the alkyllithium was used. b Time at the initial temperature prior to warming to rt.  c NaH 

















–78 ºC to rt
–78 ºC to rt
–78 ºC to rt
–50 ºC to rt
–50 ºC to rt
–78 ºC to rt
































–78 ˚C to rt
3.71
3.61a: R = TMS
3.61c: R = Me
3.62a: R = TMS
3.62b: R = Me
Major result: 
Starting fluoride 3.71 
was detected.
Decomposition of furan












Repeated difficulties accessing naphthyne from a monohalonaphthalene prompted 
us to revise our approach.  In the synthesis of vineomycinone B12 and in prior glycal 
work (Sections 1.3.3 and 2.6), we had found that dihalonaphthalenes were excellent 
precursors of benzynes, and we moved to a tactic to access these dihaloarenes. 
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3.5. ATTEMPTS TO ACCESS DIHALONAPHTHALENES 
3.5.1. Dihalonaphthalenes via halogenation of oxabicycles 
The deprotonation of monohalonaphthalenes 3.57, 3.60, and 3.71 had proved 
difficult (Figure 3.5),95 and we had found in our prior work that o-dihalo systems were 
more reliable for benzyne generation (Section 2.6).  We thus chose to investigate the 
preparation of o-dihalonaphthols such as 3.72.   
 




















3.57: X = Br
3.60: X = Cl




There are several literature examples in which dihalonaphthols are formed from 
oxabicycles (Scheme 3.30).164 Balci reported the unexpected formation of the 
dichlorinated oxabicycle 3.74 during the Pd-catalyzed esterification of alkene 3.73.  This 
minor product underwent ring opening and aromatized readily when treated with silica 
gel to afford naphthol 3.76.   
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For our synthesis, we would need to introduce a halogen atom that would undergo 
metal-halogen exchange readily, so we examined the dibromination of oxabicycles with 
the aim of converting them to dibromonaphthols.  Indeed, the dibromination of 
oxabicycles is also known. However, rearrangement products are observed under certain 
conditions (Scheme 3.31).165 Dastan reported that the treatment of oxabicycle 3.73 with 
Br2 at room temperature resulted in the exclusive formation of rearranged aldehyde 3.77.  
When oxabicycle 3.73 was treated with dibromotetrachloroethane (DBTCE) at elevated 
temperature and irradiated with a sunlamp, a regioisomeric mixture of the dibrominated 
oxabicycles 3.78 and 3.79 was formed in very good yield.  It appears that it is the cationic 
species that undergoes the rearrangement readily, whereas the radical species does not 
rearrange.   
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Balci and Dastan also used molecular bromine at elevated temperature to attain a 
mixture of dibromides 3.78 and 3.79 (Scheme 3.32). These oxabicyclic dibromides can 
undergo elimination to furnish alkenes when treated with potassium tert-butoxide.166 
Bromoalkene 3.80 can undergo bromination again at elevated temperature to furnish 
tribromides 3.81 and 3.82, and when this mixture was subjected to the same conditions 
for elimination, dibromoalkene 3.83 was obtained.   
 







































The conversion of brominated alkenes to phenols has been reported by Schlosser 
(Scheme 3.33).167 Schlosser used the same conditions as Balci to access bromoalkenes 
3.86 and 3.87.  Both alkenes 3.86 and 3.87 underwent ring opening in good yield by 
treatment with HCl in MeOH, affording phenols 3.88 and 3.89, respectively.   
 



































Given this promising precedent, our aim was to perform successive bromination-
elimination reactions and then to effect ring opening of the dibromide 3.90, forming 
dibromonaphthalene 3.91 (Table 3.5).  Bromination of alkene 3.36 using molecular 
bromine at elevated temperature provided a complex mixture of products (entry 1).  
Analysis of the mixture by IR spectroscopy revealed the presence of an OH stretch and 
carbonyl stretch, presumably from a rearranged product and a ring-opened product.  After 
several attempts to brominate 3.36 using molecular bromine, Dastan’s conditions were 
tried (entries 2-4).  No reaction occurred when 3.36 was treated with AIBN and DBTCE 
(entry 2), and attempts to brominate alkene 3.36 at elevated temperature for extended 
 152 
periods of time resulted in a mixture of unidentified products (entries 3 and 4). 
Bromination of the olefin using PyHBr3 was examined (entry 5); however, this reaction 
also gave a complex mixture, and dibromide 3.90 was not isolated.   
 





























OH and C=O strech a
NR b
singlets at 9.8, 10.0 ppm b OH stretch a
mainly SM, s at 10.0 ppm b
complex mixture
Br2, CCl4
AIBN, DBTCE, CCl4 h!
AIBN, DBTCE, CCl4 h!
AIBN, DBTCE, CCl4 h!
PyHBr3, CH2Cl2

























Our attention was turned to a model system at this point, as the supply of 
oxabicycle 3.36 was limited (Scheme 3.34).  To synthesize the model, the cycloaddition 
of 2-chloro-1,4-dimethoxybenzene (3.92) and 2-methylfuran was conducted to provide 
alkene 3.93 in 50% unoptimized yield.  The bromination of 3.93 was tried both under 
reflux and at colder temperatures, but it did not appear that dibromide 3.94 was being 
formed by LRMS.   
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In addition to the desired brominated oxabicycle 3.94, the rearranged compounds, 
ketone 3.95 and aldehyde 3.96 are potential products of the bromination (Figure 3.4). 
When 3.93 was treated with Br2 at elevated temperature, singlets that may correspond to 
aldehyde protons were observed in the 1H NMR spectrum of the crude mixture.  The 
major spot by TLC was found to be a mixture of products, and analysis of this mixture by 
IR spectroscopy revealed an OH stretch.  It was obvious at this point that this method 
would be difficult to apply to our system, and this approach to dibromonaphthalenes was 
abandoned.   
 











3.5.2. 3-Halofurans to access dihalonaphthalenes 
We were still interested in accessing dihalonaphthalenes, so we reinvestigated an 
approach that was briefly attempted by Dr. Li.  Dihalonaphthalenes 3.97 could come 
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from halogenated oxabicycle 3.98 via ring-opening and halogenation (Scheme 3.35).  The 
oxabicycle would be accessed via the addition of a 3-halofuran 3.99 to a sugar lactone 
3.100.   
 
































Dr. Li had attempted the ring opening with chlorinated oxabicycle 1.272, but 
when 1.272 was treated with TFA, there was no reaction (Scheme 3.36).  Treatment of 
1.272 with TMSOTf did not furnish 1.274; rather a phenolic product that had lost the 
sugar portion of the molecule was isolated, although this phenol was not fully 
characterized.    
 






















1.272 1.274  
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We felt that this approach warranted reinvestigation because we had discovered 
that ring-opening conditions are very substrate-specific, and perhaps a chlorinated 
oxabicycle could be opened with a different Lewis acid.  ZnCl2 would serve as our 
starting point, given our success using this Lewis acid for the ring opening of glycals.   
Our studies began with chlorofuran 3.103 that Li had used, although we 
developed a modified synthesis (Scheme 3.37).  Due to the inefficiency and difficult 
distillations when generating 3-chlorofuran from 3-bromofuran,168 lactone 3.100 was 
reacted with lithiated 3-bromofuran to provide lactol 3.101.  Reduction of 3.101 
furnished furyl glycoside 3.102, which was efficiently converted to the chloride 3.103.  
The stage was set to investigate the benzyne cycloaddition with this substrate.  We again 
used triflate 3.49 as we had the most success using this substrate in other bimolecular 
cycloadditions.  The reaction proceeded in 44% yield, and required a threefold excess of 
furan 3.103.  The cycloaddition was not regioselective as we had hoped, but we were able 
to separate the desired regioisomer 3.104 and test the ring opening step.  If we could 
access naphthol 3.105, this would allow for two possible methods of benzyne generation.  
Naphthol 3.105 could either be protected and deprotonated to form benzyne directly, or 
an additional halogen could be introduced to produce a dihalonaphthalene, followed by 
benzyne generation.  Unfortunately, chloride 3.104 proved as robust as chloride 1.272, 
and was unreactive when mild Lewis or Brønsted acids were used.  When 3.104 was 
subjected to stronger Lewis acidic conditions, such as TMSOTf, the naphthol 3.106 was 
formed.  
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The difficulty encountered in effecting ring opening of 3.104 and the formation of 
naphthol 3.106 can both be attributed to carbocation stability (Scheme 3.38).  Ring 
opening in the desired orientation would give intermediate 3.107, with a carbocation that 
is destabilized by the inductive electron withdrawing effect of the chlorine atom.  
Opening of the oxabicycle in the undesired orientation would give intermediate 3.108, 
where the carbocation can be stabilized, as shown by canonical form 3.109.  
 157 
Unfortunately, this system cannot rearomatize without expulsion of the glycoside to 
produce naphthol 3.106.   
 





















































This setback prompted us to reexamine this approach.  We needed a substrate that 
had electronic factors that would outweigh the destabilization of 3.107.  We decided to 
investigate a glycal for the sequence (Scheme 3.39).  Glycals have been found to ring 
open more readily in prior work (Chapter 2), and the stabilizing effect of the enol ether 
was hoped to outweigh the destabilizing effect of the chlorine atom in the ring opening 
step (Figure 3.7).   
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In a novel application of our methodology to form furyl glycals, lithiated 2-
bromofuran was reacted with 2-deoxysugar lactone 3.108, and the intermediate adduct 
underwent elimination to provide furyl glycal 3.109 (Scheme 3.39).  Reaction of 3.109 
with n-BuLi effected metal-halogen exchange, and trapping the intermediate anion with 
C2Cl6 gave 3.110.  The benzyne that was generated from triflate 3.49 reacted with 3.110 
to give a separable mixture of cycloadducts.  Cycloadduct 3.112 was found to open to 
form a hydrogen-bonded phenol that was tentatively assigned 3.113; however, other 
“phenolic” signals were observed as singlets around 9–10 ppm in the 1H NMR spectrum 
of the crude material.  As noted in Chapter 2, these glycals are prone to decomposition on 
silica gel.  We were unable to optimize this ring-opening reaction.   
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3.6. REVISION OF THE SYNTHESIS: A NEW TETHER STRATEGY 
The continual difficulties with the generation of benzyne from 
monohalonaphthalenes prompted us to repeat Dr. Li’s successful reaction for generating 
benzyne from a chloronaphthalene.  Thus, benzyne generation from chloride 1.276 was 
investigated to ensure that the prior art could be reproduced (Scheme 3.40).  
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Treatment of chloronaphthalene 1.276 with s-BuLi at –100 ºC, followed by 
treatment with furan effectively produced adduct 1.277 in 50% yield.  Having reproduced 
Dr. Li’s result, a question was raised: Why could we deprotonate chloride 1.276 and not 
chloride 3.53, which had the C ring installed and could be readily elaborated to the 
natural product?  One possible reason is the acidity of the additional benzylic positions on 
the aromatic ring in chloride 3.53.  It is well precedented that benzylic positions can be 
deprotonated using strong base.169 We reexamined the 1H NMR spectra obtained from the 
attempted deuteration reactions of compounds such as 3.53 to determine if there was any 
deuterium incorporated in the benzylic region of the spectrum.  Unfortunately, due to the 
numerous benzyl protecting groups on the glycoside, it could not be determined 
definitively if deuterium had indeed been incorporated.   
 





























We sought to form a molecule similar to chloride 1.276, which was known to 
form naphthyne, and we revised our retrosynthesis accordingly.  In this new approach, 5-
hydroxyaloin A (3.5) would come from the global deprotection and desulfurization of 
3.114 (Scheme 3.41).  Phenol 3.114 would arise from cleavage of the one-carbon silicon 
tether and ring opening of silane 3.115, which is the product of the intramolecular 
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cycloaddition of halide 3.116.  Introduction of the sulfide moiety is key, as it is necessary 
to control the regioselectivity of the ring opening.  Compound 3.116 would come from 
the etherification of halophenol 3.117 and silyl bromide 3.118. 3-Furanmethanol (3.119) 
would be used to access 3.118. The use of the one-carbon tether is preferred since 
hydroboration-oxidation conditions used to install the two-carbon tether could potentially 
oxidize the sulfur atom.  We sought to avoid an oxidation step completely, as a sufoxide 
or sulfone would destabilize the desired carbocation in ring opening step.   
 















































































In order to evaluate this new plan, 3-furanmethanol (3.119) was treated with n-
BuLi, followed by treatment with dimethyl disulfide (Scheme 3.42).  According to 
literature precedent, lithiation of 3.119 occurs at C(2) due to chelation, thus we were able 
to form sulfide 3.120 regioselectively.170 The regiochemistry was assigned based on the 
1H NMR spectrum (C4: d, J = 2.1 Hz; C5: d, J = 2.1 Hz) and was confirmed by NOE 
experiments. Protection of 3.120 provided silyl ether 3.121, which was lithiated and 
treated with bromomethyl chlorodimethylsilane to provide 3.118.  
 





































During scale up, we found that the yield of silyl ether 3.121 could be improved by 
carrying on the crude mixture from the sulfide-forming step (Scheme 3.43).  In the event, 
unpurified 3.120 was treated with TBSCl and imidazole to give 3.121 in 82% yield. 
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    then MeSSMe
2. TBSCl, imidazole, DMF
     then chromatography
82% (2 steps)
3.119 3.121  
 
With the synthesis of the furan for the C ring of 5-hydroxyaloin A (3.5) in place, 
efforts were turned toward optimizing the synthesis of bromophenol 3.124, which had 
been previously synthesized using a different route.  Cycloaddition of furan 3.18 with the 
benzyne generated from 3.84 gave 3.122 in 74% yield (Scheme 3.44).  Dr. Li had 
reported the ring-opening of adduct 3.122 to be low yielding when BF3•OEt2 was used.  
We discovered that this reaction could be optimized by treating cycloadduct 3.122 with 
ZnCl2.  Although the mixture of 3.122 and ZnCl2 had to be stirred at least 24 h for starting 
material to be consumed, this modification provided phenol 3.123 in 93% yield.  This 
was a significant result, as Dr. Li had hypothesized that the C(2)-substituent of sugars 
was responsible for decreased yields in the ring opening step, which had prompted us to 
investigate glycals as a 2-deoxygenated substrate for this reaction (Chapter 2). The result 
for the conversion of 3.122 to 3.123 was significant; we had shown that it is the choice of 
Lewis acid, rather than the C(2)-substituent that is responsible for low yields in the ring 
opening step. Finally, treatment of 3.123 with PyHBr3 furnished bromide 3.124 in 
quantitative yield.   
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With an efficient synthesis of furan 3.118 and phenol 3.124 in place, efforts were 
made to link these compounds via an etherification reaction (Table 3.6).  Keeping in 
mind studies by Schecter and Kreeger (Section 1.3.2, Scheme 1.41),91, 92 which indicated 
that sodium alkoxides were less likely to attack at the silicon atom, we began with 
Na2CO3 and NaH (entries 1-3).  Even with heating, starting phenol 3.124 was recovered 
in nearly quantitative yield (entries 1 and 2).  Using K2CO3 gave a complex mixture, and 
an additional phenolic signal in the 1H NMR spectrum of the crude material prompted us 
to investigate other conditions. The best results for this reaction were obtained when 
Cs2CO3 was used (entries 6-10).  This transformation was very slow, and stirring at room 
temperature for 2 days furnished the desired ether in only 27% yield.  Increasing the 
molar equivalencies of silane 3.118 did not improve the yield (entry 8), and omission of 
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TBAI resulted in no reaction (entry 9).  Switching the solvent to DMF led to no 
significant improvement.   
 
Table 3.6: Williamson etherification with bromophenol 3.125 




















































a Isolated yield after column chromatography.  b 2 eq. of silane 3.118 were used.  










































Although the yield of the etherification was low, enough of ether 3.125 was 
prepared to determine if the cycloaddition could be achieved with this substrate (Scheme 
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3.45).  Unfortunately, we were not able to effect the intramolecular cycloaddition when 
bromide 3.125 was treated with LDA.   
 




































The reason that the cycloaddition reaction was first tried with bromide 3.125 was 
simply accessibility.  A direct synthesis of chlorophenol 125 had not yet been achieved; 
we had formed chloride 1.276 via bromide 3.124a in past work (Scheme 3.46).  Since we 
wanted to maintain a free phenol, we could not readily convert bromide 3.124 to a 
chloride using this method.  
 


















3.124: R = H
MeO
Br











While working on the etherification of bromide 3.124, the direct chlorination of 
naphthol 122 finally proved fruitful, and NCS in DMF gave chloronaphthol 125 cleanly 
and in good yield (Scheme 3.47).  The etherification reaction was not straightforward, 
however.  The reaction was very slow when K2CO3 was used, even with prolonged 
heating.  Many reaction conditions were tried using Cs2CO3, and by comparison of the 1H 
NMR spectra of bromide 124 and the “purified” mixture of chloride 126, it appeared that 
the desired ether was present; however, it could not be separated from the mixture.   
 




















































We have consistently found the Mitsunobu etherification to be the most efficient 
method to link furans to phenols.  Consequently, we converted bromide 3.118 to acetate 
3.127 in 93% yield, and reduction of 3.127 provided alcohol 3.128, also in 93% yield 
(Scheme 3.48).  
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3.118 3.1283.127  
 
Alcohol 3.128 underwent the Mitsunobu etherification smoothly with 3.125, and 
the desired ether 3.126 was produced in 65% yield (Scheme 3.49).  Treatment of ether 
3.126 with s-BuLi at –45 ºC, followed by warming to –10 ºC provided cycloadduct 3.114 
in 50% yield.  Desilylation by treatment with TBAF afforded methyl ether 3.129. When 
TFA or ZnCl2 was added to 3.129, this resulted in intractable mixtures. However 
treatment with CSA furnished anthrone 3.114. Only a desulfurization and global 
deprotection was needed to convert 3.114 to the natural product. We had finally achieved 
a synthesis of a tricyclic structure that could potentially be elaborated to 5-hydroxyaloin 
A.   
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The desulfurization of 3.114 was then attempted using excess Raney-Ni (Scheme 
3.50).  Deactivated Raney Ni was first tried, using both MeOH and EtOH as solvent.  
Unfortunately, at room temperature there was no reaction.  Activated Raney Ni gave 
mixtures, most likely due to various debenzylation products, some of which were 
isolated. Incomplete debenzylation was a continual problem with this reaction.  We could 
not achieve complete debenzylation using Raney Ni, and heating and prolonged reaction 
times led to intractable mixtures of many products.   
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The desulfurization of 3.114 was also attempted using nickel boride, generated in 
situ from the reaction of NiCl2 and sodium borohydride (Scheme 3.51).171, 172 The product 
of this reaction was a reduced anthrone, as evidenced by the disappearance of the 
carbonyl stretch in the IR spectrum.  Surprisingly, the carbon-sulfur bond remained 
intact.  We began to wonder about the accessibility of the thiomethyl group and whether 
our system might be too hindered for the desulfurization to take place.   
 






























In order to determine if the benzyloxy protecting groups on the sugar might be 
preventing the desulfurization, we reversed the order of the final steps and performed the 
global deprotection step first.  Compound 3.114 was thus treated with BBr3 to remove the 
benzyl groups from the sugar and the methyl groups protecting the hydroquinone 
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(Scheme 3.52). The product that we obtained had not undergone demethylation, although 
the benzyl groups were effectively removed.  An unexpected observation in the 1H NMR 
spectrum of the major product was the disappearance of the singlet corresponding to the 
hydrogen-bonded phenol.   
 
























   –78 ºC
ii. MeOH, 23 ºC
 
 
Although the product of the reaction in Scheme 3.52 was not fully characterized, 
we hypothesized that a boron chelate was formed, and the reaction was run again, this 
time adding acidic methanol and stirring overnight in an attempt to break up any such 
chelates (Scheme 3.53). The reappearance of the singlet corresponding to the hydrogen-
bonded phenol at 12.2 ppm in the 1H NMR spectrum supported our hypothesis.  
We made many attempts to demethylate 3.114 using BBr3. We increased reaction 
time and temperature in an effort to remove the methyl protecting groups from 3.114; 
however, none of these trials met with success. Increasing the temperature at which BBr3 
was added resulted in reduced isolated yield of 3.132. 
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Scheme 3.53: Attempted global deprotection 
i. BBr3, CH2Cl2
   –78 ºC
ii. HCl in MeOH






















3.114 3.132  
 
Our difficulties effecting the demethylation of this system are not particularly 
surprising, as there are many examples in the literature where methyl ether cleavage 
using BBr3 is problematic, especially in situations where stable chelates can form.  For 
example, it is often difficult to cleave a second methyl ether in examples where removal 
of the first results in the formation of a chelate (Scheme 3.54).173 The formation of 3.134 
would build up negative charge up on the aromatic ring, making other methoxy groups on 
that ring harder to remove.  One methoxy group was removed from 3.133, furnishing 
exclusively phenol 3.135.    
 



























3.133 3.134 3.135  
 
In the synthesis of ventilone, Piggot and Wege report difficulty removing the 
second methoxy group from quinone 3.136 (Scheme 3.55).174 When 3.136 was treated 
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with BBr3, they were only able to isolate 3.137, the product of a single demethylation. In 
order to access the desired hydroquinone 3.138, Et2O was added to the reaction, and the 
mixture was stirred for an extended period of time at –78 ºC.  They proposed that the 
ether broke up the chelate that had formed, allowing the second methyl ether to be 
cleaved.   
 



































3.138   
 
Deprotecting methyl groups had presented problems in the Martin group synthesis 
of galtamycinone (Scheme 3.56).94 Various conditions were tried in an attempt to 
demethylate, however, the methyl group was extremely robust.  The inability to cleave 
methyl ether 3.139 caused the group to publish a formal synthesis, in which the route to 
an earlier intermediate was reported. The compound that constituted the formal synthesis 
was a key intermediate of Suzuki’s total synthesis of the natural product.   
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3.139 3.140  
 
Given this precedent, we knew that our system would be difficult to demethylate, 
however we hoped that we could employ non-chelating conditions to accomplish this.  
We had found that we could streamline the synthesis by treating cycloadduct 3.115 with 
CSA (Scheme 3.57), providing 3.141 80% yield.  Recall that the two-step tether 
cleavage/ring opening procedure provided 3.114 in only 40% yield over two steps.  
Compound 3.141 was thus used from this point on in the deprotection reactions, as the 
TBS ether should be also be cleaved under the strong Lewis acidic conditions.      
 
































We first attempted to utilize the procedure from the synthesis of ventilone A to 
deprotect anthrone 3.141 (Scheme 3.58).174 Following the addition of BBr3 at –78 ºC, 
Et2O was added, and then the mixture was allowed to warm to room temperature.  Even 
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with overnight stirring following the addition of Et2O, 3.132 was the major product of the 
reaction.   
 













BBr3 (30 eq.) then

















Because the free phenol group of 3.141 could facilitate chelate formation, we 
attempted the deprotection on 3.115.  Given our precedent for tandem desilylation/ring 
opening (Scheme 3.57), we treated 3.115 with BBr3 and BBr3•DMS (Scheme 3.59).  The 
chelate would not be able to form as readily with this molecule, and we thought that we 
might be able to streamline the synthesis even further.  Unfortunately, complex mixtures 
of products were obtained from these reactions.   
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–78 ºC to 0 ºC
3.115 3.132  
 
TMS-I was also examined as a reagent for the demethylation of 3.141 (Scheme 
3.60).  Demethylation of 3.141 did not occur at cold temperature, and when 3.141 was 
treated with TMSI at room temperature or elevated temperature an intractable mixture 
was obtained, and the desired anthrone 3.132 was not isolated.   
 































Given our difficulties in the present synthesis of hydroxyaloin A, coupled with 
literature and group precedent for difficulties associated with the demethylation of similar 
systems, we investigated an approach that did not rely on such a difficult deprotection 
late in the game.  With benzyl groups already present on the sugar, it was logical to 
pursue a benzyne that would introduce the same protecting groups onto the aryl portion 
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of the molecule.  Toward this end, the phenols of chlorohydroquinone (3.142) were 
protected as benzyl ethers, giving 3.143 in 81% yield (Scheme 3.61).  The cycloaddition 
of the benzyne generated from 3.143 with glycosyl furan 3.18 provided cycloadduct 
3.144 in only 53% yield.  Although the conditions were identical to those used to form 
methyl analog 3.122, we could not achieve the same yields.  We attribute the decreased 
yield in this reaction with a steric interaction.  We had seen in the past a decrease in 
efficiency when C(2)-substituted sugars were employed as opposed to 2-deoxysugars.95 
The large protecting groups on the benzyne are probably the cause for the diminished 
yields.   
 



































    CH2Cl2 










Nevertheless, we were able to obtain cycloadduct 3.144 in 53% yield, and we 
were able to recover furan 3.18.  Fortunately, ring opening of 3.144 proceeded in 
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excellent yield, and ortho chlorination of the resultant phenol was achieved, providing 
3.145 in 64% overall yield from 3.144.   
We were poised to perform the etherification of chloride 3.145 with silyl alcohol 
3.128.  This reaction had previously been optimized for the methyl analog in PhCH3, with 
a high yield of 65%. Optimal conditions for this etherification using THF allowed us to 
achieve a 72% yield of ether 3.146 (Scheme 3.62).  The intramolecular naphthyne 
cycloaddition of 3.146 was achieved in 33% yield. Despite many attempts, this reaction 
could not be further optimized. 
 





























































We accessed an anthrone using our newly developed tandem process; treatment of 
3.147 with CSA produced anthrone 3.148 in 80% yield (Scheme 3.63).  Deprotection of 
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3.148 using BBr3 resulted in the formation of a thiomethyl analog of 5-hydroxyaloin A 
3.149, leaving only a final desulfurization to access the natural product.   
 

























































Desulfurizations were then attempted on both the perbenzylated anthrone 3.148 
and thiomethyl analong 3.149.  Because desulfurizations of aryl thiomethyl compounds 
using Raney nickel are well precedented,175-178 we again attempted to apply these 
conditions (Scheme 3.64).  Unfortunately, the sulfide was extremely robust, and we were 
unable to desulfurize 3.149. 
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The debenzylation and desulfurization of 3.148 was also attempted, with an added 
balloon of hydrogen gas in an attempt to speed up the reaction (Scheme 3.65).  The major 
product was fully debenzylated, however the sulfide was still present, and the benzylic 
methylene of the aglycone was not present in the 1H NMR spectrum.  It is precedented 
that activated Raney nickel can cleave the hydroxy group of benzylic alcohols.179 
 


























Desulfurization of 3.148 using nickel boride was also attempted (Scheme 3.66).172 
Again, the anthrone was reduced, and the sulfide was still present.  It should be noted that 
when 2–3 equivalents of nickel boride was employed, the reduced anthrone was the only 
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product.  Use of a large excess of nickel boride (10–20 equivalents) resulted in the 
formation of an intractable mixture of products.   
 































We then attempted to “deactivate” the nickel boride to prevent the reduction of 
the anthrone. The mixture of NiCl2 and NaBH4 was first heated under reflux, and then 
3.148 was added to the mixture as a solution in EtOAc (Scheme 3.66) or 3.149 as a 
solution in MeOH (Scheme 3.67).  These reactions were completely ineffective, and 
starting material was recovered from the reaction.  
 

































































Further investigation into the proposed mechanism for desulfurization using 
nickel boride may give insight into the lack of success with these reactions.  
Mechanistically, it is believed that hydrogen gas, formed from sodium borohydride and 
the protic alcohol, is adsorbed to the metal surface, forming Ni2B2•H3.172 However, nickel 
boride loses its activity upon aging much faster than Raney nickel. It has been speculated 
that the active reducing agent is a transient nickel hydride complex is formed, and this is 
critical to the activity of the complex, and that it is not simply preadsorbed hydrogen on 
the surface that contributes to the activity.172 This is the reason these desulfurizations are 
generally carried out in a manner such that the nickel boride is generated in the presence 
of the sulfide and, even after five minutes, nickel boride has been shown to lose activity.  
In retrospect, the reactions shown in Schemes 3.66 and 3.67 may have failed because the 
active reducing species was not present in the mixture.   
NiCRAs are non-pyrophoric nickel complex reducing agents that are known to 
cleave sulfides180 as well as sulfoxides and sulfones.181 We thus attempted to use NiCRA 
to desulfurize 3.148 (Scheme 3.68).  This approach was also ineffective, as complex 
mixtures of products were obtained.   
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Given the lack of success in the desulfurization of sulfides, sulfoxide 3.151 was 
formed by from 3.148 by treatment with mCPBA at –30 ºC (Scheme 3.69).  Because 
sulfoxides and sulfones are more easily reduced, this approach might be superior, 
although sulfoxide formation added steps to our synthesis.  We also anticipated that this 
would allow for more options for conditions to desulfurize 3.151 as sulfoxides are more 
amenable to reduction via single electron transfer reagents.   
 





























3.148 3.151  
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We initially tried the previously mentioned methods to desulfurize sulfone 3.151.  
Namely, activated and deactivated Raney nickel, sodium boride, and NiCRAs were 
employed in an attempt to cleave sulfoxide 3.151 (Scheme 3.70).  Sulfoxide 3.151 proved 
as resistant as sulfides 3.148 and 3.149 to desulfurization under these reductive 
conditions, and we were unable to effect C–S bond scission.   
 























Single electron transfer reagents were then explored for the desulfurization of 
sulfoxide 3.151.  Sodium/mercury amalgam in the presence of dibasic sodium phosphate 
is known to cleave sulfoxides, however starting material was recovered quantitatively 
from this reaction (Scheme 3.71).  Increasing the reaction time to several days or heating 
only resulted in lower recovery of 3.151.   
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Desulfurization of 3.151 was then attempted using samarium iodide, generated by 
sonication of a mixture of samarium metal and iodine in THF (Scheme 3.72).182 When 
3.151 was treated with the samarium iodide solution, a new spot formed, however the 
product was not desulfurized 3.150 as was expected, rather a sulfide peak was detected in 
the 1H NMR spectrum.  Partial debenzylation had also occurred, and the isolated 
compound was tentatively assigned 3.153 based on the 1H NMR spectrum.   
 










































SUMMARY AND CONCLUSIONS 
Two approaches to 5-hydroxyaloin A have been explored.  In our first approach, 
the symmetrically substituted C ring of 5-hydroxyaloin A was formed first, using both an 
intramolecular and bimolecular approach. We demonstrated reduced cleavage of the 
silicon tether by implementing Grignard reagents for benzyne generation. Silicon tethers 
are extremely useful when performing aryne cycloadditions that are not electronically 
poised to undergo regioselective cycloadditions. However, this work has also shown that, 
in some situations, it is more convenient to perform the cycloaddition without 
regiocontrol and to separate the regioisomers that are formed.   
Naphthyne generation via direct deprotonation of monohalonaphthalenes is an 
extremely substrate-dependent process, and seems to work better when more inductively 
electron-withdrawing groups are directly attached to the naphthalene ring.  This is 
illustrated by the difficulty in generating naphthyne from substrates such as 3.57, 3.60, 
and 3.71 and our successes generating naphthyne from substrates such as 1.276, 3.126, 
and 3.146.   
The demethylation of aryl methyl ethers is not always a straightforward task, and 
can be extremely problematic with chelating substrates.  Our difficulties with 
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demethylation necessitated a reworking of our synthesis, which involved employing a 
novel, perbenzylated aryne.   
A synthesis of the thiomethyl analog of hydroxyaloin A 3.159 has been 
accomplished using a one carbon silicon tether to control the regiochemistry of a 
naphthyne cycloaddition (Schemes 3.73 and 3.74).  Although the desulfurization of this 
molecule has yet to be achieved, current efforts are focused on finding conditions to 
effect this transformation, and the details of this work will be disclosed in due course.   
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     72% (2 steps)
3.119 3,121
3.118 3.128  
 188 



































    CH2Cl2 











































































    65%
i. BBr3, CH2Cl2
   –78 ºC
ii.HCl in MeOH




Chapter 4: Experimental Methods 
4.1. GENERAL 
Unless otherwise noted, solvents and reagents were used without purification.  
Tetrahydrofuran (THF) and diethyl ether (Et2O) were dried by passage through two 
columns of activated neutral alumina.  Methanol (CH3OH), acetonitrile (CH3CN), and 
N,N-dimethylformamide (DMF) were dried by passage through two columns of activated 
molecular sieves.  Toluene was dried by sequential passage through a column of activated 
neutral alumina followed by a column of Q5 reactant.  Methylene chloride, triethylamine, 
N,N-diisopropylamine, and N,N-diisopropylethylamine were distilled from calcium 
hydride prior to use.  Benzene was distilled from sodium/benzophenone.  Acetone was 
prepared by drying over 4Å MS overnight.  All solvents were determined to contain less 
than 50 ppm H2O by Karl Fischer coulometric moisture analysis.  All reactions involving 
air or moisture sensitive reagents or intermediates were performed under an inert 
atmosphere of nitrogen or argon in glassware that was flame dried.  Volatile solvents 
were removed under reduced pressure using a Büchi rotary evaporator.  Thin layer 
chromatography was run on pre-coated silica gel plates with a 0.25 mm thickness 
containing 60F-254 indicator (Merck).  The plates were visualized by staining with 
AMCAN (ammonium molybdate/cerium ammonium nitrate), potassium permagnate, or 
p-anisaldehyde.  Liquid chromatography was performed using forced flow (flash 
chromatography) of the indicated solvent system on 230–400 mesh silica gel (E. Merck 
reagent silica gel 60).  Flash chromatography was performed with ICN Silica gel 60 
according to Still’s protocol.183  
Proton nuclear magnetic resonance (1H NMR) were obtained as solutions in the 
indicated deuterated solvent.  Chemical shifts are reported in parts per million (ppm) and 
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are referenced to the indicated deuterated solvent.  Coupling constants (J) are reported in 
Hz and the splitting abbreviations used are: s, singlet; d, doublet; t, triplet; q, quartet; m, 
multiplet; comp, complex multiplet; br, broad; app, apparent.  Carbon nuclear magnetic 
resonance spectra (13C NMR) were obtained using the solvent indicated as the internal 
reference. Infrared (IR) spectra were obtained either neat on sodium chloride or as 
solutions in the solvent indicated. 
Reaction temperatures refer to the bath temperature, and baths between –10 ºC 
and –20 ºC were maintained using a brine/ice/dry ice.  Bath temperatures between –40 ºC 
and –50 ºC were prepared with dry ice/CH3CN.  –78 ºC baths were made using 
(CH3)2O/dry ice.  Baths between –95 ºC and –100 ºC were prepared by adding N2(l) to 
Et2O.   
 
4.2. REAGENT PREPARATION  
Triflic anhydride (Tf2O), acetic anhydride (Ac2O), and trifluoroacetic anhydride  
(TFAA) were distilled from P2O5 immediately prior to use.  Benzyl bromide (BnBr) and 
methyl iodide (MeI) were passed through a column of neutral alumina just before use.  
ZnCl2 was prepared by heating under vacuum three times, and then dissolving in the 
indicated solvent.  Triethylsilane (Et3SiH) and trimethylsilyl trifluoromethanesulfonate 
(TMSOTf) were distilled from calcium hydride prior to use. 
 
2-Furyllithium: t-Butyllithium (1.6 M, 0.94 mL, 1.5 mmol) was added dropwise 
to a stirred solution of freshly distilled furan (102 mg, 109 μL, 1.5 mmol) in THF (2.7 
mL) at –78 ºC.  The reaction mixture was stirred for 10 min at –78 ºC whereupon it was 
transferred to a –10 ºC bath and stirring was continued for 40 min. 
 191 
 
Isopropyl magnesium chloride (i-PrMgCl): i-PrCl (3.9 mL, 43 mmol) was 
added dropwise to acid-washed Mg0 (1.13 g, 47 mmol) in THF (40 mL).  The mixture 
was heated gently with a heat gun until the reaction initiated, and then the solution was 
stirred for 20 h at rt. Stirring was discontinued and the solids were allowed to settle, at 
which point the clear liquid was cannulated into a Schlenk flask. 
 
 Lithium diisopropylamine (LDA): n-BuLi (0.25 mL, 2.03 M, 0.50 mmol) was 
added dropwise to a solution of (i-Pr)2NH (70 µL, 50.6 mg, 0.5 mmol) in THF (0.5 mL) 































benzyloxymethyl-3,4-dihydro-2H-pyran (2.18). (KP1-226).  A solution of ZnCl2 in 
Et2O (540 µL, 0.54 mmol, 1 M) was added to 2.16 (319 mg, 0.45 mmol) in CH2Cl2 (4.5 
mL) at –78 ºC.  The reaction was stirred at –78 ºC for 5 min.  The reaction flask was 
transferred to a 0 ºC bath, and stirring was continued for 20 min.  A solution of saturated 
NaHCO3 (5 mL) was added, the layers were separated, and the aqueous layer was 
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extracted with CH2Cl2 (3 x 1 mL).  The combined organic layers were dried (Na2SO4), 
filtered through a pad of Celite, and concentrated under reduced pressure.  The residue 
was dried under vacuum, and used directly in the next step without further purification.   
BnBr (165 μL, 1.40 mmol) and NaH (54 mg, 1.40 mmol, 60% dispersion in 
mineral oil) were added to the crude naphthol in DMF (4.5 mL).  The reaction mixture 
was stirred at 25 ºC for 0.5 h, whereupon 50% NaHCO3 (15 mL) and ether (10 mL) were 
added.  The layers were separated, and the aqueous layer was extracted with ether (3 x 5 
mL).  The combined organic layers were dried (Na2SO4), and concentrated under reduced 
pressure.  The crude product was purified by flash chromatography, eluting with 
EtOAc/hexanes (1:5) to afford 271 mg (85%) of 2.18 as a viscous yellow oil: 1H NMR 
(500 MHz, CDCl3) δ 7.51 (comp, 2 H), 7.35-7.15 (comp, 19 H), 6.81 (d, J = 8.0 Hz, 1 H), 
6.78 (d, J = 8.6 Hz, 1 H), 6.73 (d, x= 8.4 Hz, 1 H), 5.12 (s, 2 H), 4.92 (br s, 1 H), 4.88 (d, 
J = 11.0 Hz, 1 H), 4.68–4.87 (comp, 2 H), 4.59 (d, J = 11.6 Hz, 1 H), 4.49 (d, J = 12.0 
Hz, 1 H), 4.46 (br d, J = 6.8, 1 H), 4.41 (d, J = 12.0, 1 H), 4.21 (br d, J = 9.8, 1 H), 4.00 
(dd, J = 6.8, 9.8 Hz, 1 H), 3.81 (d, J = 3.2, 2 H), 3.79 (s, 3 H), 3.73 (s, 3 H); 13C NMR δ 
156.8, 151.5, 150.5, 138.8, 138.5, 138.4, 137.4, 130.6, 128.6, 128.4, 128.3, 128.2, 128.0, 
127.8, 127.64, 127.59, 127.5, 127.4, 127.3, 127.1, 127.0, 119.7, 108.1, 107.9, 107.3, 78.7, 
78.1, 75.2, 74.1, 73.4, 71.5, 70.1, 69.0, 57.7, 56.9; IR (neat) 3062, 3029, 1272, 1086, 
1054 cm–1; mass spectrum (CI) m/z 708.3091 [C46H44O7 (M+) requires 708.3087] 709 
(base), 601. 
NMR Assignments: 1H NMR (500 MHz, CDCl3) δ 7.51 (comp, 2 H, Ph C-H and 
C9-H), 7.35-7.15 (comp, 19 H, Ph C-H and C8-H), 6.81 (d, J = 8.0 Hz, 1 H, Ph C-H), 
6.78 (d, J = 8.6 Hz, 1 H, C15-H), 6.73 (d, J = 8.4 Hz, 1 H, C14-H), 5.12 (s, 2 H, Bn C-H), 
4.92 (br s, 1 H, C2-H), 4.88 (d, J = 11.0 Hz, 1 H, Bn C-H), 4.68–4.87 (comp, 2 H, Bn C-
H), 4.59 (d, J = 11.6 Hz, 1 H, Bn C-H), 4.41 (d, J = 12.0 Hz, 1 H, Bn C-H), 4.21 (br d, J 
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= 9.8, 1 H, C5-H), 4.00 (dd, J = 6.8, 9.8 Hz, 1 H, C4-H), 3.81 (d, J = 3.2, 2 H, C6-H), 
3.79 (s, 3 H, C17-H), 3.73 (s, 3 H, C18-H); 13C NMR δ 156.8, 151.5, 150.5, 138.8, 138.5, 
138.4, 137.4, 130.6, 128.6, 128.4, 128.3, 128.2, 128.0, 127.8, 127.64, 127.59, 127.5, 
127.4, 127.3, 127.1, 127.0, 119.7, 108.1, 107.9, 107.3, 96.8 (C2) 78.7 (C3), 78.1 (C5), 
































benzyloxymethyl-tetrahydro-pyran-3-ol (2.19).  (KP1-270).  BH3•THF in THF (380 
μL, 0.382 mmol, 1 M) was added to naphthalene 2.18 (27 mg, 0.038 mmol) in THF (0.4 
mL).  The mixture was stirred at room temperature for 2 h, and then was cooled to 0 °C, 
whereupon NaOH (0.6 mL, 1.78 mmol, 3 M) was added, dropwise over 5 min.  H2O2 
(0.24 mL, 1.78 mmol, 30 wt % aqueous solution) was added, the ice bath was removed, 
and stirring was continued for 1 h.  Water (1 mL) and Et2O (1.5 mL) were added, the 
layers were separated, and the aqueous layer was extracted with Et2O (3 x 2 mL).  The 
organic layers were combined, dried (Na2SO4), and concentrated.  The residue was 
purified by flash chromatography, eluting with EtOAc/Hexanes (1:5), to give 18 mg 
(64%) of glycoside 2.19 as a yellow oil: 1H NMR (500 MHz, C6D6) δ 7.92 (d, J = 8.4 Hz, 
1 H), 7.52–7.46 (comp, 4 H), 7.36–7.03 (comp, 16 H), 6.75 (d, J = 8.4 Hz, 1 H), 6.56 (d, 
 194 
J = 8.6 Hz, 1 H), 6.47 (d, J = 8.6 Hz, 1 H), 6.00 (d, J = 9.4 Hz, 1 H), 5.21 (d, J = 11.6 Hz, 
1 H), 5.09 (d, J = 11.6 Hz, 1 H), 5.01 (d, J = 11.6 Hz, 1 H), 4.84 (s, 2 H), 4.75 (d, J = 
11.2 Hz, 1 H), 4.53 (d, J = 12.2 Hz, 1 H), 4.43 (d, J = 12.2 Hz, 1 H), 4.06 (dt, J = 5.2, 9.0 
Hz, 1 H), 4.02 (app t, J = 8.3 Hz, 1 H) 8.86–3.83 (comp, 2 H), 3.55 (s, 3 H), 3.33 (s, 3 H), 
2.47 (d, J = 5.4 Hz, 1 H); 13C NMR (125 MHz) δ 156.6, 153.0, 151.0, 140.0, 139.6, 
139.2, 138.3, 128.51, 128.48, 128.3, 127.9, 127.6, 127.5, 127.4, 127.2, 120.7, 109.5, 
107.8, 107.5, 88.4, 80.5, 78.9, 78.7, 78.6, 75.2, 75.1, 73.6, 71.4, 70.1, 57.3, 55.6; IR 
(neat) 3474, 3062, 3029, 1595, 1280, 1057 cm-1; mass spectrum (CI) m/z 727.3285 
[C39H41O7 (M+1) requires 727.3271], 709 (base), 621, 601.   
NMR Assignments: 1H NMR (500 MHz, C6D6) δ 7.92 (d, J = 8.4 Hz, 1 H, C9-
H), 7.52–7.46 (comp, 4 H, Ar-H), 7.36–7.03 (comp, 16 H, Ar-H), 6.75 (d, J = 8.4 Hz, 1 
H, C8-H), 6.56 (d, J = 8.6 Hz, 1 H, C14-H), 6.47 (d, J = 8.6 Hz, 1 H, C13-H), 6.00 (d, J = 
9.4 Hz, 1 H, C1-H), 5.21 (d, J = 11.6 Hz, 1 H, Bn C-H), 5.09 (d, J = 11.6 Hz, 1 H, Bn C-
H), 5.01 (d, J = 11.6 Hz, 1 H, Bn C-H), 4.84 (s, 2 H, Bn C-H), 4.75 (d, J = 11.2 Hz, 1 H, 
Bn C-H), 4.53 (d, J = 12.2 Hz, 1 H, Bn C-H), 4.43 (d, J = 12.2 Hz, 1 H, Bn C-H), 4.06 
(dt, J = 5.2, 9.0 Hz, 1 H, C2-H), 4.02 (app t, J = 8.3 Hz, 1 H, C4-H) 8.86–3.83 (comp, 3 
H, C5-H and C6-H), 3.55 (s, 3 H, C17-H), 3.33 (s, 3H, C18-H), 2.47 (d, J = 5.4 Hz, 1 H, 
OH); 13C NMR (125 MHz) δ 156.6, 153.0, 151.0, 140.0, 139.6, 139.2, 138.3, 128.51, 
128.48, 128.3, 127.9, 127.6, 127.5, 127.4, 127.2, 120.7, 109.5 (C8), 107.8 (C13), 107.5 
(C14), 88.4 (C4), 80.5 (C5), 78.9 (C1 or C2), 78.7 (C1 or C2), 78.6 (C4), 75.2 (Bn C), 






























3,4-dihydro-2H-pyran (2.24). (KP1-203). A solution of ZnCl2 in Et2O (110 µL, 0.11 
mmol, 1 M) was added to 2.23 (49 mg, 0.096 mmol) in CH2Cl2 (1.0 mL) at –78 ºC and 
the mixture was stirred at –78 ºC for 5 min.  The reaction flask was transferred to a 0 ºC 
bath, and stirring was continued for 20 min.  A solution of saturated NaHCO3 (1 mL) was 
added, the layers were separated, and the aqueous layer was extracted with CH2Cl2 (3 x 1 
mL).  The combined organic layers were dried (Na2SO4), filtered through a pad of Celite, 
and concentrated under reduced pressure.  The residue was dried under vacuum, and used 
directly in the next step without further purification.   
BnBr (35 μL, 0.29 mmol) and NaH (12 mg, 0.29 mmol, 60% dispersion in 
mineral oil) were added to the crude naphthol in DMF (1.0 mL).  The reaction mixture 
was stirred at 25 ˚C for 0.5 h, whereupon 50% NaHCO3 (2 mL) and ether (2 mL) were 
added.  The layers were separated, and the aqueous layer was extracted with ether (3 x 2 
mL).  The combined organic layers were dried (Na2SO4) and concentrated under reduced 
pressure.  The residue was purified by flash chromatography, eluting with 
EtOAc/hexanes (1:5) to afford 32 mg (55%) of 2.24 as a yellow oil: 1H NMR (500 MHz, 
C6D6) δ 7.50–7.46 (comp, 2 H), 7.41–7.38 (comp, 3 H), 7.26–7.10 (comp, 12 H), 6.60 (d, 
J = 8.5 Hz, 1 H), 6.57 (d, J = 8.5 Hz, 1 H), 5.17 (m, 1 H), 5.06 (d, J = 11.5 Hz, 1 H), 4.79 
(s, 2 H), 4.76 (d, J = 11.5 Hz, 1 H), 4.69–4.66 (comp, 2 H), 4.54 (d, J = 12.0 Hz, 1 H), 
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4.41 (m, 1 H), 3.87 (dd, J = 9.9, 6.8 Hz, 1 H), 3.54 (s, 3 H), 3.50 (br s, 3 H), 1.50 (d, J = 
6.8 Hz, 3 H); 13C NMR (125 MHz) δ 160.0, 157.3, 152.4, 151.1, 139.7, 139.5, 138.2, 
130.7, 128.53, 128.48, 128.47, 128.3, 128.2, 128.1, 127.92, 127.91, 127.64, 127.58, 
127.56, 127.2, 120.5, 108.4, 108.19, 108.2, 80.7, 79.4, 75.0, 74.2, 71.2, 70.2, 57.4, 56.7, 
55.0, 18.2; IR (neat) 3060, 3025, 1655, 1273, 1056 cm-1; mass spectrum (CI) m/z 
603.2747 [C39H39O6 (M+1) requires 603.2747] 495 (base), 325, 309. 
NMR Assignments: 1H NMR (500 MHz, C6D6) δ 7.50–7.46 (comp, 2 H, Ph-H or 
C8-H or C9-H), 7.41–7.38 (comp, 3 H, Ph-H or C8-H or C9-H), 7.26–7.10 (comp, 12 H, 
Ph-H or C8-H or C9-H), 6.60 (d, J = 8.5 Hz, 1 H, C14-H), 6.57 (d, J = 8.5 Hz, 1 H, C13-
H), 5.17 (m, 1 H, C2-H), 5.06 (d, J = 11.5 Hz, 1 H, Bn C-H), 4.79 (s, 2 H, Bn C-H), 4.76 
(d, 11.5 Hz, 1 H, Bn C-H), 4.69–4.66 (comp, 2 H, Bn C-H and C3-H), 4.54 (d, J = 12.0 
Hz, 1 H, Bn C-H), 4.41 (m, 1 H, C5-H), 3.87 (dd, J = 9.9, 6.8 Hz, 1 H, C4-H), 3.54 (s, 3 
H, C17-H), 3.50 (br s, 3 H, C18-H), 1.50 (d, J = 6.8 Hz, 3 H, C6-H); 13C NMR (125 
MHz) δ 160.0, 157.3 , 152.4, 151.1, 139.7, 139.5, 138.2, 130.7, 128.53, 128.48, 128.47, 
128.3, 128.2, 128.1, 127.92, 127.91, 127.64, 127.58, 127.56, 127.2, 120.5, 108.4 (C14), 
108.1 (C13), 97.2 (C2), 80.7 (C4), 79.4 (C3), 75.0 (C5), 74.2 (C2), 71.2 (Bn C), 70.2 (Bn 































tetrahydro-pyran-3-ol (2.26) (KP1-278).  BH3•THF in THF (790 μL, 0.79 mmol, 1 M) 
was added to naphthalene 2.24 (47 mg, 0.079 mmol) in THF (1.0 mL).  The mixture was 
stirred at room temperature for 2 h, and then was cooled to 0 °C, whereupon NaOH (0.9 
mL, 2.6 mmol, 3 M) was added, dropwise over 5 min.  H2O2 (0.24 mL, 2.6 mmol, 30 wt 
% aqueous solution) was added, the ice bath was removed, and stirring was continued for 
1 h.  Water (7 mL) and Et2O (7 mL) were added, the layers separated, and the aqueous 
layer was extracted with Et2O (3 x 7 mL).  The organic layers were combined, dried 
(Na2SO4), and concentrated.  The residue was purified by flash chromatography, eluting 
with EtOAc/Hexanes (1:5) to give 34 mg (70%) of 2.26 as a white solid: mp 131–133 °C; 
1H NMR (500 MHz, C6D6) δ 7.91 (d, J = 8.4 Hz, 1 H), 7.52-7.47 (comp, 4 H), 7.39–7.37 
(comp, 2 H), 7.27–7.09 (comp, 9 H), 6.80 (d, J = 8.4 Hz, 1 H), 6.55 (d, J = 8.6 Hz, 1 H), 
6.46 (d, J = 8.6 Hz, 1 H), 5.98 (d, J = 9.0 Hz, 1 H), 5.23 (d, J = 11.2 Hz, 1 H), 5.06 (d, J 
= 11.2 Hz, 1 H), 5.00 (d, J = 11.2 Hz, 1 H), 4.85 (s, 2 H), 4.66 (d, J = 11.2 Hz, 1 H), 4.03 
(td, J = 9.0, 5.6 Hz, 1 H), 3.8 (app t, J = 9.0 Hz, 1 H), 3.77–3.72 (m, 1 H), 3.55 (s, 3 H), 
3.43 (app t, J = 9.0 Hz, 1 H), 3.32 (s, 3 H), 2.52 (d, J = 5.6 Hz, 1 H), 1.42 (d, J = 6.2 Hz, 
3 H); 13C NMR (125 MHz) δ 156.5, 153.0, 151.0, 140.0, 139.6, 138.4, 128.6, 128.51, 
128.49, 128.48, 128.40, 128.29, 128.26, 128.19, 128.1, 127.9, 127.64, 127.59, 127.58, 
127.3, 127.2, 120.6, 109.6, 108.0, 107.4, 88.3, 84.7, 78.9, 78.4, 76.4, 75.3, 75.2, 71.5, 
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57.3, 55.6, 18.9; IR (neat) 3572, 3060, 3025, 1602, 1290 cm-1; mass spectrum (CI) m/z 
622.2845 [C39H41O7 (M+1) requires 622.2852], 603, 530, 515 (base). 
NMR Assignments: 1H NMR (500 MHz, C6D6) δ 7.91 (d, J = 8.4 Hz, 1 H, C9-
H), 7.52–7.47 (comp, 4 H, Ph-H), 7.39–7.37 (comp, 2 H, Ph-H), 7.27–7.09 (comp, 9 H, 
Ph-H), 6.80 (d, J = 8.4 Hz, 1 H, C8-H), 6.55 (d, J = 8.6 Hz, 1 H, C14-H), 6.46 (d, J = 8.6 
Hz, 1 H, C13-H), 5.98 (d, J = 9.0 Hz, 1 H, C1-H), 5.23 (d, J = 11.2 Hz, 1 H, Bn C-H), 
5.06 (d, J = 11.2 Hz, 1 H, Bn C-H), 5.00 (d, J = 11.2 Hz, 1 H, Bn C-H), 4.85 (s, 2 H, Bn 
C-H), 4.66 (d, J = 11.2 Hz, 1 H, Bn C-H), 4.03 (td, J = 9.0, 5.6 Hz, 1 H, C2-H), 3.8 (app 
t, J = 9.0 Hz, 1 H, C3-H), 3.77–3.72 (m, 1 H, C5-H), 3.55 (s, 3 H, C17-H), 3.43 (app t, J 
= 9.0 Hz, 1 H, C4-H), 3.32 (s, 3 H, C18-H), 2.52 (d, J = 5.6 Hz, 1 H, O-H), 1.42 (d, J = 
6.2 Hz, 3 H, C6-H); 13C NMR (125 MHz) δ 156.5, 153.0, 151.0, 140.0, 139.6, 138.4, 
128.6, 128.51, 128.49, 128.48, 128.40, 128.29, 128.26, 128.19, 128.1, 127.9, 127.64, 
127.59, 127.58, 127.3, 127.2, 120.6, 109.6 (C8), 108.0 (C13), 107.4 (C14), 88.3 (C3), 
84.7 (C4), 78.9 (C2), 78.4 (C1), 76.4 (Bn C), 75.3 (Bn C), 75.2 (Bn C), 71.5 (Bn C), 57.3 


















dihydro-2H-pyran (2.46). (KP1-117). 2-Furyllithium (1.2 mL, 0.29 mmol, 2.5 M) was 
added dropwise via syringe to 2.45 (115 mg, 0.27 mmol) in THF (2.7 mL) at –78 ºC.  
The mixture was stirred at –78 ºC for 1.5 h, whereupon triethylamine (82 mg, 112 μL, 
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0.81 mmol), DMAP (36 mg, 0.32 mmol) in THF (300 μL), and TFAA (142 mg, 95 µL, 
0.66 mmol) were added sequentially.  The reaction was allowed to warm slowly with 
stirring to room temperature over a period of 4 h, and then stirring was continued at room 
temperature for 14 h.  A 50% solution of aqueous NaHCO3 (4 mL) was added and the 
layers were separated.  The aqueous layer was extracted with EtOAc (3 x 5 mL).  The 
organic layers were combined, dried (Na2SO4), and concentrated under reduced pressure.  
The residue was purified by flash chromatography eluting with Et2O/Hexanes (1:5) to 
afford 19 mg (15%) of 2.46 as a yellow solid: mp = 41–44 °C; 1H NMR (500 MHz, 
CDCl3) δ 7.37–7.25  (comp, 16 H), 6.43 (d, J = 3.4 Hz, 1 H), 6.37 (dd, J = 3.4, 1.8 Hz, 1 
H), 5.47 (dd, J = 3.4, 0.9 Hz, 1 H), 4.87 (d, J = 12.0 Hz, 1 H), 4.72 (d, J = 12.1 Hz, 1 H), 
4.67 (d, J = 12.0 Hz, 1 H), 4.66 (d, J = 12.1 Hz, 1 H), 4.53 (d, J = 12.0 Hz, 1 H), 4.45 (d, 
J = 12.0 Hz, 1 H), 4.37–4.34 (m, 1 H), 4.32 (dd, J = 0.9, 3.4 Hz, 1 H), 4.02 (ddd, J = 3.4, 
2.5, 0.9 Hz, 1 H), 3.86 (dd, J = 10.3, 6.9 Hz, 1 H), 3.80 (dd, J = 10.3, 5.2 Hz, 1 H); 13C 
NMR (125 MHz) δ 149.0, 144.6, 142.4, 138.6, 138.4, 138.2, 128.4, 128.3, 128.1, 127.8, 
127.7, 127.6, 127.5, 127.5, 111.4, 107.4, 95.0, 76.3, 73.4, 73.1, 71.4, 71.0, 70.9, 68.2; IR 
(neat) 3013, 2849, 1661, 1091 cm-1; mass spectrum (CI) m/z 483.2158 [C31H30O5 (M+1) 
requires 483.2171], 471, 465 (base).   
NMR Assignments: 1H NMR (500 MHz) δ 7.37–7.25 (comp, 16 H, Ph C-H), 
6.43 (d, J = 3.4 Hz, 1 H, C3-H), 6.37 (dd, J = 3.4, 1.8 Hz, 1 H, C2-H), 5.47 (dd, J = 3.4, 
0.9 Hz, 1 H, C6-H), 4.87 (d, J = 12.0 Hz, 1 H, BnC-H), 4.72 (d, J = 12.1 Hz, 1 H, Bn C-
H), 4.67 (d, J = 12.0, 1 H, Bn C-H), 4.66 (d, J = 12.1 Hz, 1 H, BnC-H), 4.53 (d, J = 12.0 
Hz, 1 H, BnC -H), 4.45 (d, J = 12.0 Hz, 1 H, Bn C-H), 4.37–4.34 (m, 1 H, C9-H), 4.32 
(dd, J = 3.4, 0.9, Hz 1 H, C7-H), 4.02 (ddd, J = 3.4, 2.5, 0.9 Hz, 1 H, C8-H), 3.86 (d, J = 
10.3, 6.9 Hz, 1 H, C10-H), 3.80 (d, J = 10.3, 5.2 Hz, 1 H, C10-H); 13C NMR (125 MHz) δ 
149.0, 144.6, 142.4, 138.6, 138.4, 138.2, 128.4, 128.3, 128.1, 127.8, 127.7, 127.6, 127.5, 
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127.5 (Ar-C), 111.4 (C2), 107.4 (C3), 95.0 (C6), 76.3 (C9), 73.4 (C11, C12, or C13), 



















 (2R, 3R, 4R)-Trisbenzyloxy-1-furan-2-yl-5-hydroxyhexan-1-one.  The above 
reaction also yielded 72 mg (62%) of hydroxy ketone 2.47 as a yellow oil: 1H NMR (400 
MHz) δ 7.55 (dd, J = 1.4 Hz, 0.7, 1 H), 7.35–7.20 (comp, 15 H), 7.15 (dd, J = 3.8, 0.7 
Hz, 1 H), 6.50 (dd, J = 3.8, 1.7 Hz, 1 H), 4.79 (d, J = 11.3 Hz, 1 H), 4.63 (d, J = 11.3 Hz, 
1 H), 4.60–4.57 (comp, 3 H), 4.51 (d, J = 12.0 Hz, 1 H), 4.48–4.42 (comp, 2 H), 4.00–
3.94 (m, 1 H), 3.77 (dd, J = 4.1, 3.4 Hz, 1 H), 3.58–3.48 (comp, 2 H), 3.11 (dd, J = 16.4, 
4.1 Hz, 1 H), 2.86 (d, J = 5.5 Hz, 1 H); 13C NMR (100 MHz) δ 187.2, 152.8, 146.5, 
137.9, 128.4, 128.3, 128.1, 127.91, 127.88, 127.83, 127.72, 127.67, 117.5, 112.3, 79.1, 
73.8, 73.4, 73.1, 71.0, 70.0, 40.5; IR (neat) 3481, 3020, 2867, 1672, 1085 cm-1; mass 
spectrum (CI) m/z 501.2260 [C31H33O6 (M+1) requires 501.2277], 483 (base), 393, 375, 
285. 
NMR assignments: 1H NMR (400 MHz) δ 7.55 (dd, J = 1.4, 0.7 Hz, 1 H, C1-H), 
7.35–7.20 (comp, 15 H, Ph C-H), 7.15 (dd, J = 3.8, 0.68 Hz, 1 H, C3-H), 6.50 (dd, J = 
1.7, 3.8 Hz, 1 H, C2-H), 4.79 (d, J = 11.3 Hz, 1 H, Bn C-H), 4.63 (d, J = 11.3 Hz, 1 H, 
Bn C-H), 4.60–4.57 (comp, 3 H), 4.51 (d, J = 12.0 Hz, 1 H, Bn C-H), 4.48-4.42 (comp, 2 
H, Bn C-H), 4.00–3.94 (m, 1 H), 3.77 (dd, J = 4.1, 3.4 Hz, 1 H), 3.58–3.48 (comp, 2 H), 
3.11 (dd, J = 16.4, 4.1 Hz, 1 H), 2.86 (d, J = 5.5 Hz, 1 H); 13C NMR (100 MHz) δ 187.2 
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(C5), 152.8, 146.5, 137.9, 128.4, 128.3, 128.1, 127.91, 127.88, 127.83, 127.72, 127.67 































dimethoxy-11-oxatricyclo[6.2.1.02,7]undeca-2(7)3,5,9-tetraene (KP1-283).  (2.48) A 
solution of s-BuLi (1.21 M, 0.41 mL, 0.57 mmol) was added to 2-chloro-1,4-
dimethoxybenzene (2.15) (81 μL, 0.57 mmol) in THF at –95 ºC, dropwise over a 5 min 
period.  The reaction mixture was stirred at –95 ºC for 10 min, whereupon a solution of 
2.46 (91.4 mg, 149 mmol) in THF (0.4 mL) was added dropwise over a 5 min period.  
The reaction mixture was warmed to –10 ºC over 45 min, whereupon a 30% aqueous 
solution of NH4Cl (2 mL) was added.  The layers were separated, and the aqueous layer 
was extracted with Et2O (3 x 4 mL).  The combined organic layers were dried (Na2SO4) 
and concentrated under reduced pressure.  The residue was purified by flash 
chromatography, eluting with Et2O/Hexanes (1:7 then 1:5) to afford 89 mg (75%) of 
cycloadduct 2.48 as a 1:1 mixture of diastereomers: 1H NMR δ 7.37–7.22 (comp, 15 H), 
7.08 (d, J = 5.6 Hz, 1 H), 6.89 (dd, J = 5.6, 1.81 Hz, 1 H), 6.52 (d, J = 8.8 Hz, 1 H), 6.46 
(d, J = 9.0 Hz, 1 H), 5.88 (d, J = 1.8 Hz, 1 H), 4.97 (d, J = 11.2 Hz, 1 H), 4.67–4.57 
(comp, 3 H), 4.55 (d, J = 11.7 Hz, 1 H), 4.52 (d, J = 11.7 Hz, 1 H), 4.16–4.12 (m, 1 H), 
4.00 (s, 1 H), 4.95–4.92 (m, 1 H), 3.85 (m, 1 H), 3.74, (s, 3 H), 3.59–3.52 (m, 2 H), 3.42 
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(br s, 3 H); 13C NMR δ 148.5, 147.2, 144.0, 141.9, 139.6, 139.5, 138.9, 138.3, 137.0, 
128.4, 128.3, 128.0, 127.8, 127.64, 127.57, 127.33, 127.30, 127.25, 112.3, 111.6, 99.6, 
98.2, 79.2, 75.7, 74.8, 73.6, 73.5, 71.9, 70.3, 69.3, 56.3, 56.2; IR (neat) 3062, 3029, 1602, 
1494, 1257, 1056 cm-1; mass spectrum (CI) m/z 603.2747 [C39H39O7 (M+1) requires 
603.2747] 495 (base), 325, 309. 
NMR Assignments: 1H NMR δ 7.37–7.22 (comp, 15 H, Ph-H), 7.08 (d, J = 5.6 
Hz, 1 H, C8-H), 6.89 (dd, J = 5.6, 1.8 Hz, 1 H, C9-H), 6.52 (d, J = 9.0 Hz, 1 H, C13-H or 
C14-H), 6.46 (d, J = 9.0 Hz, 1 H, C13-H or C14-H), 5.88 (d, J = 1.8 Hz, 1 H, C10-H), 
4.97 (d, J = 11.2 Hz, 1 H, Bn C-H), 4.67–4.57 (comp, 3 H, Bn C-H), 4.55 (d, J = 11.7 Hz, 
1 H, Bn C-H), 4.52 (d, J = 11.7 Hz, 1 H, Bn C-H), 4.16–4.12 (m, 1 H), 4.00 (s, 1 H), 
4.95-4.92 (m, 1 H), 3.85 (m, 1 H), 3.74, (s, 3 H, C15-H), 3.59–3.52 (comp, 2 H), 3.42 (br 
s, 3 H, C16-H); 13C NMR δ 148.5, 147.2, 144.0, 141.9, 139.6, 139.5, 138.9, 138.3, 137.0, 
128.4, 128.3, 128.0, 127.8, 127.64, 127.57, 127.33, 127.30, 127.25, 112.3, 111.6, 99.6, 































benzyloxymethyl-3,4-dihydro-2H-pyran (KP1-286).  (2.49). A solution of ZnCl2 in 
Et2O (1 M, 0.44 µL, 0.44 mmol) was added to 2.48 (186 mg, 0.360 mmol) in CH2Cl2 (3.6 
mL) at –78 ºC.  The reaction was stirred at –78 ºC for 5 min.  The reaction flask was 
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transferred to a 0 ºC bath, and stirring was continued for 20 min.  A solution of saturated 
NaHCO3 (4 mL) was added, the layers were separated, and the aqueous layer was 
extracted with CH2Cl2 (3 x 4 mL).  The combined organic layers were combined, dried 
(Na2SO4), filtered through a pad of Celite, and concentrated under reduced pressure.  The 
crude naphthol was dried under vacuum, and used in the next step without further 
purification.   
BnBr (27 μL, 0.23 mmol) and NaH (9.2 mg, 0.23 mmol, 60% dispersion in 
mineral oil) were added to the crude naphthol in DMF (3.5 mL) and the reaction mixture 
was stirred at 25 ºC for 0.5 h, whereupon a 25% solution of NaHCO3  (4 mL) and ether (4 
mL) were added.  The layers were separated and the aqueous layer was extracted with 
ether (3 x 5 mL).  The organic layers were combined, dried (Na2SO4), and concentrated 
under reduced pressure.  The residue was purified by flash chromatography, eluting with 
EtOAc/hexanes (1:5) to afford 75 mg (30%) of naphthalene 2.49: 1H NMR (500 MHz, 
CDCl3) δ 7.57–7.56 (comp, 2H), 7.40–7.22 (comp, 19 H), 6.86 (d, J = 8.0 Hz, 1 H), 6.81 
(d, J = 8.6 Hz, 1 H), 6.78 (d, J = 8.6 Hz, 1 H), 5.17 (s, 2 H), 4.98 (d, J = 12 Hz, 1 H), 4.90 
(d, J = 1.4 Hz, 1 H), 4.71 (d, J = 12.0 Hz, 1 H), 4.73 (d, J = 12.2 Hz, 1 H), 4.68 (d, J = 
12.2 Hz, 1H), 4.43–4.39 (comp, 4 H), 4.08–4.07 (m, 1 H), 3.83 (s, 3 H), 3.79–3.77 
(comp, 2 H), 3.72 (br s, 3 H); 13C NMR (125 MHz, CDCl3) δ 158.0, 156.6, 151.6, 150.5, 
138.9, 138.3, 137.4, 130.6, 128.4, 128.3, 128.2, 128.1, 127.8, 127.6, 127.5, 127.4, 127.1, 
119.8, 108.2, 108.1, 107.9, 107.7, 96.5, 76.6, 73.3, 72.4, 71.5, 70.7, 70.0, 68.7, 57.6, 
57.1; IR (neat) 3060, 3025, 1258, 1063 cm-1; mass spectrum (CI) m/z 727.3193 [C39H39O8 
(M+1) requires 727.3193] 727 (base), 710, 602.   
NMR Assignments: 1H NMR (500 MHz, CDCl3) δ 7.57–7.56 (comp, 2 H, Ph C-
H, C9-H), 7.40-7.22 (comp, 19 H, Ph C-H), 6.86 (d, J = 8.0z, 1 H, C8-H), 6.81 (d, J = 8.6 
Hz, 1 H, C13-H), 6.78 (d, J = 8.6 Hz, 1 H, C14-H), 5.17 (s, 2 H, Bn C-H), 4.98 (d, J = 12 
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Hz, 1 H, Bn C-H), 4.90 (d, J = 1.4 Hz, 1 H, C2-H), 4.71 (d, J = 12.0 Hz, 1 H, Bn C-H), 
4.73 (d, J = 12.2 Hz, 1 H, Bn C-H), 4.68 (d, J = 12.2 Hz, 1 H, Bn C-H), 4.43–4.39 (comp, 
4H, Bn C-H and C5-H and C3-H), 4.08–4.07 (m, 1 H, C4-H), 3.83 (s, 3 H, C17-H), 3.79–
3.77 (comp, 2 H, C6-H), 3.72 (br s, 3 H, C18-H); 13C NMR (125 MHz, CDCl3) δ 158.0, 
156.6, 151.6, 150.5, 138.9, 138.3, 137.4, 130.6, 128.4, 128.3, 128.2, 128.1, 127.8, 127.6, 
127.5, 127.4, 127.1, 119.8, 108.2, 108.1, 107.9, 107.7, 96.5 (C2), 76.6 (C3), 73.3 (Bn C), 

































benzyloxymethyl-tetrahydro-pyran-3-ol (2.50).  (KP1-282). A solution of BH3•THF in 
THF (0.31 mL, 0.31 mmol, 1 M) was added to 2.49 (22 mg, 0.31 mmol) in THF (0.5 mL) 
at rt.  The mixture was stirred at room temperature for 2 h, and then was cooled to 0 °C, 
whereupon NaOH (3 M, 0.30 mL, 0.92 mmol) was added, dropwise over 5 min.  H2O2 
(80 µL, 0.92 mmol, 30 wt % aqueous solution) was added at 0 °C, and the reaction 
mixture was warmed to room temperature and stirring was continued for 1 h.  Water was 
added (2 mL), and the reaction mixture was diluted with Et2O (3 mL).  The layers were 
separated, and the aqueous layer was extracted with Et2O (3 x 3 mL).  The organic layers 
were combined, dried (Na2SO4), and concentrated.  The residue was purified by flash 
chromatography, eluting with EtOAc/Hexanes (1:5), to give 12 mg (55%) of 2.50 as a 
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viscous yellow oil: 1H NMR (500 MHz, C6D6) δ 8.00 (d, J = 8.2 Hz, 1 H), 7.51–7.47 
(comp, 4 H), 7.42–7.40 (comp, 2 H), 7.26–7.07 (comp, 14 H), 6.63 (d, J = 8.5 Hz, 1 H), 
6.57 (d, J = 8.5 Hz, 1 H), 6.51 (d, J = 8.5 Hz, 1 H), 6.06 (d, J = 9.2 Hz, 1 H), 5.18 (d, J = 
11.6 Hz, 1 H), 4.77–4.68 (comp, 6 H), 4.33 (d, J = 12.0 Hz, 1 H), 4.28 (d, J = 12.0 Hz, 1 
H), 4.15 (d, J = 3.0 Hz, 1 H), 3.77–3.73 (comp, 2 H), 3.76 (dd, J = 13.4, 9.7 Hz, 1 H), 
3.63 (dd, J = 9.6, 3.0 Hz, 1 H), 3.55 (s, 3 H), 3.42 (s, 3 H), 2.31 (d, J = 4.5 Hz, 1 H); 13C 
NMR (125 MHz) δ 156.5, 153.0, 151.4, 140.0, 139.7, 139.0, 138.4, 128.62, 128.59, 
128.5, 128.4, 127.7, 127.63, 127.60, 127.5, 127.4, 120.7, 109.6, 108.1, 107.6, 85.6, 79.4, 
78.4, 75.8, 75.3, 74.5, 73.6, 72.8, 71.4, 69.7, 57.4, 55.8; IR (neat) 3478, 3062, 3029, 
1595, 1281, 1109, 1064 cm-1; mass spectrum (CI) m/z 726.3193 [C46H46O8 (M+) requires 
726.3193], 710, 602 (base). 
NMR Assignments: 1H NMR (500 MHz, C6D6) δ 8.00 (d, J = 8.2 Hz, 1 H, C9-
H), 7.51–7.47 (comp, 4 H, Ph-H), 7.42–7.40 (comp, 2 H, Ph-H), 7.26–7.07 (comp, 14 H, 
Ph-H), 6.63 (d, J = 8.5 Hz, 1 H, C8-H), 6.57 (d, J = 8.5 Hz, 1 H, C13-H or C14-H), 6.51 
(d, J = 8.5 Hz, 1 H, C13-H or C14-H), 6.06 (d, J = 9.2 Hz, 1 H, C1-H), 5.18 (d, J = 11.6 
Hz, 1 H, Bn C-H), 4.77–4.68 (comp, 6 H, Bn C-H and C2-H), 4.33 (d, J = 12.0 Hz, 1 H, 
Bn C-H), 4.28 (d, J = 12.0 Hz, 1 H, Bn C-H), 4.15 (d, J = 3.0 Hz, 1 H, C4-H), 3.77–3.73 
(comp, 2 H, C5-H and C6-H), 3.76 (dd, J = 13.4, 9.7 Hz, 1 H, C6-H), 3.63 (dd, J = 9.6, 
3.0 Hz, 1 H, C3-H), 3.55 (s, 3 H, C17-H or C18-H), 3.42 (s, 3 H, C17-H or C18-H), 2.31 
(d, J = 4.5 Hz, 1 H, OH); 13C NMR (125 MHz) δ156.5, 153.0, 151.4, 140.0, 139.7, 139.0, 
138.4, 128.62, 128.59, 128.5, 128.4, 127.7, 127.63, 127.60, 127.5, 127.4, 120.7, 109.6 
(C9), 108.1 (C13 or C14), 107.6 (C13 or C14), 85.6 (C3), 79.4 (C1), 78.4 (C5), 75.8 (Bn 
C), 75.3  (C2), 74.5 (Bn C), 73.6 (Bn C), 72.8 (Bn C), 71.4 (Bn C), 69.7 (C6), 57.4 (C17 

















4-Azido-3,6-dimethoxy-2-methyltetrahydropyran (2.64).  (KP2-124).  MeI 
(106 µL, 1.70 mmol) and NaH (85 mg, 2.13 mmol, 60 wt % dispersion) were added to a 
solution of 2.63 (266 mg, 1.42 mmol) in DMF (14 mL).  The reaction was stirred for 1 h 
at ambient temperature, whereupon MeI (100 µL, 228 mg, 1.61 mmol) and NaH (40 mg, 
1.0 mmol, 60 wt % dispersion) were added.  The reaction mixture was stirred at room 
temperature for 25 h, whereupon water (20 mL) and Et2O (40 mL) were added.  The 
layers were separated, and the aqueous layer was extracted with Et2O (3 x 40 mL).  The 
organic layers were combined, and then washed with water (2 x 150 mL) and brine (1 x 
150 mL).  The organic layer was dried (Na2SO4) and concentrated under reduced 
pressure.  The residue was purified by flash chromatography eluting with Et2O/hexanes 
(1:9) to afford 285 mg (quantitative) of 2.64 as a clear oil: 1H NMR (500 MHz) δ 4.66 (d, 
J = 3.6 Hz, 1 H), 3.73 (ddd, J = 12.4, 9.4, 5.0 Hz, 1 H), 3.62 (dq, J = 9.4, 6.2 Hz, 1 H), 
3.57 (s, 3 H), 3.29 (s, 3 H), 2.70 (app t, J = 9.4 Hz, 1 H), 2.06 (ddd, J = 13.2, 5.0, 1.2 Hz, 
1 H), 1.59 (ddd, J = 13.2, 12.4, 3.6, 1 H), 1.27 (d, J = 6.2 Hz, 3 H); 13C NMR (125 MHz) 
δ 97.3, 86.0, 67.2, 60.6, 59.6, 54.6, 35.5, 17.9; IR (neat) 2012, 1128, 1099, 1050 cm-1; 
mass spectrum (LRCI) m/z 202 [C8H15N3O3 (M+1) requires 202.1113] 170 (base), 127, 
115.   
NMR Assignments.  1H NMR (500 MHz) δ 4.66 (d, J = 3.6 Hz, 1 H, C1-H), 3.73 
(ddd, J = 12.4, 9.4, 5.0 Hz, 1 H, C3-H), 3.62 (dq, J = 9.4, 6.2 Hz, 1 H, C5-H), 3.57 (s, 3 
H, C7-H or C8-H), 3.29 (s, 3 H, C7-H or C8-H), 2.70 (app t, J = 9.4 Hz, 1 H, C4-H), 2.06 
(ddd, J = 13.2, 5.0, 1.2 Hz, 1 H, C2-H), 1.59 (ddd, J = 13.2, 12.4, 3.6 Hz, 1 H, C2-H), 
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1.27 (d, J = 6.2 Hz, 3 H, C6-H); 13C NMR (125 MHz) δ 97.3 (C1), 86.0 (C4), 67.2 (C5), 
















4-Azido-5-methoxy-6-methyltetrahydropyran-2-ol (2.65).  (KP2-126).  Methyl 
acetate 2.64 (109 mg, 0.542 mmol) in AcOH/H2O (4:1, 3 mL) was heated at 110 °C for 
1.5 h.  The reaction mixture was cooled to room temperature and the solvent was 
removed under reduced pressure to give the crude product as a solid that was purified by 
flash chromatography eluting with Et2O/hexanes (1:5) to give 69 mg (68%) of 2.65 
(white solid) as an inseparable mixture of diastereomers (85:15); mp = 99–101 °C; 1H 
NMR (500 MHz) δ 5.27–5.26 (m, 0.85 H), 4.80 (ddd, J = 9.4, 6.2, 2.0 Hz, 0.15 H), 3.90 
(dqd, J = 9.4, 6.2, 0.4 Hz, 0.85 H), 3.82 (ddd, J = 12.4, 9.4, 5.0 Hz, 0.85 H), 3.58 (s, 2.55 
H), 3.57 (s, 0.45 H), 3.44 (ddd, J = 12.4, 9.2, 5.0 Hz, 0.15 H), 3.34 (dq, J = 9.0, 6.2 Hz, 
0.15 H), 2.96–2.90 (m, 0.15 H), 2.73 (app t, J = 9.2 Hz, 0.15 H), 2.70 (app t, J = 9.4 Hz, 
0.85 H), 2.44-2.41 (m, 0.85 H), 2.24 (ddd, J = 12.9, 5.0, 2.0 Hz, 0.15 H), 2.10 (ddd, J = 
6.4, 5.0, 1.4 Hz, 0.85 H), 1.62–1.55 (m, 0.85 H), 1.54–1.53 (m, 0.15), 1.47 (td, J = 12.9, 
9.2 Hz, 0.15 H), 1.32 (d, J = 6.2 Hz, 0.45 H), 1.26 (d, J = 6.2 Hz, 2.55 H); 13C NMR (125 
MHz) δ 93.7, 91.1, 86.2, 85.6, 72.4, 67.5, 61.6, 60.7, 60.6, 59.1, 38.0, 35.5, 18.0; IR 
(neat) 3367, 2109, 1264, 1146, 1103 cm-1; mass spectrum (CI) m/z 186.0886 [C7H12N3O3 
(M+1) requires 186.0879] 170 (base), 101.   
NMR Assignments. 1H NMR (500 MHz) δ 5.27–5.26 (m, 0.85 H, C1-H), 4.80 
(ddd, J = 9.4, 6.2, 2.0 Hz, 0.15 H, C1-H), 3.90 (dqd, J = 9.4, 6.2, 0.4 Hz, 0.85 H, C5-H), 
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3.82 (ddd, J = 12.4, 9.4, 5.0 Hz, 0.85 H, C3-H), 3.58 (s, 2.55 H, C7-H), 3.57 (s, 0.45 H, 
C7-H), 3.44 (ddd, J = 12.4, 9.2, 5.0 Hz, 0.15 H, C3-H), 3.34 (dq, J = 9.0, 6.2 Hz, 0.15 H, 
C5-H), 2.96–2.90 (m, 0.15 H, OH), 2.73 (app t, J = 9.2 Hz, 0.15 H, C4-H), 2.70 (app t, J 
= 9.4 Hz, 0.85 H, C4-H), 2.44–2.41 (m, 0.85 H, OH), 2.24 (ddd, J = 12.9, 5.0, 2.0 Hz, 
0.15 H, C2-H), 2.10 (ddd, J = 6.4, 5.0, 1.4 Hz, 0.85 H, C2-H), 1.62–1.55 (m, 0.85 H, C2-
H), 1.54–1.53 (m, 0.15, C1-H), 1.47 (td, J = 12.9, 9.2 Hz, 0.15 H, C2-H), 1.32 (d, J = 6.2 
Hz, 0.45 H, C6-H), 1.26 (d, J = 6.2 Hz, 2.55 H, C6-H); 13C NMR (125 MHz) δ 93.7 (C1 
minor), 91.1 (C1 major), 86.2 (C4 major), 85.6 (C4 minor), 72.4 (C5 minor), 67.5 (C5 
major), 61.6 (C5 minor), 60.7 (C7 minor), 60.6 (C7 minor), 59.1 (C3 major), 38.0 (C2 















4-Azido-5-methoxy-6-methyl-tetrahydro-pyran-2-one (2.66).  (KP2-127).  4 Å 
Molecular sieves (127 mg) were added to 2.65 (68 mg, 0.36 mmol) in CH2Cl2 (3 mL).  
The solution was stirred for 10 min, and NMO (64 mg, 0.55 mmol) and TPAP (10 mg, 
0.028 mmol) were added.  The reaction was stirred for 20 min then the solvents were 
removed under reduced pressure.  The residue was passed through a plug of silica, eluting 
with EtOAc to yield 52 mg (77%) of 2.66 as a clear oil.  1H NMR (500 MHz) δ 4.15 (dq, 
J = 8.8, 6.4 Hz, 1 H), 3.88 (dt, J = 7.4, 6.4 Hz, 1 H), 3.57 (s, 3 H), 3.08 (dd, J = 8.8, 6.4 
Hz, 1 H), 2.95 (dd, J = 17.3, 6.4 Hz, 1 H), 2.92 (dd, J = 17.3, 7.4 Hz, 1 H), 1.46 (d, J = 
6.4 Hz, 3 H); 13C NMR (125 MHz) δ 168.0, 88.4, 76.1, 59.8, 58.8, 34.1, 18.7; IR (neat) 
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3437, 2104, 1745, 1238, 1109, 1066 cm-1; MASS SPECTRUM (CI) m/z 186.0884 
[C7H12N3O3 (M+1) requires 186.0879] 186 (base), 170, 143, 127.   
NMR Assignments:  1H NMR (500 MHz) δ 4.15 (dq, J = 8.8, 6.4 Hz, 1 H, C5-
H), 3.88 (dt, J = 7.4, 6.4 Hz, 1 H, C3-H), 3.57 (s, 3 H, C7-H), 3.08 (dd, J = 8.8, 6.4 Hz, 1 
H, C4-H), 2.95 (dd, J = 17.3, 6.4 Hz, 1 H, C2-H), 2.92 (dd, J = 17.3, 7.4 Hz, 1 H, C2-H), 
1.46 (d, J = 6.4 Hz, 3 H, C6-H); 13C NMR (125 MHz) δ 168.0 (C1), 88.4 (C4), 76.1 (C5), 





















(3-Methoxy-2-methyl-6-oxo-tetrahydro-pyran-4-yl)-carbamic acid tert-butyl 
ester (2.67).   (KP2-141).  Palladium on activated carbon (7 mg, 10 wt % palladium) was 
added to azide 2.66 (70 mg, 0.38 mmol) in optima grade EtOAc (4 mL).  The reaction 
vessel was purged with Ar, and a solution of Boc anhydride (124 mg, 0.57 mmol) in 
optima grade EtOAc (1 mL) was added.  The reaction vessel was purged with H2, and the 
reaction was stirred at room temperature under a H2 atmosphere for 8 h.  The reaction 
was filtered through a plug of Celite eluting with EtOAc.  The filtrate was concentrated 
under reduced pressure and the crude residue was purified by flash chromatography, 
eluting with EtOAc/hexanes (1:2) to give 85 mg (87%) of 2.67 as a white solid: mp = 
131–132 °C; 1H NMR (500 MHz) δ 4.68 (br d, J = 5.8 Hz, 1 H), 4.10 (ddd, J = 8.2, 6.2 
Hz, 1 H), 4.02 (br s, 1 H), 3.49 (s, 3 H), 3.14 (dd, J = 8.2, 4.2 Hz, 1 H), 2.89 (dd, J = 
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16.3, 5.8 Hz, 1 H), 2.61 (dd, J = 16.3, 4.2 Hz, 1H), 1.44 (d, J = 6.2 Hz, 3 H), 1.42 (s, 9 
H); 13C NMR (125 MHz) δ 170.4, 154.7, 83.6, 76.4, 58.5, 48.7, 34.4, 28.3, 19.0; IR (neat) 
3354, 1754, 1678, 1526, 1245, 1168, 1118 cm-1; mass spectrum (CI) m/z 260.1501 
[C12H22NO5 (M+1) requires 260.1498] 244, 232, 204 (base).   
NMR Assignments: 1H NMR (500 MHz) δ 4.68 (br d, J= 5.8 Hz, 1 H, N-H), 
4.10 (ddd, J = 8.2, 6.2 Hz, 1 H, C5-H), 4.02 (br s, 1 H, C3-H), 3.49 (s, 3 H, C7-H), 3.14 
(dd, J = 8.2, 4.2 Hz, 1 H, C4-H), 2.89 (dd, J = 16.3, 5.8 Hz, 1 H, C2-H), 2.61 (dd, J = 
16.3, 4.2 Hz, 1H, C2-H), 1.44 (d, J = 6.2 Hz, 3 H, C6-H), 1.42 (s, 9 H, C12-H); 13C NMR 
(125 MHz) δ 170.4 (C10), 154.7 (C1), 83.6 (C11), 76.4 (C5), 58.5 (C7), 48.7 (C3), 34.4 



















(2S,3R,4S,6R)-Acetic acid 4-azido-6-benzyloxy-2-methyltetrahydropyran-3-yl 
ester (2.69).  (KP2-201).  A mixture of acetic acid 5-acetoxy-4-azido-6-
methyltetrahydropyran-2-yl ester 2.62 (171 mg, 0.67 mmol), benzyl alcohol (172 µL, 180 
mg, 1.66 mmol), and K-10 Montmorillonite (340 mg) in anhydrous benzene (2 mL) was 
heated at 90 °C for 24 h. The mixture was allowed to cool to room temperature and 
filtered through Celite, eluting with EtOAc.  The combined filtrate and washings were 
concentrated and the residue was purified by flash chromatography, eluting with 
Et2O/hexanes (1:15) to give 102 mg (50%) of 2.69 as a colorless oil: 1H NMR (500 MHz, 
CDCl3) δ 7.37–7.24 (comp, 5 H), 7.94 (d, J = 3.5 Hz, 1 H), 4.67 (app t, J = 9.8 Hz, 1 H), 
4.66 (d, J = 11.9 Hz, 1 H), 4.46 (d, J = 11.9 Hz, 1 H), 3.90 (ddd, J = 12.3, 9.8, 4.9 Hz, 1 
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H), 3.82 (dq, J = 9.8, 6.3 Hz, 1 H), 2.17–2.02 (m, 1 H), 2.11 (s, 3 H), 1.74 (ddd, J = 13.1, 
12.3, 3.5 Hz, 1 H), 1.15 (d, J = 6.3 Hz, 3 H); 13C NMR (125 MHz, CDCl3) δ 170.0, 137.3, 
128.5, 127.91, 127.89, 95.5, 75.5, 69.1, 66.1, 57.7, 35.2, 20.8, 17.4; IR (neat) 2101, 1764, 
1225, 1043 cm-1; mass spectrum (CI) m/z 306.1457 [C15H20N3O4 (M+1) requires 
306.1454], 198 (base), 156.   
NMR Assignments: 1H NMR (500 MHz, CDCl3) δ 7.37–7.24 (comp, 5 H, Ph C-
H), 7.94 (d, J = 3.5 Hz, 1 H, C1-H), 4.67 (app t, J = 9.8 Hz, 1 H, C4-H), 4.66 (d, J = 11.9 
Hz, 1 H, C9-H), 4.46 (d, J = 11.9 Hz, 1 H, C9-H), 3.90 (ddd, J = 12.3, 9.8, 4.9 Hz, 1 H, 
C3-H), 3.82 (dq, J = 9.8, 6.3 Hz, 1 H, C5-H), 2.17–2.02 (m, 1 H, C2-H), 2.11 (s, 3 H, C7-
H), 1.74 (ddd, J = 13.1, 12.3, 3.5 Hz, 1 H, C2-H), 1.15 (d, J = 6.3 Hz, 3 H, C6-H); 13C 
NMR (125 MHz, CDCl3) δ 170.0 (C8), 137.3 (Ph C), 128.5 (Ph C), 127.91 (Ph C), 
127.89 (Ph C), 95.5 (C1), 75.5 (C4), 69.1 (C9), 66.1 (C5), 57.7 (C3), 35.2 (C2), 20.8 

















(KP2-202).  A mixture of acetate 2.69 (313 mg, 1.03 mmol) and K2CO3 (7 mg, 0.05 
mmol) in MeOH (10 mL) was stirred at room temperature for 24 h.  The solvent was 
removed under reduced pressure, and the residue was dried under vacuum to give an 
alcohol:  1H NMR (500 MHz, CDCl3) δ 7.36–7.27 (comp, 5 H), 4.93 (d, J = 3.5 Hz, 1 H), 
4.66 (d, J = 12.5 Hz, 1 H), 4.45 (d, J = 12.5 Hz, 1 H), 3.80 (ddd, J = 12.0, 9.6, 4.9 Hz, 1 
H), 3.73 (dq, J = 9.6, 6.2 Hz, 1 H), 3.14 (td, J = 9.6, 3.9 Hz, 1 H), 2.19 (ddd, J = 12.9, 
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4.9, 1.1 Hz, 1 H), 2.11 (d, J = 3.9 Hz, 1 H), 1.73 (ddd, J = 12.9, 12.0, 3.5 Hz, 1 H), 2.56 
(d, J = 6.2 Hz, 3 H); 13C NMR (125 MHz, CDCl3) δ 137.4, 128.5, 127.92, 127.86, 95.7, 
76.0, 70.0, 67.9, 60.5, 34.9, 17.7; IR (neat) 3438, 2103, 1255, 1123, 1049, 1023 cm-1; 
mass spectrum (CI) m/z 278.1505 [C14H20N3O3 (M+1) requires 278.1426], 191, 170,159, 
127 (base).   
NMR Assignments: 1H NMR (500 MHz, CDCl3) δ 7.36–7.27 (comp, 5 H, Ph C-
H), 4.93 (d, J = 3.5 Hz, 1 H, C1-H), 4.66 (d, J = 12.5 Hz, 1 H, C7-H), 4.45 (d, J = 12.5 
Hz, 1 H, C7-H), 3.80 (ddd, J = 12.0, 9.6, 4.9 Hz, 1 H, C3-H), 3.73 (dq, J = 9.6, 6.2 Hz, 1 
H, C5-H), 3.14 (td, J = 9.6, 3.9 Hz, 1 H, C4-H), 2.19 (ddd, J = 12.9, 4.9, 1.1 Hz, 1 H, C2-
H), 2.11 (d, J = 3.9 Hz, 1 H, OH), 1.73 (ddd, J = 12.9, 12.0, 3.5 Hz, 1 H, C2-H), 2.56 (d, 
J = 6.2 Hz, 3 H, C6-H); 13C NMR (125 MHz, CDCl3) δ 137.4 (Ph C), 128.5 (Ph C), 
127.92 (Ph C), 127.86 (Ph C), 95.7 (C1), 76.0 (C4), 70.0 (C7), 67.9 (C5), 60.5 (C3), 34.9 


















(2.70).  (KP2-204). MeI (77 µL, 176 mg, 1.24 mmol) and NaH (62 mg, 1.55 mmol, 60% 
dispersion) were added to alcohol 2.69a in DMF (10 mL) and the mixture was stirred for 
20 h at room temperature.  H2O (10 mL) and EtOAc (25 mL) were added, and the layers 
were separated.  The organic layer was washed with H2O (2 x 15 mL) and brine (15 mL), 
dried (Na2SO4), and concentrated under reduced pressure.  The residue was purified by 
flash chromatography, eluting with Et2O/hexanes (1:10) to give 262 mg (92%) of 2.70 as 
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a colorless oil: 1H NMR (500 MHz, CDCl3) δ 7.35–7.26 (comp, 5 H), 4.88 (d, J = 3.6 Hz, 
1 H), 4.64 (d, J = 11.8 Hz, 1 H), 4.42 (d, J = 11.8 Hz, 1 H), 3.81 (ddd, J = 12.5, 9.4, 5.0 
Hz, 1 H), 3.71 (dq, J = 9.4, 6.4 Hz, 1 H), 3.57 (s, 3 H), 2.72 (app t, J = 9.4 Hz, 1 H), 2.11 
(ddd, J = 13.2, 5.0, 1.2 Hz, 1 H), 1.62 (ddd, J = 13.2, 12.5, 3.6 Hz, 1 H), 1.27 (d, J = 6.4 
Hz, 3 H); 13C NMR (125 MHz, CDCl3) δ 137.5, 128.5, 127.9, 127.8, 95.5, 86.1, 68.9, 
67.6, 60.6, 59.8, 35.5, 17.9; IR (neat) 2102, 1255, 1124, 1099, 1024 cm-1; mass spectrum 
(CI) m/z 278.1505 [C14H20N3O3 (M+1) requires 278.1426], 191, 170, 159, 127 (base). 
NMR Assignments: 1H NMR (500 MHz, CDCl3) δ 7.35–7.26 (comp, 5 H, Ph C-
H), 4.88 (d, J = 3.6 Hz, 1 H, C1-H), 4.64 (d, J = 11.8 Hz, 1 H, C8-H), 4.42 (d, J = 11.8 
Hz, 1 H, C8-H), 3.81 (ddd, J = 12.5, 9.4, 5.0 Hz, 1 H, C3-H), 3.71 (dq, J = 9.4, 6.4 Hz, 1 
H, C5-H), 3.57 (s, 3 H, C7-H), 2.72 (app t, J = 9.4 Hz, 1 H, C4-H), 2.11 (ddd, J = 13.2, 
5.0, 1.2 Hz, 1 H, C2-H), 1.62 (ddd, J = 13.2, 12.5, 3.6 Hz, 1 H, C2-H), 1.27 (d, J = 6.4 
Hz, 3 H, C6-H); 13C NMR (125 MHz, CDCl3) δ 137.5 (Ph C), 128.5 (Ph C), 127.9 (Ph 
C), 127.8 (Ph C), 95.5 (C1), 86.1 (C4), 68.9 (C8), 67.6 (C5), 60.6 (C7), 59.8 (C3), 35.5 

















(2.70a).  (KP2-157).  A solution of azide 2.70 (127 mg, 0.46 mmol) in Et2O (2.3 mL) was 
cooled to 0 °C and LiAlH4 (480 µL, 18 mg, 1 M in THF) was added dropwise.  The 
reaction was warmed to room temperature, and stirring was continued for 10 min.  The 
mixture was cooled to 0 °C, and H2O (18 µL), 15% aqueous NaOH (18 µL), and H2O (55 
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µL) were then added sequentially.  The mixture was filtered through Celite, and the 
filtrate was removed under reduced pressure to give 115 mg of an amine: 1H NMR (500 
MHz, CDCl3) δ 7.32–7.26 (comp, 5 H), 4.86 (d, J = 3.8 Hz, 1 H), 4.65 (d, J = 11.9 Hz, 1 
H), 4.42 (d, J = 11.9 Hz, 1 H), 3.69 (dq, J = 9.3, 6.4 Hz, 1 H), 3.54 (s, 3 H), 3.22 (ddd, J 
= 12.2, 9.3, 4.8 Hz, 1 H), 2.55 (app t, J = 9.3 Hz, 1 H), 2.01 (ddd, J = 13.3, 4.8, 1.1 Hz, 1 
H), 1.56 (ddd, J = 13.3, 12.2, 3.8 Hz, 1 H), 1.26 (d, J = 6.4 Hz, 3 H); 13C NMR (125 
MHz, CDCl3) δ 137.9, 128.4, 127.7, 127.6, 96.1, 89.2, 68.7, 67.5, 60.7, 48.9, 38.4, 18.3; 
IR (neat) 3553, 3283, 1123, 1097, 1024 cm-1; mass spectrum (CI) m/z 252.1599 
[C14H20N3O3 (M+1) requires 252.1521], 144 (base), 127, 118.   
NMR Assignments: 1H NMR (500 MHz, CDCl3) δ 7.32–7.26 (comp, 5 H, Ph C-
H), 4.86 (d, J = 3.8 Hz, 1 H, C1-H), 4.65 (d, J = 11.9 Hz, 1 H, C8-H), 4.42 (d, J = 11.9 
Hz, 1 H, C8-H), 3.69 (dq, J = 9.3, 6.4 Hz, 1 H, C5-H), 3.54 (s, 3 H, C7-H), 3.22 (ddd, J = 
12.2, 9.3, 4.8 Hz, 1 H, C3-H), 2.55 (app t, J = 9.3 Hz, 1 H, C4-H), 2.01 (ddd, J = 13.3, 
4.8, 1.1 Hz, 1 H, C2-H), 1.56 (ddd, J = 13.3, 12.2, 3.8 Hz, 1 H, C2-H), 1.26 (d, J = 6.4 
Hz, 3 H, C6-H); 13C NMR (125 MHz, CDCl3) δ 137.9 (Ph C), 128.4 (Ph C), 127.7 (Ph 
C), 127.6 (Ph C), 96.1 (C1), 89.2 (C4), 68.7 (C8), 67.5 (C5), 60.7 (C7), 48.9 (C3), 38.4 






















carbamic acid tert-butyl ester (2.71). (KP2-158).  A solution of the amine 2.70a 
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experiment (115 mg, 0.458 mmol) in CH2Cl2 (5 mL) was cooled to 0 °C, and Boc2O (150 
mg, 0.678 mmol) in CH2Cl2 (1 mL) was added.  The mixture was stirred at 0 °C for 5 
min, and then at room temperature for 24 h.  The mixture was concentrated under 
reduced pressure, and the residue was purified by flash chromatography, eluting with 
Et2O/hexanes (1:1) to give 141 mg (88%) of 2.71 as a white solid: mp 113–115 °C; 1H 
NMR (500 MHz, CDCl3) δ 7.31–7.23 (comp, 5 H), 4.85 (dd, J = 3.7, 1.4 Hz, 1 H), 4.65 
(d, J = 12.0 Hz, 1 H), 4.46 (br s, 1 H), 4.43 (d, J = 12.0 Hz, 1 H), 3.96–3.89 (m, 1 H), 
3.76 (dq, J = 9.3, 6.2 Hz, 1 H), 3.46 (s, 3 H), 2.83-2.79 (m, 1 H), 2.13 (dd, J = 4.7, 1.6 
Hz, 1 H), 1.79–1.74 (m, 1 H), 1.43 (s, 9 H), 1.25 (d, J = 6.2 Hz, 3 H); 13C NMR (125 
MHz, CDCl3) δ 155.4, 137.9, 128.3, 127.7, 127.5, 95.5, 85.0, 79.4, 68.6, 57.6, 59.4, 48.8, 
36.3, 28.4, 18.2; IR (neat) 3344, 1686, 1534, 1176, 1127, 1104 cm-1; mass spectrum (CI) 
m/z 352.2125 [C19H29NO5 (M+1) requires 352.2046], 244, 188 (base), 127. 
NMR Assignments:  1H NMR (500 MHz, CDCl3) δ 7.31–7.23 (comp, 5 H, Ph C-
H), 4.85 (dd, J = 3.7, 1.4 Hz, 1 H, C1-H), 4.65 (d, J = 12.0 Hz, 1 H, C11-H), 4.46 (br s, 1 
H, NH), 4.43 (d, J = 12.0 Hz, 1 H, C11-H), 3.96–3.89 (m, 1 H, C3-H), 3.76 (dq, J = 9.3, 
6.2 Hz, 1 H, C5-H), 3.46 (s, 3 H, C7-H), 2.83–2.79 (m, 1 H, C4-H), 2.13 (dd, J = 4.7, 1.6 
Hz, 1 H, C2-H), 1.79–1.74 (m, 1 H, C2-H), 1.43 (s, 9 H, C10-H), 1.25 (d, J = 6.2 Hz, 3 
H, C6-H); 13C NMR (125 MHz, CDCl3) δ 155.4 (C8), 137.9 (Ph C), 128.3 (Ph C), 127.7 
(Ph C), 127.5 (Ph C), 95.5 (C1), 85.0 (C4), 79.4 (C9), 68.6 (C11), 67.6 (C5), 59.4 (C7), 





















methylcarbamic acid tert-butyl ester (2.72).  (KP2-167).  A mixture of carbamate 2.71 
(398 mg, 1.13 mmol), MeI (84 µL, 1.36 mmol) and NaH (68 mg, 1.70 mmol, 60% 
dispersion in mineral oil) in anhydrous DMF (15 mL) was stirred at room temperature for 
30 min, whereupon MeOH (5 mL), H2O (30 mL), and Et2O (50 mL) were added.  The 
layers were separated, and the organic layer was washed with H2O (2 x 30 mL) and brine 
(1 x 30 mL).  The combined organic layers were dried (Na2SO4), and concentrated under 
reduced pressure.  The residue was purified by flash chromatography, eluting with 
Et2O/hexanes (1:1) to afford 400 mg (97%) of 2.72 as a clear oil:  1H NMR (500 MHz, 
CDCl3) δ 7.36–7.26 (comp, 5 H), 4.91 (d, J = 3.5 Hz, 1 H), 4.61 (d, J = 12.1 Hz, 1 H), 
4.46 (d, J = 12.1 Hz, 1 H), 4.25-4.20 (m, 1 H), 3.64 (dq, J = 9.3, 6.3 Hz, 1 H), 3.33 (s, 3 
H), 3.08 (app t, J = 9.3 Hz, 1 H), 2.74 (s, 3 H), 1.97 (td, J = 12.9, 3.5 Hz, 1 H), 1.73 (dd, J 
= 12.9, 4.7 Hz, 1 H), 1.41 (s, 9H), 1.19 (d, J = 6.3 Hz, 3 H); 13C NMR (125 MHz, CDCl3) 
δ 154.5, 137.7, 127.6, 126.9, 126.8, 95.3, 80.2, 78.1, 67.6, 67.1, 57.4, 52.8, 32.8, 27.6, 
17.5; IR (neat) 1693, 1365, 1151, 1127 cm-1; mass spectrum (CI) m/z 366.2284 
[C20H32NO5 (M+1) requires 366.2202], 258, 202 (base).   
NMR Assignments: 1H NMR (500 MHz, CDCl3) δ 7.36–7.26 (comp, 5 H, PhC-
H), 4.91 (d, J = 3.5 Hz, 1 H, C1-H), 4.61 (d, J = 12.1 Hz, 1 H, C12-H), 4.46 (d, J = 12.1 
Hz, 1 H, C12-H), 4.25–4.20 (m, 1 H, C3-H), 3.64 (dq, J = 9.3, 6.3 Hz, 1 H, C5-H), 3.33 
(s, 3 H, C7-H), 3.08 (app t, J = 9.3 Hz, 1 H, C4-H), 2.74 (s, 3 H, C8-H), 1.97 (td, J = 
 217 
12.9, 3.5 Hz, 1 H, C2-H), 1.73 (dd, J = 12.9, 4.7 Hz, 1 H, C2-H), 1.41 (s, 9H, C11-H) 
1.19 (d, J = 6.3 Hz, 3 H, C6-H); 13C NMR (125 MHz, CDCl3) δ 154.5 (C9), 137.7 (PhC), 
127.6 (PhC), 126.9 (PhC), 126.8 (PhC), 95.3 (C1), 80.2 (C4), 78.1 (C10), 67.6 (C12), 




















methylcarbamic acid tert-butyl ester (2.72a).  (KP2-160).  A mixture of benzyl acetal 
2.72 (100 mg, 0.27 mmol) and 10% Pd/C (10 mg) in EtOAc (7 mL) was stirred under H2 
(1 atm) for 38 h. An additional portion of 10% Pd/C was added (15 mg), and stirring was 
continued under H2 for 10 h.  The reaction was filtered through celite, and the filtrate was 
concentrated to afford 70 mg of an anomeric mixture of lactols as a white solid.  The 
lactols were isolated as a mixture (1:5) of α- and β-anomers: mp 138–140 °C.  Upon 
heating at 100 °C in DMSO-d6, the lactols equilibrated to a 1:1 mixture of anomers: 1H 
NMR (500 MHz, DMSO-d6, 100 °C) δ 6.16–6.15 (m, 1 H), 5.82 (s, 1 H), 5.10–5.09 (m, 1 
H), 4.66 (dd, J = 11.6, 6.2 Hz, 1 H), 4.25–4.20 (m, 1 H), 3.87–3.80 (comp, 2 H), 3.32 (s, 
6 H), 3.28 (dq, J = 8.8, 6.1 Hz, 1 H), 3.03–2.96 (comp, 2 H), 2.75 (s, 3 H), 2.73 (s, 3 H), 
1.88 (td, J = 12.9, 3.5 Hz, 1 H), 1.72-1.70 (comp, 2 H), 1.60 (dd, J = 12.6, 4.4 Hz, 1 H), 
1.420 (s, 9 H), 1.417 (s, 9 H), 1.21 (d, J = 6.1 Hz, 3 H), 1.11 (d, J = 6.2 Hz, 3 H); 13C 
NMR (125 MHz, DMSO-d6, 100 °C) δ 154.5, 154.4, 93.4, 89.5, 80.8, 80.1, 78.2, 78.0, 
70.9, 66.0, 57.5, 57.2, 56.0, 52.6, 36.1, 34.1, 29.7, 27.67, 27.66, 17.73, 17.70; IR (neat) 
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3388, 1692, 1673, 1364, 1155, 1112 cm-1;  mass spectrum (CI) m/z 276.1817 [C13H25NO5 
(M+1) requires 276.1733], 258 (base), 220, 202.   
NMR Assignments: 1H NMR (500 MHz, DMSO-d6, 100 °C) δ 6.16–6.15 (m, 1 
H, OH), 5.82 (s, 1 H, OH), 5.10–5.09 (m, 1 H, C1-H), 4.66 (dd, J = 11.6, 6.2 Hz, 1 H, 
C1-H), 4.25–4.20 (m, 1 H, C3-H), 3.87–3.80 (comp, 2 H, C5-H and C3-H), 3.32 (s, 6 H, 
C7-H), 3.28 (dq, J = 8.8, 6.1 Hz, 1 H, C5-H), 3.03–2.96 (comp, 2 H, C4-H and C4-H), 
2.75 (s, 3 H, C8-H), 2.73 (s, 3 H, C8-H), 1.88 (td, J = 12.9, 3.5 Hz, 1 H, C2-H), 1.72–
1.70 (comp, 2 H, C2-H and C2-H), 1.60 (dd, J = 12.6, 4.4 Hz, 1 H, C2-H), 1.420 (s, 9 H, 
C11-H), 1.417 (s, 9 H, C11-H), 1.21 (d, J = 6.1 Hz, 3 H, C6-H), 1.11 (d, J = 6.2 Hz, 3 H, 
C6-H); 13C NMR (125 MHz, DMSO-d6, 100 °C) δ 154.5 (C9), 154.4 (C9), 93.4 (C1), 
89.5 (C1), 80.8 (C4), 80.1 (C4), 78.2 (C10), 78.0 (C10), 70.9 (C5), 66.0 (C5), 57.5 (C7), 
57.2 (C7), 56.0 (C3), 52.6 (C3), 36.1 (C2), 34.1 (C2), 29.7, 27.67 (C8), 27.66 (C8), 17.73 




















methylcarbamic acid tert-butyl ester (2.68).  (KP2-162).  Lactol 2.72a from the 
preceding experiment (74 mg) in CH2Cl2 (7 mL), NMO (47 mg, 0.41 mmol), and TPAP 
(5 mg, 0.014 mmol) containing 4 Å powdered molecular sieves (95 mg) was stirred for 
0.5 h.  The solvent was removed under reduced pressure, and the residue was purified by 
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flash chromatography eluting with EtOAc/hexanes (2:3) to give 69 mg (93%) of lactone 
2.68 as a white solid: mp 73–74 °C; 1H NMR (500 MHz, DMSO-d6, 100 °C) δ 4.23 (dq, J 
= 8.7, 6.4 Hz, 1 H), 4.16 (td, J = 8.7, 6.4 Hz, 1 H), 3.48 (app t, J = 8.7 Hz, 1 H), 3.39 (s, 3 
H), 2.98 (dd, J = 17.2, 8.7 Hz, 1 H), 2.79 (s, 3 H), 2.52 (dd, J = 17.2, 6.4 Hz, 1 H), 1.43 
(s, 9 H), 1.35 (d, J = 6.4 Hz, 3 H); 13C NMR (125 MHz, DMSO-d6, 100 °C) δ 169.1, 
154.1, 79.2, 79.0, 74.4, 57.5, 54.6, 33.2, 31.3, 27.6, 17.6; IR (neat) 1750, 1690, 1366, 
1148, 1109 cm-1; mass spectrum (CI) m/z 274.1649 [C13H24NO5 (M+1) requires 
274.1576], 246, 218 (base). 
NMR Assignments: 1H NMR (500 MHz, DMSO-d6, 100 °C) δ 4.23 (dq, J = 8.7, 
6.4 Hz, 1 H, C5-H), 4.16 (td, J = 8.7, 6.4 Hz, 1 H, C3-H), 3.48 (app t, J = 8.7 Hz, 1 H, 
C4-H), 3.39 (s, 3 H, C3-H), 2.98 (dd, J = 17.2, 8.7 Hz, 1 H, C2-H), 2.79 (s, 3 H, C8-H), 
2.52 (dd, J = 17.2, 6.4 Hz, 1 H, C2-H), 1.43 (s, 9 H, C11-H), 1.35 (d, J = 6.4 Hz, 3 H, 
C6-H); 13C NMR (125 MHz, DMSO-d6, 100 °C) δ 169.1 (C9), 154.1 (C1), 79.2 (C4 or 
C10), 79.0 (C4 or C10), 74.4 (C5), 57.5 (C4), 54.6 (C3), 33.2 (C2), 31.3 (C8), 27.6 























methylcarbamic acid tert-butyl ester (2.73).  (KP2-188).  2-Furyllithium (0.910 mmol, 
0.27 M, 3.4 mL) was added to a solution of lactone 2.68 (0.758 mmol) in THF (8.0 mL) 
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at –78 °C. The mixture was stirred at –78 °C for 2 h, whereupon Et3N (230 mg, 2.27 
mmol, 316 µL), DMAP (102 mg, 0.910 mmol) in THF (0.30 mL) and TFAA (398 mg, 
1.90 mmol, 267 µL) were added sequentially. The cold bath was allowed to warm to 
room temperature over 4.5 h. A 50% aqueous solution of NaHCO3 (15 mL) and Et2O (15 
mL) were added, the layers were separated, and the mixture was extracted with EtOAc (3 
x 15 mL). The combined organic layers were dried (Na2SO4), filtered, and concentrated 
under reduced pressure. The crude residue was purified by flash chromatography, eluting 
with Et2O/hexanes (1:3) to give 226 mg (92%) of furyl glycal 2.73:  1H NMR (500 MHz, 
DMSO-d6, 100 °C) δ 7.58–7.57 (m, 1 H), 6.48–6.46 (comp, 2 H), 4.97 (d, J = 2.8 Hz, 1 
H), 3.97 (dq, J = 9.5, 6.2 Hz, 1 H), 3.42 (s, 3 H), 3.33 (app t, J = 8.6 Hz, 1 H), 2.73 (s, 3 
H), 1.43 (s, 9 H), 1.40 (d, J = 6.2 Hz, 3 H); 13C NMR (125 MHz, DMSO-d6, 100 °C) δ 
154.6, 147.8, 145.6, 142.5, 110.7, 106.4, 96.8, 78.4, 77.2, 74.5, 57.7, 55.4, 29.2, 27.6, 
17.0; IR (neat) 3119, 1693, 1392, 1366, 1327, 1139, 1115 cm-1; mass spectrum (CI) m/z 
324.1803 [C17H26NO5 (M+1) requires 324.1811] 268 (base), 194.   
NMR Assignments: 1H NMR (500 MHz, DMSO-d6, 100 °C) δ 7.58–7.57 (m, 1 
H, C9-H), 6.48–6.46 (comp, 2 H, C7-H and C8-H), 4.97 (d, J = 2.8 Hz, 1 H, C2-H), 3.97 
(dq, J = 9.5, 6.2 Hz, 1 H, C5-H), 3.42 (s, 3 H, C10-H), 3.33 (app t, J = 8.6 Hz, 1 H, C4-
H), 2.73 (s, 3 H, C11-H), 1.43 (s, 9 H, C14-H), 1.40 (d, J = 6.2 Hz, 3 H, C6-H); 13C NMR 
(125 MHz, DMSO-d6, 100 °C) δ 154.6, 147.8, 145.6, 142.5, 110.7 (C8 or C7), 106.4 (C8 



























butyl ester (2.74).  (KP2-166).  s-BuLi (220 µL, 0.30 mmol, 1.21 M) was added 
dropwise to a solution of 2-chloro-1,4-dimethoxybenzene (51 mg, 0.30 mmol) in THF 
(1.5 mL) at –95 °C.  The solution was stirred at –95 °C for 15 min, whereupon 2.73 (48 
mg, 0.15 mmol) in THF (0.3 mL) was added dropwise.  The resultant mixture was 
warmed to –5 °C over a 1 h period, at which time a 50% aqueous NH4Cl (2 mL) was 
added and the solution warmed to rt.  The layers were separated, and the aqueous layer 
was extracted with Et2O (3 x 2 mL).  The organic layer was dried (Na2SO4) and 
concentrated.  The residue was purified by flash chromatography, eluting with 
EtOAc/hexanes (1:2) to give 68 mg (quantitative) of 2.74: mass spectrum (CI) m/z 
460.2336 [C25H34NO7 (M+1) requires 460.2335] 404, 386 (base) 329; IR (neat) 1692, 





































dihydro-2H-pyran-4-yl]-methylcarbamic acid tert-butyl ester (2.79).  (KP2-195).  A 
solution of ZnCl2 in Et2O (380 µL, 0.38 mmol, 1 M) was added to 2.74 (146 mg, 0.32 
mmol) in CH2Cl2 (6 mL) at –25 °C.  The cold bath was immediately removed, and 
stirring was continued at rt for 45 min, whereupon a saturated aqueous solution of 
NaHCO3 (6 mL) and Et2O (6 mL) were added.  The layers were separated, and the 
aqueous layer was extracted with Et2O (3 x 6 mL), dried (Na2SO4), concentrated, and 
dried under vacuum.   
A mixture of the crude naphthol, MeI (71 mg, 0.50 mmol, 31 µL), and NaH (25 
mg, 0.626 mmol, 60% dispersion in mineral oil) in DMF (4.2 mL) was stirred for 1.5 h at 
rt, whereupon H2O (8 mL) and Et2O (15 mL) were added.  The layers were separated, and 
the organic layer was washed with H2O (2 x 10 mL) and brine (1 x 10 mL), dried 
(Na2SO4), and concentrated.  The residue was purified by flash chromatography, eluting 
with EtOAc/hexanes (1:4) to give 108 mg (72%) of 2.79 as a yellow oil: 1H NMR (500 
MHz, DMSO-d6, 100 °C) δ 7.28 (d, J = 7.9 Hz, 1 H), 6.96 (d, J = 8.6 Hz, 1 H), 6.93–6.89 
(comp, 2 H), 4.89–4.87 (m, 1 H), 4.37 (d, J = 2.4 Hz, 1 H), 4.06 (dq, J = 9.6, 6.4 Hz, 1 H) 
3.87 (s, 3 H), 3.84 (s, 3 H), 3.80 (s, 3 H), 3.45 (s, 3 H), 3.33 (app t, J = 9.6 Hz, 1 H), 2.83 
(s, 3 H), 1.45 (s, 9 H), 1.31 (d, J = 6.4 Hz, 3 H); 13C NMR (125 MHz, DMSO-d6, 100 °C) 
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δ 159.2, 157.0, 154.8, 150.8, 149.8, 129.5, 126.0, 123.7, 118.8, 109.1, 107.8, 106.3, 97.0, 
78.2, 77.4, 74.1, 57.5, 57.4, 56.4, 56.1, 55.7, 27.7, 17.0; mass spectrum (CI) m/z 474.2491 
[C26H36NO7 (M+1) requires 474.2492] (base), 418, 343; IR (neat) 1691, 1590, 1391, 
1271, 1137 cm-1. 
NMR Assignments: 1H NMR (500 MHz, DMSO-d6, 100 °C) δ 7.28 (d, J = 7.9 
Hz, 1 H, C13-H), 6.96 (d, J = 8.6 Hz, 1 H, Ar-H), 6.93–6.89 (comp, 2 H, Ar-H), 4.89–
4.87 (m, 1 H, C3-H), 4.37 (d, J = 2.4 Hz, 1 H, C2-H), 4.06 (dq, J = 9.6, 6.4 Hz, 1 H, C5-
H), 3.87 (s, 3 H), 3.84 (s, 3 H), 3.80 (s, 3 H), 3.45 (s, 3 H, C7-H), 3.33 (app t, J = 9.6 Hz, 
1 H, C4-H), 2.83 (s, 3 H, C8-H), 1.45 (s, 9 H, C11-H), 1.31 (d, J = 6.4 Hz, 3 H, C6-H); 
13C NMR (125 MHz, DMSO-d6, 100 °C) δ 159.2, 157.0, 154.8, 150.8, 149.8, 129.5 
(C13), 126.0, 123.7, 118.8, 109.1 (Ar C), 107.8 (Ar C), 106.3 (Ar C), 97.0 (C2), 78.2 































dihydro-2H-pyran-4-yl]-dimethylamine (2.80).  (KP2-207).  LAH in THF (1.0 mL, 1.0 
mmol, 1 M) was added to a solution of 2.79 in THF (3 mL), and the solution was warmed 
to 70 °C in a sealed vial for 12 h.  The mixture was cooled to 0 °C, whereupon H2O (40 
µL), 15% NaOH (40 µL), and H2O (120 µL) were added sequentially.  The mixture was 
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filtered through Celite, and the filtrate was concentrated to give 51 mg (78%) of 2.80 as a 
yellow oil: 1H NMR (500 MHz, CDCl3) δ 7.33 (d, J = 8.0 Hz, 1 H), 6.82 (s, 2 H), 6.78 (d, 
J = 8.0 Hz, 1 H), 4.77 (br s, 1 H), 4.07 (dq, J = 8.4, 6.4 Hz, 1 H), 3.93 (s, 3 H), 3.87 (s, 3 
H), 3.85 (s, 3 H), 3.61 (s, 3 H), 3.51 (dd, J = 8.4, 2.4 Hz, 1 H), 3.24 (app t, J = 8.4 Hz, 1 
H), 2.41 (s, 6 H), 1.40 (d, J = 6.4 Hz, 3 H); 13C NMR (125 MHz, CDCl3) δ 159.7, 157.7, 
151.4, 150.5, 130.6, 126.9, 124.7, 119.5, 108.4, 107.4, 105.8, 95.4, 78.9, 75.5, 64.9, 59.8, 
57.9, 56.9, 56.5, 40.9, 17.9; mass spectrum (CI) m/z 388.2125 [C22H30NO5 (M+1) requires 
388.2124], 343 (base), 315, 284; IR (neat) 1589, 1462, 1391, 1271, 1252, 1097, 1076, 
1056 cm-1. 
NMR Assignments: 1H NMR (500 MHz, CDCl3) δ 7.33 (d, J = 8.0 Hz, 1 H, C10-
H), 6.82 (s, 2 H, C15-H and C16-H), 6.78 (d, J = 8.0 Hz, 1 H, C11-H), 4.77 (br s, 1 H, 
C2-H), 4.07 (dq, J = 8.4, 6.4 Hz, 1 H, C5-H), 3.93 (s, 3 H), 3.87 (s, 3 H), 3.85 (s, 3 H), 
3.61 (s, 3 H, C7-H), 3.51 (dd, J = 8.4, 2.4 Hz, 1 H, C3-H), 3.24 (app t, J = 8.4 Hz, 1 H, 
C4-H), 2.41 (s, 6 H, C8-H), 1.40 (d, J = 6.4 Hz, 3 H, C6-H); 13C NMR (125 MHz, CDCl3) 
δ 159.7, 157.7, 151.4, 150.5, 130.6 (C10), 126.9, 124.7, 119.5, 108.4 (C15 or C16), 107.4 
(C15 or C16), 105.8 (C11), 95.4 (C2), 78.9 (C4), 75.5 (C5), 64.9 (C3), 59.8 (C7), 57.9, 


































dihydro-2H-pyran-4-yl]-dimethylammonium borate (2.81).  (KP2-255).  BH3•THF in 
THF (97 µL, 0.097 mmol, 1 M) was added to a solution of 2.80 (34 mg, 0.088 mmol) in 
THF (1 mL) at 0 °C.  The mixture was stirred for 45 min, warmed to rt, and concentrated 
to give 35 mg of 2.81 (quantitative): 1H NMR (500 MHz, CDCl3) δ 7.42 (d, J = 8.0 Hz, 1 
H), 6.83 (s, 2 H), 6.79 (d, J = 8.0 Hz), 5.26 (d, J = 2.8 Hz, 1 H), 4.10 (dq, J = 10.2, 6.6 
Hz, 1 H), 3.94 (s, 3 H), 3.88 (s, 3 H), 3.84 (s, 3 H), 3.77 (dd, J = 7.4, 2.8 Hz, 1 H), 3.62–
3.58 (m, 1 H), 3.54 (s, 3 H), 2.76 (s, 3 H), 2.68 (s, 3 H), 2.68 (s, 3 H), 1.45 (d, J = 6.4 Hz, 
3 H); 13C NMR (125 MHz, CDCl3) δ 161.8, 158.1, 151.6, 150.3, 130.9, 128.0, 127.8, 
127.6, 126.7, 123.6, 119.5, 108.5, 107.7, 105.7, 95.0, 78.7, 75.7, 70.3, 58.1, 57.9, 57.1, 
56.5, 52.0, 48.1, 18.3; mass spectrum (CI) m/z 402.2446 [C22H33BNO5 (M+1) requires 
402.2452], 388, 345, 344 (base), 343; IR (neat) 2379, 2320, 2276, 1588, 1463, 1392, 
1274, 1248, 1168, 1091, 1057 cm-1. 
NMR Assignments: 1H NMR (500 MHz, CDCl3) δ 7.42 (d, J = 8.0 Hz, 1 H, C11-
H), 6.83 (s, 2 H, C16-H and C17-H), 6.79 (d, J = 8.0 Hz, C12-H), 5.26 (d, J = 2.8 Hz, 1 
H, C2-H), 4.10 (dq, J = 10.2, 6.6 Hz, 1 H, C5-H), 3.94 (s, 3 H, C20-H), 3.88 (s, 3 H, 
C21-H or C22-H), 3.84 (s, 3 H, C21-H or C22-H), 3.77 (dd, J = 7.4, 2.8 Hz, 1 H, C3-H), 
3.62–3.58 (m, 1 H, C4-H), 3.54 (s, 3 H, C7-H), 2.76 (s, 3 H, C8-H or C9-H), 2.68 (s, 3 H, 
C8-H or C9-H) 1.45 (d, J = 6.4 Hz, 3 H, C6-H); 13C NMR (125 MHz, CDCl3) δ 161.8, 
158.1, 151.6, 150.3, 130.9 (C11), 128.0, 127.8, 127.6, 126.7, 123.6, 119.5, 108.5 (C16 or 
C17), 107.7 (C16 or C17), 105.7 (C12), 95.0 (C2), 78.7 (C4), 75.7 (C5), 70.3 (C3), 58.1 
(C7), 57.9 (C20), 57.1 (C21 or C22), 56.5 (C21 or C22), 52.0 (C8 or C9), 48.1 (C8 or 







1,4-Dimethoxynaphthalene (2.95).  (KP1-300).  Na2S2O4 (11 g, 61 mmol) was 
dissolved in 100 mL of H2O, and the resulting solution was added to a solution of 1,4-
naphthoquinone (1.20 g, 7.6 mmol) in CH2Cl2/Et2O (1:3, 130 mL).  The biphasic mixture 
was shaken in a separatory funnel for 10 min.  The layers were separated, and the organic 
layer was washed with brine (80 mL), dried (Na2SO4), and concentrated under reduced 
pressure.  The residue was then dried under vacuum for 0.5 h and used directly in the 
next step. 
NaH (0.76 g, 19.0 mmol, 60 wt % dispersion) was added in three portions over a 
20 min period to a mixture of the residue and MeI (2.4 g, 1.1 mL, 17 mmol) in DMF (16 
mL).  The reaction mixture was stirred at ambient temperature for 3 h, at which point 
MeOH (7 mL) was added.  The mixture was partitioned between EtOAc (15 mL) and 
H2O (15 mL), and the aqueous layer was extracted with EtOAc (3 x 30 mL).  The 
combined organic layers were washed with water (3 x 100 mL), dried (Na2SO4), and 
concentrated under reduced pressure.  The residue was purified by flash chromatography 
eluting with Et2O/hexanes (1:30) to give (1.15 g, 80%) of 2.95 as a white solid.  Spectra 
































dimethoxy-1,4-epoxyanthracene (2.96).  (KP2-38).  n-BuLi (85 µL, 0.20 mmol, 2.37 
M) was added dropwise to a solution of furan 2.99 (51 mg, 0.13 mmol) and 2-bromo-3-
chloro-1,4-dimethoxynaphthalene 2.95 (61 mg, 0.20 mmol) in Et2O (1.3 mL) at –78 °C.  
The reaction was warmed from –78 °C to 0 °C over a 1 h period, whereupon 50% NH4Cl 
(2 mL) and Et2O (1 mL) were added and the layers were separated.  The aqueous layer 
was extracted with Et2O (3 x 2 mL), dried (Na2SO4), and concentrated under reduced 
pressure.  The residue was purified by flash chromatography eluting with EtOAc/hexanes 
(1:5) to give 67 mg (89%) of 1,4-epoxyanthracene 2.96 as a yellow foam (60:40 
inseparable mixture of diastereomers): 1H NMR (500 MHz) δ 8.10–8.00 (comp, 1 H), 
7.98–7.93 (comp, 1 H), 7.49–7.43 (comp, 2 H), 7.36–7.25 (comp, 10 H), 7.03 (d, J = 6.6 
Hz, 0.6 H), 7.00 (dd, J = 5.6, 1.8 Hz, 0.4 H), 6.99–6.97 (comp, 1 H), 6.18–6.17 (comp, 1 
H), 5.49 (d, J = 2.6 Hz, 0.4 H), 5.38 (d, J = 2.4 Hz, 0.6 H), 4.69 (d, J = 11.0 Hz, 0.6 H), 
4.93 (d, J = 11.0 Hz, 0.4 H), 4.77–4.71 (comp, 3 H), 4.62–4.58 (comp, 1 H), 4.44–4.10 
(comp, 1 H), 4.29–4.22 (comp, 1 H), 4.04 (s, 1.8 H), 4.03 (s, 1.2 H), 3.82 (s, 1.8 H), 3.80 
(s, 1.2 H), 3.71–3.65 (comp, 1 H), 1.51 (d, J = 6.4 Hz, 1.8 H), 1.48 (d, J = 6.4 Hz, 1.2 H);  
13C NMR (125 MHz) δ 150.7, 150.3, 144.9, 144.73, 144.68, 144.6, 142.1, 141.6, 140.4, 
140.2, 138.53, 138.48, 138.4, 138.3, 134.1, 133.4, 129.0, 128.9, 128.8, 128.5, 128.39, 
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128.37, 128.3, 128.23, 128.21, 128.03, 128.00, 127.8, 127.74, 127.70, 127.57, 127.5, 
126.5, 126.4, 122.8, 122.7, 122.4, 122.3, 100.0, 98.4, 90.3, 89.8, 80.8, 80.7, 79.8, 79.5, 
77.5, 77.1, 75.4, 74.8, 74.3, 74.2, 70.44, 70.38, 63.4, 63.3, 61.01, 60.99, 17.78, 17.76; IR 
(neat) 3069, 3035, 1343, 1285, 1092 cm-1.   
NMR Assignments: 1H NMR (500 MHz) δ 8.10–8.00 (comp, 1 H, Ar-H), 7.98–
7.93 (comp, 1 H, Ar-H), 7.49–7.43 (comp, 2 H, Ar-H), 7.36–7.25 (comp, 10 H, Ph-H), 
7.03 (d, J = 6.6 Hz, 0.6 H, C8-H or C9-H), 7.00 (dd, J = 5.6, 1.8 Hz, 0.4 H, C8-H or C9-
H), 6.99–6.97 (comp, 1 H, C8-H or C9-H), 6.18–6.17 (comp, 1 H, C10-H), 5.49 (d, J = 
2.6 Hz, 0.4 H, C2-H), 5.38 (d, J = 2.4 Hz, 0.6 H, C2-H), 4.69 (d, J = 11.0 Hz, 0.6 H, Bn 
C-H), 4.93 (d, J = 11.0 Hz, 0.4 H, Bn C-H), 4.77–4.71 (comp, 2 H, Bn C-H), 4.62–4.58 
(comp, 1 H, Bn C-H), 4.44–4.10 (comp, 1 H, C3-H), 4.29–4.22 (comp, 1 H, C5-H), 4.04 
(s, 1.8 H, C21-H or C22-H), 4.03 (s, 1.2 H, C21-H or C22-H), 3.82 (s, 1.8 H, C21-H or 
C22-H), 3.80 (s, 1.2 H, C21-H or C22-H), 3.71–3.65 (comp, 1 H, C4-H), 1.51 (d, J = 6.4 
Hz, 1.8 H, C6-H), 1.48 (d, J = 6.4 Hz, 1.2 H, C6-H);  13C NMR (125 MHz) δ 150.7, 
150.3, 144.9, 144.73, 144.68, 144.6, 142.1 (C8 or C9), 141.6 (C8 or C9), 140.4 (C8 or 
C9), 140.2 (C8 or C9), 138.53, 138.48, 138.4, 138.3, 134.1, 133.4, 129.0, 128.9, 128.8, 
128.5, 128.39, 128.37, 128.3, 128.23, 128.21, 128.03, 128.00, 127.8, 127.74, 127.70, 
127.57, 127.5, 126.5 (Ar C), 126.4 (Ar C), 122.8 (Ar C), 122.7 (Ar C), 122.4 (Ar C), 
122.3 (Ar C), 100.0 (C2 minor), 98.4 (C2 major), 90.3, 89.8, 80.8 (C10), 80.7 (C10), 79.8 
(C4), 79.5 (C4), 77.5 (C3), 77.1 (C3), 75.4 (C5), 74.8 (C5), 74.3 (Bn C), 74.2 (Bn C), 
70.44 (Bn C), 70.38 (Bn C), 63.4 (C21 or C22 minor), 63.3 (C21 or C22 major), 61.01 






























3,4-dihydro-2H-pyran (2.98).  (KP2-78).  LDA (0.29 mL, 0.179 mmol, 0.61 M) was 
added to a solution of 2-bromo-1,4-dimethoxynaphthalene 2.97 in THF at –78 °C.  Furan 
2.22 (48 mg, 0.179 mmol) was added, and the reaction mixture was transferred to a –45 
°C bath, where stirring was continued for 2.5 h.  A 50% solution of NH4Cl was added (1 
mL), and the layers were separated.  The aqueous layer was extracted with Et2O (3 x 1 
mL).  The organic layers were combined, dried (Na2SO4), and concentrated under 
reduced pressure.  The residue was purified by flash chromatography eluting with 
EtOAc/Hexanes (1:5) to afford 24 mg (48%) of cycloadduct 2.96, along with 10 mg 
(20%) of disubstituted furan 2.98: 1H NMR (500 MHz) δ 8.21 (d, J = 8.2 Hz, 1 H), 8.08 
(d, J = 8.2 Hz, 1 H), 7.54 (ddd, J = 8.2, 6.8, 1.2 Hz, 1 H), 7.47 (ddd, J = 8.2, 6.8, 1.2 Hz, 
1 H), 7.41–7.39 (comp, 2 H), 7.36–7.27 (comp, 8 H), 7.22 (s, 1 H), 7.08 (d, J = 3.4 Hz, 1 
H), 6.67 (d, J = 3.4 Hz, 1 H), 5.58 (d, J = 3.0 Hz, 1 H), 4.90 (d, J = 11.4 Hz, 1 H), 4.75 
(d, J = 11.4 Hz, 1 H), 4.74 (d, J = 11.4 Hz, 1 H), 4.68 (d, J = 11.6 Hz, 1 H), 4.43 (dd, J = 
6.2, 3.0 Hz, 1 H), 4.17 (dq, J = 8.6, 6.4 Hz, 1 H), 4.04 (s, 3 H), 3.83 (s, 3 H), 3.61 (dd, J = 
8.6, 6.2 Hz, 1 H), 1.49 (d, J = 6.4 Hz, 3 H); 13C NMR (125 MHz) δ 152.0, 150.6, 147.7, 
146.1, 145.6, 138.5, 138.2, 129.1, 128.4, 128.0, 127.80, 127.77, 127.7, 126.9, 126.2, 
125.7, 122.4, 122.2, 111.7, 110.4, 101.0, 95.5, 79.4, 76.9, 74.5, 73.9, 70.6, 60.6, 55.8, 
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17.5; mass spectrum (CI) m/z 563.3435 [C36H34O6 (M+1) requires 563.2433] 563 (base), 
457, 455, 316.   
NMR Assignments: 1H NMR (500 MHz) δ 8.21 (d, J = 8.2 Hz, 1 H, C14-H or 
C17-H), 8.08 (d, J = 8.2 Hz, 1 H, C14-H or C17-H), 7.54 (ddd, J = 8.2, 6.8, 1.2 Hz, 1 H, 
C15-H or C16-H), 7.47 (ddd, J = 8.2, 6.8, 1.2 Hz, 1 H, C15-H or C16-H), 7.41–7.39 
(comp, 2 H, Ph-H), 7.36–7.27 (comp, 8 H, Ph-H), 7.22 (s, 1 H, C20-H), 7.08 (d, J = 3.4 
Hz, 1 H, C8-H or C9-H), 6.67 (d, J = 3.4 Hz, 1 H, C8-H or C9-H), 5.58 (d, J = 3.0 Hz, 1 
H, C2-H), 4.90 (d, J = 11.4 Hz, 1 H, Bn C-H), 4.75 (d, J = 11.4 Hz, 1 H, Bn C-H), 4.74 
(d, J = 11.4 Hz, 1 H, Bn C-H), 4.68 (d, J = 11.6 Hz, 1 H, Bn C-H), 4.43 (dd, J = 6.2, 3.0 
Hz, 1 H, C3-H), 4.17 (dq, J = 8.6, 6.4 Hz, 1 H, C5-H), 4.04 (s, 3 H, C21-H or C22-H), 
3.83 (s, 3 H, C21-H or C22-H), 3.61 (dd, J = 8.6, 6.2 Hz, 1 H, C4-H), 1.49 (d, J = 6.4 Hz, 
3 H, C6-H); 13C NMR (125 MHz) δ 152.0, 150.6, 147.7, 146.1, 145.6, 138.5, 138.2, 
129.1, 128.4, 128.0, 127.80, 127.77, 127.7, 126.9 (C15 or C16), 126.2, 125.7 (C15 or 
C16), 122.4 (C14 or C17), 122.2 (C14 or C17), 111.7 (C8 or C9), 110.4 (C8 or C9), 
101.0 (C20), 95.5 (C2), 79.4 (C4), 76.9 (C3), 74.5 (C5), 73.9 (Bn C), 70.6 (Bn C), 60.6 


















5-(tert-Butyldimethylsilanyloxymethyl)-benzene-1,3-diol (3.16).  (KP2-212).  
Imidazole (133 mg, 1.95 mmol) and TBSCl (249 mg, 1.50 mmol) were added to a 
solution of 3,5-dihydroxybenzyl alcohol138 (3.15) (210 mg, 1.50 mmol) in DMF (7 mL).  
The mixture was stirred at rt for 2 h, whereupon H2O (15 mL) and EtOAc (15 mL) were 
 231 
added.  The layers were separated, and the organic layer was washed with brine (1 x 15 
mL), dried (Na2SO4), and concentrated in vacuo.  The residue was purified by flash 
chromatography, eluting with EtOAc/hexanes (1:2) to give 359 mg (94%) of a silyl ether. 
I2 (789 mg, 3.12 mmol) and NaHCO3 (285 mg, 3.40 mmol) were added 
sequentially to a solution of the ether from the preceding reaction (720 mg, 2.83 mmol) in 
THF/H2O (1:1, 36 mL) at 0 °C.  The mixture was stirred at 0 °C for 15 min, then warmed 
at rt for 15 min.  EtOAc (50 mL) and H2O (40 mL) were added, and the layers were 
separated.  The organic layer was washed with brine (1 x 50 mL), dried (Na2SO4), 
concentrated, and dried under vacuum to give 3.16 (white needles): mp = 151–152 ºC; 1H 
NMR (500 MHz, CDCl3) δ 6.53 (s, 2 H), 5.23 (s, 2 H), 4.62 (s, 2 H), 0.92 (s, 9 H), 0.079 
(s, 6 H); 13C NMR (125 MHz, CDCl3) δ 155.42, 144.7, 104.8, 75.0, 64.1, 25.9, 18.4, -5.3; 
mass spectrum (CI) m/z 380.0307 [C13H21IO3Si (M+) requires 380.0305] 271, 127 (base); 
IR (neat) 3458, 1035, 836. 
NMR Assignments: 1H NMR (500 MHz, CDCl3) δ 6.53 (s, 2 H, C3-H), 5.23 (s, 2 
H, OH), 4.62 (s, 2 H, C5-H), 0.92 (s, 9 H, C8-H), 0.079 (s, 6 H, C6-H); 13C NMR (125 


























hydroxy-2-iodo-phenyl ester (3.13).  (KP2-304). Tf2O (1.84 g, 6.51 mmol, 1.1 mL) was 
added to a solution of aryl 3.16 iodide containing N(iPr)2Et (1.2 mL, 6.79 mmol) in 
CH2Cl2 (30 mL) at –78 °C.  The mixture was stirred at –78 °C for 10 min, at which time a 
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saturated solution of NH4Cl (30 mL) was added and the reaction mixture warmed to rt.  
The layers were separated, and the organic layer was washed with brine (1 x 30 mL), 
dried (Na2SO4), and concentrated.  The residue was purified by flash chromatography 
eluting with Et2O/hexanes (1:20) to give 1.44 g (79%) of a bis triflate.  
Cs2CO3 (5.20 g, 16.0 mmol) was added to a solution of the bis triflate from the 
previous reaction in glyme (100 mL), and the mixture was warmed at 75 °C for 16 h.  
The reaction mixture was then cooled to rt, and a 50% aqueous solution of NH4Cl (100 
mL) and Et2O (70 mL) were added.  The layers were separated, and the aqueous layer 
was extracted with Et2O (3 x 100 mL).  The organic layers were combined, dried 
(Na2SO4), and concentrated.  The residue was purified by flash chromatography, eluting 
with EtOAc/hexanes (1:9) to give 1.50 g, 28% of 3.13 as a yellow oil: 1H NMR (500 
MHz, CDCl3) δ 6.93–6.92 (comp, 2H), 5.66 (s, 1 H), 4.68 (s, 2 H), 0.92 (s, 9 H), 0.086 (s, 
6 H); 13C NMR (125 MHz, CDCl3) δ 156.8, 150.3, 145.9, 120.3, 117.1, 111.5, 111.4, 
63.4, 25.8, 18.3, -5.4; mass spectrum (CI) m/z 512.9864 [C14H21O5F3SiSI (M+1) requires 
512.9876], 381 (base); IR (neat) 3490, 1426, 1215, 1139, 839 cm-1. 
NMR Assignments: 1H NMR (500 MHz, CDCl3) δ 6.93–6.92 (comp, 2H, C4-H 
and C2-H), 5.66 (s, 1 H, OH), 4.68 (s, 2 H, C7-H), 0.92 (s, 9 H, C10-H), 0.086 (s, 6 H, 
C8-H); 13C NMR (125 MHz, CDCl3) δ 156.8 (C5), 150.3, 145.9, 120.3, 117.1, 111.5, 








































yl]-silanyl}-methoxy)-2-iodophenyl ester (3.20).  (KP2-295).  A solution of furyl 
glycoside 3.18 (178 mg, 0.24 mmol), phenol 3.13 (123 mg, 0.24 mmol), TBAI (106 mg, 
0.29 mmol), and Na2CO3 (107 mg, 1.0 mmol) in DMF (3 mL) was heated at 70 °C for 16 
h, at which time the mixture was cooled to room temperature, and EtOAc (15 mL) and 
H2O (10 mL) were added.  The mixture was shaken vigorously, and the layers were 
separated.  The organic layer was washed with H2O (2 x 15 mL) and brine (2 x 15 mL), 
dried (Na2SO4), and concentrated.  The residue was purified by flash chromatography, 
eluting with Et2O/hexanes (1:10) and Et2O/hexanes (1:4) to give 174 mg (62%) of 3.20 as 
a clear oil: 1H NMR (500 MHz, CDCl3) δ 7.33-7.22 (comp, 13 H), 7.16–7.13 (comp, 5 
H), 6.91 (s, 1 H), 6.90–6.88 (comp, 2 H), 6.82 (d, J = 3.2 Hz, 1 H), 6.70 (s, 1 H), 6.48 (d, 
J = 3.2 Hz, 1 H), 4.90 (d, J = 11.0 Hz, 1 H), 4.85 (d, J = 11.0 Hz, 1 H), 4.83 (d, J = 10.7 
Hz, 1 H), 4.62 (s, 2 H), 4.59 (d, J = 12.1 Hz, 1 H), 4.57 (d, J = 10.7 Hz, 1 H), 4.52 (d, J = 
12.1 Hz, 1 H), 4.45 (d, J = 10.3 Hz, 1 H), 4.37 (d, J = 9.7 Hz, 1 H), 4.00 (td, J = 9.3, 4.5 
Hz, 1 H), 3.76–3.70 (comp, 6 H), 3.58-3.55 (m, 1 H), 0.92 (s, 9 H), 0.48 (s, 3 H), 0.47 (s, 
3 H), 0.07 (s, 6 H); 13C NMR (125 MHz, CDCl3) δ 161.5, 156.8, 156.3, 151.4, 145.5, 
138.9, 138.4, 138.3, 138.1, 128.7, 128.6, 128.5, 128.3, 128.1, 128.03, 127.96, 127.94, 
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127.85, 123.1, 120.3, 117.7, 111.5 , 110.6  107.7, 86.8, 82.0, 80.5, 79.7, 78.4, 75.9, 75.4, 
75.1, 75.0, 73.7, 69.2, 64.0, 61.9, 26.0, 18.5, -4.41, -4.40, -5.1; mass spectrum (CI) m/z 
1171.2618 [C55H63O11F3Si2SI (M+1) requires 1171.2627] (base); IR (neat) 1424, 1213, 
1140, 1096, 1062, 838 cm-1. 
NMR Assignments: 1H NMR (500 MHz, CDCl3) δ 7.33–7.22 (comp, 13 H, PhC-
H), 7.16–7.13 (comp, 5 H, PhC-H), 6.91 (s, 1 H, C14-H), 6.90–6.88 (comp, 2 H, PhC-H), 
6.82 (d, J = 3.2 Hz, 1 H, C8-H), 6.70 (s, 1 H, C16-H), 6.48 (d, J = 3.2 Hz, 1 H, C7-H), 
4.90 (d, J = 11.0 Hz, 1 H), 4.85 (d, J = 11.0 Hz, 1 H), 4.83 (d, J = 10.7 Hz, 1 H), 4.62 (s, 
2 H, C17-H), 4.59 (d, J = 12.1 Hz, 1 H), 4.57 (d, J = 10.7 Hz, 1 H), 4.52 (d, J = 12.1 Hz, 
1 H), 4.45 (d, J = 10.3 Hz, 1 H), 4.37 (d, J = 9.7 Hz, 1 H), 4.00 (td, J = 9.3, 4.5 Hz, 1 H), 
3.76-3.70 (comp, 6 H), 3.58–3.55 (m, 1 H), 0.92 (s, 9 H, C20-H), 0.48 (s, 3 H, C10-H), 
0.47 (s, 3 H, C10-H), 0.07 (s, 6 H, C18-H); 13C NMR (125 MHz, CDCl3) δ 161.5, 156.8, 
156.3, 151.4, 145.5, 138.9, 138.4, 138.3, 138.1, 128.7, 128.6, 128.5, 128.3, 128.1, 128.03, 
127.96, 127.94, 127.85, 123.1, 120.3, 117.7, 111.5 (C14), 110.6 (C7), 107.7 (C16), 86.8, 
82.0, 80.5, 79.7, 78.4, 75.9, 75.4, 75.1, 75.0, 73.7, 69.2, 64.0 (C17), 61.9, 26.0, 18.5 














tetrahydro-2H-pyran-2-yl)furan-2-yl)dimethyl(vinyl)silane (3.23). (KP3-115).  A 
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solution of s-BuLi (1.53 mL, 2.14 mmol, 1.4 M) in hexanes was added dropwise to a 
solution of furan 3.18 (973 mg, 1.65 mmol) in THF (20 mL) at –78 °C.  The resultant 
black mixture was stirred at –78 °C for 3 h, whereupon chlorodimethylvinylsilane was 
added dropwise.  The cold bath was allowed to warm to rt over a 4 h period, and stirring 
was continued at rt for 12 h.  A 60% aqueous NaCl solution (30 mL) and EtOAc (30 mL) 
were added, and the layers were separated.  The aqueous layer was extracted with EtOAc 
(2 x 30 mL).  The combined organic layers were dried (Na2SO4) and concentrated under 
reduced pressure.  The residue was purified by flash chromatography, eluting with 
Et2O/hexanes (1:5) to give 858 mg (77%) of 3.23 as a light yellow oil.  Spectra were 










































iodophenyl alchohol (3.26).  (KP3-151).  DIAD (9 mg, 0.043 mmol, 8 µL) was added 
dropwise to a solution of 3.24 (23 mg, 0.033 mmol), phenol 3.15 (38 mg, 0.099 mmol), 
and PPh3 (17 mg, 0.043 mmol) in Et2O (400 µL) and the mixture was stirred at rt for 17 
h, whereupon it was concentrated under reduced pressure.  The residue was purified by 
flash chromatography, eluting with EtOAc/toluene (1:99 then 1:49) to give 31 mg (89%) 
of 3.26 as a clear oil: 1H NMR (500 MHz, CDCl3) δ 7.32–7.23 (comp, 13 H), 7.18–7.14 
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(comp, 5 H), 6.94–6.92 (comp, 2 H), 6.68 (d, J = 3.2 Hz, 1 H), 6.59–6.58 (m, 1 H), 6.45 
(d, J = 3.2 Hz, 1 H), 6.30–6.29 (m, 1 H), 5.39 (s, 1 H), 4.91 (d, J = 11.0 Hz, 1 H), 4.86 (d, 
J = 11.0 Hz, 1 H), 4.83 (d, J = 10.0 Hz, 1 H), 4.61 (s, 2 H), 4.59 (d, J = 12.1 Hz, 1 H), 
4.58 (d, J = 10.0 Hz, 1 H), 4.52 (d, J = 12.1 Hz, 1 H), 4.46 (d, J = 10.3 Hz, 1 H), 4.35 (d, 
J = 9.7 Hz, 1 H), 4.14–4.06 (comp, 2 H), 3.99 (d, J = 10.3 Hz, 1 H), 3.91–3.87 (m, 1 H), 
3.76–3.70 (comp, 4 H), 3.57–3.54 (dt, J = 7.1, 3.1 Hz, 1 H), 1.42 (app t, J = 8.0 Hz, 2 H), 
0.92 (s, 9 H), 0.34 (s, 6 H), 0.07 (s, 6 H); 13C NMR (125 MHz, CDCl3) δ 158.4, 
157.9,156.1, 155.9, 144.5, 138.7, 138.2, 138.1, 137.8, 128.4, 128.33, 128.28, 128.0, 
127.91, 127.86, 127.76, 127.73, 127.70, 127.59, 127.57, 121.6, 110.1, 105.0, 101.7, 86.5, 
81.8, 79.4, 78.1, 76.2, 75.6, 75.1, 74.8, 74.7, 73.5, 69.0, 66.4, 64.3, 25.9, 18.3, 16.2, -2.8, 
-2.9, -5.3; IR (neat) 3354, 1430, 1252, 1078 cm-1; mass spectrum (CI) m/z 1054.3361 
[C55H67NIO9Si2 (M+) requires 1054.3368], 949, 929, 839 (base).  
NMR Assignments: 1H NMR (500 MHz, CDCl3) δ 7.32–7.23 (comp, 13 H, Ph 
C-H), 7.18–7.14 (comp, 5 H, Ph C-H), 6.94–6.92 (comp, 2 H, Ph C-H), 6.68 (d, J = 3.2 
Hz, 1 H, C8-H), 6.59–6.58 (m, 1 H, C19-H), 6.45 (d, J = 3.2 Hz, 1 H, C9-H), 6.30–6.29 
(m, 1 H, C17-H), 5.39 (s, 1 H, OH), 4.91 (d, J = 11.0 Hz, 1 H, Bn C-H), 4.86 (d, J = 11.0 
Hz, 1 H, Bn C-H), 4.83 (d, J = 10.0 Hz, 1 H, Bn C-H), 4.61 (s, 2 H, C20-H), 4.59 (d, J = 
12.1 Hz, 1 H, Bn C-H), 4.58 (d, J = 10.0 Hz, 1 H, Bn C-H), 4.52 (d, J = 12.1 Hz, 1 H, Bn 
C-H), 4.46 (d, J = 10.3 Hz, 1 H, Bn C-H), 4.35 (d, J = 9.7 Hz, 1 H, C6-H), 4.14–4.06 
(comp, 2 H, C13-H), 3.99 (d, J = 10.3 Hz, 1 H, Bn C-H), 3.91–3.87 (m, 1 H, C5-H), 
3.76–3.70 (comp, 4 H), 3.57–3.54 (dt, J = 7.1, 3.1 Hz, 1 H), 1.42 (app t, J = 8.0 Hz, 2 H, 
C12-H), 0.92 (s, 9 H, C22-H), 0.34 (s, 6 H, C11-H), 0.07 (s, 6 H, C21-H). 13C NMR (125 
MHz, CDCl3) δ 158.4, 157.9, 156.1, 155.9, 144.5, 138.7, 138.2, 138.1, 137.8, 128.4 (Ph 
C), 128.33 (Ph C), 128.28 (Ph C), 128.0 (Ph C), 127.91 (Ph C), 127.86 (Ph C), 127.76 
(Ph C), 127.73 (Ph C), 127.70 (Ph C), 127.59 (Ph C), 127.57 (Ph C), 121.6 (C8), 110.1 
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(C9), 105.0 (C19), 101.7 (C17), 86.5, 81.8 (C13), 79.4 (C5), 78.1, 76.2 (Bn C), 75.6 (Bn 
C), 75.1 (Bn C or C6), 74.8 (Bn C or C6), 74.7, 73.5 (Bn C), 69.0, 66.4 (C13), 64.3 










































yl]-silanyl}methoxy)-2-iodophenyl ester (3.25).  (KP3-147).  Tf2O (42 mg, 0.15 mmol, 
25 µL), which was freshly distilled from P2O5, was added dropwise to a solution of 3.26 
(143 mg, 0.14 mmol) and N(iPr)2Et (21 mg, 0.163 mmol, 28 µL) in CH2Cl2 at –78 °C.  
Stirring was continued at –78 °C for 20 min, whereupon 50% aqueous NH4Cl (2 mL) was 
added, and the mixture was warmed to rt.  The layers were separated, and the aqueous 
layer was extracted with CH2Cl2 (3 x 4 mL).  The combined organic layers were dried 
(Na2SO4) and concentrated.  The crude residue was purified by column chromatography, 
eluting with Et2O/hexanes (1:5) to afford 138 mg (86%) of 3.25 as a clear oil: 1H NMR 
(500 MHz, CDCl3) δ 7.34–7.26 (comp, 13 H), 7.19–7.16 (comp, 5 H), 6.95–6.94 (comp, 
2 H), 6.92 (s, 1 H), 6.72 (d, J = 3.1 Hz, 1 H), 6.63 (s, 1 H), 6.48 (d, J = 3.1 Hz, 1 H), 4.92 
(d, J = 10.9 Hz, 1 H), 4.88 (d, J = 10.9 Hz, 1 H), 4.86 (d, J = 10.5 Hz, 1 H), 4.66 (s, 2 H), 
4.62–4.59 (comp, 2 H), 4.53 (d, J = 12.0 Hz, 1 H), 4.50 (d, J = 10.3 Hz, 1 H), 4.17–4.07 
(comp 2 H), 4.00 (d, J = 10.3 Hz, 1 H), 3.92 (td, J = 9.2, 4.4 Hz, 1 H), 3.79–3.72 (comp, 
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4 H), 3.60–3.57 (m, 1 H), 1.47 (t, J = 8.2 Hz, 1 H), 0.94 (s, 9 H), 0.37 (s, 3 H), 0.36 (s, 3 
















































yl]-silanyl}methoxy)-2-iodophenyl ester (3.35).  (KP3-278).  p-Chlorobenzenesulfonyl 
chloride (108 mg, 0.51 mmol) was added to a solution of 3.26 (490 mg, 0.47 mmol) and 
Et3N (56 mg, 0.56 mmol, 77 µL) in CH2Cl2, (5 mL) and the mixture was stirred at room 
temperature for 16 h, whereupon H2O (5 mL) was added.  The layers were separated, and 
the aqueous layer was extracted with CH2Cl2 (3 x 5 mL).  The combined organic layers 
were dried (Na2SO4), and concentrated.  The residue was purified by flash 
chromatography eluting with Et2O/hexanes (1:5) to give 505 mg (88%) of 3.35 as a 
viscous oil: 1H NMR (500 MHz, C6D6) δ 7.86 (dt, J = 11.3, 2.4 Hz, 2 H), 7.45 (dt, J = 
11.3, 2.4 Hz, 2 H), 7.32–7.23 (comp, 13 H), 7.17–7.14 (comp, 5 H), 6.93–6.91 (comp, 3 
H), 6.67 (d, J = 3.2 Hz, 1 H), 6.60 (s, 1 H), 6.44 (d, J = 3.2 Hz, 1 H), 4.90 (d, J = 11.0 Hz, 
1 H), 4.85 (d, J = 11.0 Hz, 1 H), 4.83 (d, J = 10.7 Hz, 1 H), 4.62–4.57 (comp, 4 H), 4.51 
(d, J = 12.1 Hz, 1 H), 4.47 (d, J = 10.3 Hz, 1 H), 4.35 (d, J = 9.7 Hz, 1 H), 4.11–4.03 (m, 
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1 H), 3.96 (d, J = 10.3 Hz, 1 H), 3.89–3.86 (m, 1 H), 3.75–3.70 (comp, 4 H), 3.55 (dt, J = 
9.3, 3.1 Hz, 1 H), 1.40 (dd, J = 8.5, 6.9 Hz, 2 H), 0.91 (s, 9 H), 0.310 (s, 3 H), 0.0308 (s, 
3 H), 0.068 (s, 3 H); 13C NMR (125 MHz, CDCl3) δ 159.1, 158.2, 156.3, 150.8, 144.6, 
141.1, 138.6, 138.2, 138.1, 137.8, 134.6, 130.2, 129.4, 128.4, 128.34, 128.28, 128.0, 
127.9, 127.84, 127.77, 127.73, 127.61, 127.58, 121.7, 112.2, 110.0, 107.6, 86.5, 81.8, 
80.9, 79.5, 78.1, 76.3, 75.6, 75.1, 74.8, 74.7, 73.5, 69.0, 66.8, 63.9, 25.9, 16.1, -2.89, -
2.93, -5.3; IR (neat) 3060, 3025, 1384, 1363, 1190, 1095, 1065, 838, 781 cm–1; mass 
spectrum (ESI) m/z 1246.398 [C61H70ClIO11SSi2H2O+ requires 1246.302] 635, 335, 301 
(base), 149. 
NMR Assignments:  1H NMR (500 MHz, CDCl3) δ 7.86 (dt, J = 11.3, 2.4 Hz, 2 
H, C25-H), 7.45 (dt, J = 11.3, 2.4 Hz, 2 H, C26-H), 7.32–7.23 (comp, 13 H, Ph C-H), 
7.17–7.14 (comp, 5 H, Ph C-H), 6.93–6.91 (comp, 3 H, Ph C-H and C18-H), 6.67 (d, J= 
3.2 Hz, 1 H, C8-H), 6.60 (s, 1 H, C20-H), 6.44 (d, J= 3.2 Hz, 1 H, C9-H), 4.90 (d, J= 
11.0 Hz, 1 H, Bn C-H), 4.85 (d, J = 11.0 Hz, 1 H, Bn C-H), 4.83 (d, J = 10.7 Hz, 1 H, Bn 
C-H), 4.62–4.57 (comp, 4 H, Bn C-H and C21-H), 4.51 (d, J = 12.1 Hz, 1 H, Bn C-H), 
4.47 (d, J = 10.3 Hz, 1 H, C6-H), 4.35 (d, J = 9.7 Hz, 1 H, Bn C-H), 4.11–4.03 (m, 1 H, 
C14-H), 3.96 (d, J = 10.3 Hz, 1 H, C6-H), 3.89–3.86 (m, 1 H, C5-H), 3.75–3.70 (comp, 4 
H, Bn C-H), 3.55 (dt, J = 9.3, 3.1 Hz, 1 H), 1.40 (dd, J = 8.5, 6.9 Hz, 2 H, C13-H), 0.91 
(s, 9 H, C23-H), 0.310 (s, 3 H, C11-H or C12-H), 0.0308 (s, 3 H, C11-H or C12-H), 
0.068 (s, 3 H, C22-H); 13C NMR (125 MHz, CDCl3) δ 159.1, 158.2, 156.3, 150.8, 144.6, 
141.1, 138.6, 138.2, 138.1, 137.8, 134.6, 130.2 (C25), 129.4 (C26), 128.4 (Ph C), 128.34 
(Ph C), 128.28 (Ph C), 128.0 (Ph C), 127.9 (Ph C), 127.84 (Ph C), 127.77 (Ph C), 127.73 
(Ph C), 127.61 (Ph C), 127.58 (Ph C), 121.7 (C8), 112.2 (C18), 110.0 (C9), 107.6 (C20), 
86.5, 81.8 (C5), 80.9, 79.5, 78.1, 76.3, 75.6, 75.1, 74.8, 74.7, 73.5, 69.0, 66.8 (C14), 63.9, 





























Benzyl-3-(benzyloxy)-5-(4-chlorophenylsulfonyloxy)-4-iodobenzoate (3.43).  
(KP4-267).  4-Chlorobenzene sulfonyl chloride (1.51 g, 7.15 mmol) was added to a 
solution of 3.42 (2.99 g, 6.50 mmol) and Et3N (790 mg, 7.80 mmol, 1.1 mL) in CH2Cl2 
(50 mL) and the mixture was stirred for 18 h.  H2O (50 mL) was added and the layers 
were separated.  The aqueous layer was extracted with CH2Cl2 (2 x 50 mL).  The 
combined organic layers were dried (MgSO4), concentrated, and the residue was 
recrystallized from EtOH to give 3.75 g of 3.43 (91%) (white needles): mp = 108–110 
ºC; 1H NMR (500 MHz, CDCl3) δ 7.87 (dt, J = 9.2, 2.4 Hz, 2 H), 7.58 (d, J = 1.7 Hz, 1 
H), 7.47 (dt, J = 9.2, 2.4 Hz, 2 H), 7.45–7.30 (comp, 11 H), 5.34 (s, 2 H), 5.17 (s, 2 H); 
13C NMR (125 MHz, CDCl3) δ 164.7, 159.0, 151.1, 141.5, 135.4, 134.3, 132.2, 130.2, 
129.6, 128.7, 128.6, 128.5, 128.3, 128.2, 127.1, 116.1, 111.1, 90.8, 71.6, 67.4; IR (neat) 
1720, 1444, 1383, 1187, 1055 785 cm-1; mass spectrum (CI) m/z 634.9789 [C27H21O6SClI 
(M+1) requires 634.9792].   
NMR Assignments: 1H NMR (500 MHz, CDCl3) δ 7.87 (dt, J = 9.2, 2.4 Hz, 2 H, 
C8-H) 7.58 Hz (d, J = 1.7 Hz, 1 H, C2-H), 7.47 (dt, J = 9.2, 2.4 Hz, 2 H, C9-H), 7.45–
7.30 (comp, 11 H, Ph C-H, C6-H), 5.34 (s, 2 H, C13-H), 5.17 (s, 2 H, C11-H); 13C NMR 
(125 MHz, CDCl3) δ 164.7, 159.0, 151.1, 141.5, 135.4, 134.3, 132.2, 130.2 (C8), 129.6 
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(C9), 128.7, 128.6, 128.5, 128.3, 128.2, 127.1, 116.1 (C6), 111.1 (C2), 90.8, 71.6 (C11), 


























(3.44).  (KP4-240).  A solution of DIBAL-H in PhCH3 (3.82 mmol, 3.8 mL, 1 M) was 
added to 3.43 (971 mg, 1.53 mmol) in PhCH3 (15 mL) at –78 ºC, and the mixture was 
stirred at for 5 min.  The cold bath was removed, and stirring was continued for 1.5 h.  2 
N HCl was added and the layers were separated.  The aqueous layer was extracted with 
Et2O (2 x 15 mL).  The combined organic layers were dried (MgSO4) and concentrated.  
The residue was purified by flash chromatography, eluting with CH2Cl2 to afford 706 mg 
(87%) of 3.44 as a cottony solid:  mp = 99–100 ºC; 1H NMR (500 MHz, CDCl3) δ 7.89 
(dt, J = 9.3, 2.4 Hz, 2 H), 7.50 (dt, J = 9.3, 2.4 Hz, 2 H), 7.45–7.43 (comp, 2 H), 7.38–
7.34 (comp, 2 H), 7.32–7.29 (m, 1 H), 7.02–7.01 (m, 1 H), 6.828–6.825 (m, 1 H), 5.12 (s, 
2 H), 4.65 (d, J = 3.4 Hz, 2 H), 1.86 (t, J = 3.4 Hz, 1 H); 13C NMR (125 MHz, CDCl3) δ 
159.0, 150.9, 143.9, 141.3, 135.9, 134.4, 130.3, 129.5, 128.6, 128.1, 127.0, 113.5, 108.9, 
82.0, 71.3, 64.2; IR (neat) 3377, 1574, 1421, 1380, 1188, 1085, 783 cm-1; mass spectrum 
(CI) m/z 530.9534 [C20H17O5SClI (M+1) requires 530.9530], 513 (base).   
NMR Assignments: 1H NMR (500 MHz, CDCl3) δ 7.89 (dt, J = 9.3, 2.4 Hz, 2 H, 
C8-H), 7.50 (dt, J = 9.3, 2.4 Hz, 2 H, C9-H), 7.45–7.43 (comp, 2 H, Ph C-H), 7.38–7.34 
(comp, 2 H, Ph C-H), 7.32–7.29 (m, 1 H, Ph C-H), 7.02–7.01 (m, 1 H, C2-H), 6.828–
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6.825 (m, 1 H, C6-H), 5.12 (s, 2 H, C11-H), 4.65 (d, J = 3.4 Hz, 2 H, C12-H), 1.86 (t, J = 
3.4 Hz, 1 H, OH); 13C NMR (125 MHz, CDCl3) δ 159.0, 150.9, 143.9, 141.3, 135.9, 
134.4, 130.3 (C8), 129.5 (C9), 128.6 (Ph C), 128.1(Ph C), 127.0 (Ph C), 113.5 (C2), 




























(3.45).  (KP4-241): A mixture of 3.44 (35 mg, 0.066 mmol), MgO (5 mg, 0.13 mmol), 
and 2-benzyloxy-1-methylpyridinium triflate (46 mg, 0.13 mmol) in PhCF3 (1 mL) was 
heated at 80 ºC for 22 h.  The mixture was cooled to rt and filtered through celite, eluting 
with PhCH3.  The filtrate was concentrated, and the resulting residue was purified by 
flash chromatography, eluting with Et2O/hexanes (1:7) to give 33 mg (80%) of 3.45 as a 
white cottony solid: mp = 123–124 ºC; 1H NMR (500 MHz, CDCl3) δ 7.88 (dt, J = 9.3, 
2.4 Hz, 2 H), 7.47 (dt, J = 9.3, 2.4 Hz, 2 H), 7.44–7.43 (comp, 2 H), 7.38–7.29 (comp, 8 
H), 7.00–6.99 (m, 1 H), 6.813–6.810 (m, 1 H), 5.11 (s, 2 H), 4.52 (s, 2 H), 4.49 (s, 2 H); 
13C NMR (125 MHz, CDCl3) δ 159.0, 150.9, 141.4, 141.3, 137.7, 135.9, 134.4, 130.3, 
129.5, 128.6, 128.5, 128.1, 127.9, 127.8, 127.0, 114.3, 109.6, 82.2, 72.4, 71.3, 70.9; IR 
(neat) 1421, 1382, 1189, 1085, 1083, 783; mass spectrum (CI) m/z 621.0004 
[C27H23O5SClI (M+1) requires 621.0000], 621 (base), 513. 
NMR Assignments: 1H NMR (500 MHz, CDCl3) δ 7.88 (dt, J = 9.3, 2.4 Hz, 2 H, 
C8-H), 7.47 (dt, J = 9.3, 2.4 Hz, 2 H, C9-H), 7.44–7.43 (comp, 2 H, PhC-H), 7.38–7.29 
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(comp, 8 H, PhC-H), 7.00–6.99 (m, 1 H, C2-H), 6.813–6.810 (m, 1 H, C6-H), 5.11 (s, 2 
H, C12-H), 4.52 (s, 2 H, C11-H or C13-H), 4.49 (s, 2 H, C11-H or C13-H); 13C NMR 
(125 MHz, CDCl3) δ 159.0, 150.9, 141.4, 141.3, 137.7, 135.9, 134.4, 130.3 (C8), 129.5 
(C9), 128.6 (Ph C), 128.5 (Ph C), 128.1 (Ph C), 127.9 (Ph C), 127.8 (Ph C), 127.0 (Ph C), 
























Benzyl 3-(benzyloxy)-4-iodo-5-(trifluoromethylsulfonyloxy)benzoate (3.47). 
(KP4-269).  Tf2O (318 mg, 1.13 mmol, 190 µL) was added dropwise to a mixture of 3.42 
(472 mg, 1.02 mmol) and i-PrNEt2 (158 mg, 1.22 mmol, 215 µL) in CH2Cl2 (10 mL) at –
78 ºC.  Stirring was continued for 20 min, whereupon a saturated solution of NaHCO3 
was added (10 mL).  The bath was removed, and the mixture was warmed to rt.  The 
layers were separated and the aqueous layer was extracted with CH2Cl2 (2 x 20 mL).  The 
combined organic layers were dried (MgSO4) and concentrated.  The residue was 
recrystallized from EtOH to give 441 mg (73%) of 3.47 as a white cottony solid: mp = 
100–101 ºC; 1H NMR (500 MHz, CDCl3); δ 7.61 (s, 1 H), 7.51 (s, 1 H), 7.48–7.34 
(comp, 10 H), 5.36 (s, 2 H), 5.22 (s, 2 H); 13C NMR (125 MHz, CDCl3) δ 164.3, 159.5, 
151.3, 135.3, 132.7, 128.74, 128.71, 128.6, 128.4, 128.2, 127.2, 115.3, 111.9, 90.1, 71.8, 
67.6; IR (neat) 1724, 1416, 1217, 1138, 1063, 812 cm-1; mass spectrum (CI) m/z 
592.9739 [C22H17O6F3S (M+1) requires 592.9731]. 
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NMR Assignments: 1H NMR (500 MHz, CDCl3); δ 7.61 (s, 1 H, C2-H), 7.51 (s, 
1 H, C6-H), 7.48–7.34 (comp, 10 H, PhC-H), 5.36 (s, 2 H, C9-H), 5.22 (s, 2 H, C7-H); 
13C NMR (125 MHz, CDCl3) δ 164.3, 159.5, 151.3, 135.3, 132.7, 128.74 (Ph C), 128.71 
(Ph C), 128.6 (Ph C), 128.4 (Ph C), 128.2 (Ph C), 127.2 (Ph C), 115.3 (C6), 111.9 (C2), 























(3.48).  (KP4-294).  DIBAL-H (3.80 mmol, 3.8 mL, 1 M solution in PhCH3) was added 
to a solution of 3.47 (900 mg, 1.52 mmol) in PhCH3 (10 mL) at –78 ºC, and the mixture 
was stirred at for 5 min.  The cold bath was removed, and stirring was continued at for 
0.5 h.  2 N HCl was added, and the layers were separated.  The aqueous layer was 
extracted with Et2O (2 x 10 mL), and the combined organic layers were dried and 
concentrated.  The residue was heated under reflux in hexanes while EtOH was added 
dropwise until the solid went into solution.  Recrystallization from this solution gave 702 
mg (93%) of 3.48 as a cottony solid: mp = 120–121 ºC; 1H NMR (500 MHz, CDCl3) δ 
7.49–7.47 (comp, 2 H), 7.41–7.38 (comp, 2 H), 7.35–7.34 (m, 1 H), 6.95 (s, 1 H), 6.89 (s, 
1 H), 5.17 (s, 2 H), 4.68 (d, J = 5.9 Hz, 2 H), 1.83 (t, J = 5.9 Hz, 1 H); 13C NMR (125 
MHz, CDCl3) δ 159.5, 151.3, 144.5, 135.6, 128.7, 128.2, 127.1, 112.3, 109.5, 81.5, 71.5, 
63.9; IR (neat) 3160, 1426, 1215, 1196, 820 cm-1; mass spectrum (CI) m/z 488.9479 
[C15H13O5F3S (M+1) requires 488.9481], 471 (base). 
 245 
NMR Assignments: 1H NMR (500 MHz, CDCl3) δ 7.49–7.47 (comp, 2 H, Ph C-
H), 7.41–7.38 (comp, 2 H, Ph C-H), 7.35–7.34 (m, 1 H, Ph C-H), 6.95 (s, 1 H, C2-H), 
6.89 (s, 1 H, C6-H), 5.17 (s, 2 H, C7-H), 4.68 (d, J = 5.9 Hz, 2 H, C8-H), 1.83 (t, J = 5.9 
Hz, 1 H, OH); 13C NMR (125 MHz, CDCl3) δ 159.5, 151.3, 144.5, 135.6, 128.7 (Ph C), 

























(3.49).  (KP4-273). A mixture of 3.48 (105 mg, 0.215 mmol), MgO (15 mg, 0.363 
mmol), and 2-benzyloxy-1-methylpyridinium triflate (127 mg, 0.363 mmol) in PhCF3 (1 
mL) was heated at 80 ºC for 20 h.  The mixture was cooled to rt and filtered through 
celite, eluting with PhCH3.  The filtrate was concentrated, and the residue was purified by 
flash chromatography, eluting with Et2O/hexanes (1:10) to give 120 mg (97%) of 3.49 as 
a yellow oil: 1H NMR (500 MHz, CDCl3) δ 7.48–7.46 (comp, 2H), 7.40–7.30 (comp, 8 
H), 6.94 (s, 1 H), 6.88 (s, 1 H), 5.16 (s, 2 H), 4.53 (s, 2 H), 4.51 (s, 2 H); 13C NMR (125 
MHz, CDCl3) δ 159.4, 151.2, 142.1, 137.5, 135.7, 128.7, 128.5, 128.2, 128.0, 127.1, 
113.1, 110.3, 81.6, 72.6, 71.5, 70.6; IR (neat) 1422, 1217, 1138, 1066, 741; mass 
spectrum (CI) m/z 578.9943 [C22H19O5F3S (M+1) requires 578.9950]. 
NMR Assignments: 1H NMR (500 MHz, CDCl3) δ 7.48–7.46 (comp, 2H, Ph C-
H), 7.40–7.30 (comp, 8 H, Ph C-H), 6.94 (s, 1 H, C2-H), 6.88 (s, 1 H, C6-H), 5.16 (s, 2 
H, C8-H), 4.53 (s, 2 H, C9-H or C11-H), 4.51 (s, 2 H, C9-H or C11-H); 13C NMR (125 
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MHz, CDCl3) δ 159.4, 151.2, 142.1, 137.5, 135.7, 128.7 (Ph C), 128.5 (Ph C), 128.2 (Ph 
C), 128.0 (Ph C), 127.1 (Ph C), 113.1 (C2), 110.3 (C6), 81.6, 72.6 (C8), 71.5 (C9 or 






























2H-pyran-2-yl)-8-(benzyloxy)-6-((benzyloxy)methyl)naphthalen-1-ol (3.37).  (KP3-
285).  Method A (via tether) i-PrMgCl (0.089 mmol, 100 µL, 0.90 M) was added 
dropwise to a solution of sulfonate 3.35 (91 mg, 0.074 mmol) in THF at –78 °C.  The 
mixture was stirred at –78 °C for 5 min, the cold bath was removed, and the mixture was 
stirred at ambient temperature for 12 h, whereupon a 50% solution of NH4Cl (2 mL) and 
Et2O (2 mL) were added.  The layers were separated and the aqueous layer was extracted 
with Et2O (3 x 2 mL).  The combined organic layers were washed with brine (1 x 5 mL), 
dried (Na2SO4), and concentrated.  The residue was dissolved in DMF (1.5 mL) and solid 
TBAF (90 mg, 0.34 mmol) was added.  The mixture was then heated at 70 °C for 7 h, 
whereupon H2O (3 mL) and EtOAc (3 mL) were added.  The layers were separated, and 
the aqueous layer was extracted with EtOAc (2 x 3 mL).  The combined organic layers 
were washed with brine (2 x 10 mL), dried (Na2SO4), concentrated, and the residue was 
purified by flash chromatography eluting with EtOAc/hexanes (1:2) to give 34 mg (64%) 
of a diol.  BnBr (17 mg, 0.098 mmol, 12 µL) and NaH (7 mg, 0.10 mmol, 60% 
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dispersion) were added to the diol in DMF, and the mixture was stirred for 3 h at rt, 
whereupon H2O (3 mL) and EtOAc (3 mL) were added.  The layers were separated, and 
the aqueous layer was extracted with EtOAc (2 x 3 mL). The combined organic layers 
were dried (Na2SO4) and concentrated.  The residue was purified by flash 
chromatography eluting with Et2O/hexanes (1:2) to give 24 mg (56%) of 3.37.  The 
residue was dissolved in CH2Cl2 (1 mL) and TFA (5 drops) was added.  The mixture was 
stirred for 18 h, whereupon a saturated solution of NaHCO3 (2 mL) and CH2Cl2 (1 mL) 
were added.  The layers were separated, and the aqueous layer was extracted with CH2Cl2 
(3 x 2 mL).  The combined organic layers were combined, dried (Na2SO4), and 
concentrated in vacuo.  The residue was purified by flash chromatography eluting with 
Et2O/hexanes (1:4) to give 20 mg (87%) of 3.37 as a yellow oil. 
Method B (untethered approach) (KP5-51): n-BuLi (770 µL, 2.5 M, 1.93 
mmol) was added dropwise over 30 min to a mixture of triflate 3.49 (1.01 g, 1.75 mmol) 
and furan 3.18 (3.60 g, 6.10 mmol) in THF (20 mL) at –78 ºC.  The mixture was stirred 
for 20 min at –78 ºC, whereupon a saturated solution of NH4Cl was added (20 mL).  The 
mixture was warmed to rt and the layers were separated.  The aqueous layer was 
extracted with Et2O (3 x 20 mL), dried (MgSO4), and concentrated.  The residue was 
purified by flash chromatography eluting with Et2O/hexanes (1:5 then 1:4) to give 863 
mg (55%) of a mixture of 4 isomers, 3.36 and 3.39.  
TFA (6 drops) was added to the mixture of isomers 3.36 and 3.39 (109 mg, 0.122 
mmol) in CH2Cl2 (3 mL) and the mixture was stirred for 14 h, whereupon NaHCO3 (3 
mL) and Et2O (5 mL) were added.  The layers were separated, and the aqueous layer was 
extracted with Et2O (2 x 3 mL), dried (MgSO4), and concentrated.  The residue was 
purified by flash chromatography, eluting with Et2O/hexanes (1:3 then 1:1) to give 31 mg 
(28%) of phenol 3.37: 1H NMR (500 MHz, CDCl3) δ 9.64 (s, 1 H), 7.89 (s, 1 H), 7.53-
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7.48 (comp, 3H), 7.44–7.23 (comp, 22 H), 7.10–6.97 (comp, 4 H), 6.86 (d, 8.2 Hz, 1 H), 
6.64 (m, 2 H), 5.29 (s, 2 H), 4.95 (d, J = 10.9, 1 H), 4.92 (d, J = 9.9 Hz, 1 H), 4.89 (d, J = 
10 Hz, 1 H), 4.76 (s, 1 H), 4.67 (d, J = 9.9 Hz, 1 H), 4.62 (d, J = 12.0 Hz, 1 H), 4.52 (s, 2 
H), 4.51 (d, J = 12.0 Hz, 1 H), 4.41 (s, 2 H), 4.17 (d, J = 10.3 Hz, 1 H), 3.94–3.76 (comp, 
5 H), 3.67-3.62 (m, 1 H), 3.52 (d, J =10.3 Hz, 1 H) ppm; 13C NMR (125 MHz, CDCl3) δ  
156.0, 155.1, 138.7, 138.5, 138.4, 138.3, 137.5, 136.0, 135.1, 134.5, 129.0, 128.9, 128.4, 
128.3, 128.2, 128.1, 127.95, 127.82, 127.73, 127.65, 127.61, 127.5, 127.45, 127.43, 
117.5, 114.9, 110.3, 104.7, 87.0, 79.5, 78.3, 75.8, 75.2, 74.6, 73.3, 72.4, 72.0, 71.7, 69.1; 
IR (neat) 3388, 1453, 1097, 1068 cm-1; mass spectrum (ESI) m/z 893.4048 [C59H57O8+ 
(M+1) requires 893.4012]. 
NMR Assignments: 1H NMR (500 MHz, CDCl3) δ 9.64 (s, 1 H, OH), 7.89 (br s, 
1 H), 7.53-7.48 (comp, 3H, Ph C-H and C15-H), 7.44–7.23 (comp, 22 H, Ph C-H), 7.10-
6.97 (comp, 4 H, Ph C-H), 6.86 (d, 8.2 Hz, 1 H, Ph C-H), 6.64 (m, 2 H, Ph C-H), 5.29 (s, 
2 H, Bn C-H), 4.95 (d, J = 10.9, 1 H, Bn C-H), 4.92 (d, J = 9.9 Hz, 1 H, Bn C-H), 4.89 
(d, J = 10 Hz, 1 H, Bn C-H), 4.76 (s, 1 H), 4.67 (d, J = 9.9 Hz, 1 H, Bn C-H), 4.62 (d, J = 
12.0 Hz, 1 H, Bn C-H), 4.52 (s, 2 H), 4.51 (d, J = 12.0 Hz, 1 H, Bn C-H), 4.41 (s, 2 H, Bn 
C-H), 4.17 (d, J = 10.3 Hz, 1 H, C6-H), 3.94–3.76 (comp, 5 H), 3.67-3.62 (m, 1 H), 3.52 
(d, J =10.3 Hz, 1 H, C6-H) ppm; 13C NMR (125 MHz, CDCl3) δ  156.0 (C14), 155.1, 
138.7 (Ph C), 138.5 (Ph C), 138.4 (Ph C), 138.3 (Ph C), 137.5 (Ph C), 136.0 (Ph C), 
135.1 (Ph C), 134.5 (Ph C), 129.0, 128.9, 128.4, 128.3, 128.2, 128.1, 127.95, 127.82, 
127.73, 127.65, 127.61, 127.5, 127.45, 127.43, 117.5, 114.9, 110.3 (C15), 104.7, 87.0, 































(3.50). From the above reaction (Method B) 33 mg (31%) of 3.50 was also isolated: 1H 
NMR (500 MHz, CDCl3) δ 7.36 (s, 1 H), 7.52 (d, J = 8.1 Hz, 1 H), 7.48–7.46 (comp, 2 
H), 7.36–7.20 (comp, 25 H), 7.02–6.90 (comp, 4 H), 6.68 (d, J = 8.1 Hz, 1 H), 6.50–6.48 
(comp, 2 H), 6.13 (d, J = 9.5 Hz, 1 H), 5.90 (s, 1 H), 5.11 (d, J = 10.7 Hz, 1 H), 4.86 (d, J 
= 10.7 Hz, 1 H) 4.82 (d, J = 11.2 Hz, 1 H), 4.78 (d, J = 11.0 Hz, 1 H), 4.66–4.61 (comp, 4 
H), 4.57–4.51 (comp, 4 H), 4.20 (d, J = 10.5 Hz, 1 H), 3.70 (dd, J = 11.0, 1.9 Hz, 1 H), 
3.68–3.66 (m, 1 H), 3.63 (app t, J = 9.5 Hz, 1 H), 3.48 (d, J = 10.3 Hz, 1 H), 3.39 (app t, 
J = 9.3 Hz, 1 H), 3.31 (ddd, J = 9.8, 4.4, 1.9 Hz, 1 H), 3.27 (app t, J = 8.8 Hz, 1 H); 13C 
NMR (125 MHz, CDCl3) δ 156.8, 151.2, 138.9, 138.8, 138.3, 138.22, 138.20, 136.9, 
134.4, 128.66, 128.56, 128.54, 128.4, 128.32, 128.29, 128.25, 128.1, 127.91, 127.89, 
127.86, 127.77, 127.72, 127.6, 127.53, 127.45, 127.42, 127.0, 125.9, 125.8, 124.8, 113.8, 
109.5, 107.5, 86.5, 86.4, 78.7, 78.6, 78.7, 78.6, 75.4, 74.4, 74.3, 73.4, 72.4, 71.9, 71.1, 
69.6; IR (neat) 3321, 1453, 1361, 1091, 1028 cm-1; mass spectrum (CI) m/z 893.4049 
[C59H57O8+ (M+1) requires 893.4012] 
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NMR Assignments: 1H NMR (500 MHz, CDCl3) δ 7.36 (s, 1 H, C12-H), 7.52 (d, 
J = 8.1 Hz, 1 H, C8-H), 7.48–7.46 (comp, 2 H, Ph C-H), 7.36–7.20 (comp, 24 H, Ph C-
H), 7.02–6.90 (comp, 4 H, Ph C-H), 6.68 (d, J = 8.1 Hz, 1 H, C9-H), 6.50–6.48 (comp, 2 
H), 6.13 (d, J = 9.5 Hz, 1 H, C1-H), 5.90 (s, 1 H, OH), 5.11 (d, J = 10.7 Hz, 1 H Bn C-
H), 4.86 (d, J = 10.7 Hz, 1 H Bn C-H) 4.82 (d, J = 11.2 Hz, 1 H Bn C-H), 4.78 (d, J = 
11.0 Hz, 1 H, Bn C-H), 4.66–4.61 (comp, 4 H Bn C-H), 4.57–4.51 (comp, 4 H), 4.20 (d, 
J = 10.5 Hz, 1 H), 3.70 (dd, J = 11.0, 1.9 Hz, 1 H, C6-H), 3.68–3.66 (m, 1 H, C6-H), 3.63 
(app t, J = 9.5 Hz, 1 H, C4-H), 3.48 (d, J = 10.3 Hz, 1 H, Bn -H), 3.39 (app t, J = 9.5 Hz, 
1 H, C3-H), 3.31 (ddd, J = 9.5, 4.4, 1.9 Hz, 1 H, C5-H), 3.27 (app t, J = 9.5 Hz, 1 H, C2-
H); 13C NMR (125 MHz, CDCl3) δ 156.8, 151.2, 138.9, 138.8, 138.3, 138.22, 138.20, 
136.9, 134.4, 128.66, 128.56, 128.54, 128.4, 128.32, 128.29, 128.25, 128.1, 127.91, 
127.89, 127.86, 127.77, 127.72, 127.6, 127.53, 127.45, 127.42, 127.0, 125.9, 125.8, 
124.8, 113.8 (C12), 109.5, 107.5, 86.5 (C5 or C2), 86.4 (C5 or C2), 78.7, 78.6, 78.7, 
78.6, 75.4 (Bn C), 74.4 (Bn C), 74.3 (Bn C), 73.4 (Bn C), 72.4 (Bn C), 71.9 (Bn C), 71.1 






















(methylthio)furan-2-yl)tetrahydro-2H-pyran (3.54).  (KP4-251).  A solution of s-BuLi  
in cyclohexane (1.47 M, 2.3 mL, 3.42 mmol) was added dropwise to furan 3.18 (1.55 g, 
2.63 mmol) in THF (25 mL) at –78 ºC and the mixture was stirred for 3.5 h.  Dimethyl 
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disulfide (330 µL, 3.68 mmol) was then added dropwise.  The cold bath was allowed to 
warm to rt over a 9 h period, and stirring was continued at rt for 8 h.  Brine (20 mL) was 
added, and the layers were separated.  The aqueous layer was extracted with Et2O (3 x 20 
mL), and the combined organic layers were dried (MgSO4) and concentrated.  The 
residue was recrystallized from EtOH to give 1.04 g (62%) of 3.54 as pale yellow 
needles: mp = 80–82 ºC; 1H NMR (500 MHz, CDCl3) δ 7.34–7.21 (comp, 16 H), 7.20–
7.14 (comp, 2 H), 7.03–7.01 (comp, 2 H), 6.43 (d, J = 3.2 Hz, 1 H), 6.41 (d, J = 3.2 Hz, 1 
H), 4.93 (d, J = 11.2 Hz, 1 H), 6.41 (d, J = 3.2 Hz, 1 H), 4.93 (d, J = 11.2 Hz, 1 H), 4.84 
(d, J = 10.7 Hz, 1 H), 4.59 (d, J = 12.2 Hz, 1 H), 4.58 (d, J = 10.7 Hz, 1 H), 4.54 (d, J = 
10.5 Hz, 1 H), 4.53 (d, J = 12.2 Hz, 1 H), 4.28 (d, J = 9.8 Hz, 1 H), 4.11 (d, J = 10.5 Hz, 
1 H), 3.88 (app t, J = 8.8 Hz, 1 H), 3.76–3.68 (comp, 4 H), 3.56 (ddd, J = 6.3, 4.2, 2.2 Hz, 
1 H), 2.37 (s, 3 H); 13C NMR (125 MHz, CDCl3) δ 153.7, 147.6, 138.7, 138.15, 138.06, 
137.8, 128.4, 128.33, 128.31, 128.10, 128.07, 128.0, 127.9, 127.8, 127.7, 127.65, 127.58, 
115.2, 111.7, 86.6, 81.2, 79.4, 78.0, 75.6, 75.1, 74.83, 74.77, 73.5, 69.0, 18.9; IR (neat) 
1496, 1453, 1096, 1068; mass spectrum (CI) m/z 637.2620 [C36H41O6S (M+1) requires 
637.2624], 488, 487 (base).   
NMR Assignments: 1H NMR (500 MHz, CDCl3) δ 7.34–7.21 (comp, 16 H, Ph 
C-H), 7.20–7.14 (comp, 2 H, Ph C-H), 7.03–7.01 (comp, 2 H, Ph C-H), 6.43 (d, J = 3.2 
Hz, 1 H, C8-H or C9-H), 6.41 (d, J = 3.2 Hz, 1 H, C8-H or C9-H), 4.93 (d, J = 11.2 Hz, 1 
H, Bn C-H), 6.41 (d, J = 3.2 Hz, 1 H, Bn C-H), 4.93 (d, J= 11.2 Hz, 1 H, Bn C-H), 4.84 
(d, J = 10.7 Hz, 1 H, Bn C-H), 4.59 (d, J = 12.2 Hz, 1 H, Bn C-H), 4.58 (d, J = 10.7 Hz, 1 
H, Bn C-H), 4.54 (d, J = 10.5 Hz, 1 H, Bn C-H), 4.53 (d, J = 12.2 Hz, 1 H, Bn C-H), 4.28 
(d, J = 9.8 Hz, 1 H), 4.11 (d, J = 10.5 Hz, 1 H, Bn C-H), 3.88 (app t, J = 8.8 Hz, 1 H), 
3.76–3.68 (comp, 4 H), 3.56 (ddd, J = 6.3, 4.2, 2.2 Hz, 1 H), 2.37 (s, 3 H, C11-H); 13C 
NMR (125 MHz, CDCl3) δ 153.7, 147.6, 138.7, 138.15, 138.06, 137.8, 128.4, 128.33, 
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128.31, 128.10, 128.07, 128.0, 127.9, 127.8, 127.7, 127.65, 127.58, 115.2, 111.7, 86.6, 
































2H-pyran-2-yl)-8-(benzyloxy)-6-((benzyloxy)methyl)-2-bromonaphthalen-1-ol (3.56).  
(KP4-112).  Pyridinium bromide perbromide (26 mg, 0.081 mmol) was added to a 
solution of 3.37 in CH2Cl2 (1.5 mL) at 0 °C, and the mixture was stirred for 15 min.  The 
ice bath was removed and stirring was continued for 15 min.  A saturated solution of 
Na2S2O3 (3 mL) and Et2O (5 mL) were added, and the layers were separated.  The organic 
layer was washed with Na2S2O3 (2 x 3 mL) and H2O (2 x 3 mL), dried (MgSO4), and 
concentrated under reduced pressure.  The residue was purified by flash chromatography, 
eluting with Et2O/hexanes (1:3) to give 68 mg (95%) of bromophenol 3.56:  1H NMR 
(500 MHz, CDCl3) δ 10.30 (s, 1 H), 7.84 (s, 1 H), 7.74 (s, 1 H), 7.51-7.48 (comp, 2 H), 
7.45–7.21 (comp, 23 H), 7.10–7.00 (comp, 4 H), 6.63–6.61 (comp, 2 H), 5.28 (comp, 3 
H), 4.72 (s, 1 H), 4.66 (d, J = 10.9 Hz, 1 H), 4.61 (d, J = 12.0 Hz, 1 H), 4.53 (d, J = 12.0 
Hz, 1 H), 4.50 (s, 2 H), 4.42 (s, 2 H), 4.25 (d, J = 10.2 Hz, 1 H), 4.25 (d, J = 10.2 Hz, 1 
H), 3.87–3.74 (comp, 5 H), 3.64–3.63 (m, 1 H), 3.59 (d, J = 10.3 Hz, 1 H) ppm; 13C NMR 
(125 MHz, CDCl3) δ 155.2, 151,1, 140.6, 138.7, 138.4, 138.3, 138.1, 137.3, 136.6, 134.6, 
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134.6, 133.6, 138.7, 138.4, 138.3, 138.1, 137.3, 136.6, 134.6, 133.6, 129.2, 129.1, 128.5, 
128.44, 128.37, 128.3, 128.0, 127.98, 127.8 127.7, 127.6, 127.5, 129.17, 129.15, 128.47, 
128.44, 128.37, 128.3, 127.99, 127.98, 127.8, 127.75, 127.74, 127.6, 127.53, 127.51; 
105.49, 86.99, 79.5, 78.2, 75.8, 75.2, 74.8, 73.3, 72.2, 72.13, 72.06, 69.0; IR (neat) 3336, 
1609, 1454, 1360, 1136, 1095, 1068, 1028 cm-1; mass spectrum (ESI) m/z 993.2973 
[C59H55O8NaBr+ requires 993.3003]. 
NMR Assignments: 1H NMR (500 MHz, CDCl3) δ 10.30 (s, 1 H, OH), 7.84 (s, 1 
H), 7.74 (s, 1 H), 7.51-7.48 (comp, 2 H), 7.45–7.21 (comp, 23 H, Ph C-H and C11-H), 
7.10–7.00 (comp, 4 H), 6.63–6.61 (comp, 2 H, C9-H), 5.28 (comp, 3 H, Bn C-H), 4.72 (s, 
1 H), 4.66 (d, J = 10.9 Hz, 1 H, Bn C-H), 4.61 (d, J = 12.0 Hz, 1 H, Bn C-H), 4.53 (d, J = 
12.0 Hz, 1 H, Bn C-H), 4.50 (s, 2 H, Bn C-H), 4.42 (s, 2 H, Bn C-H), 4.25 (d, J = 10.2 
Hz, 1 H, Bn C-H), 4.25 (d, J = 10.2 Hz, 1 H, Bn C-H), 3.87–3.74 (comp, 5 H), 3.64–3.63 
(m, 1 H), 3.59 (d, J = 10.3 Hz, 1 H) ppm; 13C NMR (125 MHz, CDCl3) δ  155.2, 151,1, 
140.6, 138.7, 138.4, 138.3, 138.1, 137.3, 136.6, 134.6, 134.6, 133.6, 138.7, 138.4, 138.3, 
138.1, 137.3, 136.6, 134.6, 133.6, 129.2, 129.1, 128.5, 128.44, 128.37, 128.3, 128.0, 
127.98, 127.8 127.7, 127.6, 127.5, 129.17, 129.15, 128.47, 128.44, 128.37, 128.3, 127.99, 
127.98, 127.8, 127.75, 127.74, 127.6, 127.53, 127.51, 105.49, 86.99, 79.5, 78.2, 75.8, 

































pyran (3.57).  (KP4-106).  NaH (10 mg, 0.25 mmol, 60% dispersion) was added to a 
solution of phenol 3.56 (120 mg, 0.12 mmol) and BnBr (31 mg, 0.19 mmol, 23 µL) in 
DMF (1 mL), and the solution was stirred for 1 h, at which point EtOAc (5 mL) and H2O 
(4 mL) were added.  The layers were separated, and the aqueous layer was extracted with 
EtOAc (2 x 5 mL).  The combined organic layers were dried (MgSO4) and concentrated 
under reduced pressure.  The crude residue was purified by flash chromatography, eluting 
with Et2O/hexanes (1:5) to give 80 mg (62%) of naphthalene 3.57:  1H NMR (500 MHz, 
CDCl3) δ 7.88 (comp, 2 H), 7.39–7.16 (comp, 25 H), 7.08–6.99 (comp, 4 H), 6.56 (br s, 2 
H), 5.19 (s, 2 H), 5.03–5.00 (comp, 1 or 2 H), 4.96 (d, J = 10.9 Hz, 1 H), 4.90 (d, J = 10.9 
Hz, 1 H), 4.89 (s, 1 H), 4.65 (d, J = 10.6 Hz, 1 H), 4.62 (d, J = 12.3 Hz, 1 H), 4.54 (d, J = 
12.3 Hz, 1 H), 4.48 (s, 2 H), 4.37 (s, 2 H), 4.25 (d, J = 10.3 Hz, 1 H), 3.87–3.74 (comp, 4 
H), 3.68–3.64 (m, 1 H), 3.54 (3.54, d, J = 10.3 Hz, 1 H) ppm; 13C NMR (125 MHz, 
CDCl3) δ  155.3, 138.7, 138.3, 138.2, 137.4, 137.2, 136.8, 136.5, 134.5, 138.7, 138.3, 
138.2, 137.4, 137.2, 136.8, 136.5, 134.5, 128.5, 128.44, 128.40, 128.37, 128.3, 128.1, 
128.0, 127.9, 127.85, 127.82, 127.77, 127.7, 127.63, 127.56, 127.53, 127.49, 121.8, 
115.3, 108.4, 96.1, 86.9, 79.5, 78.2, 76.1, 75.8, 75.2, 74.8, 73.3, 72.1, 71.9, 71.7, 69.0; IR 
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(neat) 1570, 1453, 1094, 1067; mass spectrum (ESI) m/z 1083.3442 [C66H61O8BrNa+ 
requires 1083.346]. 
NMR Assignments: 1H NMR (500 MHz, CDCl3) δ 7.88 (comp, 2 H), 7.39–7.16 
(comp, 25 H), 7.08–6.99 (comp, 4 H), 6.56 (br s, 2 H), 5.19 (s, 2 H, Bn C-H), 5.03–5.00 
(comp, 2 H, Bn C-H), 4.96 (d, J = 10.9 Hz, 1 H, Bn C-H), 4.90 (d, J = 10.9 Hz, 1 H, Bn 
C-H), 4.89 (s, 1 H), 4.65 (d, J = 10.6 Hz, 1 H, Bn C-H), 4.62 (d, J = 12.3 Hz, 1 H, Bn C-
H), 4.54 (d, J = 12.3 Hz, 1 H, Bn C-H), 4.48 (s, 2 H, Bn C-H), 4.37 (s, 2 H, Bn C-H), 
4.25 (d, J = 10.3 Hz, 1 H), 3.87–3.74 (comp, 4 H), 3.68–3.64 (m, 1 H), 3.54 (3.54, d, J = 
10.3 Hz, 1 H) ppm; 13C NMR (125 MHz, CDCl3) δ  155.3 (C14), 138.7, 138.3, 138.2, 
137.4, 137.2, 136.8, 136.5, 134.5, 138.7, 138.3, 138.2, 137.4, 137.2, 136.8, 136.5, 134.5, 
128.5, 128.44, 128.40, 128.37, 128.3, 128.1, 128.0, 127.9, 127.85, 127.82, 127.77, 127.7, 
127.63, 127.56, 127.53, 127.49, 121.8, 115.3 (C11), 108.4, 96.1, 86.9, 79.5, 78.2, 76.1, 
































pyran (3.60). (KP3-291).  SO2Cl2 was added to a solution of 3.37 (15 mg, 0.017 mmol) 
and benzylmethylamine (0.8 mg, 0.065 mmol, 1 µL) in PhCH3 at 70 °C.  The mixture 
was stirred for 1 h and cooled to rt.  A saturated solution of NaHCO3 (1 mL) and EtOAc 
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(1 mL) were added.  The layers were separated, and the organic layer was washed with 2 
N HCl (1 mL) and brine (1 mL), dried (Na2SO4), and concentrated.  The residue was 
purified by flash chromatography, eluting with Et2O/hexanes (1:4) to give 9 mg (56%) of 
3.59.  
NaH (1 mg, 0.022 mmol, 60% dispersion) was added to a solution of phenol 3.59 
(10 mg, 0.011 mmol) and BnBr (4 mg, 0.022 mmol, 3 µL) in DMF (0.5 mL), and the 
mixture was stirred for 3 h, whereupon H2O (3 mL) and EtOAc (3 mL) were added.  The 
layers were separated, and the organic layer was washed with H2O (2 x 3 mL) and brine 
(2 x 3 mL), dried (Na2SO4), and concentrated.  The residue was purified by flash 
chromatography, eluting with Et2O/hexanes (1:4) to give 7 mg (64%) of 3.60: 1H NMR 
(500 MHz, CDCl3) δ 7.82 (s, 1 H), 7.72 (s, 1 H), 7.42-6.97 (comp, 33 H), 6.55–6.54 
(comp, 3 H), 5.20 (s, 2 H), 5.01 (d, J = 12.3 Hz, 1 H), 5.00 (d, J = 12.3 Hz, 1 H), 4.95 (d, 
J = 10.9 Hz, 1 H), 4.89 (d, J = 10.9 Hz, 1 H), 4.88 (d, J = 10.6 Hz, 1 H), 4.65 (d, J = 10.6 
Hz, 1 H), 4.62 (d, J = 12.3 Hz, 1 H), 4.54 (d, J = 12.3 Hz, 1 H), 4.49 (s, 2 H), 4.38 (s, 2 
H), 4.24 (d, J = 10.3 Hz, 1 H), 3.86–3.74 (comp, 5 H), 3.69–3.64 (m, 1 H), 3.54 (d, J = 
10.3 Hz, 1 H) ppm; 13C NMR (125 MHz, CDCl3) δ 140.1, 138.7, 138.34, 138.26, 137.4, 
137.2, 136.7, 136.6, 128.5, 128.44, 128.43, 128.41, 128.37, 128.21, 128.15, 127.97, 
127.96, 127.86, 127.80, 127.78, 127.7, 127.64, 127.57, 127.54, 108.3, 86.9, 79.6, 78.2, 
77.3, 77.2, 77.0, 76.9, 76.8, 76.2, 75.7, 75.1, 74.8, 73.3, 72.1, 71.9, 71.7, 69.0, 86.9, 79.6, 
78.2, 77.3, 76.2, 75.7, 75.1, 74.8, 73.3, 72.1, 71.9, 71.7, 69.0; mass spectrum (ESI) m/z 
1039.3947 [C66H61ClNaO8+ requires 1039.3947].  
NMR Assignments: 1H NMR (500 MHz, CDCl3) δ 7.82 (s, 1 H), 7.72 (s, 1 H), 
7.42–6.97 (comp, 33 H, Ph C-H), 6.55–6.54 (comp, 3 H, Ph C-H), 5.20 (s, 2 H), 5.01 (d, 
J = 12.3 Hz, 1 H, Bn C-H), 5.00 (d, J = 12.3 Hz, 1 H, Bn C-H), 4.95 (d, J = 10.9 Hz, 1 H, 
Bn C-H), 4.89 (d, J = 10.9 Hz, 1 H, Bn C-H), 4.88 (d, J = 10.6 Hz, 1 H, Bn C-H), 4.65 (d, 
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J = 10.6 Hz, 1 H, Bn C-H), 4.62 (d, J = 12.3 Hz, 1 H, Bn C-H), 4.54 (d, J = 12.3 Hz, 1 H, 
Bn C-H), 4.49 (s, 2 H, Bn C-H), 4.38 (s, 2 H, Bn C-H), 4.24 (d, J = 10.3 Hz, 1 H), 3.86-
3.74 (comp, 5 H), 3.69–3.64 (m, 1 H), 3.54 (d, J = 10.3 Hz, 1 H) ppm; 13C NMR (125 
MHz, CDCl3) δ 140.1, 138.7, 138.34, 138.26, 137.4, 137.2, 136.7, 136.6, 128.5, 128.44, 
128.43, 128.41, 128.37, 128.21, 128.15, 127.97, 127.96, 127.86, 127.80, 127.78, 127.7, 
127.64, 127.57, 127.54, 108.3, 86.9, 79.6, 78.2, 77.3, 77.2, 77.0, 76.9, 76.8, 76.2, 75.7, 
75.1, 74.8, 73.3, 72.1, 71.9, 71.7, 69.0, 86.9, 79.6, 78.2, 77.3, 76.2, 75.7, 75.1, 74.8, 73.3, 
































pyran (3.71).  (KP4-106).  n-BuLi (0.096, 385 µL, 0.25 M) was added dropwise to 
bromide 3.57 (93 mg, 0.088 mmol) in THF (1.5 mL) at –78 ˚C.  The mixture was stirred 
for 0.5 h, whereupon NFS 3.70 in THF (0.5 mL) was added dropwise, and stirring was 
continued at –78 ˚C for 2 h.  The mixture was warmed to rt and H2O (4 mL) and Et2O (2 
mL) were added.  The layers were separated, and the aqueous layer was extracted with 
Et2O (3 x 2 mL), and the combined organic layers were dried (MgSO4) and concentrated 
under reduced pressure.  The residue was purified by flash chromatography, eluting with 
Et2O/hexanes (1:6).  The crude product was recrystallized from EtOH (2 x) to give 
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fluoride 45: 1H NMR (500 MHz, CDCl3) δ 7.79 (br s, 1 H), 7.48–7.46 (comp, 2 H), 7.36-
7.21 (comp, 24 H), 7.05–6.93 (comp, 4 H), 6.52 (br d, J = 5.0 Hz, 1 H), 5.20 (s, 2 H), 
5.04 (d, J = 4.4 Hz, 1 H), 5.00 (d, J = 4.4 Hz, 1 H), 4.96–4.88 (comp, 3 H), 4.68–4.60 
comp, 4 H), 4.56-4.51 (comp, 3 H), 4.40 (d, J = 12.0 Hz, 1 H), 4.38 (d, J = 12.0 Hz, 1 H), 
4.21 (d, J = 10.4 Hz, 1 H), 3.86–5.75 (comp, 6 H), 3.68–3.66 (m, 1 H), 3.51 (d, J = 10.4 
Hz, 1 H); 13C NMR (125 MHz, CDCl3) δ 156.0, 155.9, 152.5, 141.9, 140.9, 138.72, 
138.66, 138.5, 138.42, 138.35, 137.4, 137.3, 137.2, 136.8, 135.4, 134.4, 131.5, 128.6, 
128.5, 128.43, 128.42, 128.41, 128.40, 128.36, 128.3, 128.17, 128.16, 128.14, 127.95, 
127.93, 127.91, 127.89, 127.86, 127.81, 127.76, 127.72, 127.70, 127.62, 127.60, 127.56, 
127.0, 121.9, 107.9, 86.9, 79.5, 78.3, 77.4, 75.7, 75.1, 75.0, 74.8, 73.4, 72.2, 72.1, 71.9, 
71.8, 71.5, 69.1, 65.4; mass spectrum (ESI) m/z 1023.4243 [C66H61O8FNa+ requires 
1023.429]. 
NMR Assignments: 1H NMR (500 MHz, CDCl3) δ 7.79 (br s, 1 H), 7.48–7.46 
(comp, 2 H), 7.36–7.21 (comp, 24 H, Ph C-H), 7.05–6.93 (comp, 4 H, Ph C-H), 6.52 (br 
d, J = 5.0 Hz, 1 H), 5.20 (s, 2 H, Bn C-H), 5.04 (d, J = 4.4 Hz, 1 H), 5.00 (d, J = 4.4 Hz, 1 
H), 4.96–4.88 (comp, 3 H), 4.68–4.60 comp, 4 H), 4.56–4.51 (comp, 3 H), 4.40 (d, J = 
12.0 Hz, 1 H, Bn C-H), 4.38 (d, J = 12.0 Hz, 1 H, Bn C-H), 4.21 (d, J = 10.4 Hz, 1 H), 
3.86–5.75 (comp, 6 H), 3.68–3.66 (m, 1 H), 3.51 (d, J = 10.4 Hz, 1 H); 13C NMR (125 
MHz, CDCl3) δ 156.0, 155.9, 152.5, 141.9, 140.9, 138.72, 138.66, 138.5, 138.42, 138.35, 
137.4, 137.3, 137.2, 136.8, 135.4, 134.4, 131.5, 128.6, 128.5, 128.43, 128.42, 128.41, 
128.40, 128.36, 128.3, 128.17, 128.16, 128.14, 127.95, 127.93, 127.91, 127.89, 127.86, 
127.81, 127.76, 127.72, 127.70, 127.62, 127.60, 127.56, 127.0, 121.9, 107.9, 86.9, 79.5, 






















bromofuran-2-yl)tetrahydro-2H-pyran (3.102).  (KP5-71).  3-Bromofuran (159 mg, 
1.08 mmol, 97 µL) was added dropwise to a solution of LDA (1.18 mmol, 2.7 mL, 0.44 
M) at –78 ºC and the solution was stirred for 2.5 h, whereupon a solution of lactone 3.100 
(530 mg, 0.98 mmol) in THF (2 mL) was added dropwise.  The mixture was stirred for 
10 min at –78 ºC, the cold bath was removed, and stirring was continued for 1 h, at which 
point H2O (5 mL) and Et2O (7 mL) were added and the layers were separated.  The 
aqueous layer was extracted with Et2O (3 x 5 mL).  The combined organics were washed 
with brine (15 mL), dried (MgSO4), and concentrated under reduced pressure.  The 
residue was dried under vacuum and used directly in the next step. 
TMSOTf (239 mg, 1.08 mmol, 195 µL) was added, dropwise over 20 min, to the 
crude product and Et3SiH (375 mg, 3.23 mmol, 520 µL) in CH2Cl2 (20 mL) at –40 ºC and 
the reaction was stirred for 5 min, whereupon NaHCO3 (20 mL) was added and the layers 
were separated.  The aqueous layer was extracted with CH2Cl2 (3 x 20 mL), dried 
(MgSO4), and concentrated under reduced pressure.  Recrystallization from EtOH 
afforded 369 mg (56%) of glycosyl furan 3.102: 1H NMR (500 MHz, CDCl3) δ 7.37 (d, J 
= 1.9 Hz, 1 H), 7.33–7.21 (comp, 16 H), 7.17–7.15 (comp, 2 H), 7.04–7.03 (comp, 2 H), 
6.45 (d, J = 1.9 Hz, 1 H), 4.91 (d, J = 11.0 Hz, 1 H), 4.86 (d, J = 10.9 Hz, 1 H), 4.84 (d, 
J = 10.3 Hz, 1 H), 4.60 (d, J = 12.5 Hz, 1 H), 4.58 (d, J = 11.0 Hz, 1 H), 4.53–4.46 
(comp, 3 H), 4.06 (d, J = 10.6 Hz, 1 H), 3.94 (dd, J = 9.7, 9.0 Hz, 1 H), 3.78–3.70 
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(comp, 4 H), 3.58 (ddd, J = 9.7, 3.8, 2.5 Hz, 1 H); 13C NMR (125 MHz, CDCl3) δ 148.0, 
142.7, 138.6, 138.2, 138.1, 137.7, 128.39, 128.38, 128.1, 128.0, 127.8, 127.74, 127.70,  
127.6, 127.5, 114.3, 100.9, 86.6, 80.4, 79.6, 77.9, 75.7, 75.1, 74.6, 73.5, 72.6; mass 
spectrum (CI) m/z 669.1813 [C38H37BrO6 (M+1) requires 669.1812]; IR (neat) 1143, 
1095, 1058. 
NMR Assignments: 1H NMR (500 MHz, CDCl3) δ 7.37 (d, J = 1.9 Hz, 1 H, C 
10-H), 7.33–7.21 (comp, 16 H, Ph C-H), 7.17–7.15 (comp, 2 H, Ph C-H), 7.04-7.03 
(comp, 2 H, Ph C-H), 6.45 (d, J = 1.9 Hz, 1 H, C9- H), 4.91 (d, J = 11.0 Hz, 1 H, Bn C-
H), 4.86 (d, J = 10.9 Hz, 1 H, Bn C-H), 4.84 (d, J = 10.3 Hz, 1 H, Bn C-H), 4.60 (d, J = 
12.5 Hz, 1 H, Bn C-H), 4.58 (d, J = 11.0 Hz, 1 H, Bn C-H), 4.53–4.46 (comp, 3 H, Bn C-
H), 4.06 (d, J = 10.6 Hz, 1 H), 3.94 (dd, J = 9.7, 9.0 Hz, 1 H), 3.78–3.70 (comp, 4 H), 
3.58 (ddd, J = 9.7, 3.8, 2.5 Hz, 1 H); 13C NMR (125 MHz, CDCl3) δ 148.0, 142.7 (C10), 
138.6, 138.2, 138.1, 137.7, 128.39, 128.38, 128.1, 128.0, 127.8, 127.74, 127.70,  127.6, 





















chlorofuran-2-yl)tetrahydro-2H-pyran (3.103).  (KP5-73).  n-BuLi was added 
dropwise to bromide 3.102 (369 mg, 0.551 mmol) in THF (3 mL) at –78 ºC and the 
mixture was stirred for 20 min, whereupon C2Cl6 (261 mg, 1.10 mmol) in THF (1.5 mL) 
was added and stirring was continued at at –78 ºC for 20 min.  The cold bath was 
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removed, and stirring was continued for 1.5 h, at which time NaHCO3 (5 mL) was added 
and the layers were separated.  The aqueous layer was extracted with Et2O (3 x 3 mL) 
then the combined organic layers were washed with brine (10 mL) dried (MgSO4), and 
concentrated under reduced pressure.  The residue was purified by flash chromatography, 
eluting with 1:5 Et2O/hexanes to give 190 mg (55%) of chloride 3.103.  Spectra were in 





























Cycloadduct (3.104).  (KP5-81).  n-BuLi (130 µL, 0.30 mmol, 2.33 M) was 
added, dropwise over 10 min, to a mixture of furan 3.103 (125 mg, 0.200 mmol) and 
triflate 3.49 (39 mg, 0.067 mmol) in THF (1 mL) at –78 ºC and the mixture was stirred 
for 20 min, whereupon NH4Cl (2 mL) and Et2O (2 mL) were added and the layers were 
separated.  The aqueous layer was extracted with Et2O (3 x 2 mL), and the organic layers 
were combined, washed with brine (10 mL), dried (MgSO4), and concentrated under 
reduced pressure.  Flash chromatography, eluting with Et2O/hexanes (1:10 then 1:5) gave 
13 mg (21%) of 3.104: 1H NMR (500 MHz, CDCl3) δ 7.38–7.16 (comp, 37 H), 7.10 (s, 1 
H), 6.74 (s, 1 H), 6.61 (d, J = 2.0 Hz, 1 H), 6.00 (d, J = 2.0 Hz, 1 H), 5.07 (s, 2 H), 4.93 
(d, J = 11.0 Hz, 1 H), 4.88 (d, J = 11.0 Hz, 1 H), 4.84–4.80 (comp, 2 H), 4.72 (d, J = 10.5 
Hz, 1 H), 4.55 (d, J = 11.0 Hz, 1 H), 4.41–4.38 (comp, 5 H), 4.27 (s, 2 H), 3.90–3.83 
(comp, 2 H), 3.68–3.65 (comp, 2 H), 3.53-3.47 (comp, 2 H); 13C NMR (125 MHz, 
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CDCl3) δ 151.7, 150.1,149.4, 138.6, 138.44, 138.37, 138.3, 138.0, 137.9, 137.0, 135.6, 
135.4, 128.6, 128.4, 128.39, 128.35, 128.27, 128.13, 128.05, 128.01, 127.82, 127.79, 
127.68, 127.62, 127.56, 127.49, 127.44, 127.41, 127.37, 116.7, 111.5, 93.9, 87.6, 79.9, 
79.6, 78.8, 78.5, 75.8, 75.0, 74.6, 73.1, 72.1, 72.0, 70.7, 69.4; IR (neat) 1453, 1148, 1095, 
1028 cm-1; mass spectrum (CI) m/z 926.3584 [C59H55ClO8 (M+) requires 926.3585]. 
NMR Assignments: 1H NMR (500 MHz, CDCl3) δ 7.38–7.16 (comp, 37 H, Ph 
C-H), 7.10 (s, 1 H, C13-H), 6.74 (s, 1 H, C15-H), 6.61 (d, J = 2.0 Hz, 1 H, C9-H), 6.00 
(d, J = 2.0 Hz, 1 H, C10-H), 5.07 (s, 2 H), 4.93 (d, J = 11.0 Hz, 1 H, Bn C-H), 4.88 (d, J 
= 11.0 Hz, 1 H, Bn C-H), 4.84–4.80 (comp, 2 H, Bn C-H), 4.72 (d, J = 10.5 Hz, 1 H, Bn 
C-H), 4.55 (d, J = 11.0 Hz, 1 H, Bn C-H), 4.41–4.38 (comp, 5 H, Bn C-H), 4.27 (s, 2 H, 
Bn C-H), 3.90-3.83 (comp, 2 H), 3.68-3.65 (comp, 2 H), 3.53–3.47 (comp, 2 H); 13C 
NMR (125 MHz, CDCl3) δ 151.7, 150.1,149.4, 138.6, 138.44, 138.37, 138.3, 138.0, 
137.9, 137.0, 135.6, 135.4, 128.6, 128.4, 128.39, 128.35, 128.27, 128.13, 128.05, 128.01, 
127.82, 127.79, 127.68, 127.62, 127.56, 127.49, 127.44, 127.41, 127.37, 116.7 (C13), 
111.5 (C15), 93.9, 87.6, 79.9, 79.6 (C10), 78.8, 78.5, 75.8 (Bn C), 75.0 (Bn C), 74.6, 73.1 






























From the above procedure, 14 mg (23%) of the undesired regioisomer was 
isolated: 1H NMR (500 MHz, CDCl3) δ 7.35-7.22 (comp, 28 H), 7.18-7.15 (comp, 5 H), 
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7.11-7.10 (comp, 2 H), 6.92 (s, 1 H), 6.61 (d, J = 1.9 Hz, 1 H), 6.59 (s, 1 H), 5.79 (d, J = 
1.9 Hz, 1 H), 4.92 (d, J = 11.0 Hz, 1 H), 4.87 (d, J = 9.7 Hz, 1 H), 4.86 (d, J = 9.1 Hz, 1 
H), 4.89 (d, J = 10.3 Hz, 1 H), 4.76-4.73 (comp, 2 H), 4.56–4.54 (comp, 3 H), 4.57-4.47 
(m, 1 H), 4.38 (d, J = 9.6 Hz, 1 H), 4.36 (s, 2 H), 3.85 (t, J = 9.4 Hz, 1 H), 3.78 (t, J = 
11.3 Hz, 1 H), 3.55–3.51 (comp, 2 H), 3.40 (dd, J = 11.3, 5.2 Hz, 1 H), 3.24 (ddd, J = 
10.0, 5.3, 2.1 Hz, 1 H); 13C NMR (125 MHz, CDCl3) δ 153.3, 152.1, 150.6, 138.8, 138.5, 
138.32, 138.31, 138.2, 137.2, 135.6, 133.5, 128.5, 128.4, 128.34, 128.32, 128.12, 128.11, 
127.9, 127.82, 127.81, 127.7, 127.6, 127.5, 127.42, 127.40, 127.22, 127.21, 113.2, 110.9, 
94.3, 87.4, 82.0, 79.8, 79.0, 78.9, 75.6, 75.2, 74.9, 74.7, 72.9, 72.3, 72.1, 69.8, 69.0; IR 
(neat) 1454, 1151, 1094, 1057 cm-1; mass spectrum (CI) m/z 927.3665 [C59H55ClO8 
(M+1) requires 927.3664] (base), 892, 819. 
NMR Assignments: 1H NMR (500 MHz, CDCl3) δ 7.35–7.22 (comp, 28 H, Ph 
C-H), 7.18–7.15 (comp, 5 H, Ph C-H), 7.11-7.10 (comp, 2 H, Ph C-H), 6.92 (s, 1 H, C12-
H), 6.61 (d, J = 1.9 Hz, 1 H, C14-H), 6.59 (s, 1 H, C14-H), 5.79 (d, J = 1.9 Hz, 1 H, C10-
H), 4.92 (d, J = 11.0 Hz, 1 H, Bn C-H), 4.87 (d, J = 9.7 Hz, 1 H, Bn C-H), 4.86 (d, J = 
9.1 Hz, 1 H, Bn C-H), 4.89 (d, J = 10.3 Hz, 1 H, Bn C-H), 4.76–4.73 (comp, 2 H, Bn C-
H), 4.56–4.54 (comp, 3 H, Bn C-H), 4.57–4.47 (m, 1 H), 4.38 (d, J = 9.6 Hz, 1 H), 4.36 
(s, 2 H), 3.85 (t, J = 9.4 Hz, 1 H), 3.78 (t, J = 11.3 Hz, 1 H), 3.55–3.51 (comp, 2 H), 3.40 
(dd, J = 11.3, 5.2 Hz, 1 H), 3.24 (ddd, J = 10.0, 5.3, 2.1 Hz, 1 H); 13C NMR (125 MHz, 
CDCl3) δ 153.3, 152.1, 150.6, 138.8, 138.5, 138.32, 138.31, 138.2, 137.2, 135.6 (C9), 
133.5, 128.5, 128.4, 128.34, 128.32, 128.12, 128.11, 127.9, 127.82, 127.81, 127.7, 127.6, 
127.5, 127.42, 127.40, 127.22, 127.21, 113.2 (C12), 110.9 (C14), 94.3, 87.4, 82.0 (C10), 




















79). ZnCl2 (180 µL, 0.18 mmol, 1 M in Et2O) was added to 1.304 (17 mg, 0.018 mmol) in 
CH2Cl2 (1 mL) and the mixture was heated at 85 ºC for 1 h.  The mixture was cooled to 
rt, whereupon NaHCO3 (2 mL) and Et2O (2 mL) were added and the layers were 
separated.  The aqueous layer was extracted with Et2O (3 x 2 mL), dried (MgSO4) and 
concentrated.  The residue was purified by flash chromatography, eluting with 
Et2O/hexanes (1:7) to afford 3 mg (43%) of 3.106: 1H NMR (500 MHz, CDCl3) δ 7.82 
(dd, J = 9.0, 0.8 Hz, 1 H), 7.73 (s, 1 H), 7.50–7.49 (comp, 2 H), 7.41–7.38 (comp, 2 H), 
7.35–7.34 (comp, 4 H), 7.31 (d, J = 9.0 Hz, 1 H), 7.31–7.27 (comp, 2 H), 6.99 (s, 1 H), 
5.93 (br s, 1 H), 5.22 (s, 2 H), 4.69 (s, 2 H), 4.55 (s, 2 H); 13C NMR (125 MHz, CDCl3) δ 
206.9, 154.8, 146.8, 138.2, 136.8, 128.6, 128.4, 128.0, 127.9, 127.7, 127.5, 125.3, 125.2, 
125.1, 115.5, 115.0, 113.3, 105.8, 72.6, 72.1, 70.3; IR (neat) 3516, 3351, 1594, 1454, 
1410, 1374, 1272, 1052; mass spectrum (CI) m/z 405.1256 [C25H22ClO3 (M+1) requires 
405.1257]. 
NMR Assignments: 1H NMR (500 MHz, CDCl3) δ 7.82 (d, J = 9.0 Hz, 1 H, C3- 
H), 7.73 (s, 1 H, C7-H), 7.50–7.49 (comp, 2 H), 7.41–7.38 (comp, 2 H), 7.35–7.34 
(comp, 4 H), 7.31 (d, J = 9.0 Hz, 1 H, C4-H), 7.31–7.27 (comp, 2 H), 6.99 (s, 1 H, C9-
H), 5.93 (br s, 1 H, OH), 5.22 (s, 2 H, C11-H), 4.69 (s, 2 H, Bn C-H), 4.55 (s, 2 H, Bn C-
H); 13C NMR (125 MHz, CDCl3) δ 154.8, 146.8, 138.2, 136.8, 128.6, 128.4, 128.0, 127.9, 
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127.7, 127.5, 125.3, 125.2, 125.1 (C4), 115.5 (C3), 115.0, 113.3 (C7), 105.8 (C9), 72.6 




















3,4-dihydro-2H-pyran (3.109).  (KP5-114).  3-Bromofuran (2.13 g, 14.5 mmol) was 
added dropwise over 3 min to a solution of LDA (0.66 M, 15.8 mmol, 24 mL) at –78 ºC 
and the mixture was stirred for 2.5 h, whereupon lactone 3.108 (5.70g, 13.2 mmol) in 
THF (15 mL) was added dropwise over 15 min.  Stirring was continued for 2 h at –78 ºC, 
whereupon Et3N (4.00 g, 39.6 mmol, 5.5 mL), a solution of DMAP (1.77 g, 15.8 mmol) 
in THF (12 mL), and TFAA (6.93, 33.0 mmol, 2.4 mL) were added sequentially and 
stirring was continued for 20 min.  The cold bath was removed, and the mixture was 
stirred an additional 40 min.   NaHCO3 (40 mL) was added, the layers were separated, 
and the aqueous layer was extracted with Et2O (3 x 40 mL).  The combined organic 
layers were washed with brine (100 mL), dried (Na2SO4), and concentrated.  The residue 
was purified by flash chromatography, eluting with Et2O/hexanes (1:15), affording 4.87 g 
(66%) of furyl glycal 3.109: 1H NMR (500 MHz, CDCl3) δ 7.41–7.36 (comp, 16 H), 6.44 
(d, J = 1.9 Hz, 1 H), 5.63 (d, J = 3.8 Hz, 1 H), 4.85 (d, J = 11.3 Hz, 1 H), 4.70 (d, J = 
11.3 H, 1 H), 4.68 (d, J = 11.7 Hz, 1 H), 4.65 (d, J = 12.2 Hz, 1 H), 4.61 (d, J = 12.2 Hz, 
1 H), 4.60 (d, J = 11.7 Hz, 1 H), 4.37 (dd, J = 6.2, 3.8 Hz, 1 H), 4.00 (dd, J = 7.4, 6.2 Hz, 
1 H), 3.91 (dd, J = 11.0, 4.3 Hz), 3.87 (dd, J = 11.0, 2.9 Hz, 1 H); 13C NMR (125 MHz, 
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CDCl3) δ 144.8, 144.4, 142.2, 138.33, 138.26, 138.22, 128.41, 128.38, 128.3, 127.9, 
127.8, 127.72, 127.70, 127.6, 127.5, 116.0, 98.8, 98.1, 77.7, 76.2, 74.0, 73.7, 73.6, 70.4, 
68.3; IR (neat) 1496, 1454, 1099, 1027, 697 cm-1; mass spectrum (ESI) m/z 561. 1276 
[C31H29BrO5 (M+1) requires 561.1277], 455, 454, 453 (base). 
NMR Assignments: 1H NMR (500 MHz, CDCl3) δ 7.41–7.36 (comp, 16 H, Ph 
C-H, C10-H), 6.44 (d, J = 1.9 Hz, 1 H, C9-H), 5.63 (d, J = 3.8 Hz, 1 H, C2-H), 4.85 (d, J 
= 11.3 Hz, 1 H, Bn C-H), 4.70 (d, J = 11.3 Hz, 1 H, Bn C-H), 4.68 (d, J = 11.7 Hz, 1 H, 
Bn C-H), 4.65 (d, J = 12.2 Hz, 1 H, Bn C-H), 4.61 (d, J = 12.2 Hz, 1 H, Bn C-H), 4.60 (d, 
J = 11.7 Hz, 1 H, Bn C-H), 4.37 (dd, J = 6.2, 3.8 Hz, 1 H, C3-H), 4.00 (dd, J = 7.4, 6.2 
Hz, 1 H, C4-H), 3.91 (dd, J = 11.0, 4.3 Hz, C6-H), 3.87 (dd, J = 11.0, 2.9 Hz, 1 H, C6-
H); 13C NMR (125 MHz, CDCl3) δ 144.8, 144.4, 142.2, 138.33, 138.26, 138.22, 128.41 
(PhC), 128.38 (Ph C), 128.3 (Ph C), 127.9 (Ph C), 127.8 (Ph C), 127.72 (Ph C), 127.70 
(Ph C), 127.6 (Ph C), 127.5 (Ph C), 116.0 (C9), 98.8 (C2), 98.1, 77.7 (C5), 76.2 (C3), 




















3,4-dihydro-2H-pyran (3.110).  (KP5-85).  n-BuLi (2.37 M, 1.52 mmol, 640 µL) was 
added dropwise to bromide 3.109 (712 mg, 1.27 mmol) in THF (10 mL) at –78 ºC and 
the mixture was stirred for 10 min, at which point the cold bath was removed and stirring 
was continued for 1 h.  A saturated solution of NaHCO3 was added (10 mL) and the 
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layers were separated.  The aqueous layer was extracted with Et2O (3 x 15 mL), and the 
organic layers were combined, dried (Na2SO4), and concentrated under reduced pressure.  
The residue was purified by flash chromatography, eluting with Et2O/hexanes (1:19) to 
provide 598 mg (91%) of chloride 3.110: 1H NMR (500 MHz, CDCl3) δ 7.41–7.34 
(comp, 16 H), 6.39 (d, J = 1.9 Hz, 1 H), 5.58  (d, J = 3.2 Hz, 1 H), 4.84 (d, J = 11.3 Hz, 1 
H), 4.70–5.94 (comp, 5 H), 4.36 (dd, J = 6.2, 3.2 Hz, 1 H), 4.22 (ddd, J = 4.6, 3.2, 2.8 Hz, 
1 H), 3.98 (dd, J = 8.5, 6.0 Hz, 1 H), 3.90 (dd, J = 11.0, 4.6 Hz, 1 H), 3.87 (dd. J = 11.0, 
3.0 Hz, 1 H); 13C NMR (125 MHz, CDCl3) δ 144.5, 142.8, 141.5, 138.33, 138.27, 138.21, 
128.41, 128.38, 128.32, 127.9, 127.8,  127.72,  127.67,  127.65, 127.5, 113.8, 113.7, 98.5, 
77.6, 76.1, 74.0, 73.7, 73.5, 70.4, 68.2; mass spectrum (ESI) m/z 517.1783 [requires 
517.1782], 409 (base); IR (neat) 1453, 1101, 1027 cm-1.   
NMR Assignments: 1H NMR (500 MHz, CDCl3) δ 7.41–7.34 (comp, 16 H, Ph 
C,-H, C10-H), 6.39 (d, J = 1.9 Hz, 1 H, C9- H), 5.58 (d, J = 3.2 Hz, 1 H, C2-H), 4.84 (d, 
J = 11.3 Hz, 1 H, Bn C-H), 4.70-5.94 (comp, 5 H, Bn C-H), 4.36 (dd, J = 6.2, 3.2 Hz, 1 
H, C3-H), 4.22 (ddd, J = 4.6, 3.2, 2.8 Hz, 1 H, C5-H), 3.98 (dd, J = 8.5, 6.0 Hz, 1 H, C4-
H), 3.90 (dd, J = 11.0, 4.6 Hz, 1 H, C6-H), 3.87 (dd. J = 11.0, 3.0 Hz, 1 H, C6-H); 13C 
NMR (125 MHz, CDCl3) δ 144.5, 142.8, 141.5, 138.33, 138.27, 138.21, 128.41 (Ph C), 
128.38 (Ph C), 128.32 (Ph C), 127.9 (Ph C), 127.8 (Ph C),  127.72 (Ph C),  127.67 (Ph 
C),  127.65 (Ph C), 127.5 (Ph C), 113.8 (C9), 113.7 (C2), 98.5 (C5), 77.6 (C3), 76.1 (Bn 




























Cycloadduct (3.112).  (KP5-99).  A solution of n-BuLi in hexanes (2.5 M, 24 
µL, 0.060 mmol, 2.5 M) was added dropwise to a solution of glycal 3.110 (52 mg, 0.10 
mmol) and triflate 3.49 (29 mg, 0.050 mmol) in THF (1.0 mL) at –100 ºC and the 
mixture was transferred to a –78 ºC bath, which was allowed to warm to –55 ºC over a 20 
min period, whereupon a saturated solution of NH4Cl (3 mL) was added and the mixture 
warmed to rt.  Et2O (3 mL) was added and the layers were separated.  The aqueous layer 
was extracted with Et2O (3 x 2 mL), and the combined organic layers were dried 
(Na2SO4) and concentrated under reduced pressure.  The residue was purified by flash 
chromatography eluting with Et2O/hexanes (gradient column 1:20 / 1:15 / 1:10 / 1:3) to 
provide 11 mg (27%) of 3.112: (major diastereomer) 1H NMR (500 MHz, CDCl3) δ 7.37-
7.36 (comp, 4 H), 7.33-7.21 (comp, 21 H), 6.76 (s, 1 H), 6.71 (d, J = 2.1 Hz, 1 H), 5.91 
(d, J = 2.1 Hz, 1 H), 5.41 (d, J = 2.9 Hz, 1 H), 5.06 (s, 2 H), 4.83 (d, J = 11.4 Hz, 1 H), 
4.69 (d, J = 11.4 Hz, 1 H), 4.66 (d, J = 11.7 Hz, 1 H), 4.60 (d, J = 12.0 Hz, 1 H), 4.57-
5.52 (comp, 3 H), 4.34 (ddd, J = 8.2, 5.0, 3.5 Hz, 1 H), 4.28 (dd, J = 6.0, 2.9 Hz, 1 H), 
4.00 (dd, J = 8.5, 7.0 Hz, 1 H), 4.93-3.88 (comp, 3 H); (minor diastereomer) 1H NMR 
(500 MHz, CDCl3) δ 7.37-7.36 (comp, 4 H), 7.33-7.23 (comp, 17 H), 6.77 (s, 1 H), 6.70 
(d, J = 2.0 Hz, 1 H), 5.92 (d, J = 1.8 Hz, 1 H), 5.38 (d, J = 2.6 Hz, 1 H), 5.05 (s, 2 H), 
4.86 (d, J = 11.2 Hz, 1 H), 4.71, (d, J = 11.5 Hz, 1 H), 4.66 (d, J = 11.5 Hz, 1 H), 4.61 (d, 
J = 12.3 Hz, 1 H), 4.57 (d, J = 12.3 Hz, 1 H), 4.53 (d, J = 11.7 Hz, 1 H), 4.39 (s, 1 H), 
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4.35 (dd, J = 6.5, 2.6 Hz, 1 H), 4.32 (comp, 2 H), 4.27 (ddd, J = 8.8, , 4.1, 2.3 Hz, 4.05 
(d, J = 9.1, 6.5 Hz, 1 H), 3.97 (d, J = 10.9, 4.1 Hz, 1 H), 3.88 (d, J = 10.9, 2.3 Hz, 1 H); 


















279). A solution of n-BuLi in hexanes (2.5 M, 38 mL, 94 mmol) was added to 3-
furanmethanol (4.5 g, 46 mmol, 4.2 µL) in THF (250 mL) at –78 ºC, and the mixture was 
stirred for 1 h, whereupon the mixture was placed in a 0 ºC bath and stirring was 
continued for 1 h.  Dimethyl disulfide (923 µL, 10.2 mmol) was added and the mixture 
was stirred at 0 ºC for 4 h.  The ice bath was removed, and the mixture was stirred for 16 
h, at which point H2O (800 mL) and Et2O (800 mL) were added.  The layers were 
separated, and organic layer was washed with brine (800 mL), dried (MgSO4), and 
concentrated under reduced pressure.   
TBSCl (7.6 g, 51 mmol) was added to a solution of the residue from the previous 
reaction and imidazole (7.8 g, 115 mmol) in DMF (250 mL) and the mixture was stirred 
for 16 h, whereupon H2O (1 L) and Et2O (1 L mL) were added.  The layers were mixed 
well, separated, and the organic layer was washed with brine (700 mL), dried (MgSO4), 
and concentrated.  The residue was purified by flash chromatography, eluting with 
PhCH2/hexanes (1:5) to afford 9.70 g (82%) of silane 3.121: 1H NMR (400 MHz, CDCl3) 
δ 7.41 (d, J = 2.1 Hz, 1 H), 6.45 (d, J = 2.1 Hz, 1 H), 4.59 (s, 2 H), 2.32 (s, 3 H), 0.90 (s, 
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9 H), 0.069 (s, 6 H); 13C NMR (100 MHz, CDCl3) δ 144.5, 142.8, 129.3, 111.8, 57.4, 
25.9, 23.9, 18.8, 18.3, -5.15. IR (neat) 1256, 1090, 1058, 837, 776 cm-1; mass spectrum 
(ESI) m/z 258.1180 [C12H22O2SSi (M+) requires 258.1110]. 
NMR Assignments: 1H NMR (400 MHz, CDCl3) δ 7.41 (d, J = 2.1 Hz, 1 H), 
6.45 (d, J = 2.1 Hz, 1 H), 4.59 (s, 2 H), 2.32 (s, 3 H), 0.90 (s, 9 H), 0.069 (s, 6 H); 13C 





















yl)dimethylsilane (3.118).  (KP5-186).  A solution of n-BuLi in hexanes (2.23 M, 150 
µL, 0.34 mmol) was added to furan 3.121 (80 mg, 0.31 mmol) in Et2O (3 mL) at rt and 
the mixture was stirred for 2 h.  Bromomethylchlorodimethylsilane (51 µL, 0.37 mmol) 
was added dropwise, and the mixture was stirred for 12 h, whereupon a saturated solution 
of NH4Cl (3 mL) was added.  The layers were separated, and the aqueous layer was 
extracted with Et2O (3 x 2 mL), dried (MgSO4), and concentrated under reduced pressure.  
The residue was purified by flash chromatography eluting with PhCH3/hexanes (1:5) to 
afford 101 mg (79%) of bromide 3.118 as a light oil: 1H NMR (600 MHz, CDCl3) δ 6.76 
(s, 1 H), 4.56 (s, 2 H), 2.60 (s, 2 H), 2.35 (s, 3 H), 0.90 (s, 9 H), 0.39 (s, 6 H), 0.075 (s, 6 
H); 13C NMR (125 MHz, CDCl3) δ 159.3, 147.8, 128.4, 123.3, 57.4, 26.0, 18.4, 18.3, 
15.6, –4.4, –5.2; IR (neat) 1253, 1082, 1054 cm-1; mass spectrum (CI) m/z 409.0686 
[C15H29BrO2SSi2 (M+1) requires 409.0688], 395, 329 (base). 
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NMR Assignments: 1H NMR (600 MHz, CDCl3) δ 6.76 (s, 1 H, C3-H), 4.56 (s, 2 
H, C5-H), 2.60 (s, 2 H, C11-H), 2.35 (s, 3 H, C6-H), 0.90 (s, 9 H, C9-H), 0.39 (s, 6 H, 
C10-H), 0.075 (s, 6 H, C7-H); 13C NMR (150 MHz, CDCl3) δ 159.3 (C1), 147.8 (C2), 
128.4 (C4), 123.3 (C3), 57.4 (C5), 26.0 (C9), 18.4 (C8 or C6), 18.3 (C8 or C6), 15.6 
























yl)dimethylsilyl)methyl acetate (3.127).  (KP5-190).  A mixture of TBAI (227 mg, 
0.615 mmol), NaOAc (126 mg, 1.54 mmol), and bromide 3.118 (126 mg, 0.307 mmol) in 
DMF (3 mL) was stirred at rt for 18 h, at whereupon the mixture was heated at 80 ºC for 
6 h.  The mixture was cooled to rt, H2O (6 mL) and Et2O (6 mL) were added, and the 
layers were separated. The aqueous layer was extracted with Et2O (3 x 4 mL), and then 
the combined Et2O layers were washed with H2O (10 mL) and brine (10 mL), dried 
(MgSO4), and concentrated under reduced pressure.  The residue was purified by flash 
chromatography, eluting with Et2O/hexanes (1:15) to yield 94 mg (79%) of acetate 3.127 
as a light oil: 1H NMR (600 MHz, CDCl3) δ 6.73 (s, 1 H), 4.56 (s, 2 H), 3.92 (s, 2 H), 
2.35 (s, 3 H), 2.02 (s, 3 H), 0.90 (s, 9 H), 0.32 (s, 6 H), 0.073 (s, 6 H); 13C NMR (150 
MHz, CDCl3) δ 171.7, 159.3, 147.7, 128.3, 123.2, 57.5, 56.0, 20.7, 18.4, 18.3, –4.8, –5.2; 
IR (neat) 1744, 1253, 1222, 1082, 1053 cm-1; mass spectrum (CI) m/z 388.1562 
[C17H32O4SSi2 (M+) requires 388.1560]. 
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 NMR Assignments: 1H NMR (600 MHz, CDCl3) δ 6.73 (s, 1 H, C3-H), 4.56 (s, 2 
H, C5-H), 3.92 (s, 2 H, C11-H), 2.35 (s, 3 H, C6-H), 2.02 (s, 3 H, C13-H), 0.90 (s, 9 H, 
C9-H), 0.32 (s, 6 H, C10-H), 0.073 (s, 6 H, C7-H); 13C NMR (150 MHz, CDCl3) δ 171.7 
(C12), 159.3 (C1), 147.7 (C2), 128.3 (C4), 123.2 (C3), 57.5 (C5), 56.0 (C5), 20.7 (C13), 





















yl)dimethylsilyl)methanol (3.128). (KP5-235). A solution of acetate 3.127 (59 mg, 
0.152 mmol) in Et2O (1 mL) was added dropwise to mixture of LAH (14 mg, 0.379 
mmol) in Et2O (0.5 mL) at 0 ºC and the mixture was stirred for 15 min, whereupon 
EtOAc (1 mL) was added dropwise.  The mixture was stirred an additional 10 min at 0 
ºC, and then NH4Cl was added (2 mL) and stirring was continued at 0 ºC for 10 min.  The 
mixture was warmed to rt, and extracted with Et2O (3 x 3 mL).  The combined organic 
layers were washed with H2O (2 mL) and brine (2 mL), dried (MgSO4), and concentrated 
under reduced pressure.  The residue was purified by flash chromatography, eluting with 
Et2O/hexanes (1:7), affording 49 mg (93%) of alcohol 3.128: 1H NMR (400 MHz, 
CDCl3) δ 6.76 (s, 1 H), 4.56 (s, 2 H), 3.55 (s, 2 H), 2.34 (s, 3 H), 0.90 (s, 9 H), 0.31 (s, 6 
H), 0.076 (s, 6 H); 13C NMR (150 MHz, CDCl3) δ 160.1, 147.7, 128.4, 123.2, 57.4, 54.6, 
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26.0, 18.4, -5.2, -5.3; mass spectrum (CI) m/z 347.1531 [C15H30O3SSi2 (M+1) requires 
347.1532]; IR (neat) 3374, 1251, 1081, 1053 cm-1.   
NMR Assignments: 1H NMR (400 MHz, CDCl3) δ 6.76 (s, 1 H, C3-H), 4.56 (s, 2 
H, C5-H), 3.55 (s, 2 H, C11-H), 2.34 (s, 3 H, C6-H), 0.90 (s, 9 H, C9-H), 0.31 (s, 6 H, 
C10-H), 0.076 (s, 6 H, C7-H); 13C NMR (150 MHz, CDCl3) δ 160.1 (C1), 147.7 (C2), 











































(3.126).  (KP5-247).  DIAD (28 mg, 0.14 mmol, 28 µL) was added to PPh3 (37 mg, 0.14 
mmol) in THF (0.50 mL) at 0 ºC, and stirring was continued at 0 ºC for 5 min.  This 
mixture was added, dropwise via syringe, to a mixture of alcohol 3.128 (38 mg, 0.11 
mmol) and phenol 3.125 (83 mg, 0.11 mmol) in THF (1 mL) at 0 ºC.  After 5 min, the ice 
bath was removed, and stirring was continued at rt for 24 h, at which point the mixture 
was concentrated.  Purification of the residue by flash chromatography eluting with 
EtOAc/PhCH3 (1:100) gave 78 mg (65%) of ether 3.126: 1H NMR (600 MHz, CDCl3) δ 
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7.86 (s, 1 H), 7.37–7.24 (comp, 13 H), 7.20-7.19 (comp, 2 H), 7.06–7.04 (m, 1 H), 7.98–
6.95 (comp, 2 H), 6.83 (s, 1 H), 6.78 (d, J = 8.7 Hz, 1 H), 6.70 (d, J = 8.7 Hz, 1 H), 6.46-
6.45 (comp, 2 H), 6.15 (d, J = 9.2 Hz, 1 H), 4.94 (d, J = 11.2 Hz, 1 H), 4.87 (dd, J = 10.6, 
2.8 Hz, 1 H), 4.67–4.56 (comp, 4 H), 4.57 (s, 2 H), 4.24 (d, J = 10.2 Hz, 1 H), 3.91 (d, J 
= 12.3 Hz, 1 H), 3.84–3.76 (comp, 9 H), 3.72-3.69 (comp, 4 H), 3.53 (d, J = 10.2 Hz, 1 
H), 3.44 (app t, J = 9.2 Hz, 1 H), 2.34 (s, 3 H), 0.89 (s, 9 H), 0.531 (s, 3 H), 0.526 (s, 3 
H), 0.075 (s, 6 H); 13C NMR (150 MHz, CDCl3) δ 160.3, 153.8, 152.2, 150.3, 147.5, 
138.9, 138.4, 138.3, 137.8, 133.5, 128.5, 128.41, 128.36, 128.35, 128.1, 128.0, 127.8, 
127.75, 127.73, 127.70, 127.6, 127.50, 127.45, 127.2, 126.4, 125.5, 123.2, 122.8, 107.8, 
107.5, 87.1, 86.3, 79.5, 78.8, 75.4, 75.1, 74.8, 73.3, 69.3, 67.3, 57.49, 57.46, 56.3, 26.0, 
18.4, –4.6, –5.2; IR (neat) 1357, 1258, 1102, 1079, 1053. 
NMR Assignments: 1H NMR (600 MHz, CDCl3) δ 7.86 (s, 1 H, C14-H), 7.37–
7.24 (comp, 13 H, Ph C-H), 7.20–7.19 (comp, 2 H, Ph C-H), 7.06-7.04 (m, 1 H, Ph C-H), 
7.98-6.95 (comp, 2 H, Ph C-H), 6.83 (s, 1 H, C3-H), 6.78 (d, J = 8.7 Hz, 1 H, C18-H or 
C19-H), 6.70 (d, J = 8.7 Hz, 1 H, C18-H or C19-H), 6.46–6.45 (comp, 2 H, Ph C-H), 
6.15 (d, J = 9.2 Hz, 1 H, C23-H), 4.94 (d, J = 11.2 Hz, 1 H, Bn C-H), 4.87 (dd, J = 10.6, 
2.8 Hz, 1 H), 4.67–4.56 (comp, 4 H, Bn C-H), 4.57 (s, 2 H, C5-H), 4.24 (d, J = 10.2 Hz, 1 
H), 3.91 (d, J = 12.3 Hz, 1 H, Bn C-H), 3.84–3.76 (comp, 9 H), 3.72–3.69 (comp, 4 H), 
3.53 (d, J = 10.2 Hz, 1 H), 3.44 (app t, J = 9.2 Hz, 1 H, C24-H), 2.34 (s, 3 H, C6-H), 0.89 
(s, 9 H, C9-H), 0.531 (s, 3 H, C10-H), 0.526 (s, 3 H, C10-H), 0.075 (s, 6 H, C7-H); 13C 
NMR (150 MHz, CDCl3) δ 160.3, 153.8, 152.2, 150.3, 147.5, 138.9, 138.4, 138.3, 137.8, 
133.5, 128.5, 128.41, 128.36, 128.35, 128.1, 128.0, 127.8, 127.75, 127.73, 127.70, 127.6, 
127.50, 127.45, 127.2, 126.4, 125.5, 123.2, 122.8, 107.8 (C18 or C19), 107.5 (C18 or 
C19), 87.1, 86.3, 79.5, 78.8, 75.4, 75.1, 74.8, 73.3, 69.3, 67.3, 57.49, 57.46, 56.3, 26.0 



















Cycloadduct (3.115).  (KP5-252).  s-BuLi (1.3 M, 83 µL, 0.107 mmol) was 
added dropwise to ether 3.126 in THF (1 mL) at –78 ºC and stirring was continued for 
1.5 h.  The dry ice was removed from the cold bath, and the bath was allowed to warm to 
–10 ºC over a 40 min period, whereupon a saturated solution of NH4Cl (3 mL) and Et2O 
(2 mL) were added and the layers separated.  The aqueous layer was extracted with Et2O 
(3 x 2 mL), and the combined organics were dried (MgSO4) and concentrated.  The 
residue was purified by flash chromatography, eluting with Et2O/hexanes (1:3), providing 


















yl)anthracen-9(10H)-one (3.114).  (KP5-268).  TBAF (22 mg, 0.084 mmol) in DMF 
(200 µL) was added to 3.129 in DMF (500 µL) and the mixture was stirred for 30 min, 
whereupon H2O (2 mL) and Et2O (2 mL) were added.  The layers were separated and the 
aqueous layer was extracted with Et2O (4 x 1 mL).  The combined organic layers were 
washed with H2O (5 mL) and brine (5 mL), dried (MgSO4), and concentrated.  The 
residue was dried under vacuum, and used crude in the next step. 
Camphorsulfonic acid (CSA) (2 mg, 8 µmol) was added to the residue in CH2Cl2 
(500 µL) and the mixture was stirred at ambient temperature for 24 h, whereupon 
NaHCO3 (1.5 mL) and Et2O (1 mL) were added and the layers were separated.  The 
aqueous layer was extracted with Et2O (4 x 1 mL), and the organic layers were combined, 
dried (MgSO4) and concentrated under reduced pressure.  The residue was purified by 
flash chromatography, eluting with Et2O/hexanes (1:5 then 1:4) to provide 7 mg (39%) of 
anthrone 3.114: 1H NMR (400 MHz, CDCl3) δ 12.23 (s, 1 H), 7.58 (d, J = 7.4 Hz, 1 H), 
7.41–7.10 (comp, 18 H), 6.95–6.92 (comp, 2 H), 6.13 (s, 1 H), 5.19 (d, J = 12.2 Hz, 1 H), 
5.15 (d, J = 12.2 Hz, 1 H), 4.98 (d, J = 11.0, 1 H), 4.91 (d, J = 14.3 Hz, 1 H), 4.78–4.75 
(comp, 2 H), 4.61 (s, 2 H), 4.41 (d, J = 11.3 Hz, 1 H), 4.37 (d, J = 11.3 Hz, 1 H) 3.93 (s, 3 
H), 3.91 (s, 3 H), 3.80–3.75 (comp, 2 H), 3.67–3.62 (comp, 2 H), 3.53–3.31 (comp, 4 H), 
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55). Camphorsulfonic acid (2 mg, 0.01 mmol) was added to 3.115 (9 mg, 0.009 mmol) in 
CH2Cl2 (2 mL) and the mixture was stirred for 16 h, whereupon NaHCO3 (2 mL) and 
Et2O (2 mL) were added. The layers were separated, and the aqueous layer was extracted 
with Et2O (3 x 2 mL). The combined organic layers were dried (MgSO4) and 
concentrated.  The residue was purified by flash chromatography, eluting with 
EtOAc/hexanes (1:5) to afford 6 mg (75%) of 3.141: 1H NMR (500 MHz, CDCl3) δ 12.22 
(s, 1 H), 7.57–7.56 (d, J = 7.3 Hz, 1 H), 7.38–7.18 (comp, 18 H), 7.13–7.10 (comp, 4 H), 
6.91 (d, J = 9.2 Hz, 1 H), 6.12 (d, J = 0.9 Hz, 1 H), 5.16 (s, 2 H), 5.05–4.96 (comp, 2 H), 
4.81–4.74 (comp, 2 H), 4.61–4.58 (comp, 2 H), 4.37 (s, 2 H), 3.91 (s, 3 H), 3.89 (s, 3 H), 
3.78 (dd, J = 11.5, 2.9 Hz, 1 H), 3.63 (app t, J = 9.3 Hz, 1 H), 3.52 (d, J = 11.5 Hz, 2.9 
Hz, 1 H), 3.45–3.36 (comp, 3 H), 3.09–3.06 (m, 1 H), 1.92 (s, 3 H), 0.95 (s, 9 H), 0.12 (s, 
3 H), 0.10 (s, 3 H); 13C NMR (150 MHz, CDCl3) δ 190.7, 160.9, 159.8, 157.4, 153.8, 
 278 
151.9, 149.0, 144.1, 140.6, 138.9, 138.5, 138.2, 135.1, 128.5, 128.4, 128.1, 128.0, 127.97, 
127.95, 127.7, 127.6, 127.5, 127.4, 127.3, 127.0, 126.9, 126.5, 123.1, 121.9, 121.3, 116.2, 
114.7, 111.1, 88.2, 82.1, 79.1, 78.4, 78.1, 74.9, 74.7, 73.5, 73.4, 69.2, 63.9, 56.6, 56.3, 
35.6, 30.3, 26.0, 25.6, 20.6, 18.4, -5.2, -5.3; mass spectrum (ESI) m/z 1005.4031 
[C64H61O9S (M+1) requires 982.4146]. 
NMR Assignments: 1H NMR (500 MHz, CDCl3) δ 12.22 (s, 1 H, OH), 7.57–7.56 
(d, J = 7.3 Hz, 1 H, Ph C-H), 7.38–7.18 (comp, 18 H, Ph C-H and C17-H), 7.13–7.10 
(comp, 4 H, Ph C-H and C10-H or C11-H), 6.91 (d, J = 9.2 Hz, 1 H C10-H or C11-H), 
6.12 (d, J = 0.9 Hz, 1 H, C7-H), 5.16 (s, 2 H, Bn C-H), 5.05–4.96 (comp, 2 H, Bn C-H), 
4.81–4.74 (comp, 2 H, Bn C-H), 4.61–4.58 (comp, 2 H, Bn C-H), 4.37 (s, 2 H, Bn C-H), 
3.91 (s, 3 H, C25-H or C26-H), 3.89 (s, 3 H, C25-H or C26-H), 3.78 (dd, J = 11.5, 2.9 
Hz, 1 H, C6-H), 3.63 (app t, J = 9.3 Hz, 1 H, C3-H), 3.52 (d, J = 11.5 Hz, 2.9 Hz, 1 H, 
C6-H), 3.45–3.36 (comp, 3 H, C4-H and C2-H and C1-H), 3.09–3.06 (m, 1 H, C5-H), 
1.92 (s, 3 H, C21-H), 0.95 (s, 9 H, C23-H), 0.12 (s, 3 H, C22-H), 0.10 (s, 3 H, C22-H); 
13C NMR (150 MHz, CDCl3) δ 190.7 (C14), 160.9, 159.8, 157.4, 153.8, 151.9, 149.0, 
144.1, 140.6, 138.9, 138.5, 138.2, 135.1, 128.5 (Ph C), 128.4 (Ph C), 128.1 (Ph C), 128.0 
(Ph C), 127.97 (Ph C), 127.95 (Ph C), 127.7 (Ph C), 127.6 (Ph C), 127.5 (Ph C), 127.4 
(Ph C), 127.3 (Ph C), 127.0 (Ph C), 126.9 (Ph C), 126.5 (Ph C), 123.1, 121.9, 121.3, 
116.2, 114.7 (C10 or C11), 111.1, 88.2 (C3), 82.1 (C1), 79.1 (C5), 78.4 (C2), 78.1 (C4), 
74.9 (Bn C), 74.7 (Bn C), 73.5 (Bn C), 73.4 (Bn C), 69.2 (C6), 63.9 (C24), 56.6 (C25 or 



















(2-Chloro-1,4-phenylene)bis(oxy)bis(methylene)dibenzene (3.143). (KP6-65). 
NaH (1.23 g, 31.5 mmol, 60 % dispersion) was added in two portions to a solution of 
chlorohydroquinone (3.142) (2.08 g, 12.9 mmol, 90%) and BnBr (3.7 mL, 30.1 mmol) in 
DMF (100 mL).  The mixture was stirred for 24 h, whereupon H2O (100 mL) and Et2O 
(300 mL) were added.  The layers were separated, and the organic layer was washed with 
H2O (3 x 100 mL) and brine (2 x 100 mL), dried (MgSO4), and concentrated.  The 
residue was recrystallized from EtOH to provide 3.37 g (81%) of 3.143: 1H NMR (500 
MHz, CDCl3) δ 7.45–7.29 (comp, 10 H), 7.04 (d, J = 2.9 Hz, 1 H), 6.87 (d, J = 9.0 Hz, 1 
H), 6.77 (dd, J = 9.0, 2.9 Hz, 1 H), 5.07 (s, 2 H), 4.98 (s, 2 H); 13C NMR (150 MHz, 
CDCl3) δ 153.4, 148.7, 136.8, 136.7, 128.6, 128.5, 128.1, 127.9, 124.2, 117.2, 115.9, 
113.9, 71.9, 70.8; IR (neat) 1454, 1225, 1052, 1018, 736 cm-1; mass spectrum (CI) m/z 
324.0917 [C20H17O2 (M+1) requires 324.0917] (base), 289, 181. 
NMR Assignments: 1H NMR (500 MHz, CDCl3) δ 7.45–7.29 (comp, 10 H, PhC-
H), 7.04 (d, J = 2.9 Hz, 1 H, C6-H), 6.87 (d, J = 9.0 Hz, 1 H, C3-H), 6.77 (dd, J = 9.0, 2.9 
Hz, 1 H, C5-H), 5.07 (s, 2 H, C7-H), 4.98 (s, 2 H, C8-H); 13C NMR (150 MHz, CDCl3) δ 
153.4 (Ph C), 148.7 (Ph C), 136.8 (Ph C), 136.7 (Ph C), 128.6 (Ph C), 128.5 (Ph C), 
128.1 (Ph C), 127.9 (Ph C), 124.2 (Ph C), 117.2 (C5) 115.9 (C3), 113.9 (C6), 71.9 (C7), 



























(benzyloxymethyl)tetrahydro-2H-pyran-2-yl)naphthalen-1-ol. (KP6-104). s-BuLi (1.3 
M, 1.7 mL, 2.2 mmol) was added dropwise to a solution of chloride 3.143 (722 mg, 2.22 
mmol) in THF (20 mL) at –100 ºC.  The solution was stirred for 15 min, whereupon a 
solution of furan 3.18 (524 mg, 0.89 mmol) in THF (5 mL) was added.  The solution was 
allowed to warm to –20 ºC over a 45 min period, whereupon NH4Cl (25 mL) and Et2O 
(25 mL) were added.  The layers were separated and the aqueous layer was extracted with 
Et2O (3 x 25 mL).  The combined organic layers were washed with brine (50 mL), dried 
(MgSO4), and concentrated.  The residue was purified by flash chromatography, eluting 
with Et2O/hexanes (1:7 then 1:5) to provide 414 mg (53%) of a mixture of cycloadducts 
3.144 as a viscous oil. 
Solid ZnCl2† (128 mg, 0.942 mmol) was added to a solution of 3.144 (414 mg, 
1.98 mmol) in CH2Cl2 (7 mL), and the mixture was stirred for 14 h, whereupon NaHCO3 
(10 mL) and Et2O (15 mL) were added and the layers were separated. The organic layer 
was washed with NaHCO3 (3 x 10 mL) and brine (10 mL), dried (MgSO4), and 
concentrated to provide 411 mg (99%) of phenol 3.144a: 1H NMR (500 MHz, CDCl3) δ 
10.02 (s, 1 H), 7.77 (d, J = 8.4 Hz, 1 H), 7.50–7.20 (comp, 25 H), 7.11–7.08 (m, 1 H), 
                                                
† ZnCl2 was used without any pretreatment. 
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7.03–7.00 (comp, 2 H), 6.94 (d, J = 8.4 Hz, 1 H), 6.77 (d, J = 8.4 Hz, 1 H), 6.71 (d, J = 
8.7 Hz, 1 H), 6.57–6.55 (comp, 2 H), 6.19 (d, J = 9.1 Hz, 1 H), 5.25 (s, 2 H), 5.07 (d, J = 
11.0 Hz, 1 H), 4.87 (d, J = 11.2 Hz, 1 H), 4.82 (d, J = 11.2 Hz, 1 H), 4.79 (d, J = 10.8 Hz, 
1 H), 4.66 (d, J = 11.0 Hz, 1 H), 4.65 (d, J = 12.3 Hz, 1 H), 4.58 (d, J = 11.2 Hz, 1 H), 
4.53 (d, J = 12.3 Hz, 1 H), 4.23 (d, J = 10.3 Hz, 1 H), 4.70–3.69 (comp, 3 H), 3.52 (d, J = 
10.3 Hz, 1 H), 3.38 (app t, J = 9.1 Hz, 1 H), 3.31 (comp, 2 H); 13C NMR (125 MHz, 
CDCl3) δ 154.5, 152.0, 149.7, 139.0, 138.3, 137.0, 135.4, 129.0, 128.8, 128.6, 128.32, 
128.29, 128.26, 128.22, 128.1, 128.0, 127.74, 127.66, 127.57, 127.53, 127.44, 127.41, 
127.08, 127.05, 116.6, 111.8, 107.0, 105.2, 86.7, 86.5, 79.0, 78.6, 76.7, 75.4, 74.6, 74.4, 
73.4, 72.4, 71.5, 69.4; IR (neat) 3360, 1453, 1259, 1141, 1099, 1060, 1026, 736, 697; 
mass spectrum (ESI) m/z 901.3711 [C58H54O8Na (M+) requires 901.3711] 879, 771, 679 
(base).  
NMR Assignments: 1H NMR (500 MHz, CDCl3) δ 10.02 (s, 1 H, OH), 7.77 (d, J 
= 8.4 Hz, 1 H, C8-H), 7.50–7.20 (comp, 25 H, Ph C-H), 7.11–7.08 (m, 1 H, Ph C-H), 
7.03–7.00 (comp, 2 H, Ph C-H), 6.94 (d, J = 8.4 Hz, 1 H, C9-H), 6.77 (d, J = 8.7 Hz, 1 H, 
C13-H or C14-H), 6.71 (d, J = 8.7 Hz, 1 H, C13-H or C14-H), 6.57–6.55 (comp, 2 H, Ph 
C-H), 6.19 (d, J = 9.1 Hz, 1 H, C1-H), 5.25 (s, 2 H, Bn C-H), 5.07 (d, J = 11.0 Hz, 1 H, 
Bn C-H), 4.87 (d, J = 11.2 Hz, 1 H, Bn C-H), 4.82 (d, J = 11.2 Hz, 1 H, Bn C-H), 4.79 (d, 
J = 10.8 Hz, 1 H, Bn C-H), 4.66 (d, J = 11.0 Hz, 1 H, Bn C-H), 4.65 (d, J = 12.3 Hz, 1 H, 
Bn C-H), 4.58 (d, J = 11.2 Hz, 1 H, Bn C-H), 4.53 (d, J = 12.3 Hz, 1 H, Bn C-H), 4.23 (d, 
J = 10.3 Hz, 1 H, C6-H), 4.70–3.69 (comp, 3 H), 3.52 (d, J = 10.3 Hz, 1 H, C6-H), 3.38 
(app t, J = 9.1 Hz, 1 H, C2-H), 3.31 (comp, 2 H); 13C NMR (125 MHz, CDCl3) δ 154.5, 
152.0, 149.7, 139.0, 138.3, 137.0, 135.4, 129.0, 128.8, 128.6, 128.32, 128.29, 128.26, 
128.22, 128.1, 128.0, 127.74, 127.66, 127.57, 127.53, 127.44, 127.41, 127.08, 127.05, 
116.6, 111.8 (C9), 107.0 (C14 or C15), 105.2 (C14 or C15), 86.7, 86.5, 79.0, 78.6, 76.7 
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(benzyloxymethyl)tetrahydro-2H-pyran-2-yl)naphthalen-1-ol (3.145). (KP6-70).  
Solid NCS (21 mg, 0.16 mmol) was added to a solution of phenol 3.144a (131 mg, 0.15 
mmol) in DMF (1.5 mL).  The mixture was stirred for 16 h, whereupon H2O (3 mL) and 
Et2O (3 mL) were added.  The layers were separated, and the aqueous layer was extracted 
with Et2O (3 x 3 mL).  The combined Et2O layers were washed with H2O (2 x 3 mL) and 
brine (3 mL), dried (MgSO4), and concentrated.  The residue was purified by flash 
chromatography, eluting with Et2O/hexanes (1:7 then 1:5) to provide 88 mg (65%) of 
3.145 as an oil: 1H NMR (500 MHz, CDCl3) δ 10.60 (s, 1 H), 7.82 (s, 1 H), 7.51–7.26 
(comp, 25 H), 7.21–7.09 (comp, 3 H), 7.12–7.09 (m, 1 H), 7.02–6.99 (comp, 2 H), 6.83 
(d, J = 8.4 Hz, 1 H), 6.71 (d, J = 8.4 Hz, 1 H), 6.55 (d, J = 7.5 Hz, 2 H), 6.13 (d, J = 9.1 
Hz, 1 H), 5.24 (s, 2 H), 5.07 (d, J = 11.2 Hz, 1 H), 4.84 (d, J = 10.8 Hz, 1 H), 4.80 (d, J = 
11.3 Hz, 1 H), 4.78 (d, J = 12.7 Hz, 1 H), 4.66 (d, J = 11.0 Hz, 1 H), 4.64 (d, J = 12.7 Hz, 
1 H), 4.54 (d, J = 12.4 Hz, 1 H), 4.29 (d, J = 10.3 Hz, 1 H), 3.67–3.58 (comp, 4 H), 3.33–
3.29 (comp, 2 H), 3.24 (app t, J = 8.9 Hz, 1 H); 13C NMR (125 MHz, CDCl3) δ 152.0, 
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149.5, 149.0, 138.8, 138.7, 138.4, 138.1, 136.7, 134.9, 129.1, 129.0, 128.8, 128.7, 128.6, 
128.35, 128.33, 128.27, 128.26, 128.2, 128.0, 127.7, 127.64, 127.60, 127.59, 127.5, 
127.4, 127.1, 125.6, 117.1, 116.5, 107.2, 106.2, 86.6, 86.5, 79.0, 78.6, 76.3, 75.3, 74.8, 
74.4, 73.2, 72.6, 71.6, 69.3; IR (neat) 3306, 1453, 1042, 1255, 1105, 1098, 1060, 1026; 
mass spectrum (ESI) m/z 935.3321 [C58H54O8ClNa (M+) requires 935.3321] 914 (base), 
913 (base), 901. 
NMR Assignments: 1H NMR (500 MHz, CDCl3) δ 10.60 (s, 1 H, OH), 7.82 (s, 1 
H, C8-H), 7.51–7.26 (comp, 25 H, Ph C-H), 7.21–7.09 (comp, 3 H), 7.12–7.09 (m, 1 H), 
7.02–6.99 (comp, 2 H), 6.83 (d, J = 8.4 Hz, 1 H, C13-H or C14-H), 6.71 (d, J = 8.4 Hz, 1 
H C13-H or C14-H), 6.55 (d, J = 7.5 Hz, 2 H), 6.13 (d, J = 9.1 Hz, 1 H), 5.24 (s, 2 H, Bn 
C-H), 5.07 (d, J = 11.2 Hz, 1 H, Bn C-H), 4.84 (d, J = 10.8 Hz, 1 H, Bn C-H), 4.80 (d, J 
= 11.3 Hz, 1 H, Bn C-H), 4.78 (d, J = 12.7 Hz, 1 H, Bn C-H), 4.66 (d, J = 11.0 Hz, 1 H, 
Bn C-H), 4.64 (d, J = 12.7 Hz, 1 H, Bn C-H), 4.54 (d, J = 12.4 Hz, 1 H, Bn C-H), 4.29 (d, 
J = 10.3 Hz, 1 H, C6-H), 3.67–3.58 (comp, 4 H), 3.33–3.29 (comp, 2 H), 3.24 (app t, J = 
8.9 Hz, 1 H); 13C NMR (125 MHz, CDCl3) δ 152.0, 149.5, 149.0, 138.8, 138.7, 138.4, 
138.1, 136.7, 134.9, 129.1, 129.0, 128.8, 128.7, 128.6, 128.35, 128.33, 128.27, 128.26, 
128.2, 128.0, 127.7, 127.64, 127.60, 127.59, 127.5, 127.4, 127.1, 125.6, 117.1, 116.5, 
107.2 (C13 or C14), 106.2 (C13 or C14), 86.6, 86.5, 79.0, 78.6, 76.3 (C1), 75.3, 74.8 














































(KP6-79). DIAD (31 µL, 0.157 mmol) was added to a solution of phenol 3.145 (69 mg, 
0.078 mmol), alcohol 3.128 (54 mg, 0.157 mmol), and PPh3 (41 mg, 0.157 mmol) in THF 
(2 mL) and the mixture was stirred for 20 h, at which point it was concentrated.  The 
residue was purified by flash chromatography, eluting with Et2O/hexanes to give 70 mg 
(72%) of ether 3.146 as a light oil: 1H NMR (500 MHz, CDCl3) δ 7.87 (s, 1 H), 7.39–7.18 
(comp, 25 H), 7.06–7.04 (m, 1 H), 6.93–6.90 (comp, 2 H), 6.77 (s, 1 H), 6.69 (d, J = 8.7 
Hz, 1 H), 6.62 (d, J = 8.7 Hz, 1 H), 6.42–6.41 (comp, 2 H), 6.19 (d, J = 9.1 Hz, 1 H), 5.16 
(d, J = 13.2 Hz, 1 H), 5.11 (d, J = 13.2 Hz, 1 H), 4.99 (d, J = 11.2 Hz, 1 H), 4.78 (d, J = 
11.2 Hz, 1 H), 4.75 (d, J = 11.2 Hz, 1 H), 4.71 (d, J = 11.2 Hz, 1 H), 4.65–4.61 (comp, 2 
H), 4.55–4.52 (comp, 4 H), 4.23 (d, J = 10.3 Hz, 1 H), 4.05 (d, J = 12.4 Hz, 1 H), 3.91 (d, 
J = 12.4 Hz, 1 H), 3.663 (s, 1 H), 3.657 (s, 1 H), 3.61 (app t, J = 9.6 Hz, 1 H), 3.42 (d, J = 
10.1 Hz, 1 H), 3.31–3.27 (comp, 2 H), 3.20 (app t, J = 8.9 Hz, 1 H), 2.30 (s, 3 H), 0.89 (s, 
9 H), 0.42 (s, 3 H), 0.39 (s, 3 H), 0.066 (s, 6 H); 13C NMR (125 MHz, CDCl3) δ 160.3, 
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153.7, 151.6, 148.8, 147.4, 138.9, 138.7, 138.4, 137.9, 137.8, 136.9, 134.2, 128.6, 128.4, 
128.34, 128.31, 128.2, 128.1, 128.0, 127.9, 127.7, 127.63, 127.59, 127.56, 127.55, 
127.45, 127.44, 127.41, 127.3, 127.2, 126.3, 125.7, 123.3, 123.1, 110.9, 108.1, 86.7, 86.3, 
79.0, 78.5, 76.4, 75.3, 74.9, 74.4, 73.2, 72.5, 71.6, 69.3, 67.5, 57.4, 30.0, 18.5, 18.4, –
4.62, –4.27, –5.2; mass spectrum (ESI) m/z 1263.4670 [C73H81O10SSi2ClNa (M+) requires 
1263.4670] 1241 (base), 1226; IR (neat) 1355, 1142, 1099, 1058, 1028 cm–1.   
NMR Assignments: 1H NMR (500 MHz, CDCl3) δ 7.87 (s, 1 H, C8-H), 7.39–
7.18 (comp, 25 H, Ph C-H), 7.06–7.04 (m, 1 H, Ph C-H), 6.93–6.90 (comp, 2 H, Ph C-H), 
6.77 (s, 1 H, C20-H), 6.69 (d, J = 8.7 Hz, 1 H, C13-H or C14-H), 6.62 (d, J = 8.7 Hz, 1 
H, C13-H or C14-H), 6.42–6.41 (comp, 2 H, C24-H), 6.19 (d, J = 9.1 Hz, 1 H, C1-H), 
5.16 (d, J = 13.2 Hz, 1 H, Bn C-H), 5.11 (d, J = 13.2 Hz, 1 H, Bn C-H), 4.99 (d, J = 11.2 
Hz, 1 H, Bn C-H), 4.78 (d, J = 11.2 Hz, 1 H, Bn C-H), 4.75 (d, J = 11.2 Hz, 1 H, Bn C-
H), 4.71 (d, J = 11.2 Hz, 1 H, Bn C-H), 4.65–4.61 (comp, 2 H), 4.55–4.52 (comp, 4 H), 
4.23 (d, J = 10.3 Hz, 1 H), 4.05 (d, J = 12.4 Hz, 1 H), 3.91 (d, J = 12.4 Hz, 1 H), 3.663 (s, 
1 H, C17-H), 3.657 (s, 1 H, C17-H), 3.61 (app t, J = 9.6 Hz, 1 H), 3.42 (d, J = 10.1 Hz, 1 
H, C6-H), 3.31–3.27 (comp, 2 H), 3.20 (app t, J = 8.9 Hz, 1 H), 2.30 (s, 3 H, C23-H), 
0.89 (s, 9 H, C27-H), 0.42 (s, 3 H, C18-H), 0.39 (s, 3 H, C18-H), 0.066 (s, 6 H, C25-H); 
13C NMR (125 MHz, CDCl3) δ 160.3, 153.7, 151.6, 148.8, 147.4, 138.9, 138.7, 138.4, 
137.9, 137.8, 136.9, 134.2, 128.6, 128.4, 128.34, 128.31, 128.2, 128.1, 128.0, 127.9, 
127.7, 127.63, 127.59, 127.56, 127.55, 127.45, 127.44, 127.41, 127.3, 127.2, 126.3, 
125.7, 123.3, 123.1, 110.9 (C13 or C14), 108.1 (C13 or C14), 86.7, 86.3, 79.0, 78.5, 76.4 
(C1), 75.3, 74.9, 74.4, 73.2, 72.5, 71.6, 69.3, 67.5, 57.4, 30.0, 18.5, 18.4, -4.67 (C18), -













































199). s-BuLi (205 µL, 0.266 mmol, 1.3 M) was added dropwise to ether 3.146 (254 mg, 
0.204 mmol) in THF (4 mL) at –50 ºC and stirring was continued for 1.5 h.  The dry ice 
was removed from the cold bath, and the bath was allowed to warm to –10 ºC over a 25 
min period, whereupon a saturated solution of NH4Cl (4 mL) was added and the layers 
separated.  The aqueous layer was extracted with Et2O (3 x 4 mL), and the combined 
organics were dried (MgSO4) and concentrated.  The residue was purified by flash 
chromatography, eluting with Et2O/hexanes (1:3), providing 83 mg (34%) of a 
cycloadduct and 106 mg (42%) of starting ether 3.146. 
CSA (6 mg, 0.02 mmol) was added to the cycloadduct (83 mg, 0.069 mmol) in 
CH2Cl2 (5 mL) and the mixture was stirred for 16 h, whereupon NaHCO3 (5 mL) and 
Et2O (7 mL) were added and the layers were separated. The aqueous layer was extracted 
with Et2O (3 x 5 mL), dried (MgSO4), and concentrated.  The residue was purified by 
flash chromatography, eluting with EtOAc/hexanes (1:8) to provide 65 mg (83%) of 
anthrone 3.148 as an oil: 1H NMR (600 MHz, CDCl3) δ 12.37 (s, 1 H), 7.52–7.47 (comp, 
4 H), 7.40–7.18 (comp, 27 H), 7.15–7.12 (comp, 4 H), 6.93 (d, J = 9.1 Hz, 1 H), 6.78 (d, 
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J = 9.1 Hz, 1 H), 6.26 (s, 1 H), 5.26 (d, J = 13.8 Hz, 1 H), 5.20 (d, J = 12.5 Hz, 1 H), 5.19 
(d, J = 13.6 Hz, 1 H), 5.15 (d, J = 10.6 Hz, 1 H), 5.08–5.05 (comp, 2 H), 4.96 (d, J = 11.0 
Hz, 1 H), 4.83 (dd, J = 15.5, 1.0 Hz, 1 H), 4.72 (d, J = 11.0 Hz, 1 H), 4.61 (s, 2 H), 4.39 
(s, 2 H), 3.75 (dd, J = 11.7, 3.3 Hz, 1 H), 3.65 (ddd, J = 10.7, 6.8, 1.4 Hz, 1 H), 3.52 (dd, 
J = 11.6, 1.2 Hz, 1 H), 3.43 (app t, J = 9.5 Hz, 1 H), 3.41–3.37 (comp, 3 H), 3.08 (ddd, J 
= 9.7, 3.2, 1.3 Hz, 1 H), 1.98 (s, 3 H), 0.97 (s, 9 H), 0.14 (s, 3 H), 0.13 (s, 3 H); 13C NMR 
(150 MHz, CDCl3) δ 190.4, 152.7, 151.9, 147.8, 144.2, 140.5, 138.9, 138.5, 138.2, 
137.21, 137.18, 135.2, 128.6, 128.48, 128.46, 128.38, 128.1, 128.0, 127.86, 127.85, 
127.67, 127.62, 127.61, 127.5, 127.3, 127.0, 126.9, 126.7, 126.4, 124.3, 121.8, 121.4, 
117.7, 114.8, 114.0, 88.3, 82.1, 79.2, 78.4, 78.2, 74.9, 74.7, 73.41, 73.38, 71.8, 70.1, 69.2, 
63.9, 35.9, 29.7, 26.0, 20.7, 18.4, -5.2, -5.3; IR (neat) 1452, 1259, 1106, 1088 cm–1; mass 
spectrum (ESI) m/z 1157.4664 [C70H74NaO10SSi+ (M+) requires 1157.4664], 703. 
NMR Assignments: 1H NMR (600 MHz, CDCl3) δ 12.37 (s, 1 H, OH), 7.52–7.47 
(comp, 4 H, Ph C-H), 7.40–7.18 (comp, 27 H, Ph C-H), 7.15–7.12 (comp, 4 H, Ph C-H), 
6.93 (d, J = 9.1 Hz, 1 H, C10-H or C11-H), 6.78 (d, J = 9.1 Hz, 1 H, C10-H or C11-H), 
6.26 (s, 1 H, C7-H), 5.26 (d, J = 13.8 Hz, 1 H, Bn C-H), 5.20 (d, J = 12.5 Hz, 1 H, Bn C-
H), 5.19 (d, J = 13.6 Hz, 1 H, Bn C-H), 5.15 (d, J = 10.6 Hz, 1 H, Bn C-H), 5.08–5.05 
(comp, 2 H, Bn C-H), 4.96 (d, J = 11.0 Hz, 1 H, Bn C-H), 4.83 (dd, J = 15.5, 1.0 Hz, 1 H, 
Bn C-H), 4.72 (d, J = 11.0 Hz, 1 H, Bn C-H), 4.61 (s, 2 H, Bn C-H), 4.39 (s, 2 H, Bn C-
H), 3.75 (dd, J = 11.7, 3.3 Hz, 1 H, C6-H), 3.65 (ddd, J = 10.7, 6.8, 1.4 Hz, 1 H, C3-H), 
3.52 (dd, J = 11.6, 1.2 Hz, 1 H, C6-H), 3.43 (app t, J = 9.5 Hz, 1 H, C4-H), 3.41–3.37 
(comp, 3 H, C2-H and C1-H), 3.08 (ddd, J = 9.7, 3.2, 1.3 Hz, 1 H, C5-H), 1.98 (s, 3 H, 
C21-H), 0.97 (s, 9 H, C23-H), 0.14 (s, 3 H, C22-H), 0.13 (s, 3 H, C22-H); 13C NMR (150 
MHz, CDCl3) δ 190.4 (C14), 152.7 (C16), 151.9, 147.8, 144.2, 140.5, 138.9, 138.5, 
138.2, 137.21, 137.18, 135.2, 128.6 (Ph C), 128.48 (Ph C), 128.46 (Ph C), 128.38 (Ph C), 
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128.1 (Ph C), 128.0 (Ph C), 127.86 (Ph C), 127.85 (Ph C), 127.67 (Ph C), 127.62 (Ph C), 
127.61 (Ph C), 127.5 (Ph C), 127.3 (Ph C), 127.0 (Ph C), 126.9 (Ph C), 126.7 (Ph C), 
126.4 (Ph C), 124.3, 121.8, 121.4, 117.7, 114.8 (C10 or C11), 114.0 (C10 or C11), 88.3 
(C3), 82.1 (C1), 79.2 (C5), 78.4 (C2), 78.2 (C4), 74.9 (Bn C), 74.7 (Bn C), 73.41 (Bn C), 
73.38 (Bn C), 71.8 (Bn C), 70.1 (Bn C), 69.2 (C6), 63.9 (C25), 35.9 (C7), 26.0 (C23), 


































(3.149).  (KP6-117). BBr3 (870 µL, 0.87 mmol, 1 M in CH2Cl2) was added dropwise to a 
solution of 3.148 (23 mg, 0.029 mmol) in CH2Cl2 at –78 ºC.  After 30 min, a solution of 
HCl in MeOH (0.28 M, 2 mL, 0.56 mmol) was added and stirring was continued for 1 h, 
whereupon the cold bath was removed and the mixture was stirred at room temperature 
for 16 h. The mixture was concentrated and the residue was purified twice by flash 
chromatography, eluting with EtOAc/MeOH (99:1) to furnish 7 mg (50%) of 3.149: 1H 
NMR (600 MHz, acetone D6) δ 12.29 (s, 1 H), 11.49 (s, 1 H), 8.15 (s, 1 H), 7.22 (s, 1 H), 
7.21 (d, J = 8.9 Hz, 1 H), 6.83 (d, J = 8.9 Hz, 1 H), 5.59 (s, 1 H), 5.06 (d, J = 15.6, 1 H), 
4.54 (br s, 1 H), 4.22 (br s, 1 H), 4.15 (br s, 1 H) 3.84–3.82 (comp, 2 H), 3.73–3.69 
(comp, 3 H), 3.30–3.15 (comp, 4 H), 2.33 (s, 3 H); 13C NMR (150 MHz, CDCl3) δ 126.1, 
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110.4, 80.5, 81.0, 78.9, 70.2, 69.0, 62.3, 61.2 40.5, 20.5; IR (neat) 3386 (br), 1458, 1419, 
1196, 1078; mass spectrum (ESI) m/z 481.1164 [C22H24O10S+ (M+) requires 481.1090]. 
NMR Assignments: 1H NMR (600 MHz, C6D6) δ 12.29 (s, 1 H, OH), 11.49 (s, 1 
H, OH), 8.15 (s, 1 H, OH), 7.22 (s, 1 H, C17-H), 7.21 (d, J = 8.9 Hz, 1 H, C10-H or C11-
H), 6.83 (d, J = 8.9 Hz, 1 H, C10-H or C11-H), 5.59 (s, 1 H, C1-H), 5.06 (d, J = 15.6, 1 
H), 4.54 (br s, 1 H), 4.22 (br s, 1 H), 4.15 (br s, 1 H) 3.84–3.82 (comp, 2 H), 3.73–3.69 
(comp, 3 H), 3.30–3.15 (comp, 4 H), 2.33 (s, 3 H, C22-H); 13C NMR (150 MHz, CDCl3) 
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